Natura &Co Holding (NTCOY) 20-F 8 Apr 22 2021 FY Annual report (foreign) Financial data

Cover page

Cover page	12 Months Ended
	Dec. 31, 2021shares
Document Information [Line Items]
Document Type	20-F
Amendment Flag	false
Entity Registrant Name	Natura &Co Holding S.A.
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	FY
Entity Central Index Key	0001776967
Current Fiscal Year End Date	--12-31
Document Period End Date	Dec. 31, 2021
Document Registration Statement	false
Document Annual Report	true
Document Transition Report	false
Document Shell Company Report	false
Entity File Number	001-39169
Entity Incorporation, State or Country Code	D5
Entity Address, Address Line One	Avenida Alexandre Colares
Entity Address, Address Line Two	No. 1188, Sala A17-Bloco A
Entity Address, Address Line Three	Parque Anhanguera
Entity Address, City or Town	São Pau1o
Entity Address, Postal Zip Code	05106-000
Entity Address, Country	BR
Entity Common Stock, Shares Outstanding	1,379,584,737
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Document Accounting Standard	International Financial Reporting Standards
Entity Shell Company	false
Auditor Name	PricewaterhouseCoopers
Auditor Firm ID	1351
Auditor Location	São Paulo, Brazil
Business Contact [Member]
Document Information [Line Items]
Contact Personnel Name	Guilherme Strano Castellan
Entity Address, Address Line One	Avenida Alexandre Colares
Entity Address, Address Line Two	No. 1188, Sala A17-Bloco A
Entity Address, Address Line Three	Parque Anhanguera
Entity Address, City or Town	São Paulo
Entity Address, Postal Zip Code	05106-000
Entity Address, Country	BR
City Area Code	+55 (11)
Local Phone Number	4389-7881
Common Shares [Member]
Document Information [Line Items]
Security Exchange Name	NYSE
No Trading Symbol Flag	true
Title of 12(b) Security	Common shares, no par value (the “Natura &Co Holding Shares”)
American Depositary Shares [Member]
Document Information [Line Items]
Security Exchange Name	NYSE
Trading Symbol	NTCO
Title of 12(b) Security	American Depositary Shares (the “ADSs”) (as evidenced by American Depositary Receipts), each representing two Natura &Co Holding Shares

STATEMENT OF FINANCIAL POSITION

STATEMENT OF FINANCIAL POSITION - BRL (R$) R$ in Thousands		Dec. 31, 2021	Dec. 31, 2020
CURRENT
Cash and cash equivalents		R$ 4007257	R$ 5821672
Short-term investments		1,978,740	2,520,648
Trade receivables		3,476,359	3,597,535
Inventories		5,403,526	4,544,270
Recoverable taxes		1,029,625	1,071,349
Income tax and social contribution		508,130	242,091
Derivative financial instruments		81,159	139,856
Other current assets		912,160	616,120	[1]
Current assets other than assets held for sale		17,396,956	18,553,541
Assets held for sale		52,921	181,279
Total current assets		17,449,877	18,734,820
NON-CURRENT
Recoverable taxes		1,349,624	932,212
Income tax and social contribution		84,729	478,524
Deferred income tax and social contribution	[2]	2,954,074	1,339,725
Judicial deposits		585,284	566,190
Derivative financial instruments		893,970	1,768,122
Short-term investments		36,921	16,104
Other noncurrent assets		1,763,051	1,527,668	[1]
Total noncurrent assets		7,667,653	6,628,545
Property, plant and equipment		5,377,408	5,235,057
Intangible assets		26,857,583	26,917,128
Right-of-use		3,095,969	3,402,047
Total noncurrent assets		42,998,613	42,182,777
TOTAL ASSETS		60,448,490	60,917,597
CURRENT
Borrowings, financing and debentures		945,069	3,805,649
Leases		1,005,523	1,059,661
Trade payable and reverse factoring operations		6,770,579	6,774,205
Dividends and interest on shareholders' equity payable		180,772	0
Payroll, profit sharing and social charges		1,255,348	1,340,683
Tax liabilities		766,430	785,367
Income tax and social contribution		365,457	441,253
Derivative financial instruments		458,492	61,201
Provision for tax, civil and labor risks		230,097	199,733
Other current liabilities		1,716,110	1,691,834
Total current liabilities		13,693,877	16,159,586
NON-CURRENT
Borrowings, financing and debentures		11,771,763	10,017,264
Lease		2,542,339	2,798,794
Payroll, profit sharing and social charges		53,748	43,763
Tax liabilities		114,797	109,454
Deferred income tax and social contribution	[2]	994,041	1,288,045
Provision for tax, civil and labor risks		1,768,744	2,000,444
Other noncurrent liabilities		942,456	1,113,139
Total noncurrent liabilities		18,187,888	17,370,903
TOTAL LIABILITIES		31,881,765	33,530,489
SHAREHOLDERS' EQUITY
Capital stock		12,481,683	12,377,999
Treasury shares		(151,342)	(11,667)
Capital reserve		10,478,804	11,052,135
Legal profit reserve		871,223	120,166
Retained (losses) income		0	(759,937)
Other comprehensive income		4,865,202	4,585,631
Equity attributable to owners of parent excluding transaction with shareholders		28,545,570	27,364,327
Non-controlling interest in shareholders' equity of subsidiaries		21,155	22,781
Total shareholders' equity		28,566,725	27,387,108
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY		R$ 60448490	R$ 60917597
[1]	some amounts originally presented as of December 31, 2020 were reclassified for a better disclosure. Note that this reclassification does not impact the total amount originally presented as current and non-current assets.
[2]	Balance already includes any offsetting of deferred tax assets and liabilities of the same nature and originating from the same jurisdiction.

STATEMENT OF PROFIT OR LOSS

STATEMENT OF PROFIT OR LOSS - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
STATEMENT OF PROFIT OR LOSS
NET REVENUE	R$ 40164687	R$ 36921980	R$ 14444690
Cost of Sales	(14,011,525)	(13,229,715)	(4,033,454)
GROSS PROFIT	26,153,162	23,692,265	10,411,236
OPERATING INCOME (EXPENSES)
Selling, marketing and logistics expenses	(16,999,225)	(15,702,787)	(6,395,586)
Administrative, R&D, IT and project expenses	(6,958,866)	(5,955,996)	(2,405,576)
Impairment losses on trade receivables	(837,822)	(727,695)	(209,515)
Other operating income (expenses), net	(239,019)	(516,190)	(49,311)
OPERATING INCOME BEFORE FINANCIAL RESULT	1,118,230	789,597	1,351,248
Financial income	4,006,563	4,738,391	1,955,784
Financial expenses	(5,033,540)	(5,773,810)	(2,795,874)
Taxes on formation of the Company			(206,592)
NET INCOME (LOSS) BEFORE INCOME TAX AND SOCIAL CONTRIBUTION	91,253	(245,822)	304,566
Income tax and social contribution	1,047,986	(274,744)	(149,099)
NET INCOME (LOSS) FROM CONTINUING OPERATIONS	1,139,239	(520,566)	155,467
DISCONTINUED OPERATIONS
NET LOSS FROM DISCONTINUED OPERATIONS	(98,550)	(143,112)
NET INCOME (LOSS) FOR THE YEAR	1,040,689	(663,678)	155,467
ATTRIBUTABLE TO
Controlling shareholders of the Company	1,047,960	(650,196)	155,467
Non-controlling shareholders	(7,271)	(13,482)
NET INCOME (LOSS) FOR THE YEAR	R$ 1040689	R$ 663678	R$ 155467
EARNINGS (LOSS) PER SHARE IN THE YEAR -R$
Basic	R$ 0.761	R$ 0.522	R$ 0.1796
Diluted	R$ 0.7503	R$ 0.522	R$ 0.1779

STATEMENT OF CHANGES IN SHAREHO

STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY - BRL (R$) R$ in Thousands	Total	Sharesholders' equity attributed to controlling shareholders [member]	Capital stock [member]	Treasury shares [member]	Surplus on issue/sale of shares [member]	Special reserve [member]	Additional paid-in capital [member]	Income from transactions with non-controlling shareholders [member]	Legal [member]	Tax Incentive [Member]	Retained earnings [member]	Retained (losses) earnings [member]	Other comprehensive income [member]	Non-Controlling Shareholders [member]	Transaction with shareholders [member]
Beginning balance at Dec. 31, 2018	R$ 2574102	R$ 2666168	R$ 427073	R$ 19408	R$ 72216		R$ 257114		R$ 18650	R$ 82072	R$ 1336293		R$ 492158		R$ 92066
Net income for the year	392,391	392,391										R$ 392391
Exchange rate effect on the conversion from hyperinflationary economy.	17,666	17,666											17,666
Other comprehensive income	305,182	305,182											305,182
Total comprehensive income for the year	715,239	715,239										392,391	322,848
Capital increase	52,673	52,673	52,673
Transactions in stock and restricted shares option plans:
Provision for stock and restricted shares option plans		104,078					104,078
Exercise of stock and restricted shares option plans		(2,562)		15,615	16,156		(34,333)
Cancellation of shares - RCA 16.12.19 - Protocol and convention of incorporation				3,793	(3,793)
Interest on equity declared and not yet distributed (mandatory minimum)	(110,671)	(110,671)										(110,671)
Constitution of profit retention reserve											206,268	(206,268)
Constitution of tax incentive reserve										75,452		(75,452)
Hyperinflationary economy adjustment effect	59,818	59,818					61,870				(2,052)
AGE 09.17.2019 - Capitalization of part of the balance of the Profit Reserve account			1,242,165								(1,242,165)
Ending balance (Previously stated [member]) at Dec. 31, 2019	3,392,677	3,484,743	1,721,911		84,579		388,729		18,650	157,524	298,344		815,006		(92,066)
Ending balance (Predecessor adjustments [member]) at Dec. 31, 2019	(30,331)	(30,331)	(236,475)		708,760	R$ 206592	(388,729)		R$ 18650	(157,524)	(299,772)	155,467
Ending balance at Dec. 31, 2019	3,362,346	3,454,412	1,485,436		793,339	206,592					(1,428)	155,467	815,006		(92,066)
Net income for the year	(663,678)	(650,196)										(650,196)		R$ 13482
Exchange rate effect on the conversion from hyperinflationary economy.	32,160	32,160											32,160
Other comprehensive income	3,747,173	3,738,465											3,738,465	8,708
Total comprehensive income for the year	3,115,655	3,120,429										(650,196)	3,770,625	(4,774)
Subscription of shares through the Board of Directors' Meeting held on January 3, 2020	13,302,449	13,274,894	3,397,746		9,877,148									27,555
Subscription of shares through the Board of Directors' Meeting held on June 30, 2020	2,001,118	2,001,118	2,000,000		1,118
Subscription of shares through the Board of Directors' Meeting held on July 27, 2020	14,723	14,723	14,723
Subscription of shares through the Board of Directors' Meeting held on September 30, 2020	18,863	18,863	18,863
Subscription of shares through the Board of Directors' Meeting held on October 8, 2020	5,614,750	5,614,750	5,614,750
Share repurchase	(54,936)	(54,936)		(54,936)
Losses absorbed						155,467						(155,467)
Expenses on the issue of equity values	(212,770)	(212,770)	(212,770)
Transactions in stock and restricted shares option plans:
Provision for stock and restricted shares option plans	163,322	163,322					163,322
Exercise of stock and restricted shares option plans	(5,200)	(5,200)	59,251	43,269			(111,281)					3,561
Constitution of tax incentive reserve										113,302		(113,302)
Hyperinflationary economy adjustment effect	66,788	66,788					58,496				8,292
Ending balance at Dec. 31, 2020	27,387,108	27,456,393	12,377,999	(11,667)	10,671,605	362,059	110,537			113,302	6,864	(759,937)	4,585,631	22,781	(92,066)
Net income for the year	1,040,689	1,047,960										1,047,960		(7,271)
Exchange rate effect on the conversion from hyperinflationary economy.	187,941	187,941											187,941
Other comprehensive income	97,275	91,630											91,630	5,645
Total comprehensive income for the year	1,325,905	1,327,531										1,047,960	279,571	(1,626)
Share repurchase	(174,113)	(174,113)		(174,113)
Losses absorbed					(650,196)							650,196
Transactions in stock and restricted shares option plans:
Provision for stock and restricted shares option plans	237,655	237,655					275,632				(37,977)
Exercise of stock and restricted shares option plans	(29,058)	(29,058)	103,684	34,438			(198,767)				31,587
Reclassification of subvention reserve										R$ 113302		113,302
Dividends declared and not yet distributed	(180,772)	(180,772)										(180,772)
Constitution of profit retention reserve											870,749	R$ 870749
Ending balance at Dec. 31, 2021	R$ 28566725	R$ 28637636	R$ 12481683	R$ 151342	R$ 10021409	R$ 362059	R$ 187402				R$ 871223		R$ 4865202	R$ 21155	R$ 92066

STATEMENT OF COMPREHENSIVE INCO

STATEMENT OF COMPREHENSIVE INCOME - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
STATEMENT OF COMPREHENSIVE INCOME
NET (LOSS) INCOME FOR THE YEAR	R$ 1040689	R$ 663678	R$ 155467
Other comprehensive income to be reclassified to income statement in subsequent periods:
Conversion of financial statements of controlled companies abroad	(118,410)	3,711,781	244,100
Exchange rate effect on the conversion from hyperinflationary economy	187,941	32,160	17,666
Earnings (losses) from cash flow hedge operations	(210,150)	178,006	107,337
Tax effects on (losses) earnings from cash flow hedge operations	72,939	(61,658)	(36,768)
Other comprehensive income not reclassified for the income of the year in subsequent years:
Actuarial gain (loss)	459,875	(104,650)	(14,374)
Tax effects on (losses) earnings from actuarial	(106,979)	23,694	4,887
Comprehensive income for the year, net of tax effects	1,325,905	3,115,655	478,315
ATTRIBUTABLE TO
The Company's shareholders	1,327,531	3,120,429	478,315
Noncontrolling shareholders	(1,626)	(4,774)	0
Comprehensive income for the year, net of tax effects	R$ 1325905	R$ 3115655	R$ 478315

STATEMENT OF CASH FLOWS

STATEMENT OF CASH FLOWS - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2021		Dec. 31, 2020	Dec. 31, 2019
CASH FLOW FROM OPERATING ACTIVITIES
Net (loss) income for the year	R$ 1040689		R$ 663678	R$ 155467
Adjustments to reconciliate net income (loss) for the period with net cash generated by (used in) operating activities:
Depreciation and amortization	2,791,523		2,718,856	1,117,416
Interest and exchange variation on short-term investments	(264,764)		(103,310)	(78,414)
Earnings from swap and forward derivative contracts	(441,554)		(1,090,299)	(38,703)
Provision (reversal) for tax, civil and labor risks	(66,913)		347,563	(24,509)
Inflation adjustment of judicial deposits	(15,246)		(11,242)	(13,352)
Inflation adjustment of provision for tax, civil and labor risks	25,731		37,966	9,758
Differed income tax and social contribution	(1,971,461)		274,744	149,099
Company formation tax				206,592
Income from sale and write-off of property, plant and equipment, lease and non-current assets held for sale	231,965		35,555	34,518
Interest and exchange rate variation on leases	210,669		62,250	127,398
Interest and exchange rate variation on borrowings, financing and debentures, net of acquisition costs	913,619		2,003,147	582,519
Inflation adjustment and exchange rate variation on other assets and liabilities	2,198		(71,974)	5,764
Provision for losses from property, plant and equipment, intangible and leases	3,017		155,463	3,541
Provision (reversal of provision) for stock option plans	275,632		(44,142)	59,232
Provision for losses with trade accounts receivables, net of reversals	837,822		640,676	209,505
Provision for inventory losses, net of reversals	407,207		341,799	147,140
Reversal for the provision for carbon credits	(13,618)		46,583	19,969
Effect from hyperinflationary economy	165,826		55,277	51,659
Other adjustments to reconcile net (loss) profit	(70)		(114,286)	(134,212)
Cash flows from (used in) operations before changes in working capital	4,132,272		4,620,948	2,590,386
(INCREASE) DECREASE IN ASSETS
Trade accounts receivable and related parties	(645,157)		(1,308,030)	(212,812)
Inventories	(1,117,671)		(1,444,671)	(194,698)
Recoverable taxes	(315,458)		(770,102)	(6,369)
Other assets	(299,770)		152,811	(56,440)
Subtotal	(2,378,056)		(3,369,992)	(470,319)
INCREASE (DECREASE) IN LIABILITIES
Domestic and foreign trade accounts payable and related parties	467,538		1,004,231	117,080
Payroll, profit sharing and social charges, net	(42,274)		749,609	(15,855)
Tax liabilities	(13,232)		382,695	91,520
Other liabilities	(154,650)		(93,252)	21,204
Subtotal	257,382		2,043,283	213,949
CASH GENERATED BY (USED IN) OPERATING ACTIVITIES	2,011,598		3,294,238	2,334,017
OTHER CASH FLOWS FROM OPERATING ACTIVITIES
Payment of income tax and social contribution	(976,542)		(331,450)	(321,262)
Release of judicial deposits	(3,893)		66,192	9,674
Payments related to tax, civil and labor lawsuits	(132,784)		(221,429)	(27,179)
Proceeds (payments) due to settlement of derivative transactions	(9,040)		(38,835)	(66,420)
Payment of interest on lease	(219,574)		(225,420)	(134,579)
Payment of interest on borrowings, financing and debentures	(783,935)		(1,257,665)	(493,895)
NET CASH GENERATED BY (USED IN) OPERATING ACTIVITIES	(114,170)		1,285,632	1,300,356
CASH FLOW FROM INVESTING ACTIVITIES
Cash from acquisition of subsidiary			2,661,878
Additions of property, plant and equipment and intangible	(1,479,227)		(674,211)	(586,395)
Proceeds from sale of property, plant and equipment, intangible and non-current assets held for sale	114,473		104,204	22,682
Acquisition of short-term investments	(11,739,911)		(10,371,483)	(7,161,530)
Redemption of short-term investments	12,325,210		9,008,931	7,345,389
Redemption of interest on short-term investments	127,416		52,667	65,504
Receipt of dividends from subsidiaries
Investments in subsidiaries			(102,898)
NET CASH GENERATED BY (USED IN) INVESTING ACTIVITIES	(652,039)		679,088	(314,350)
CASH FLOW FROM FINANCING ACTIVITIES
Repayment of lease - principal	(1,077,611)		(843,338)	(497,905)
Repayment of borrowings, financing and debentures – principal	(7,989,607)	[1]	(8,483,892)	(2,643,575)
New borrowings, financing, and debentures	6,425,565	[2]	1,354,765	5,346,145
Acquisition of treasury shares, net of receipt of option strike price	(174,113)		51,145	(2,562)
Payment of dividends and interest on equity for the previous period			(133,937)	(152,938)
Receipt of funds due to settlement of derivative transactions	1,570,584		211,722	3,992
Acquired company's liability incurred by acquiror			(370,791)
Capital payment				52,673
Capital Increase			7,436,684	206,592
NET CASH GENERATED BY (USED IN) FINANCING ACTIVITIES	(1,245,182)		(777,642)	2,312,422
Effect of exchange rate variation on cash and cash equivalents	196,976		121,012	106
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(1,814,415)		1,308,090	3,298,534
Opening balance of cash and cash equivalents	5,821,672		4,513,582	1,215,048
Closing balance of cash and cash equivalents	4,007,257		5,821,672	4,513,582
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	R$ 1814415		R$ 1308090	R$ 3298534
[1]	The repayment made in the year ended December 31, 2021 mainly refer to the early redemption of the Company’s Notes in the amount of USD 750 million (corresponding to roughly R$ 4.0 billion, carried out in May 2021 (see note 20.1 .iii)) and to the settlements of the 2 nd series of the 7 th issue of debentures in the amount of R$ 1,827 million and of the 2 nd series of the 9 th issue of debentures in the amount of R$ 308 million, both carried out in September 2021. In addition, on April 15, 2021, the Company and its subsidiary redeemed the total principal amount due under their respective promissory notes, equivalent to R$ 500,000 of the Company and R$ 250,000 of the subsidiary
[2]	New borrowing and financing raised within the year ended December 31, 2021 basically refer to the offer carried out by the Company of the notes linked to the sustainability goals in the amount of USD 1 billion, approximately R$ 5.6 billion (see note 20.1 .iv) and the new credit facility in the amount of one hundred million pounds (£ 100 million), approximately R$ 742 million, obtained by subsidiary The Body Shop (see note .iii).

GENERAL INFORMATION

GENERAL INFORMATION	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
General Information	1. GENERAL INFORMATION Natura &Co Holding S.A. (“Natura &Co”) was incorporated on January 21, 2019, with the purpose of holding interests in other companies, whose main business is in the cosmetics, fragrance and personal hygiene segments, through the manufacturing, distribution, and sale of their products. Natura &Co and its subsidiaries are hereinafter referred to as “Company”. Brands managed by the Company include “Natura”, “Avon”, “The Body Shop” and “Aesop”. In addition to using the retail market, e-commerce, business-to-business (B2B) and franchises as sales channels for the products, the subsidiaries highlight the performance of the direct sales channel carried out by the Natura, The Body Shop and Avon Consultant(s). After restructuring activities carried out for the acquisition process of Avon Products, Inc. (“Avon”), which was completed on January 3, 2020 (note 4), Natura &Co became the holding company of the Natura group. Additionally, on January 6, 2020, Natura &Co began trading American Depositary Receipts (“ADRs”) on the New York Stock Exchange (“NYSE”), under the ticker “NTCO”.

MANAGEMENT STATEMENT AND BASIS

MANAGEMENT STATEMENT AND BASIS FOR PRESENTATION OF THE FINANCIAL STATEMENTS	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Management Statement And Basis Of Presentation Of The Financial Statements	2. MANAGEMENT STATEMENT AND BASIS FOR PRESENTATION OF THE FINANCIAL STATEMENTS The consolidated financial statements have been prepared and are being presented in accordance with the International Financial Reporting Standards (“IFRS”), issued by the International Accounting Standards Board (“IASB”). The financial statements show all the relevant information specific to the financial statements, and only that, which are consistent with those used by Management. The Company’s financial statements were approved by the Board of Directors and authorized for issuance at the meeting held on April 8, 2022. The consolidated financial statements for the year ended December 31, 2019 were recast to give retrospective effect to the changes in the Company’s reportable segments (note 26.1) on the Company's FS of December 31, 2020. The Company’s comparative historical consolidated information presented, for the statements of profit or loss, comprehensive income, changes in shareholders’ equity and cash flows for the year ended December 31, 2019, do not include information from the subsidiary Avon Products Inc., since the acquisition was completed on January 3, 2020. a) Basis of presentation of Company's consolidated financial statements The consolidated financial statements were prepared based on historical cost, except for financial derivatives instruments, short-term investments and carbon credits recognized in other current and noncurrent assets that were measured at fair value and assets held for sale and discontinued operations measured at the lower of their carrying amount and the fair value net of selling expenses. The consolidated financial statements are expressed in thousands of Reais (“R$”), rounded to the nearest thousand, and the disclosures of amounts in other currencies, when necessary, were also made in thousands. The items disclosed in other currencies are duly identified, whenever applicable.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Summary of Significant Accounting Polices	3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The main accounting policies applied in the preparation of these consolidated financial statements are defined below. These practices have been applied consistently in all the years presented, except for the accounting policies adopted for the first time in 2021 3.29 3.1 Current versus non-current classification The Company presents assets and liabilities in the balance sheet based on current/non-current classification. An asset is current when it is (i) expected to be realized or intended to be sold or consumed in the normal operating cycle; (ii) held primarily for the purpose of trading; (iii) expected to be realized within twelve twelve A liability is current when (i) it is expected to be realized in the normal operating cycle; (ii) it is held primarily for commercial purposes; (iii) it is due to be settled within twelve twelve Deferred tax assets and liabilities are classified as non-current assets and liabilities, as disclosed in note 3.17 3.2 Foreign currency translation Functional currency The items included in the financial statements of the Company and each of the companies included in the consolidated financial statements are measured using the currency of the main economic environment in which each of the companies operates (“functional currency”). The financial statements are presented in the Company’s functional and presentation currency, the Brazilian Real. 3.2.1 Transactions and balances in a currency other than the functional currency Transactions in foreign currency, that is, any currency other than the functional currency, are translated into the functional currency of the entities included in these consolidated financial statements using the exchange rates prevailing on the dates of the transactions. Balance sheet account balances are translated using the exchange rates prevailing on the dates of the reporting period. Gains and losses from exchange rate variation arising from the settlement of such transactions and the translation of monetary assets and monetary liabilities denominated in foreign currency are recognized in the income statement as “finance income” and “finance expenses”. 3.2.2 Subsidiaries with different functional currency In preparing the consolidated financial statements, the income statement and cash flow statement and all other changes of assets and liabilities of foreign subsidiaries, whose functional currency is not the Brazilian Real, are translated into Brazilian Reais at the monthly average exchange rates, which approximates the exchange rate in effect on the date of the transactions. The balance sheet is translated into Brazilian Reais at the exchange rate prevailing at the reporting date. The effects of exchange rate variations resulting from these translations are presented under item Other Comprehensive Income (“OCI”) in the statement of comprehensive income, and in shareholders’ equity. The translation calculation is different for Natura Cosméticos S.A. – Argentina (“Natura Argentina”) and Cosmeticos Avon Sociedad Anonima Comercial E Industrial (“Avon Argentina"), which became a hyperinflationary economy as of July 1, 2018 (see below), in which other than the balance sheet, the revenue and expenses are translated into Reais at the exchange rates prevailing at the reporting date. 3.2.3 Hyperinflationary economy As of July 2018, Argentina has been considered a hyperinflationary economy. As per CPC 42 29 42 29 Non-monetary assets and liabilities recorded at historical cost and equity items of Natura Argentina and Avon Argentina were adjusted for inflation based on the aforementioned indexes, and effects of hyperinflation resulting from changes in the overall purchasing power were presented in the income statement. The income statement is adjusted at the end of each reporting period based on the variation in the general price index for the year. The net effect of inflation adjustment in 2021 30 For the translation of the accounting balances of the subsidiaries Natura Argentina and Avon Argentina to the reporting currency Reais used in the Company’s consolidated financial statements, the following procedures, as required by CPC 02 2 21 ➢ Assets, liabilities and net equity item balances were translated at the exchange rate prevailing at the reporting date (0.05437 and 0.06189 Argentine peso for each Brazilian Real on December 31, 2021 and 2020 ➢ Revenues and expenses of the year were translated at the exchange rate prevailing at the reporting date ( 0.05437 and 0.06189 Argentine peso for each Brazilian Real on December 31, 2021 and 2020 , respectively), instead of the average exchange rate of the year, which is used to translate currencies in non- economies. The accumulated inflation for the year ended December 31, 2021 was 50.6% (36.1% as of December 31, 2020), as per IPC index. During the year ended December 31, 2021, as a result of the application of the CPC 42 29 Consolidated 2021 2020 Net loss on hyperinflationary economy adjustment (165,826 ) (55,277 ) Impact on profit or loss (26,528 ) 18,667 Monthly average exchange rate impact 218,227 32,160 Capital reserve - 58,496 Profit reserve - 8,292 3.3 Consolidation The following procedures are applied in the preparation of the consolidated financial statements: a) Investments in subsidiaries The Company controls an entity when it is exposed to, or is entitled to, the variable returns arising from its involvement with the entity and can affect those returns by exercising its power over the entity. The financial statements of subsidiaries are included in the consolidated financial statements from the date when the Company obtains control until the date when the control ceases to exist. In the consolidated financial statements, the investments in subsidiaries are accounted for using the equity method. The financial statements of the subsidiaries are prepared at the same reporting date as the Company. Whenever necessary, adjustments are made to suit subsidiaries’ accounting policies to those of the Company. In accordance with the equity method, the portion attributable to the Company on the net income or loss for the year regarding these investments is recorded in the income statement of the Company under the item “share of profit (loss) of equity investees”. All intra-group balances, income and expenses and unrealized gains and losses arising from intra-group transactions are eliminated completely. The other comprehensive income (“OCI”) of subsidiaries is recorded directly in the Company’s shareholders’ equity under the item “OCI”. Below is a list of the Company’s direct subsidiaries as of December 31, 2021, 2020 and 2019: Interest - % 2021 2020 2019 Direct interest: Avon Products, Inc. 100.00 100.00 - Natura Cosméticos S.A. 100.00 100.00 100.00 Natura &Co International S.à r.l. 100.00 100.00 - The activities of the direct subsidiaries are described below: ➢ Avon Products, Inc.: a global manufacturer and marketer of beauty and related products, with operations started in 1886 and established under the laws of the State of New York in the United States of America on January 27, 1916. It conducts its business in the beauty sector and other consumer products through direct selling companies to create, manufacture and market beauty and non-beauty products. Its business is carried out mainly through one channel: direct selling. ➢ Natura S.A.: is a privately-held corporation, established in accordance with the laws of the Federative Republic of Brazil on June 6, 1993, for an indefinite term and the main focus of which is the commercialization of cosmetics and fragrances in general. It also operates through e-commerce and has an expanded network of its own physical stores. The subsidiaries The Body Shop International Limited (The Body Shop) and Holding Pty Ltd. (Aesop) are consolidated by this entity. ➢ Natura &Co International S.à r.l.: a company established in Luxembourg on February 14, 2020 with the main purpose of operating as the finance arm of the Company (a “ ”), centralizing the fundraising activities with external entities and providing funding for the other entities of the economic group on behalf of the company. Furthermore, the entity has also the purpose of managing and holding stakes in national and foreign companies. As of December 31, 2021, and 2020 3.4 Business combination and goodwill Business combinations (except for those involving entities under common control) are accounted for by applying the acquisition method. The consideration transferred is measured at fair value as of the date of acquisition, as well as the identifiable assets acquired, and liabilities assumed. The consideration transferred does not include amounts related to the settlement of pre-existing relationships, which are generally recognized in the statement of profit or loss for the year. The Company determines that it has acquired a business when the acquired set of activities and assets include an input and a substantive process that together significantly contribute to the ability to create outputs. The acquired process is considered substantive if it is critical to the ability to continue producing outputs, and the inputs acquired include an organized workforce with the necessary skills, knowledge, or experience to perform that process or if it significantly contributes to the ability to continue producing outputs. The financial assets and liabilities assumed are assessed for appropriate classification and designation in accordance with the contractual terms, economic circumstances, and pertinent conditions as of the acquisition date. Acquisition-related costs are recorded as expenses as incurred and recognized as other operating expenses. Any goodwill arising from the transaction is tested annually for impairment, and when circumstances indicate that the carrying amount may be impaired. Goodwill is initially measured at cost, as the excess of the aggregate amount of: (i) the consideration transferred, measured at fair value; (ii) the amount of any non-controlling interest in the acquiree; and (iii) in a business combination achieved in stages, the fair value of the acquirer’s previously held equity interest in the acquiree at the acquisition date; over the net assets acquired (identifiable net assets acquired and the liabilities assumed). When this aggregate amount is lower than the net amount of the identifiable assets acquired and the liabilities assumed, a gain on a bargain purchase is immediately recognized in the income statement. Subsequently, goodwill is measured at cost less any accumulated impairment losses. For impairment testing, goodwill acquired in a business combination is, from the acquisition date, allocated to each of the Company’s cash-generating units (“CGU”) that are expected to benefit from the combination, irrespective of whether other assets or liabilities of the acquiree are assigned to those units. In a business combination involving entities under common control, in which all the combining entities or business are ultimately controlled by the same party or parties both before and after the business combination, and that control is not transitory, the Company applies the predecessor accounting method. When applying this method, the financial statements consider the historical accounting records of the acquired entity as equivalent to the Company’s records, reflecting (a) the operating results and equity position of the acquired company in previous years; (b) the operating results of the Company and its acquired entity resulting from the restructuring; (c) the Company’s assets and liabilities at historical cost (and at the preceding fair value, when applicable); and (d) the earnings per share of the Company in all years presented (adjusted when applicable). In these cases, therefore, there is no calculation of goodwill and any effect recorded in the shareholders’ equity. 3.5 Cash and cash equivalents Cash and cash equivalents are maintained for the purpose of meeting short-term cash commitments, not for investment or other purposes. Cash and cash equivalents include cash, demand deposits and short-term investments realizable within 90 3.6 Financial instruments 3.6.1 Financial assets Initial recognition and measurement Upon initial recognition, a financial asset is measured at fair value plus or minus, in the case of a financial asset or financial liability not at fair value through profit or loss, transaction costs that are directly attributable to the acquisition or issue of the financial asset or financial liability. Subsequently, financial assets are measured at amortized cost, at fair value through other comprehensive income (“FVTOCI”), or at fair value through profit or loss (“FVTPL”). The classification of financial assets at initial recognition depends on the characteristics of the contractual cash flows of the financial asset and the business model of the Company for the management of these financial assets. The business model of the Company for managing financial assets refers to how the Company manages its financial assets to generate cash flows. The business model determines whether cash flows will result from collecting contractual cash flows, selling the financial assets, or both. Financial assets classified and measured at amortized cost are “non-derivative” financial assets held within a business model with the objective to hold financial assets to collect contractual cash flows, while financial assets classified and measured at fair value through OCI are held within a business model with the objective of holding financial assets to collect contractual cash flows and selling them. Subsequent measurement Financial assets at amortized cost Financial assets at amortized cost are subsequently measured using the effective interest method and are subject to impairment analysis. Gains or losses are recognized in the income statement when the asset is written off, modified, or impaired. The financial assets of the Company classified as amortized cost include balances of trade accounts receivable, other current assets and non-current assets balances (see note 6.6 Financial assets at fair value through profit or loss Financial assets at fair value through profit or loss are presented in the balance sheet at fair value with net changes in fair value recognized in the income statement. This category includes derivative instruments and short-term investments which the Company had not irrevocably elected to classify according to the fair value through OCI. Reassessment only occurs if there is either a change in the terms of the contract that significantly modifies the cash flows that would otherwise be required or a reclassification of a financial asset out of the fair value through profit or loss category. The financial assets measured at fair value through profit or loss are investment funds, government bonds, restricted cash, financial bills, mutual investment fund, Dynamo Beauty Ventures fund ("Fund DBV"), Certificate of Bank Deposits (CDB), carbon credit, financial and operational derivatives as presented in note 6.6. Derecognition (write-off) of financial instruments A financial asset (or, where applicable, part of a financial asset or part of a group of similar financial assets) is written off when the rights to receive cash flows from the asset have expired, when the Company transfers its rights or risk to receive cash flows from the asset or when the Company has assumed an obligation to pay the full amount of received cash flows, without significant delay, to a third party under an on-lending agreement and either (i) the Company has transferred substantially all risks and benefits of the asset, or (ii) the Company has neither transferred nor retained substantially all risks and benefits of the asset, but transferred the asset control. When the Company transfers its rights to receive cash flows of an asset or executes an on-lending agreement, it assesses whether, and at which extent, it has retained the risks and benefits of ownership. When the Company has neither transferred nor retained substantially all risks and benefits of the asset, nor transferred the control over the asset, the Company continues to recognize the asset transferred to the extent of its continued involvement. In this case, the Company also recognizes an associated liability. The transferred asset and the associated liability are measured on a basis that reflects the rights and obligations that the Company has retained. Impairment of financial assets The Company recognizes an allowance for expected credit losses (“ECL”) for all debt instruments not held at fair value through profit or loss. ECLs are based on the difference between the contractual cash flows due in accordance with the contract and all the cash flows that the Company expects to receive, discounted by an approximation of the original effective interest rate. ECLs are recognized in two 12 12 For trade accounts receivable, the Company applies a simplified approach in calculating ECLs. Therefore, the Company does not track changes in credit risk, but instead recognizes an allowance for losses based on the ECL at each reporting date. The Company has recorded a provision that is based on its historical credit loss experience, adjusted for forward-looking factors specific to the debtors and the economic environment. Further details are disclosed in note 5.6 The Company considers a financial asset in default when internal or external information indicates that the Company is unlikely to receive the outstanding contractual amounts in full. A financial asset is written off when there is no reasonable expectation of recovering the contractual cash flows. 3.6.2 Financial liabilities Initial recognition and measurement All financial liabilities are recognized initially at fair value and, in the case of borrowing, financing and debentures, net of directly attributable transaction costs. The Company’s main financial liabilities include borrowing in local and foreign currency, financing and debentures (note 20 6 21 21 19 24 25 Subsequent measurement For purposes of subsequent measurement, financial liabilities are classified in two Financial liabilities at fair value through profit or loss Financial liabilities at fair value through profit or loss include financial liabilities held for trading and financial liabilities classified upon initial recognition at fair value through profit or loss. Financial liabilities are classified as held for trading if they are incurred for the purpose of repurchasing in the short term. This category also includes derivative instruments entered into by the Company that are not classified as hedging instruments in the hedge relationships defined by CPC 38 39 Gains or losses on liabilities held for trading are recognized in the income statement. Financial liabilities designated upon initial recognition at fair value through profit or loss are designated at the initial date of recognition, and only if the criteria in CPC 48 9 Financial liabilities at amortized cost This is the most relevant category for the Company. After initial recognition, interest-bearing borrowing and financing are subsequently measured at amortized cost using the effective interest rate method. Gains and losses are recognized in profit or loss when the liabilities are written off as well as through the effective interest rate amortization process. Amortized cost is calculated by considering any premium or discount on acquisition and fees or costs that are an integral part of the effective interest rate method. The effective interest rate amortization is included as finance expenses in the income statement. This category generally applies to interest-bearing borrowing, financing and debentures (note 20 19 Derecognition A financial liability is written off when the obligation under the liability is discharged, canceled, or expires. When an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially modified, such an exchange or modification is treated as derecognition of the original liability and recognition of a new liability. The difference in the respective carrying amounts is recognized in the income statement. Offsetting of financial instruments Financial assets and financial liabilities are offset, and the net amount is reported in the balance sheet if there is a currently enforceable legal right to offset the recognized amounts and there is an intention to settle on a net basis, to realize the assets and settle the liabilities simultaneously. The offsetting of financial instruments is also applied to bank balances subject to the central treasury management system (“cash pooling”) instituted with the financial institution, in which the current account positions of the Company (including overdraft balances) are offset since the Company has a legally enforceable right to settle at the net amount and intends to settle the positions on a net basis. 3.6.3 Derivative financial instruments Derivative financial instruments transactions contracted by the Company consist of swaps and non-deliverable forwards (“NDF”) intended exclusively to hedge against foreign exchange risks related to statement of financial position, purchase of goods and property, plant and equipment, forecast exports and foreign-denominated cash flows for capital contributions in foreign subsidiaries. They are measured at fair value, and changes are recognized through profit or loss, except when they are designated as cash flow hedge accounting, which changes in fair value are recorded in OCI. The fair value of derivative instruments is measured by the treasury department of the Company based on information on each contracted transaction and related market inputs as of the reporting date of the financial statements, such as interest and exchange rates. For the purpose of hedge accounting, hedges are classified as: (i) fair value hedges when hedging the exposure to changes in the fair value of a recognized asset or liability or an unrecognized firm commitment; (ii) cash flow hedges when hedging the exposure to variability in cash flows that is either attributable to a particular risk associated with a recognized asset or liability or a highly probable forecast transaction or the foreign currency risk in an unrecognized firm commitment; and that may affect the result or (iii) hedge Even with the adoption of CPC 48 9 38 39 7.2.21 48 9 At the inception of a hedge relationship, the Company formally designates and documents the hedge relationship to which it wishes to apply hedge accounting, the risk management goal and strategy for hedging. The documentation includes identification of the hedging instrument, the hedged item, the nature of the risk being hedged and how the Company will assess the effectiveness of changes in the hedging instrument’s fair value in offsetting the exposure to changes in the hedged item’s fair value or cash flows attributable to the hedged risk. Such hedges are expected to be highly effective in achieving offsetting changes in fair value or cash flows and are assessed on an ongoing basis to determine that they actually have been highly effective throughout the financial reporting periods for which they were designated. During the years ended December 31, 2021, 2020 2019 Cash flow hedges It consists in providing hedge against variation in cash flows attributable to a specific risk related to a known asset or liability or a highly probable forecast transaction and that may affect income statement. The effective portion of changes in fair value of derivative instruments that is designated and qualified as cash flow hedge is recognized in OCI and accumulated in the “gains (losses) from cash flow hedge operations” and “tax effect on gain (loss) from cash flow hedge operations”. In a cash flow hedge, the effective portion of gain or loss from the hedge instrument is recognized directly in OCI, in shareholders’ equity, while the ineffective portion of hedge is immediately recognized as finance income (expense). For the years ended December 31, 2021, 2020 2019 6.2 Hedge accounting is discontinued when the Company terminates the hedge relationship, the hedge instrument matures or is sold, revoked or executed, or no longer qualifies to hedge accounting. Any gains or losses recognized in OCI and accumulated in shareholders’ equity up to that date remain in shareholders’ equity and are recognized when the forecast transaction is eventually recognized in the income statement. If a forecast transaction results in the subsequent recognition of a non-financial asset or liability, the cumulative gain or loss in OCI is recycled to profit or loss during the same year for which the non-financial asset acquired or non-financial liability assumed affects the profit or loss. For example, when the non-financial asset is depreciated or sold. On the other hand, if a forecast transaction results in the subsequent recognition of a financial asset or liability, the cumulative gain or loss in OCI is recycled to profit or loss during the same period for which the financial asset acquired or financial liability assumed affects the profit or loss. For example, when financial income or expense is recognized. When the forecast transaction is no longer expected, cumulative gains or losses deferred in equity are immediately recognized in the income statement. The Company assesses, throughout the hedge term, the effectiveness of its derivative instruments, as well as changes in their fair value. For the years ended December 31, 2021, 2020 2019 6.6 3.7 Trade accounts receivable Trade accounts receivable correspond to amounts receivable for the sale of goods and services in the ordinary course of the activities of the Company and are recognized to the extent that the consideration, which is unconditional, is due by the customer (that is, only the passage of time is required before payment of the consideration is due) and are measured on initial recognition at cost for the consideration to which the Company expects to be entitled in exchange for the products promised to the client. Subsequently, trade accounts receivable are measured at amortized cost by using the interest rate method and they are subject to impairment test (see note 3.1 3.8 Inventories Inventories are valued at their average cost and the net realizable value, whichever is lower. Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and the estimated costs necessary to make the sale. The Company considers the following items when determining its allowance for inventory losses: discontinued products, products with slow turnover, expired products or products nearing the expiration date and products that do not meet quality standards, recorded as “cost of sales”. 3.9 Carbon credits – carbon neutral program In 2007 This commitment, which now refers to the operations of all Natura &Co brands, and, despite Brazil having presented, in November 2021, during the twenty 26 Thus, considering the practices historically applied by the Company and the specificity of the commitments assumed and disclosed to the market and society, this commitment is considered a constructive obligation, according to CPC 25 37 The liability is estimated through audited carbon emission inventories carried out annually and valued based on the best estimate of the cash disbursement that will be required to settle the current obligation at the reporting date. As of December 31, 2021, the balance recorded as “Other non-current liabilities” (see note 24 2007 2021 The Company elected to make purchases of carbon credits by investing in projects with environmental benefits arising from the voluntary market. Thus, the costs incurred will generate carbon credits after completion or maturation of these projects. Such expenses are recorded in the line item “other current assets” (see note 15 Upon effective delivery of the related carbon neutral certificates to the Company, the obligation of being carbon neutral is effectively fulfilled; therefore, the asset balances are offset against those of the liabilities. The difference between the balances of assets and liabilities as of December 31, 2021 and 2020 3.10 Property, plant and equipment Property, plant and equipment is measured at cost of acquisition or construction, plus interest capitalized during construction period, in the case of qualifying assets, and reduced by accumulated depreciation and impairment losses, if applicable. Depreciation methods, useful lives and residual values are reviewed at each reporting date and adjusted, if applicable. Land is not depreciated. Depreciation of the other assets is calculated to reduce the cost of items of property, plant and equipment less their estimated residual values using the straight-line method over their useful lives and is recognized in the income statement. The estimated useful lives of the assets are mentioned in note 17 Gains and losses on disposals are calculated by comparing the proceeds from the sale with the carrying residual amount and are recognized in the income statement as “other operating expenses, net”. Subsequent expenditure is capitalized only if it is probable that the future economic benefits associated with the expenditure will flow to the Company. 3.11 Intangible assets Intangible assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination is their fair value at the date of acquisition. Following initial recognition, intangible assets are reported at cost less any accumulated amortization and accumulated impairment losses. Internally generated intangible assets, excluding capitalized development costs, are not capitalized and the related expenditure is reflected in profit or loss in the year in which the expenditure is incurred. The useful lives of intangible assets are assessed as either finite or indefinite. Intangible assets with finite lives are amortized over the useful economic life and assessed for impairment whenever there is an indication that the intangible asset may be impaired. The amortization period and the method for an intangible asset with a finite useful life are reviewed at least at each reporting date. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset are considered to modify the amortization period or method, as appropriate, and are treated as changes in accounting estimates. The amortization expense regarding intangible assets with finite lives is recognized in the income statement in the expense category that is consistent with the function of the intangible assets. Intangible assets with indefinite useful lives are not amortized, but are tested for impairment annually, and when circumstances indicate that the carrying amount may be impaired, either individually or at the CGU level. The assessment of indefinite life is reviewed annually to determine whether the indefinite life continues to be supportable. If not, the useful life is changed from indefinite to finite on a prospective basis. An intangible asset is written off upon disposal (i.e., at the date the receiver of the asset obtains control) or when no future economic benefits are expected from its use or disposal. Any gain or loss arising upon write-offs of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included in the income statement in item “other operating expenses, net”. The main classes of intangible assets are set forth below: 3.11.1 Software Licenses of software and enterprise management systems acquired are capitalized and amortized according to the useful lives described in note 18 Business management system acquisition and implementation costs are capitalized as intangible assets when the asset is identified, when there is evidence that future economic benefits will be generated and when the asset is controlled by the Company, taking into consideration its economic and technological viability. Contracts involving hosting and/or processing of information in the cloud (“cloud computing arrangements”) generate intangible assets to the extent that on the contract start date, the Company obtains control of the software. Contracts which only provide the right of access to the supplier's software during the term of the contract are treated as a service contract and, consequently, recognized as a

BUSINESS COMBINATIONS

BUSINESS COMBINATIONS	12 Months Ended
	Dec. 31, 2021
Disclosure of detailed information about business combination [abstract]
BUSINESS COMBINATIONS	4. BUSINESS COMBINATION Avon acquisition On January 3, 2020, the Company acquired 100% of the voting shares of Avon. The Company’s acquisition was driven to significantly amplify the reach of its multi-channel, multi-brand group. As a result of the restructuring process held upon acquisition, Avon became a wholly owned subsidiary of the Company, and the former shareholders of Avon became shareholders of the Company. As a result, Natura &Co acquired control of Avon and the acquisition was accounted for using the acquisition method. The transaction costs incurred by the Natura &Co until the conclusion of the transaction on January 3, 2020, were approximately R$ 112,000 The following table summarizes the calculation of the fair value of the compensation transferred on January 3, 2020. In thousands of R$, except for the Number of Avon outstanding common shares as of January 3, 2020 536,383,776 Multiplied by the exchange ratio of 0.600 Natura &Co Holding Shares per each Avon common share 321,830,266 Multiplied by the market price of Natura &Co shares on January 3, 2020 41.00 Compensation in the issue of shares 13,195,041 Adjustment to the transferred compensation (a) 171,073 Fair value of the Compensation to be transferred 13,366,114 a) Related to the effects of replacements and settlements of share-based payment plans, of which the amount of roughly R$80,000 refers to the share-based payment plans of Avon, in which it was substituted by Natura &Co, and approximately R$ 91,000 refers to the share purchase option plans liquidated as part of the conclusion of the transaction. These are pre-combination installments that were regarded as a transferred compensation. The fair values of the identifiable assets and liabilities of Avon as of the date of acquisition were: In thousands of R$ Purchase consideration transferred (1) 13,366,114 Fair value of acquired assets: Cash and cash equivalents 2,636,108 Trade receivables (2) 1,135,269 Inventories 1,919,683 Other current assets 1,031,136 Assets held for sale 199,050 Property, plant and equipment 2,912,482 Deferred income tax and social contribution 667,034 Right-of-use (3) 564,669 Other non-current assets 475,096 Judicial deposits 283,885 Recoverable taxes 531,930 Surplus pension plan (other assets) 553,297 Intangible assets (4) 5,846,812 Fair value of liabilities assumed: Borrowing, financing and debentures 7,256,583 Trade accounts payables 2,915,418 Payroll, profit sharing and social contributions 621,203 Dividends and interest on net equity payable 405,916 Derivative financial instruments 15,518 Other operating expenses 999,653 Provision for restructuring (other liabilities) 152,896 Lease liabilities 777,200 Tax liabilities 341,258 Income tax and social contribution 30,068 Provision for tax, civil and labor risks (5) 1,757,940 Deferred income tax and social contribution (6) 592,534 Other liabilities 1,007,623 Total identifiable net assets at fair value 1,882,641 Non-controlling interest 27,555 Goodwill arising on acquisition (7) 11,511,028 ( 1 Refers to the fair value of the acquired shares, which is the amount disbursed on the shares exchange. ( 2 The fair value of the trade accounts receivable amounts to R$ 1,135,269 and is equivalent to it carrying amount and, it is expected that the carrying amount can be collected. ( 3 The Company measured the lease liabilities acquired using the current value of the remaining lease payments on the date of acquisition. The right-of-use assets were measured at an amount equal to the lease liabilities and adjusted to reflect the favorable terms of the lease relative to market terms. ( 4 The fair value of intangibles includes the intangible assets acquired and recognized by Avon before the allocation of the fair value, in the amount of R$ 291,235, plus the effects of the allocation of the fair values described below. Fair value for the intangibles “Avon” tradename, power brands and developed technology has been calculated based on the income approach and the relief-from-royalty method. The relief-from-royalty method is often used to calculate the value of a trademark or trade name. This method is based on the concept that if an entity owns a trademark, it does not have to pay for the use of it and therefore is relieved from paying a royalty. The amount of that theoretical payment is used as a surrogate for income attributable to the intangibles. The valuation is obtained by calculating the current value of the savings in royalties Fair value for relationship with sales representatives has been calculated based on the Multi Period Excess Earnings Method (“MEEM”), method that isolates the income/cash flow that is related to the intangible asset being valued and estimates fair value through the sum of the discounted future excess earnings attributable to the intangible asset. Nature Fair value Useful life “Avon” tradename Represents the fair value of the “Avon” tradename. The relief-from-royalty method has been applied considering a benchmark of similar royalty transactions. 2,022,163 Indefinite Power brands Represents the fair value of Avon’s main brands. The relief-from-royalty method has been applied considering a benchmark of similar royalty transactions as well as the relative importance of the respective brands for Avon’s revenue generation. 517,592 20 years Technology developed Represents the fair value of all technology necessary to develop Avon products, including formulae, labeling data, manufacturing processes, regulatory approvals, product packaging, and designs. The relief-from-royalty method has been applied based on existing contractual relations involving Avon’s developed technology. 1,131,573 5 years Sales Representatives Represents the fair value of the relationship between Avon and its sales representatives. Fair value is calculated based on the active representatives by country as of the valuation date, multiplied by the respective average ticket price as well as projected information on the average ticket growth which includes future inflation. The churn rate and the projected information have been considered as significant assumptions. 1,884,249 7 to 12 years 5,555,577 (5) Contingent liabilities assumed in the acquisition that are considered current obligations arising from past events and that can be measured reliably were recognized and are initially measured at fair value on the acquisition date and subsequently measured in accordance with the requirements of CPC 15 (R1) (IFRS 3), to a higher amount that would be recognized in accordance with CPC 25 (IAS 37). The fair value of the contingent liabilities includes the liabilities assumed and recognized by Avon before the allocation of the fair value, in the amount of R$ 872,993, plus the effects of the allocation of the fair values, which totaled R$ 820,103. The table below shows the total amount of contingent liabilities assumed on the date of the transaction, including the attributed fair value: In thousands of R$ Tax 1,381,418 Civil 157,832 Labor 218,690 Total 1,757,940 (6) Consists of deferred tax liabilities of approximately R$ 81,423 related to Avon opening balance and net position of deferred tax asset and liabilities related to purchasing price allocation of tax liabilities of R$ 511,111. (7) Goodwill is attributable to strong market position and geographic regions and will result in a more diversified and balanced global portfolio, as well as expected future profitability and operational synergies, such as supply, manufacturing, distribution and efficiency of the administrative structure and revenue growth. This goodwill arising from the transaction is not expected to result in a tax benefit, that is, deductible for tax purposes. After the acquisition date, the subsidiary Avon contributed with R$18,612,091 to revenues and with R$1,542,596 in losses in the Company’s consolidated financial statements for the year ended December 31, 2020. As the acquisition date is January 3, 2020 and there was no significant transaction on the first three days of 2020, such revenues and losses represent the impact in the Company’s financial statements as if the acquisition date had occurred at the beginning of the year.

CRITICAL ACCOUNTING ESTIMATES A

CRITICAL ACCOUNTING ESTIMATES AND ASSUMPTIONS	12 Months Ended
	Dec. 31, 2021
Critical Accounting Estimates And Assumptions [Abstract]
Critical Accounting Estimates And Assumptions	5. CRITICAL ACCOUNTING ESTIMATES AND ASSUMPTIONS The preparation of the consolidated financial statements requires management to make certain judgments and use assumptions and estimates based on experience and other factors considered relevant, which affect the values of assets and liabilities, and which may present results that differ from actual results. The areas that require a higher level of judgment and have greater complexity, as well as the areas in which assumptions and estimates are significant for the financial statements, are disclosed below. 5.1 Income tax, social contribution, and other taxes Deferred tax assets are recognized for unused tax losses to the extent that it is probable that taxable profit will be available against which the losses can be utilized. Significant management judgement is required to determine the amount of deferred tax assets that can be recognized, based upon the likely timing and the level of future taxable profits, together with future tax planning strategies and other sources of income. The Company has R$12,324,912 of reportable unrecognized tax losses as of December 31, 2021 (R$ 13,369,187 on December 31, 2020). These losses relate to subsidiaries that have a history of losses, do not expire, and may not be used to offset taxable income in other subsidiaries. The subsidiaries neither have any taxable temporary difference nor any tax planning opportunities available that could partly support the recognition of these losses as deferred tax assets. Based on this, the Company determined that it cannot recognize deferred tax assets on these tax losses carried forward. 5.2 Provision for tax, civil and labor risks The Company is party to several legal and administrative procedures as described in note 23. Provisions are recorded for process related to tax, civil and labor risks related to lawsuits that represent probable, except for those related to business combinations, and are estimated with a certain degree of certainty. The assessment of the likelihood of loss includes the assessment of the available evidence, the hierarchy of laws, the available jurisprudence, the most recent court decisions, and their relevance in the legal system, as well as the assessment of legal advisors. 5.3 Post-employment health care plan The cost of the post-employment health care plan is determined using actuarial valuations. An actuarial valuation involves making various assumptions that may differ from actual developments in the future. These are based on a series of financial and demographic assumptions, such as the discount rate, medical inflation, and percentage of adhesion to the plan, which are disclosed in note 24. Due to the complexities involved in the valuation and its long-term nature, a defined benefit obligation is highly sensitive to changes in these assumptions. All assumptions are reviewed at each reporting date. 5.4 Share purchase option plan, restricted share plan, strategy-acceleration program and performance share program Estimating fair value for share-based payment transactions requires determination of the most appropriate valuation model, which depends on the terms and conditions of the grant. This estimate also requires determination of the most appropriate inputs to the valuation model including the expected life of the share option or appreciation right, volatility and dividend yield and making assumptions about it. The share purchase option plan, restricted share plan, strategy-acceleration program and performance share program are measured at fair value at the grant date and the expense is recognized in profit or loss during the vesting period and in “Additional paid-in capital” in shareholders’ equity. At the balance sheet dates, Management reviews the estimates as to the number of purchase options/restricted shares and, where applicable, recognizes the effect arising from this review in profit or loss for period against shareholders’ equity. The assumptions and models used to estimate the fair value of the purchase option plan, restricted share plan and strategy-acceleration program are disclosed in note 29.1. 5.5 Impairment of non-financial assets An impairment loss exists when the carrying amount of an asset or CGU exceeds its recoverable amount, which is the higher of fair value less cost of disposal and value in use. Fair value less costs of disposal is calculated based on information available about similar assets sold or market prices less additional costs to dispose of the asset. Value in use is calculated based on the discounted cash flow model. Cash flows derive from a budget prepared for the following three five 5.6 Allowance for trade receivables expected losses The allowance for expected losses on trade receivables from customers is estimated based on the loss risk in an aging list model. The characteristics of the Company’s trade accounts receivable are (i) immaterial financial component; (ii) non-complex receivables portfolio; and (iii) low credit risk. For trade accounts receivable, the Company applies the simplified approach in calculating expected credit losses (“ECL”) based on expected credit losses at each reporting date. The allowance determined based on (i) each of the subsidiaries credit losses historical experience, observed in each group of the trade accounts receivable aging list, and (ii) adjustments for specific forward-looking factors for defaulters and the economic environment. An estimated range is used based on the weighted average of the losses for the last 12 months. The calculation also considers the length of time of the relationship of the independent beauty consultant and a division between renegotiated and non-renegotiated overdue trade accounts receivable. 5.7 Provision for inventory losses The allowance for losses on inventories is estimated using a methodology to contemplate discontinued products, materials with slow turnover, materials with an expired expiration date or close to the expiration date, and materials outside the quality parameters. 5.8 Leases - I ncremental borrowing rate The Company cannot readily determine the interest rate implicit in the lease, therefore, it uses its incremental borrowing rate (“IBR”) to measure lease liabilities. The IBR is the interest rate that the Company would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment. The IBR therefore reflects what the Company “would have to pay”, which requires estimation when no observable rates are available (such as for subsidiaries that do not enter into financing transactions) or when they need to be adjusted to reflect the terms and conditions of the lease (for example, when leases are not in the subsidiary’s functional currency). The Company estimates the IBR using observable inputs (such as market interest rates) when available and is required to make certain entity-specific estimates. 5.9 Measurement at fair value of financial instruments When the fair value of financial assets and liabilities recorded in the balance sheet cannot be measured based on prices quoted in active markets, the fair value is measured based on valuation techniques, including the discounted cash flow model. The inputs considered in these models are obtained from observable markets, when possible. In situations where these inputs cannot be obtained from observable markets, a degree of judgment is necessary to establish the respective fair values. Associated judgments include assessment of liquidity risk, credit risk and volatility. Changes in the assumptions related to these factors could affect the fair value of financial instruments.

FINANCIAL RISK MANAGEMENT

FINANCIAL RISK MANAGEMENT	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Financial risk management	6. FINANCIAL RISK MANAGEMENT 6.1 General considerations and policies Risks and financial instruments are managed through policies, the definition of strategies and implementation of control systems, defined by the risk management committees of the entities of the group, and approved by the Company’s Board of Directors. The compliance of treasury financial instruments positions, including derivatives, in relation to these policies, is presented and assessed on a monthly basis by the Company’s Treasury Committee and subsequently submitted to the analysis of the Audit and Risk Management and Finance Committees, the Executive Committee and, if necessary, the Board of Directors. Risk management of the Company’s operations is performed by the Company’s Corporate Treasury, which is also responsible for approving short-term investments and borrowings transactions. Risk management of the subsidiaries Aesop, The Body Shop, Avon International and Natura &Co Latam is conducted by local treasury teams, subject to monitoring and approval of the Company’s Corporate Treasury. 6.2 Financial risk factors The Company’s activities expose them to several financial risks: market risks (including foreign currency and interest rate risks), credit risk and liquidity risk. The Company’s overall risk management program is focused on the unpredictability of financial markets and seeks to minimize potential adverse effects on the financial performance, using financial instruments to hedge certain risk exposures. The Company does not operate derivative instruments with the purpose of speculation. a) Market risks Market risks reflect the risks that the fair value or future cash flows of a financial instrument will fluctuate as a result of changes in market prices, including currency risk, interest rate risk and other price risks. The Company is exposed to market risks arising from their business activities. These market risks mainly comprise possible fluctuations in exchange and interest rates (detailed below in this note). Other price risks include, among others, exposures to financial instruments due to changes in commodity and raw material prices. Climatic aspects, such as the availability of natural raw material used in the products and/or significant changes in the cost of these items in view of their dependence on an environment conducive to harvesting and/or extraction in accordance with the sustainability assumptions and the commitments assumed by the Company with the environment may expose the Company to additional market risks that affect the entity's operations as well as the measurement and/or recoverability of financial instruments. As of December 31, 2021, the Company’s Management assessed these risks and concluded that they are not material. The disclosures about interest rate and liquidity risks discussed below also bring other considerations about sustainability and climate change issues. To hedge the current balance sheet positions of the Company against market risks, the following derivative instruments are used and consist of the balances in the following table, as of December 31, 2021 and 2020 Description Fair value (Level 2) Consolidated 2021 2020 Financial derivatives 516,386 1,857,869 Operating derivatives 251 (11,092 ) Total 516,637 1,846,777 b) Foreign exchange risk The Company is exposed to foreign exchange risk resulting from financial instruments and operations in currencies other than their functional currencies, as well as to operating cash flows in foreign currencies. To reduce this exposure, policies were implemented to hedge the Company from foreign exchange risk, which establish exposure levels related to these risks. The treasury procedures defined by the current policies include quarterly projection and assessment of the consolidated foreign exchange rate exposure of the Company, on which Management’s decision-making is based. The Company’s foreign exchange hedging policy considers the amounts of foreign currency of receivables and payables balances from commitments already assumed and recorded in the financial statements, as well as future cash flows, with a six Pursuant to the Foreign Exchange Hedging Policy, the derivatives entered into by the Company should eliminate the foreign exchange risk of financial instruments in currencies other than their functional currencies and should also limit losses due to exchange rate variation on future cash flows. To hedge from the foreign exchange exposures in relation to foreign currency, the Company enters transactions with derivative instruments such as swap and non-deliverable forward (“NDF” or "forward"). c) Derivative instruments to hedge foreign exchange rate risk The Company classifies derivatives between financial and operating derivatives. Financial derivatives include swaps or forwards engaged to hedge the foreign exchange risk the borrowing, financing, debt securities and intercompany borrowings denominated in foreign currency. Operating derivatives are used to hedge the foreign exchange risk from the business’s operating cash flows. As of December 31, 2021 and 2020 Financial derivatives Consolidated Fair value Gain (loss) of fair value adjustment Description 2021 2020 2021 2020 Swap agreement s: (a) Asset position: Long position - U.S. dollar 6,881,981 4,683,900 978,350 421,897 Liability position: Post-fixed CDI Rate: Short position in CDI (6,348,442 ) (2,803,797 ) (823,887 ) (172,885 ) Forward contracts (NDF): Liability position: Post-fixed CDI Rate: (137 ) - (137 ) - Short position at interbank rate (17,016 ) (22,234 ) 94 (16,778 ) Total net derivative instruments: 516,386 1,857,869 154,420 232,234 a) Swap transactions consist of swapping the exchange rate variation for a correction related to a percentage of the fluctuation of the Certificate of Bank Deposits (post-fixed CDI), in the case of Brazil. Below are the changes in net derivatives balances for the years ended on December 31, 2021 and 2020 Consolidated Balance as of December 31, 2019 725,572 Losses from swap and forward derivative contracts 1,090,299 Payment of funds due to settlement of derivative transactions – operating activity (211,722 ) Proceeds received due to settlements - financing activity 38,835 Exchange rate variation (OCI) 203,793 Balance as of December 31, 2020 1,846,777 Losses from swap and forward derivative contracts 441,554 Payment of funds due to settlement of derivative transactions – operational activity (1,570,584 ) Proceeds received due to settlements - financing activity 9,040 Exchange rate variation (OCI) (210,150 ) Balance as of December 31, 2021 516,637 For the derivative instruments held by the Company as of December 31, 2021 and 2020 Operating derivatives - Consolidated As of December 31, 2021 and 2020 Description Fair value 2021 2020 Net position in GBP and USD (404 ) (7,670 ) Forward contracts 655 (3,422 ) Total of derivative instruments, net 251 (11,092 ) Sensitivity analysis For the foreign exchange risk sensitivity analysis, the Company’s Management believes that it is important to consider, in addition to the assets and liabilities with exposure to fluctuations in exchange rates recorded in the balance sheet, the fair value of the financial instruments entered into by the Company to hedge certain exposures as of December 31, 2021 and 2020, as set forth in the table below: Consolidated 2021 2020 Borrowing and financing in foreign currency in Brazil (a) (5,897,015 ) (4,246,692 ) Trade accounts receivable in foreign currency in Brazil 307,433 236,782 Trade accounts payable in foreign currencies in Brazil (37,390 ) (14,459 ) Fair value of financial derivatives 6,882,499 4,680,478 Net asset exposure 1,255,527 656,109 (a) This analysis considers only financial assets and liabilities recorded in Brazil in foreign currency, since exposure to the foreign exchange rate variation in other countries is close to zero due to the strong currency and effectiveness of its derivatives, and it is considered that all other variables, especially interest rates, remain constant and do not consider any impact of the forecasted purchases and sales. The following table shows the projection of the incremental loss that would have been recognized in profit or loss for the subsequent year, if the current net foreign exchange exposure remains static, based on the following scenarios: Consolidated Parity - R$ vs US$ 5.5805 5.7021 4.2765 2.8510 Scenario Scenario Scenario I Scenario II Operation/Instrument Real Probable Depreciation 25% Depreciation 50% Assets denominated in US$ Fair value of “financial” derivatives 6,882,499 7,032,419 5,274,315 3,516,210 Trade accounts receivable in foreign currency in Brazil 307,433 314,130 235,597 157,065 Liabilities denominated in US$ Borrowing and financing in foreign currency in Brazil (5,897,015 ) (6,025,469 ) (4,519,102 ) (3,012,734 ) Trade accounts payable in foreign currencies in Brazil (37,390 ) (38,204 ) (28,653 ) (19,102 ) Impact on net income and shareholders’ equity 1,255,527 27,349 (293,370 ) (614,089 ) The probable scenario considers future US dollar rates for a 90 days-term. According to quotations obtained at the Brazilian Stock Exchange (“B 3 7 40 Derivative instruments designated for hedge accounting The Company formally designated its operations subject to hedge accounting for derivative instruments to hedge borrowings denominated in foreign currency and other expenses of Company, for derivative instruments contracted to hedge the purchase of nationalized materials of subsidiary Natura Indústria and for derivative instruments contracted to hedge the operating cash flows from subsidiary The Body Shop’s foreign currency purchase and sales transactions. During the year ended December 31, 2021, the Company designated the derivative instruments (forward swap) acquired in May 2021 for the hedge accounting aiming to protect against the variability of cash flow attributable to the Company’s ESG Notes issued on such date (see note 19.1 The positions of derivative instruments designated as outstanding cash flow hedge on December 31, 2021 are set out below: Cash flow hedge instrument – Consolidated Other comprehensive income Hedged item Notional currency Fair value Accumulated contract gain (loss) Gain (loss) in the period Currency Swap – US$/R$ Currency BRL 533,539 64,145 (215,944 ) Forward agreements (The Body Shop and Avon) Currency BRL - - 5,173 Forward contract (Natura Indústria) Currency BRL (129 ) (129 ) 621 Total 533,410 64,016 (210,150 ) The changes in cash flow hedge reserve recorded in OCI are shown below: Consolidated Cash flow hedge balance as of December 31, 2019 42,729 Change in the fair value of hedge instrument recognized in OCI 178,006 Tax effects on fair value of hedge instrument (61,658 ) Cash flow hedge balance as of December 31, 2020 159,077 Change in the fair value of hedge instrument recognized in OCI (210,150 ) Tax effects on fair value of hedge instrument 72,939 Cash flow hedge balance as of December 31, 2021 21,866 The Company designates as cash flow hedge the derivative instruments used to offset variations arising from foreign currency exposure, in the fair value of contracted debts, other than the functional currency and in the projected operating cash flows in foreign currency. d) Interest rate risk The interest rate risk arises from short and long-term investments, borrowing, financing and debentures. Financial instruments issued at variable rates expose the Company to cash flow risk associated with interest rate. Financial instruments issued at fixed rates expose the Company to the fair value risk associated with the interest rate. The Company’s cash flow risk associated with interest rate arises from short-term and long-term investments, borrowing and financing issued at floating rates. The Company’s Management holds, for the most part, the indexes of its exposures to deposit and lending interest rates tied to floating rates. Short-term investments are adjusted by the Certificate of bank deposits (“CDI”) whereas borrowing and financing are adjusted by the CDI and fixed rates, according to the contracts entered into with financial institutions and through the negotiation of securities with investors in that market. Additionally, the Company considered potential aspects related to sustainability and climate change commitments as part of the risks to which it is exposed in relation to the interest rate on financial instruments, except for the risks associated with the ESG notes (disclosed in item (f) below), there is no exposure to material risks which should be subject to specific disclosure. Sensitivity analysis As of December 31, 2021, there are borrowing, financing, and debentures contracts denominated in foreign currency that are linked to interest swap agreements, changing the liability index rate to the CDI variation. Accordingly, the risk of the Company becomes the exposure to the variation of the CDI. The following table presents the exposure to interest rate risks of transactions related to CDI, including derivative transactions (borrowing, financing and debentures in Brazil were considered in full, given that 99.4% of the amount is related to the CDI): Consolidated Total borrowing, financing, and debentures - in local currency (note 20 (6,914,117 ) Operations in foreign currency with derivatives related to CDI (a) (5,802,715 ) Short-term investments (notes 7 8 2,636,599 Net exposure (10,080,233 ) a) Refers to transactions involving derivatives related to CDI to hedge the borrowing, financing and debentures arrangements raised in foreign currency in Brazil. The sensitivity analysis considers the exposure of borrowing and financing, net of short-term investments, linked to CDI (notes 7 and 8). The following tables show the projection of incremental loss that would have been recognized in profit or loss for the following year, assuming that the current net liability exposure is static and the following scenarios: Description Company Risk Probable scenario Scenario II Scenario III Consolidated Net liability Rate increase (110,883 ) (369,189 ) (627,495 ) The probable scenario considers future interest rates for 90 days-term, according to B 3 e) Credit risk Credit risk refers to risk of a counterparty not complying with its contract obligations, which would result in financial losses for the Company. The Company’s sales are made to a high number of Natura and Avon Consultants and this risk is managed through a credit granting process. The result of this management is reflected in the “allowance for expected credit losses” in “trade receivables”, as shown in note 9 The Company is also subject to credit risks related to financial instruments entered for the management of its business, mainly represented by cash and cash equivalents, short-term investments and derivative instruments. The Company believes that the credit risk of transactions with financial institutions is low, as these are considered as first tier by the Management. The short-term investments policy adopted by the Company’s Management establishes the financial institutions with which the Company is allowed to do business, in addition to defining limits on funds allocation percentages and absolute amounts that may be allocated in each of these financial institutions. f) Liquidity risk Prudent liquidity risk management implies maintaining sufficient cash, short-term investments, funds available through credit facilities and the ability to settle market positions. Management monitors the Company’s liquidity level considering the expected cash flows in exchange for unused credit facilities, as shown in the following table: Consolidated 2021 2020 Total current assets 17,449,877 18,734,820 Total current liabilities (13,693,877 ) (16,159,586 ) Total net working capital 3,756,000 2,575,234 As of December 31, 2021, the carrying amount of financial liabilities, measured using the amortized cost method, considering interest payments at a floating rate and the value of debt securities reflecting the forward market interest rates, may be changed due to the variation in floating interest rates. Their corresponding maturities, considering that the Company is in compliance with contractual covenants, are evidenced below: Consolidated Less than one One five Over five Total expected cash flow Interest to be accrued Carrying amount Borrowing, financing and debentures 1,339,240 7,288,382 7,495,223 16,122,845 (3,406,013 ) 12,716,832 Lease liability 1,154,697 2,086,269 829,511 4,070,477 (522,615 ) 3,547,862 Trade accounts payables, related parties and reverse factoring operations 6,770,579 - - 6,770,579 - 6,770,579 Dividends payable 180,772 - - 180,772 - 180,772 The Company had a secured credit facility of up to seventy 2020 2021 In April 2021, a new credit facility in the amount of one 19.1 Matters related to climatic factors and other sustainability commitments assumed may expose the Company to possible risks related to its financial instruments, especially related to the potential variability of cash flows required to settle obligations with third parties on financing that involve such commitments. On May 4, 2021, subsidiary Natura Cosméticos concluded the offer of the notes linked to the sustainability goals subject to interest of 4.125% p.a. and with maturity date on May 3, 2028 (“ESG Notes”) in the total principal amount of US$1 billion, and these are guaranteed by the Company. For this offer of notes, derivative instruments were contracted for hedging purposes. The targets, to be met by 2026 6.3 Covid- 19 The Company is monitoring the evolution of the Covid- 19 2020 In view of this scenario, the Company’s Management reviews the recoverability expectations of its financial and non-financial assets in the preparation of this financial statements, considering the most recent information available and reflected in the Company’s business plans. During the years of 2021 2020 2020 On a supplementary basis, considering the uncertainties associated with the adversities observed in the economic scenario, the Management also assesses the possible effects on the consolidated financial statements, as discussed below: 6.3.1 The Company’s and its subsidiaries’ businesses were mainly affected by the pandemic during 2020 6.3.2 credit losses The Company assesses the impact of the pandemic on trade accounts receivable, due to the possibility of increasing credit risk, with the aim of ensuring the sustainability of the chain and supporting its customer network. Changes in allowances for expected credit losses are presented in Note 9 6.3.3 Retail operations (mainly composed of physical stores) are not considered essential by government authorities, which led to the closure of part of these locations during different periods of 2020 2021 19 6.3.4 The Company renegotiated contracts and obtained discounts on store lease payments, mainly during the year ended December 31, 2020, as mentioned in note 19 6.3.5 Company’s Management concluded that there are no material uncertainties that could cast significant doubt about its ability to continue operating indefinitely. 6.3.6 The Company used part of the resources from private funding and capital increase (see notes 20 25 19 2020 6.4 Cyber-incident In June 2020, the subsidiary Avon became aware that it was exposed to a cyber-incident in its Information Technology (“IT”) environment that interrupted some systems and partially affected Avon’s operations. Avon involved leading external experts in cybersecurity and general IT controls, initiating a comprehensive containment and correction effort, as well as a forensic investigation. By mid-August, Avon had reestablished all its main business processes and resumed operations in all of its markets, including all of its distribution centers. The cyber incident did not have a significant impact on the revenue performance of the subsidiary for the year ended December 31, 2020, despite having resulted in a phasing of the subsidiary’s revenue from the second to the third quarter of 2020 Although it has no indication that the accuracy and completeness of any financial information has been affected as a result of the incident, the subsidiary has performed extensive procedures to validate the accuracy and completeness of its financial information. 6.5 Capital management The Company’s capital management objectives are to ensure that the Company is continuously capable of offering return to its shareholders and benefits to other stakeholders, in addition to maintaining an ideal capital structure to reduce this capital cost. The Company monitors capital based on the financial leverage ratios. This ratio corresponds to the net debt divided by EBITDA. The net debt corresponds to total borrowing and financing (including short and long-term borrowing and financing, as shown in the consolidated balance sheet), deducted from cash and cash equivalents and short-term investments (except for “ Crer Para Ver 6.6 Fair value estimate Financial instruments that are measured at fair value at the reporting dated as prescribed by IFRS 13 46 ➢ Level 1 ➢ Level 2 1 ➢ Level 3 The carrying amounts and fair values of the Company’s financial instruments as of December 31, 2021 and 2020 Consolidated Carrying amount Fair value Note Classification by category Fair value hierarchy 2021 2020 2021 2020 Financial assets Cash and cash equivalent 7 Cash and banks Amortized cost Level 2 3,349,398 4,436,576 3,349,398 4,436,576 Certificate of bank deposits Amortized cost Level 2 7,639 808,988 7,639 808,988 Repurchase operations Fair value through profit or loss Level 2 650,220 576,108 650,220 576,108 4,007,257 5,821,672 4,007,257 5,821,572 Short-term investments 8 Government securities Fair value through profit or loss Level 2 435,898 864,940 435,898 864,940 Restricted cash Fair value through profit or loss Level 2 44 40,425 44 40,425 Financial treasury bills Fair value through profit or loss Level 2 646,586 505,152 646,586 505,152 Loan investment fund Fair value through profit or loss Level 2 896,212 817,253 896,212 817,253 DBV Fund Fair value through profit or loss Level 3 36,921 16,104 36,921 16,104 Certificate of bank deposits Fair value through profit or loss Level 2 - 292,878 - 292,878 2,015,661 2,536,752 2,015,661 2,536,752 Trade receivables 9 Amortized cost Level 2 3,476,359 3,597,535 3,476,359 3,597,535 Judicial deposits 13 Amortized cost Level 2 585,284 566,190 585,284 566,190 Carbon Credits 15 Fair value through profit or loss Level 2 11,479 4,097 11,479 4,097 Sublease receivables 15 Amortized cost Level 2 347,174 357,538 347,174 357,538 Receivables from service providers 15 Amortized cost Level 1 162,268 135,030 - 135,030 4,582,564 4,660,390 4,582,564 4,660,390 Financial and operating derivatives Fair value – Hedge accounting instruments Level 2 533,410 1,768,122 533,410 1,768,122 Financial and operating derivatives Fair value through profit or loss Level 2 441,719 139,856 441,719 139,856 975,129 1,907,978 975,129 1,907,978 Financial liabilities Borrowing, financing and debentures 20 Borrowing in local currency Amortized cost Level 2 (6,914,117 ) (9,591,809 ) (2,100,465 ) (9,466,921 ) Foreign currency borrowings Amortized cost Level 2 (5,802,715 ) (4,231,104 ) (5,755,272 ) (4,459,081 ) (12,716,832 ) (13,822,913 (7,855,737 ) (13,926,002 ) Carbon credits Fair value through profit or loss Level 2 (19,511 ) (5,560 ) (19,511 ) (5,560 ) Financial and operating derivatives Fair value through profit or loss Level 2 (458,492 ) (61,201 ) (458,492 ) (61,201 ) Lease 19 Amortized cost Level 2 (3,547,862 ) (3,858,455 ) (3,547,862 ) (3,858,455 ) Trade payable and reverse factoring operations 21 Amortized cost Level 2 (6,770,579 ) (6,774,205 ) (6,770,579 ) (6,774,205 ) Insurance payable 24 Amortized cost Level 2 (127,413 ) (159,094 ) (127,413 ) (159,094 ) Dividends payable 25 Amortized cost Level 2 (180,772 ) - (180,772 ) - When measuring, the carrying amount represents a reasonable approximate fair value, as described below: (i) the cash and cash equivalents, trade accounts receivable, accounts payable to suppliers and other current liabilities balances are equivalent to their book values, mainly due to the short-term maturities of these instruments. (ii) the short-term investment balances measured at (a) amortized cost approximate their fair values as the operations are carried out at floating interest rates and (b) fair value against profit or loss consider the rates agreed between the parties upon contracting investments, including market information that render this calculation possible; (iii) the carrying amounts of borrowing, financing and debentures are measured at their amortized cost and disclosed at fair value, which does not differ materially from carrying amounts as the agreed interest rates are consistent with current market rates; and (iv) The fair value of foreign exchange rate derivatives (swap and forward) is determined based on future exchange rates at the reporting date, with the resulting value discounted to present value. The fair value of the investment in the Dynamo Beauty Ventures Ltd. (“DBV”) Fund, classified at level 3 There were no transfers between measurement levels in the fair value hierarchy for the year ended December 31, 2021 and 2020

CASH AND CASH EQUIVALENTS

CASH AND CASH EQUIVALENTS	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Cash and cash equivalent	7. CASH AND CASH EQUIVALENTS Consolidated 2021 2020 Cash and banks 3,349,398 4,436,576 Certificate of bank deposits (a) 7,639 808,988 Repurchase operations (b) 650,220 576,108 4,007,257 5,821,672 (a) As of December 31, 202 1 , investments in Certificate of Bank Deposits (“CDB”) bear interest at an average rate of 103.0 % of the CDI (103.2% in 2020) with daily maturities redeemable with the issuer itself, without significative loss of value. (b) Repurchase operations are securities issued by banks with a commitment by the bank to repurchase the securities, and by the client to resell the security, at a defined interest rate and within a predetermined term, which are backed by public or private securities (depending on the financial institution) and are registered within the Central Agency for Custody and Financial Settlement of Securities (“CETIP”). As of December 31, 2021, repurchase operations are remunerated at an average rate of 100.0% of CDI (100.0% of the CDI as of December 31, 2020).

SHORT-TERM INVESTMENTS

SHORT-TERM INVESTMENTS	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Short-Term Investments	8 SHORT-TERM INVESTMENTS Consolidated 2021 2020 Mutual investment funds (a) 896,212 817,253 Certificate of bank deposits - 292,878 Treasury bills (b) 646,586 505,152 Government securities (LFT) (c) 435,898 864,940 DBV fund 36,921 16,104 Restricted cash 44 40,425 2,015,661 2,536,752 Current 1,978,740 2,520,648 Non-current 36,921 16,104 (a) Mutual investment funds refer to the investments of some subsidiaries of the Company, which are concentrated in the Natura entities of the Hispanic America mainly in Argentina, Chile, Colombia and Mexico. (b) As of December 31, 2021, investments in Treasury bills are remunerated at an average rate of 120.0% of the CDI (136.6% as of December 31, 2020). (c) As of December 31, 2021, investments in Government securities (LFT) are remunerated at an average rate of 102.0% of the CDI (105.9% of the CDI as of December 31, 2020). The breakdown of securities constituting the Essential Investment Fund portfolio, regarding which the Company holds 100% interest, on December 31, 2021 and 2020 is as follows: Consolidated 2021 2020 Certificate of bank deposits (CDB) - 292,878 Repurchase operations (cash and cash equivalents) 569,349 576,108 Financial letter 646,586 505,152 Government securities (LFT) 428,865 864,940 1,644,800 2,239,078

TRADE RECEIVABLES

TRADE RECEIVABLES	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
TRADE RECEIVABLES	9. TRADE RECEIVABLES Consolidated 2021 2020 Trade receivables 3,930,340 4,029,643 (-) Allowance for expected credit losses (453,981 ) (432,108 ) 3,476,359 3,597,535 Maximum exposure to credit risk on the date of the financial statements is the carrying amount of each maturity date range, net of the allowance for expected credit losses. The following table shows trade receivables by exposure to allowance for expected credit losses as of December 31, 2021 and 2020: Consolidated 2021 2020 Trade receivables Allowance for expected credit losses Trade receivables Allowance for expected credit losses Current 2,488,412 (80,087 ) 1,988,583 (53,352 ) Past due: Up to 30 days 937,227 (68,782 ) 1,506,460 (76,848 ) 31 to 60 days 140,757 (56,784 ) 173,121 (56,124 ) 61 to 90 days 97,713 (49,731 ) 111,735 (54,172 ) 91 to 180 days 266,231 (198,597 ) 249,744 (191,612 ) 3,930,340 (453,981 ) 4,029,643 (432,108 ) The changes in the allowance for expected credit losses for the year ended December 31, 2021 and 2020 are as follows: Consolidated Balance as of December 31, 2019 (107,995 ) Additions, net of reversals (640,676 ) Write-offs (a) 372,660 Exchange rate variation (56,097 ) Balance as of December 31, 2020 (432,108 ) Additions, net of reversals (837,822 ) Write-offs (a) 817,446 Exchange rate variation (1,497 ) Balance as of December 31, 2021 (453,981 ) (a) Refers to accounts overdue for more than 180 days, which are written off when the Company has no expectation of recovering the trade receivables and sales of customer portfolios.

INVENTORIES

INVENTORIES	12 Months Ended
	Dec. 31, 2021
Disclosure of Inventories [Abstract]
INVENTORIES	10. INVENTORIES Consolidated 2021 2020 Finished products 4,619,237 3,925,215 Raw materials and packaging 1,166,681 1,015,156 Auxiliary materials 195,364 170,188 Products in progress 38,189 36,025 (-) Provision for inventory losses (615,945 ) (602,314 ) 5,403,526 4,544,270 The changes in the provision for inventory losses for the years ended December 31, 2021 and 2020 are as follows: Consolidated Balance as of December 31, 2019 (185,232 ) Additions, net of reversals (a) (673,201 ) Write-offs (b) 354,692 Exchange rate variation (98,573 ) Balance as of December 31, 2020 * (602,314 ) Additions, net of reversals (a) (407,207 ) Write-offs (b) 396,233 Exchange rate variation (2,657 ) Balance as of December 31, 2021 (615,945 ) (*) the original amounts presented as of December 31, 2020 were reclassified for a better disclosure. Note that this reclassification does not impact the total amount originally presented as provision for inventory losses. a) It refers to the recognition of net allowance for losses due to discontinuation, expiration and quality, to cover expected losses on the realization of inventories, pursuant to the policy of the Company. b) It consists of write-offs of products for which there already had an allowance for losses, where the Company has no expectation of sales/realization.

RECOVERABLE TAXES

RECOVERABLE TAXES	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
RECOVERABLE TAXES	11. RECOVERABLE TAXES Consolidated 2021 2020 ICMS on purchase of goods (a) 732,853 681,147 Taxes on purchase of goods – foreign subsidiaries 313,214 230,260 ICMS on purchases of PP&E 12,138 9,578 PIS and COFINS on purchase of property, plant and equipment and purchase of goods (b) 984,737 780,841 Withholding income tax 56,356 23,637 Withholding PIS, COFINS and CSLL 1,673 1,669 Tax on Manufactured Goods - IPI (c) 114,179 77,096 Other 164,099 199,333 2,379,249 2,003,561 Current 1,029,625 1,071,349 Non-current 1,349,624 932,212 a) Tax credits related to the tax on the circulation of goods, interstate and inter-municipal transport and communication services (ICMS) were generated mainly by purchases, whose tax rate is higher than the average of sales. The Company expects to realize these credits during the ordinary course of business through offsetting with sales operations in the domestic market. b) The accumulated tax credits of PIS and COFINS basically arise from credits on purchases of raw materials used in the production and from purchase of property, plant and equipment, as well as credits arising out of the exclusion of ICMS from the calculation basis of the PIS/COFINS. The realization of these credits normally occurs through offsetting with sales operations in the domestic market. c) The balance will be used to offset IPI ( Imposto sobre Produtos Industrializados ) payable in future operations of the Company.

INCOME TAX AND SOCIAL CONTRIBUT

INCOME TAX AND SOCIAL CONTRIBUTION	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
INCOME TAX AND SOCIAL CONTRIBUTION	12. INCOME TAX AND SOCIAL CONTRIBUTION 12.1 Deferred The deferred Corporate Income Tax - IRPJ and Social Contribution on Net Income - CSLL amounts arise from temporary differences in the subsidiaries. For certain subsidiaries and the Company, deferred tax balances on tax losses were also recognized. The Company’s Management assesses the possibility of offsetting deferred income tax assets and deferred income tax liabilities according to each jurisdiction. The amounts are as follows: i) Breakdown of deferred income tax and social contribution – Assets: Consolidated 2021 2020 Tax loss carryforwards (a) 2,099,768 492,384 Allowance for expected credit losses 224,231 205,033 Provision for inventory losses 244,854 169,181 PP&E and Intangible assets – Depreciation and amortization 308,406 351,784 Lease liabilities 441,860 155,470 Other accruals, reserves and provision for tax, civil and labor risks (b) 418,861 519,293 Employee benefits 317,835 479,536 Other temporary differences 433,041 448,991 Total Deferred Tax Assets 4,488,856 2,821,671 Effect of changes in fair value of derivative instruments, including hedge accounting transactions (c) (137,410 ) (638,965 ) PP&E and Intangible assets – useful life adjustment (312,914 ) (328,698 ) Employee benefits (215,235 ) (197,458 ) Right-of-use assets (423,095 ) (171,788 ) Fair value of identifiable net assets in business combination (d) (1,002,167 ) (1,108,693 ) Other temporary differences (438,001 ) (324,389 ) Total Deferred Tax Liabilities (2,528,823 ) (2,769,991 ) Net Deferred income tax and social contribution 1,960,033 (51,680 ) Deferred income taxes and social contribution assets (e) 2,954,074 1,339,725 Deferred income taxes and social contribution liabilities (e) (994,041 ) (1,288,045 ) a) The variation in the period is due to increase in tax loss carryforwards and negative basis resulted from the recording of approximately R$823 million related to the subsidiary Avon Luxembourg S.A.R.L in the period, resulting from corporate restructuring and expectation of realization of the recorded amount. b) Includes (i) allowance under the accrual basis, reflecting authentic expenses incurred in the year, but for which suppliers have not issued invoice, a (ii) deferred revenue and (iii) other accruals not currently deductible for tax. c) Variation in the period refers to settlement of hedge instruments associated to Bonds with exposition to foreign exchange variation. d) The balance includes deferred income tax liability on the fair value of net identifiable assets in the acquisition of the subsidiaries Avon, The Body Shop and Aesop. e) Balance already includes any offsetting of deferred tax assets and liabilities of the same nature and originating from the same jurisdiction. The Company’s Management assesses the possibility of offsetting deferred income tax assets and deferred income tax liabilities according to each jurisdiction. As a result, there is a position of deferre Management monitors the performance of all its entities and evaluates whether deferred income tax assets can be realized from the four sources of taxable income: utilization of carryback losses, reversing taxable temporary differences, tax planning opportunities and forecasts of future taxable income. The Company does not have deferred income tax assets that cannot be supported by one or more of these sources of income. We emphasize that should macroeconomic and socio-political conditions change or our business operations do not improve, approximately $67 of deferred tax assets could potentially need to be offset with the recording of a valuation allowance during the next 12 months. The deferred tax assets are associated with Avon subsidiary operations that suffered a loss in earnings before tax during 2021. As of December 31, 2021, the Company had balances of deferred income tax asset on tax losses in the amount of R$12.3 billion (R$13.3 billion as of December 31, 2020) which do not expire and had not been recognized in accounting books due to historical analyses of recoverability in the respective operations. Of these amounts, R$8.2 billion are from the subsidiary Natura &Co Luxembourg Holdings S.á.r.l (previously known as “Avon Luxembourg”). Item Amount Indefinite Expiration Definite Expiration Net o perating l oss (a) 10,486,753 9,890,238 596,515 Credits (b) 668,067 - 668,067 Other future deductible Items 1,170,092 83,584 1,086,508 Total 12,324,912 9,973,822 2,351,090 a) During 2022, exp R$168 million are expected, the remaining expirations would start to occur in 2023 and future periods with the majority of tax losses. b) During 2022, expiration of approximately R$10 million are expected; the remaining expirations would start to occur in 2023 and in future periods, with the majority of claims subject to statute of limitations in 2027 . Management continuously evaluates tax planning opportunities to prevent tax attributes from expiring unutilized. As of December 31, 2021, there are no prudent and feasible tax planning opportunities that management would and could implement. In addition, for the credits noted above, there are no other sources of income available and as a result, these credits remain unrecognized. Management continuously evaluates all sources of income to allow unrecognized deferred tax asset to become recognized when it is probable that there are sufficient sources of income to allow for their recognition. Generally, recognition will occur when there is a history of profits that can be sustained and relied upon in the future and/or when facts/circumstances change indicating that a history of losses has been overcome due to elimination of loss-making factors, changes in operations and other factors. A major part of active deferred tax not recognized is associated with the acquisition of Avon’s operations. In 2021 and 2020, there was no event or circumstance that could allow its recognition. 12.2 Reconciliation of income tax and social contribution: Consolidated 2021 2020 2019 Income (loss) before income tax and social contribution (7,297 ) (388,935 ) 304,566 Taxes on Company formation - 206,592 Income (loss) before income tax and social contribution (1) (7,297 ) (388,935 ) 511,158 Income tax and social contribution at the rate of 34% 2,481 132,238 (173,794 ) Benefit of expenses with research and technological innovation 26,277 23,033 19,228 Tax incentives - 10,018 12,457 I nvestment subsidies (a) 469,863 128,173 24,864 Effect from differences of tax rates of entities abroad (139,924 ) (166,394 ) 26,907 Taxation of profits of foreign subsidiaries (77,072 ) (56,194 ) (60,305 ) Deferred income tax recognized (not recognized) from tax losses carryforward (b) 888,900 (104,160 ) (8,893 ) Tax benefits of interest on own equity (IOE) - 10,275 37,628 Exercise of purchase options and restricted share plans (57,526 ) (9,770 ) 9,697 Non-Deductible donation and contribution - (12,509 ) (4,136 ) U nited K ingdom Tax Law r ate c hange (c) (180,174 ) (63,428 ) - Withholding Taxes - (63,754 ) - Transfer pricing adjustments (36,807 ) (67,529 ) (1,156 ) Other permanent differences 151,968 (34,743 ) (31,596 ) Income tax and social contribution revenue (expenses) 1,047,986 (274,744 ) (149,099 ) Income tax and social contribution - current (923,476 ) (292,828 ) (94,780 ) Income tax and social contribution - deferred 1,971,462 18,084 (54,319 ) Effective Rate- % (14.362 ) (70.6 ) 29.2 a) The Company has tax incentives arising from its ordinary operations (Investment subsidies). b) As of December 31, 2021, the Company had balances of deferred income tax asset on tax losses in the amount of R$ 12.3 13.3 8.2 c) During 2021 and 2020 , the income tax rate in the UK was changed. In 2021 , the enacted tax rate increased from 19% to 25% ( 17% to 19% in 2020 ) which resulted in an increase in the Company’s deferred tax liabilities associated with UK. Such increase was accrued through deferred income tax expense during 2021 and 2020. ( 1 ) At consolidated level, income (loss) before income tax and social contribution included the losses with discontinued operations. On the second half of 2021, the Company approved and initiated a restructuring plan of it operations, including the establishment of Avon Luxembourg as a financial subsidiary (FINCO), for the other entities of the Group. From this restructuring, a deferred income tax asset amounting to roughly R$823 million, was recognized, based on the Management´s conclusion that recoverability of these amounts is probable in the regular course of Natura &Co Luxembourg’s activities, and which should occur within a period not exceeding 20 years. The changes in deferred asset and liability income tax and social contribution for the years ended December 31, 2021 and 2020 were as follows: Consolidated Asset Liability Balance at December 31, 2019 374,448 (450,561 ) E ffect on income statement (19,639 ) 37,723 Reserve for grant of options and restricted shares 96,181 - OCI impact (61,658 ) - Currency Translation Effect 283,359 (314,527 ) Business combination 667,034 (560,680) Balance at December 31, 2020 1,339,725 (1,288,045 ) Effect on income statement 1,728,281 243,180 Reserve for grant of options and restricted shares (106,979 ) - Transfer between income tax and deferred social contribution – assets and liabilities 16,437 (16,437 ) OCI impact 72,939 - Currency translation effect (96,329 ) 67,261 Balance as of December 31, 2021 2,954,074 (994,041 ) 12.3 Non-levy of income taxes on amounts adjusted by Selic when returning taxes unduly paid ( indébitos tributários ) On September 24, 2021, the Federal Supreme Court (STF), in a judgment with general repercussions, ruled that the levy of income tax and contribution on net income on undue tax payments adjusted by Selic was unconstitutional, concluding that the Selic rate represents a mere indemnity for delay in the payment of debt and not an increase in equity (which is the triggering event for the levy of said taxes). Based on the decision of the STF, as well as the legal grounds presented in the decision of the Supreme Court, the Company concludes that there has been a change in the facts and circumstances on which this decision was based and, as required by ICPC 22 (IFRIC 23), reassessed the expectation of being entitled to the right in relation to undue tax payments, considering that it is probable that the tax treatment will be accepted. Accordingly, the credit amounts up to the date of the STF decision were recognized in the amount of R$33,600.

JUDICIAL DEPOSITS

JUDICIAL DEPOSITS	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
JUDICIAL DEPOSITS	13. JUDICIAL DEPOSITS Judicial deposits represent restricted assets of the Company and are related to the amounts deposited and held in court until the resolution of the disputes to which they are related. The judicial deposits held by the Company as of December 31, 2021 and 2020 are as follows: Consolidated 2021 2020 Unaccrued tax proceedings (a) 273,295 262,654 Accrued tax proceedings (b) 266,828 252,961 Unaccrued civil proceedings 8,212 9,671 Accrued civil proceedings 2,821 2,189 Unaccrued labor proceedings 11,970 14,166 Accrued labor proceedings 22,158 24,549 Total judicial deposits 585,284 566,190 a) The tax proceedings related to these judicial deposits refer mainly to the ICMS-ST, disclosed in note 23.2.1, contingent liabilities - possible risk of loss. b) The tax proceedings related to these judicial deposits basically refer to the sum of amounts disclosed in note 23.1.1 and the amount accrued as explained in the note 22 . Changes in judicial deposits balances for the year ended December 31, 2021 and 2020 are presented below: Consolidated Balance as of December 31, 2019 337,255 Acquisition of subsidiary 283,885 New deposits 18,377 Redemptions (64,761 ) Inflation adjustment 11,242 Payments / write-offs for expenses (17,739 ) Exchange rate variation (2,069 ) Balance as of December 31, 2020 566,190 New deposits 39,071 Redemptions (21,533 ) Inflation adjustment 15,246 Payments / write-offs for expenses (13,645 ) Exchange rate variation (45 ) Balance as of December 31, 2021 585,284 In addition to judicial deposits, the Company has contracted insurance policies for certain lawsuits.

ASSETS HELD FOR SALE

ASSETS HELD FOR SALE	12 Months Ended
	Dec. 31, 2021
ASSETS HELD FOR SALE
ASSETS HELD FOR SALE	14. ASSETS HELD FOR SALE The assets classified as held for sale were acquired in the acquisition process of Avon. The changes in the balance for the year ended December 31, 2021 and 2020 are as follows: Consolidated 2021 2020 Balance at the beginning of the year 181,279 199,050 Additions (a) 9,028 25,779 Transfer to property, plant and equipment, other assets and liabilities (b) (25,779 ) (29,610 ) Sale (c) (97,905 ) (61,760 ) Exchange rate variation (13,702 ) 47,820 Balance as of the end of the year 52,921 181,279 a) During the third quarter of 2021, the subsidiary Avon made its operations in India available for sale. b) In the first quarter of 2021, the subsidiary Avon identified new circumstances in the sale transaction of the Saudi Arabia operation, which in 2020 was classified as an available-for-sale asset, which resulted in the reclassification of this transaction from held for sale to property, plant and equipment. At the time of the reclassification, an actual depreciation was recorded, resulting in an immaterial impact on the consolidated financial statements. c) During the third and fourth quarters of 2021, the subsidiary Avon completed the sale of the operations located in Spain, India and Saudi Arabia, resulting in a gain of roughly R$14,600. As of December 31, 2021, the assets held for sale include the subsidiary Avon properties, located in Brazil (on December 31, 2020, they were composed of Saudi Arabia, Brazil and Spain).

OTHER CURRENT AND NONCURRENT AS

OTHER CURRENT AND NONCURRENT ASSETS	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
OTHER CURRENT AND NONCURRENT ASSETS	15. OTHER CURRENT AND NONCURRENT ASSETS Consolidated 2021 2020* Marketing and advertising advances 80,078 48,767 Supplier advances 350,830 257,703 Employee advances 17,402 65,180 Rent advances and guarantee deposit (a) 172,465 183,793 Advance insurance expenses 160,911 201,573 Overfunded pension plan (b) 1,043,799 683,425 Customs broker advances - Import taxes 60,739 34,016 Sublease receivables (c) 347,174 357,538 Carbon credits 11,479 4,097 Receivables from service providers ( d ) 162,268 135,030 Other 268,066 172,666 2,675,211 2,143,788 Current 912,160 616,120 Non-current 1,763,051 1,527,668 (*) some amounts originally presented as of December 31, 2020 were reclassified for a better disclosure. Note that this reclassification does not impact the total amount originally presented as current and non-current assets. a) Mainly related to: (i) advances of lease agreements that were not included in the initial measurement of lease liabilities / right-of-use of the subsidiary The Body Shop, in accordance with the exemptions on IFRS 16 06 b) Pension plan arising from the acquisition of Avon. The variation in the period is due to the valuation of funds linked to the pension plan mainly in the United Kingdom (see note 24). c) Refers to the sublease receivable from the New York office owned by the subsidiary Avon. d) Refers to receivables mainly arising from damage that occurred with carriers and insurance companies.

PROPERTY, PLANT AND EQUIPMENT

PROPERTY, PLANT AND EQUIPMENT	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
PROPERTY, PLANT AND EQUIPMENT	16. PROPERTY, PLANT AND EQUIPMENT Consolidated Useful life range (in years) 2020 Additions Write-offs Write-offs Impairment Transfers Exchange rate variation 2021 Cost: Vehicles 2 to 5 79,227 4,951 (59,053 ) - 6,702 7,074 38,901 Tooling 3 187,852 2,097 - - 2,042 (151 ) 191,840 Tools and accessories 3 to 20 85,678 19,526 (538 ) - 5,233 1,099 110,998 Facilities 3 to 60 293,471 700 (14,486 ) - 21,231 2,536 303,452 Machinery and accessories 3 to 15 1,819,693 37,229 (98,228 ) - 85,451 115,798 1,959,943 Leasehold improvements 2 to 20 963,957 104,795 (51,588 ) (2,074) 93,589 19,825 1,128,504 Buildings 14 to 60 1,899,176 6,233 (13,322 ) 394 (6,944 ) 96,750 1,982,287 Furniture and fixture 2 to 25 566,548 107,077 (40,259 ) 3,948 19,304 3,509 660,127 Land - 661,613 295 (1,203 ) - (2,372 ) (29,960 ) 628,373 IT equipment 3 to 15 543,772 58,192 (57,574 ) - 68,645 21,545 634,580 Other assets - 36,687 - (3,628 ) - - (1,423 ) 31,636 Projects in progress - 408,385 606,440 (26,425 ) - (429,760 ) 2,806 561,446 Total cost 7,546,059 947,535 (366,304 ) 2,268 (136,879 ) 239,408 8,232,087 Depreciation value: Vehicles (33,042 ) (19,229 ) 47,501 - (5,738 ) 1,051 (9,457 ) Tooling (166,536 ) (7,705 ) - - - 77 (174,164 ) Tools and accessories (39,159 ) (32,867 ) 750 - 3,145 2,391 (65,740 ) Facilities (176,726 ) (16,453 ) 13,072 - (2,705 ) (608 ) (183,420 ) Machinery and accessories (578,762 ) (198,805 ) 91,864 - 8,463 (51,168 ) (728,408 ) Leasehold improvements (480,554 ) (153,822 ) 48,057 - (5,561 ) (10,742 ) (602,622 ) Buildings (179,729 ) (89,292 ) 13,835 - 2,801 (45,941 ) (298,326 ) Furniture and fixture (318,611 ) (95,673 ) 31,464 (291) (353 ) 13,858 (369,606 ) IT equipment (311,856 ) (115,735 ) 52,971 - (7,982 ) (9,493 ) (392,095 ) Other assets (26,027 ) (16,013 ) 1,369 - - 9,830 (30,841 ) Total depreciation (2,311,002 ) (745,594 ) 300,883 (291 ) (7,930 ) (90,745 ) (2,854,679 ) Net total 5,235,057 201,941 (65,421 ) 1,977 (144,809 ) 148,663 5,377,408 Consolidated Useful life range (in years) 2019 Acquisition of subsidiary Additions Write-offs Write-offs Impairment Transfers Exchange rate variation 2020 Cost: Vehicles 2 to 5 45,578 25,789 14,594 (17,274 ) - 1,184 9,356 79,227 Tooling 3 192,556 - 1,243 (19,713 ) - 5,650 8,116 187,852 Tools and accessories 3 to 20 11,974 52,410 11,625 (1,743 ) - 5,888 5,524 85,678 Facilities 3 to 60 309,772 1,431 81 (3,599 ) - 8,791 (23,005 ) 293,471 Machinery and accessories 3 to 15 866,451 740,328 20,098 (5,134 ) - 58,649 139,301 1,819,693 Leasehold improvements 2 to 20 615,103 58,548 34,324 (8,761 ) - 51,588 213,155 963,957 Buildings 14 to 60 386,957 1,203,081 12,275 - (115 ) 48,551 248,427 1,899,176 Furniture and fixture 2 to 25 397,727 32,566 32,530 (6,300 ) (26 ) 11,239 98,812 566,548 Land - 35,157 570,572 57 - - 4,252 51,575 661,613 IT equipment 3 to 15 297,228 112,369 27,254 (10,652 ) - 36,554 81,019 543,772 Other assets - - 36,423 - - - - 264 36,687 Other assets and projects in progress - 156,011 78,965 440,170 (592 ) - (305,305 ) 39,136 408,385 Total cost 3,314,514 2,912,482 594,251 (73,768 ) (141 ) (72,959 ) 871,680 7,546,059 Depreciation value: Vehicles (16,924 ) - (24,150 ) 10,081 - (2,093 ) 44 (33,042 ) Tooling (175,938 ) - (10,092 ) 19,684 - - (190 ) (166,536 ) Tools and accessories (3,255 ) - (42,932 ) - - 10 7,018 (39,159 ) Facilities (167,362 ) - (19,933 ) 285 - 1,044 9,240 (176,726 ) Machinery and accessories (416,736 ) - (193,657 ) 2,759 - (1,202 ) 30,074 (578,762 ) Leasehold improvements (267,371 ) - (130,631 ) 7,124 (4,900 ) (4,107 ) (80,669 ) (480,554 ) Buildings (101,785 ) - (88,593 ) - - - 10,649 (179,729 ) Furniture and fixture (193,973 ) - (81,287 ) 4,744 (284 ) 4,093 (51,904 ) (318,611 ) IT equipment (197,281 ) - (96,768 ) 8,591 (36 ) - (26,362 ) (311,856 ) Other assets - - (25,078 ) - - - (949 ) (26,027 ) Total depreciation (1,540,625 ) - (713,121 ) 53,268 (5,220 ) (2,255 ) (103,049 ) (2,311,002 ) Net total 1,773,889 2,912,482 (118,870 ) (20,500 ) (5,361 ) (75,214 ) 768,631 5,235,057

INTANGIBLE ASSETS

INTANGIBLE ASSETS	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
INTANGIBLE ASSETS	17 INTANGIBLE ASSETS Consolidated Useful life range (in years) 2020 Additions Write-offs Reversal (provision) of impairment Transfers Exchange rate variation 2021 Cost: Software 2.5 to 10 2,059,150 88,101 (114,805 ) - 280,959 179,212 2,492,617 Trademarks and patents (defined useful life) 20 to 25 894,578 - - - - (4,744 ) 889,834 Trademarks and patents (indefinite useful life) - 5,747,057 - - - - 141,566 5,888,623 Goodwill Avon (note 4) - 13,299,849 - - - - 81,341 13,381,190 Goodwill (a) - 142,090 - - - - 1,090 143,180 Goodwill The Body Shop - 1,946,741 - - - - 116,931 2,063,672 Goodwill acquisition of The Body Shop stores - 1,456 - - - - - 1,456 Relationship with retail clients 10 2,785 - - - - 95 2,880 Key money (indefinite useful life) (c) - 26,769 - (3,619 ) 1,984 - (149 ) 24,985 Key money (defined useful life) (d) 3 to 18 10,860 2,500 - (2,288 ) (5,555 ) 8,846 14,363 Relationship with franchisees and sub franchisees and sales representative (e) 7 to 15 2,959,519 - (446 ) - - 31,485 2,990,558 Technology developed (by acquired subsidiary) 5 1,595,041 - - - - (14,233 ) 1,580,808 Intangible under development 2 to 10 108,275 359,834 (1,326 ) - (147,768 ) (41,239 ) 277,776 Total cost 28,794,170 450,435 (120,196 ) (304 ) 127,636 500,201 29,751,942 Accumulated amortization: Software (1,022,498 ) (373,753 ) 116,429 - 3,760 (93,705 ) (1,369,767 ) Trademarks and patents (100,043 ) (45,782 ) - - - 2,638 (143,187 ) Key money (8,871 ) (185 ) - - 1,667 (9,128 ) (16,517 ) Relationship with retail clients (2,839 ) (286 ) - - - (93 ) (3,218 ) Relationship with franchisees and sub franchisees (419,061 ) (306,451 ) 446 - - (3,983 ) (729,049 ) Technology developed (319,009 ) (320,183 ) - - - 6,866 (632,326 ) Other intangible assets (4,721 ) (1,280 ) 1,326 - - 4,380 (295 ) Total accrued amortization (1,877,042 ) (1,047,920 ) 118,201 - 5,427 (93,025 ) (2,894,359 ) Net total 26,917,128 (597,485 ) (1,995 ) (304 ) 133,063 407,176 26,857,583 Consolidated Useful life range (in years) 2019 Acquisition of subsidiary Additions Write-offs Reversal (provision) of impairment Transfers Exchange rate variation 2020 Cost: Software 2.5 to 10 1,313,090 291,555 82,718 (15,095 ) - 258,092 128,790 2,059,150 Trademarks and patents (defined useful life) 20 to 25 116,805 517,592 - - - - 260,181 894,578 Trademarks and patents (indefinite useful life) - 2,171,585 2,022,163 - - - - 1,553,309 5,747,057 Goodwill Avon (note 4) - - 11,511,028 - - - - 1,788,821 13,299,849 Goodwill (a) - 100,237 - - - - - 41,853 142,090 Goodwill (b) - 1,434,369 34,251 - - - - 478,121 1,946,741 Goodwill acquisition of The Body Shop stores - 1,456 - - - - - - 1,456 Relationship with retail clients 10 1,987 - - - - - 798 2,785 Key money (indefinite useful life) (c) - 17,801 - - - - 1,315 7,653 26,769 Key money (defined useful life) (d) 3 to 18 12,447 - 150 - (2,051 ) 1,647 (1,333 ) 10,860 Relationship with franchisees and sub franchisees and sales representative (e) 7 to 15 602,958 1,884,249 - - - - 472,312 2,959,519 Technology developed (by acquired subsidiary) 5 - 1,131,573 - - - - 463,468 1,595,041 Other intangible assets 2 to 10 110,288 159 176,015 (15,024 ) - (175,414 ) 12,251 108,275 Total cost 5,883,023 17,392,570 258,883 (30,119 ) (2,051 ) 85,640 5,206,224 28,794,170 Accumulated amortization: Software (649,347 ) - (365,184 ) 44 - (3,643 ) (4,368 ) (1,022,498 ) Trademarks and patents (44,108 ) - (36,548 ) - - - (19,387 ) (100,043 ) Key money (2,197 ) - (535 ) - - 10 (6,149 ) (8,871 ) Relationship with retail clients (1,939 ) - (252 ) - - - (648 ) (2,839 ) Relationship with franchisees and sub franchisees (95,772 ) - (278,048 ) - - - (45,241 ) (419,061 ) Technology developed - - (294,713 ) - - - (24,296 ) (319,009 ) Other intangible assets (13,159 ) - (6,496 ) 15,020 - - (86 ) (4,721 ) Total accrued amortization (806,522 ) - (981,776 ) 15,064 - (3,633 ) (100,175 ) (1,877,042 ) Net total 5,076,501 17,392,570 (722,893 ) (15,055 ) (2,051 ) 82,007 5,106,049 26,917,128 a) Goodwill related to the acquisition of subsidiary Emeis Holdings Pty Ltd. acquisition, classified as future economic benefits from synergies. It does not have defined useful life and it is subject to annual impairment tests. b) Goodwill related to the acquisition of subsidiary The Body Shop, classified as future economic benefits from synergies. It does not have defined useful life and it is subject to annual impairment tests. In addition, on June 30, 2020, the subsidiary The Body Shop International Limited acquired the entity Aeon Forest Co. Ltd, for R$ 133,275 (¥ 2,632,000). On October 1, 2020, the transaction was concluded and resulted in an assigned amount of goodwill of R$ 34,251. c) Key money with indefinite useful life refers to payments made to former tenants, to get the right to rent the property under lease and can be subsequently negotiated with future tenants in the case of termination of the lease agreement. This balance was considered the scope of the lease standard (CPC 06 2 16 3.13.1 d) Key money with defined useful life refers to payments made to ex-tenants or lessors, to obtain the right to rent the property under the terms of the lease and which cannot be negotiated or recovered later. This balance was considered as the scope of the lease standard (CPC 06 16 e) The balance refers to identifiable intangible assets from relationship with the subsidiary The Body Shop franchisees and sub-franchisees (relationship where the franchisee owns all rights to operate within a territory) and sub-franchisees (relationship where a franchisee operate a single store within a market), with estimated useful life of 15 years. a) Impairment test of intangible assets with indefinite useful lives Goodwill arising from expected future profitability of acquired companies and intangible assets with an indefinite useful life were allocated to the subsidiaries’ CGU groups. The accordance with CPC 01 (R1) / IAS 36 - Impairment of Assets, when a CGU or group of CGU has an intangible asset with an indefinite allocated useful life, the Company must annually perform the impairment test of its carrying amount. The groups of CGU with intangible assets with indefinite useful life as of December 31, 2021 are presented below: CGU groups Trademarks and patents Goodwill Total 2021 2020 2021 2020 2021 2020 Natura &Co Latam 5,403 5,403 10,041,156 9,994,861 10,046,559 10,000,264 Avon International 2,991,963 2,850,397 3,340,035 3,304,988 6,331,998 6,155,385 TBS International 3,063,662 2,896,660 2,063,672 1,946,741 5,127,334 4,843,401 Aesop International - - 143,180 142,090 143,180 142,090 Total 6,061,028 5,752,460 15,588,043 15,388,680 21,649,071 21,141,140 The main assumptions used to calculate the value in use as of December 31, 2021 are presented below: Aesop The Body Shop Avon International Natura &Co Latam Measurement of recoverable value Discounted cash flow based on financial budgets approved by Board of Directors during a discretionary period of five years with a terminal value projected for the end of the period. Budgeted gross margin Gross margins are based on average amounts obtained in the 2 years prior to the beginning of the budgeted period and projections for the next 5 years. Estimated cost Costs based on historical data and market trends, optimization of retail and direct sales operations (renewal of the geographical presence of stores, revitalization of the franchise network) and physical expansion with growth in market share. Revenue Growth rates Growth rates are initially based on published industry research and adjusted by the expected performance for each segment given the initiatives in place for each segment as well as the respective macroeconomic environment that apply to each segment and are included in the budgets approved by Board of Directors. Perpetuity growth rate (*) Constant growth of 4.80%. Constant growth of 4.40%. Constant growth of 4.70%. Constant growth of 5.50%. Discount rate Discount rates represent the risk assessment in the current market, specific to each group of CGU, taking into account the value of money over time and the individual risks of related assets that were not incorporated in the assumptions included in the cash flow model. These cash flows were discounted using a discount rate of 13.93% p.a. for business segments of Natura &Co Latam; 11.18% p.a. for Avon International, 8.83% for TBS International and 11.19% for Aesop International, in real terms. The discount rate was based on the weighted average cost of capital that reflects the specific risk of each segment. (*) The rates are based on published market analyzes and projections regarding the reporting segment in which they operate and adjusted to reflect the assumptions considered by Management in the approved projections and to reflect the inflation differential of other currencies, when applicable. The Company performed a sensitivity analysis of variables: (i) discount rate and (ii) growth rate in perpetuity, given its potential impacts on cash flows. An increase of 1 percentage point in the discount rate or a decrease of 1 percentage point in the growth rate of the perpetuity of the cash flow of each group of CGU would not result in the need to recognize impairment losses. Based on Management’s assessment, the need to recognize impairment losses for intangible assets with indefinite useful lives in the year ended December 31, 2021 was not identified.

RIGHT OF USE AND LEASE LIABILIT

RIGHT OF USE AND LEASE LIABILITIES	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
RIGHT OF USE AND LEASE LIABILITIES	18. RIGHT OF USE AND LEASE LIABILITIES a) Right-of-use assets Consolidated Useful life in Years (a) 2020 Additions Write-offs Impairment (b) Transfers (c) Exchange rate variation 2021 Cost: Vehicles 3 157,867 32,288 (23,519 ) - - 1,426 168,062 Machinery and equipment 3 to 10 53,048 4,278 (24,140 ) - - 443 33,629 Buildings 3 to 10 1,616,833 300,181 (436,405 ) (4,690 ) 3,363 63,736 1,543,018 IT equipment 10 30,000 4,224 (3,904 ) - - 1,483 31,803 Retail stores 3 to 10 3,338,104 505,871 (489,808 ) - 3,888 59,540 3,417,595 Tools and accessories 3 3,187 256 (2,460 ) - - 70 1,053 Total cost 5,199,039 847,098 (980,236 ) (4,690 ) 7,251 126,698 5,195,160 Depreciation value: Vehicles (63,422 ) (50,181 ) 20,808 - - 1,286 (91,509 ) Machinery and equipment (21,045 ) (10,772 ) 15,067 - - (383 ) (17,133 ) Buildings (399,765 ) (268,902 ) 182,535 - (3,069 ) (17,844 ) (507,045 ) IT equipment (19,161 ) (8,364 ) 3,904 - - (789 ) (24,410 ) Retail stores (1,291,346 ) (659,109 ) 485,123 - - 6,820 (1,458,512 ) Tools and accessories (2,253 ) (681 ) 2,460 - - (108 ) (582 ) Total accrued depreciation (1,796,992 ) (998,009 ) 709,897 - (3,069 ) (11,018 ) (2,099,191 ) Net total 3,402,047 (150,912 ) (270,338 ) (4,690 ) 4,182 115,680 3,095,969 Consolidated Useful life in Years (a) 2019 Subsidiary Acquisition Additions Write-offs Impairment (b) Transfers (c) Exchange rate variation 2020 Cost: Vehicles 3 40,018 42,467 61,878 (441 ) - - 13,945 157,867 Machinery and equipment 3 to 10 15,578 14,034 11,265 - - - 12,171 53,048 Buildings 3 to 10 784,900 489,740 146,695 (16,094 ) - - 211,592 1,616,833 IT equipment 10 283 18,429 6,211 (323 ) - - 5,400 30,000 Retail stores 3 to 10 2,350,377 - 384,502 (25,189 ) (148,050 ) (2,962 ) 779,426 3,338,104 Tools and accessories 3 2,803 - - - - - 384 3,187 Total cost 3,193,959 564,670 610,551 (42,047 ) (148,050 ) (2,962 ) 1,022,918 5,199,039 Depreciation value: Vehicles (8,109 ) - (54,558 ) 192 - - (947 ) (63,422 ) Machinery and equipment (4,317 ) - (14,899 ) - - - (1,829 ) (21,045 ) Buildings (97,190 ) - (291,431 ) 12,448 - - (23,592 ) (399,765 ) IT equipment (214 ) - (18,694 ) - - - (253 ) (19,161 ) Retail stores (463,332 ) - (643,441 ) 3,527 - - (188,100 ) (1,291,346 ) Tools and accessories (936 ) - (936 ) - - - (381 ) (2,253 ) Total accrued depreciation (574,098 ) - (1,023,959 ) 16,167 - - (215,102 ) (1,796,992 ) Net total 2,619,861 564,670 (413,408 ) (25,880 ) (148,050 ) (2,962 ) 807,816 3,402,047 a) The useful lives applied refer to the term of the contracts in which the Company is sure that it will use the assets underlying the lease contracts according to the contractual terms. b) On December 31, 2021, an impairment of R$4,690 was recorded referring to the impairment loss of some stores of the and The Body Shop. On December 31, 2020, an impairment of R$148,050 was recorded; out of this amount R$140,050 was related to the legacy stores of subsidiary The Body Shop, which were previously included in the store closure plan, which were subsequently impacted by the effects of pandemic, predominantly in the United States. In the current estimate of the value in use, an annual pre-tax discount rate of 6.59% was used. c) Refers to key money related to store rentals. This amount is transferred from “right of use” to "intangible assets” when a new commercial agreement with the lessor is not yet signed Consolidated 2021 2020 Amounts recognized in the statement of profit or loss and losses for the years ended December 31, 2021 and 2020 Financial expense on lease 210,669 229,544 Amortization of right-of-use 998,009 1,023,959 Appropriation in the result of variable lease installments not included in the measurement of lease liabilities 70,075 45,952 Sublease revenue (30,026 ) (27,079 ) Short-term lease expenses and low-value assets 83,468 72,546 Benefits granted by lessor related to Covid-19 (80,037 ) (58,700 ) Other lease-related expenses 58,609 40,206 Impairment losses 4,690 144,500 Total 1,315,457 1,470,928 Amounts recognized in the financing activities in the cash flow statement Lease payments (principal) 1,077,611 843,338 Amounts recognized in the operating activities in the cash flow statement Lease payments (interest) 219,574 225,420 Variable lease payments, not included in the measurement of lease liabilities 70,787 33,835 Short-term and low-value assets lease payments 74,188 51,675 Other lease-related payments 95,824 82,150 Total 1,537,984 1,236,418 b) Lease liabilities Consolidated 2021 2020 Current 1,005,523 1,059,661 Non-current 2,542,339 2,798,794 Total 3,547,862 3,858,455 Below are the changes in lease liability balances for the year ended December 31, 2021 and 2020: Consolidated Balance as of December 31, 2019 2,517,565 New contracts and modifications 559,905 Acquisition of subsidiary 777,200 Lease payments – principal (843,338 ) Lease payments – interest (225,420 ) Appropriation of financial charges 229,544 Write-offs (a) (193,174 ) Exchange rate variation (OCI) 1,036,173 Balance as of December 31, 2020 3,858,455 New contracts and modifications 737,899 Lease payments (principal) (1,077,611 ) Lease payments (interest) (219,574 ) Appropriation of financial charges 210,669 Write-offs (a) (105,790 ) Exchange rate variation (OCI) 143,814 Balance as of December 31, 2021 3,547,862 a) The amount of lease payments, considering the interests payments, and corresponding maturities, are disclosed in note 6.2 item f. The maturity analysis of the lease liability non-current balance of are as follows: Consolidated 2021 2020 2022 - 419,240 2023 749,030 408,977 2024 575,223 406,572 2025 onwards (2025 onwards to the year 2020) 716,879 1,564,005 2026 onwards 501,207 - Total 2,542,339 2,798,794 The table below set forth the rates applied, according to the lease terms: As described in note 3.13.2, the Company applied its incremental borrowing rate as the discount rate on lease liabilities. Considering that the Company’s lease contracts are substantially contracts with payment flows indexed by inflation indices and, also considering the disclosure suggestions published in CVM Circular Letter 02/19, the Company presents below additional information on the characteristics of the lease contracts so that users of the financial statements may, at its discretion, carry out projections of future payment flows indexed to inflation. Most of the lease liabilities refer to subsidiaries Avon, The Body Shop and Aesop operations, which contracts were signed substantially in developed economies countries. Therefore, for these countries, the potential effects of the discount would not be significant given its history of low inflation rates. Contractual Payments - Consolidated Maturity Average discount rate 2022 2023 2024 2025 2026 Onwards 2027 2022-2023 0.5% to 10.8% 21,498 10,100 8,829 7,835 5,451 6,048 2024-2026 1.1% to 12.2% 1,182,969 675,518 527,363 637,337 310,950 33,917 2027-2029 1.7% to 14% 30,421 32,638 35,490 38,684 37,527 40,940 2030-2032 2.2% to 15.5% 3,212 2,992 3,390 3,850 4,371 12,645 Total 1,238,100 721,248 575,072 687,706 358,299 93,550 Projected inflation 1 5% 3% 3% 3% 3% 3% ¹ Rates obtained through future prices of DI coupons versus National Consumer Price Index (IPCA) observed in B 3

BORROWING, FINANCING AND DEBENT

BORROWING, FINANCING AND DEBENTURES	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Borrowings, Financing And Debentures	19. BORROWING, FINANCING AND DEBENTURES Reference Consolidated 2021 2020 Local currency: Financing Agency for Studies and Projects FINEP 44,193 73,076 Debentures A 1,922,732 4,042,515 BNDES - 7,789 BNDES – FINAME - 15 Promissory Note (1) - 773,949 Working capital – Mexico Operation - 14,453 Working capital – The Body Shop Operation B 526,743 500,835 Working capital – Avon Operation 164,491 145,495 Notes – Avon (2) C 4,255,958 4,033,682 Total in local currency 6,914,117 9,591,809 Foreign currency: BNDES - 1,639 Representative debt securities (“Notes”) (2) D 5,523,287 3,969,226 Resolution nº 4131 62 E 279,428 260,239 Total in foreign currency 5,802,715 4,231,104 Grand total 12,716,832 13,822,913 Current 945,069 3,805,649 Non-current 11,771,763 10,017,264 Debentures Current 350,145 2,169,786 Non-current 1,572,587 1,872,729 (1) On April 15, 2021, the Company and its subsidiary redeemed the total principal amount due under their respective promissory notes, equivalent to R$500,000 of the Company and R$250,000 of the subsidiary . (2) Balances resulting from the business combinations with Avon (Note 4) recorded at the estimated fair value. Reference Currency Maturity Charges Effective interest rate Guarantees A Real By August 2024 Interest of 112% of the CDI 1.00% + CDI and 1.15% + CDI, with maturity dates in September 2022 and August 2024. 113.0% CDI + 1.15% - CDI +1.30% None B Pounds April 2024 Sonia + interest 2.9 Sonia + interest 2.9 “Corporate” guarantee from the subsidiary Natura Cosméticos until December 2021 and “Aval” guarantee from Natura &Co from January 2022. C Dollar March 2023 and March 2043 Interest of 6.45% p.a. and 8.45% p.a. Interest of 6.45% p.a. and 8.45% p.a. None D Dollar May 2028 Interest of 4.125% p.a. 5.79% “Aval” Guarantee from Natura &Co E Dollar May 2022 Sonia + interest 1.1% p.a. Sonia + interest 1.1 “Aval” Guarantee from subsidiary Indústria e Comércio de Cosméticos Natura Ltda. Changes in the balances of borrowing, financing and debentures for the year ended December 31, 2021 and 2020 are as follows: Consolidated Balance as of December 31, 2019 10,786,374 Acquisition of subsidiary 7,250,735 New borrowing and financing 1,354,765 Repayment (8,483,892 ) Appropriation of financial charges, net of new borrowing and financing costs 1,029,705 Financial charges payment (1,293,094 ) Exchange rate variation (unrealized) 973,442 Exchange rate variation (realized) 35,429 Translation effects (OCI) 2,169,449 Balance as of December 31, 2020 13,822,913 New borrowing and financing (a) 6,425,565 Repayment (b) (7,989,607 ) Appropriation of financial charges 661,429 Financial charges payment (783,935 ) Exchange rate variation (unrealized) 252,190 Translation effects (OCI) 328,277 Balance as of December 31, 2021 12,716,832 (a) New borrowing and financing raised within the year ended December 31, 2021 basically refer to the offer carried out by the Company of the notes linked to the sustainability goals in the amount of USD 1 billion, approximately R$ 5.6 billion (see note 20.1 .iv) and the new credit facility in the amount of one hundred million pounds (£ 100 million), approximately R$ 742 million, obtained by subsidiary The Body Shop (see note .iii). (b) The repayment made in the year ended December 31, 2021 mainly refer to the early redemption of the Company’s Notes in the amount of USD 750 million (corresponding to roughly R$ 4.0 billion, carried out in May 2021 (see note 20.1 .iii)) and to the settlements of the 2 nd series of the 7 th issue of debentures in the amount of R$ 1,827 million and of the 2 nd series of the 9 th issue of debentures in the amount of R$ 308 million, both carried out in September 2021. In addition, on April 15, 2021, the Company and its subsidiary redeemed the total principal amount due under their respective promissory notes, equivalent to R$ 500,000 of the Company and R$ 250,000 of the subsidiary The maturities of non-current portion of borrowing, financing and debentures liabilities are as follows: Consolidated 2021 2020 2022 - 586,002 2023 2,812,260 6,306,782 2024 (2024 onwards for 2020) 2,249,609 3,124,480 2025 onwards 6,709,894 - Total 11,771,763 10,017,264 19.1 i) Debentures On September 28, 2017, the Company carried out the 7th issue of simple, registered, book-entry, non-convertible, unsecured debentures of Natura, in the total amount of R$ 2,600,000. A total of 260,000 debentures were issued, of which 77,273 were in the 1st series, with maturity date on September 25, 2020, and 182,727 were in the 2nd series, due on September 25, 2021, with an interest rate of CDI rate + 1.4% p.a. and CDI rate + 1.75% p.a., respectively. On September 21, 2018, the Company carried out the 9th issue of simple, non-convertible unsecured debentures, with personal guarantee, in three series, for public distribution with restricted placement efforts, in accordance with CVM Instruction 476, in the aggregate amount of R$ 1,000,000, used in the partial early amortization of R$ 1,000,000 related to the 8th issue. The issuance consisted of 100,000 debentures, of which 38,904 were in the 1st series, with maturity date on September 21, 2020, 30,831 were in the 2nd series, with maturity date on September 21, 2021, and 30,265 were in the 3rd series, with maturity date on September 21, 2022, and remuneration corresponding to 109.5%, 110.5% and 112.0%, respectively, of the cumulative variation of the Brazilian Interbank Deposits (“DI”) average daily rates, respectively. On July 22, 2019, the Company carried out the 10th issue of simple, non-convertible, unsecured debentures in four series, for public distribution with restricted placement efforts, in accordance with CVM Instruction 476, in the aggregate amount of R$1,576,450. A total of 157,645 simple, registered, book-entry, non-convertible and unsecured debentures were issued in four series, without certificate issue or provisory certificate, at a nominal unit value of R$ 10, of which 40,000 were in the 1st series, 9,570 in the 2nd series, 68,623 in the 3rd series, and 39,452 in the 4th series, all with maturity dates on August 26, 2024, and interest corresponding to 100% of the cumulative variation of the Brazilian Interbank Deposits (“DI”) average daily rates plus 1% for the 1st series and 100% of the cumulative variation of the Brazilian Interbank Deposits (“DI”) average daily rates plus 1.15% for other series. The funds from the 10th issue were used as follows: 1st series: full amortization of the 8th issue of debentures in the amount of R$ 400,000; 2nd series: partial amortization of the 3rd series of the 6th issuance in the amount of R$ 92,820; 3rd series: partial amortization of the 1st series of the 7th issuance in the amount of R$ 664,090; 4th series: partial amortization of the 1st series of the 9th issuance in the amount of R$ 382,960. On September 21, 2021, the 2nd series of the 9th issue of debentures in the amount of R$308,000 was fully settled. On September 28, 2021, the 2nd series of the 7th issue of debentures in the amount of R$1,827,000 was fully settled. The appropriation of costs related to the issue of debentures in the twelve-month period ended December 31, 2021 was R$3,096 (R$3,888 as of December 31, 2020), recorded monthly under finance expenses, in accordance with the effective interest rate method. As of December 31, 2021, the balance of issue costs to be appropriated is R$ 6,371 (R$ 9,466 as of December 31, 2020). ii) Working capital – The Body Shop On December 31, 2020, subsidiary The Body Shop had a credit facility of up to seventy million pounds (£70,000), corresponding to R$500,835, guaranteed by subsidiary Natura Cosméticos, which could be withdrawn in installments to meet its short-term financing needs. This facility was used by the subsidiary The Body Shop during the first quarter of 2021, to reinforce its working capital and liquidity needs by virtue of the Covid-19 pandemic (with annual interest payment of Sonia + 2%). This facility was paid in March 2021. On April 23, 2021, subsidiary The Body Shop International Limited contracted a facility agreement with UK Export Finance and HSBC Bank PLC in the amount of one hundred million pounds (£100 million), approximately R$742 million, with guarantee from the Company and its subsidiary Natura Cosméticos, as of January 2022, which was fully used by June 30, 2021. This facility agreement will be increased at the Sonia rate + 2.9% per annum, with maturity dates for payment of principal and interest in December 2021, April 2023 and April 2024. iii) Notes On May 21, 2021, the full optional early redemption of the Company’s Notes occurred, which were issued in 2018 by subsidiary Natura Cosméticos S.A. in the amount of US$750,000 (roughly R$ 4.0 billion), and the derivative instruments used for covering the respective risks were settled. iv) ESG debt securities (“Notes ESG ”) On May 4, 2021, Natura Cosméticos concluded the offer of the notes linked to the sustainability goals subject to annual interest of 4.125% and with maturity date on May 3, 2028 (“ESG Notes”) in the total principal amount of US$1.0 billion (approximately R$5.6 billion) and these are guaranteed by the Company. For this offer of notes, derivative instruments were contracted for foreign exchange hedging purposes. The targets, to be met by 2026, include a reduction in greenhouse gas emissions by 13% and the use of recycled plastic in packaging by at least 25%, which the Company does not have current indications that will not be met. The appropriation of costs related to the issue of the Company’s ESG Notes for the year ended December 31, 2021 was R$9,777, recorded monthly under finance expenses, in accordance with the terms of the respective issues. The balance of issue costs to be recognized on December 31, 2021 is R$94,300. v) Notes - Avon The subsidiary Avon has the following notes issued: Notes - Avon Main US$ Main R$ Annual percentage interest rate Maturity Unguaranteed 461,883 2,577,538 6.50% March 15, 2023 Unguaranteed 216,085 1,205,862 8.45% March 15, 2043 19.2 Covenants The contractual covenants associated with the debt contracts of the Company establish the maintenance of minimum financial indicators resulting from the ratio of the division of the net treasury debt by the EBITDA of the last 12 months, as well as non-financial indicators according to each contract. As of December 31, 2021 and 2020, the Company was in compliance with such covenants.

TRADE PAYABLE AND REVERSE FACTO

TRADE PAYABLE AND REVERSE FACTORING OPERATIONS	12 Months Ended
	Dec. 31, 2021
TRADE PAYABLE AND REVERSE FACTORING OPERATIONS
TRADE PAYABLE AND REVERSE FACTORING OPERATIONS	20 TRADE PAYABLE AND REVERSE FACTORING OPERATIONS Consolidated 2021 2020 Domestic trade payable 5,296,080 5,462,377 Foreign trade payable (a) 1,104,189 1,014,356 Subtotal 6,400,269 6,476,733 Reverse factoring operations (b) 370,310 297,472 Total 6,770,579 6,774,205 a) Refers to imports mainly denominated in US dollars, Euros and British pounds. b) The Company has contracts signed with Banco S.A. to directly structure a reverse factoring operation with the Company’s main suppliers. Further details on these operations are included in note 3.6.2.

TAX LIABILITIES

TAX LIABILITIES	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Tax Liabilities	21 TAX LIABILITIES Consolidated 2021 2020 ICMS (ordinary) 150,396 134,165 ICMS-ST provision (a) 58,188 61,521 Taxes on invoicing abroad 340,648 364,291 Withholding tax (IRRF) 148,081 131,368 Other taxes payable - foreign subsidiaries 138,461 136,232 Income tax 7,062 15,943 PIS and COFINS payable 144 11,857 INSS and service tax (ISS) payable 29,359 32,954 Other 8,888 6,490 Total 881,227 894,821 Current 766,430 785,367 Non-current 114,797 109,454 a) The Company has discussions about the illegality of changes in state laws to charge ICMS-ST. Part of the amount recorded as tax payable but not yet paid is being discussed in court by Company, and in some cases, the amounts are deposited in court, as mentioned in note 13.

PROVISION FOR TAX, CIVIL AND LA

PROVISION FOR TAX, CIVIL AND LABOR RISKS	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Provision For Tax, Civil And Labor Risks	22. PROVISION FOR TAX, CIVIL AND LABOR RISKS The Company is involved in certain legal issues arising in the normal course of its business, which include civil, tax, social security, labor, business and other proceedings. The Company’s Management believes that, based on the elements existing on the base date of these financial statements, the provision for tax, civil, labor, commercial and other risks is sufficient to cover possible losses on administrative and legal proceedings, as shown below. 22.1 Contingencies assessed as probable risk of loss The changes in the provision for tax, civil and labor risks and contingent liabilities are presented below: Consolidated Tax Civil Labor Contingent liabilities (business combination) Total 2021 2020 2021 2020 2021 2020 2021 2020 2021 2020 Balance at the beginning of the year 931,771 127,842 219,374 30,653 251,339 61,571 797,693 - 2,200,177 220,066 Acquisition of subsidiary (1) - 671,667 - 102,208 - 163,962 - 820,103 - 1,757,940 Additions 47,116 169,824 181,856 329,294 90,855 44,566 (22 ) 9,772 319,805 553,456 Reversals (2) (78,488 ) (71,797 ) (35,433 ) (62,013 ) (77,727 ) (4,601 ) (195,070 ) (67,482 ) (386,718 ) (205,893 ) Payments (4,965 ) (54,590 ) (88,266 ) (118,047 ) (39,553 ) (48,792 ) - - (132,784 ) (221,429 ) Inflation adjustment 4,698 5,623 2,723 4,164 7,860 6,508 10,450 21,671 25,731 37,966 Exchange rate variation (OCI) (25,609 ) 83,202 12,471 32,424 2,201 27,284 (15,466 ) 13,629 (26,403 ) 156,539 Transfers (3) (12,429 ) - 12,965 (99,309 ) (1,503 ) 841 - - (967 ) (98,468 ) Balance as of the end of the year 862,094 931,771 305,690 219,374 233,472 251,339 597,585 797,693 1,998,841 2,200,177 Current 230,097 199,733 Non-current 1,768,744 2,000,444 (1) Amounts arising from tax, labor and civil lawsuits with probability of possible and remote loss in the amount of R$709,751, R$55,624 and R$119,572, respectively, measured and recorded at the estimated fair value resulting from the business combination with Avon, in accordance with paragraph 23 of CPC 15/IFRS 3, additionally, the fair value of contingent liabilities includes liabilities assumed and recognized by Avon prior to the allocation of fair value, in the amount of R$872,993. (2) Reversals mainly refer to adhesion to state tax amnesty programs and change of labor proceedings estimates. (3) Amounts related to the 2020 period resulted from other liabilities of subsidiary Avon related to proceedings previously recognized as contingent liabilities being reclassified as other trade accounts payable. 22.1.1 Tax Consolidated tax contingencies classified as probable risk of loss mainly involve discussions about the illegality of changes in state laws for the collection of ICMS. Part of the amount not paid is being discussed in court, and in some cases, the amounts are deposited in court, as mentioned in note 13 22.1.2 Civil, commercial and other As of December 31, 2021, the Company is party to commercial and other civil lawsuits and procedures, mainly related to indemnity claims. Provisions are periodically reviewed based on the evolution of processes and the evolution of jurisprudence to reflect the best estimate. a) Talc-related disputes The subsidiary Avon has been named a defendant in numerous personal injury lawsuits filed in U.S. courts, alleging that certain talc products the Avon sold in the past were contaminated with asbestos. Many of these actions involve a number of co-defendants from a variety of different industries, including manufacturers of cosmetics and manufacturers of other products that, unlike the Avon’s products, were designed to contain asbestos. As of December 31, 2021, there were 151 individual cases pending against the Avon. During the year ended December 31, 2021, 107 new cases were shelved, and 120 cases were dismissed, settled or otherwise settled. The value of the settlements was not material, either individually or in the aggregate, to the Avon’s results of operations for the year ended December 31, 2021. Additional similar cases arising out of the use of the Avon’s talc products are reasonably anticipated. We believe that the claims asserted against us in these cases are without merit. We are defending vigorously against these claims and will continue to do so. To date, the Avon has not proceeded to trial in any case filed against it and there have been no findings of liability enforceable against the Company. However, nationwide trial results in similar cases filed against other manufacturers of cosmetic talc products have ranged from outright dismissals to very large jury awards of both compensatory and punitive damages. Given the inherent uncertainties of litigation, we cannot predict the outcome of all individual cases pending against the Company, and we are only able to make a specific estimate for a small number of individual cases that have advanced to the later stages of legal proceedings. For the remaining cases, we reserve an estimate of exposure on an aggregated and ongoing basis, which considers the historical outcomes of all cases we have resolved to date. Any accruals currently recorded on the Avon’s balance sheet with respect to these cases are not material. However, any adverse outcomes, either in an individual case or in the aggregate, could be material. Future costs to litigate these cases, which we expense as incurred, are not known but may be significant, though some costs will be covered by insurance. 22.1.3 Labor The Company, as of December 31, 2021, is a party in labor claims filed by former employees and service providers, mainly related to the payment of severance pay, overtime, salary premiums and monies owed as a result of subsidiary liability and discussion about the recognition of any employment relationship. None of these processes is individually relevant. Provisions are periodically reviewed based on the progress of lawsuits and history of losses on labor claims to reflect the best estimate. 22.2 Contingencies assessed as possible risk of loss The Company has contingencies whose expectation of loss assessed by the Company’s Management and supported by the legal advisors is classified as possible and, therefore, no provision has been recorded. As of December 31, 2021, the contingencies classified as possible loss probability totaled R$10,193,858 (R$9,559,551 as of December 31, 2020), of which R$597,585 (R$797,693 as of December 31, 2020) were recorded at the estimated fair value resulting from the business combinations with Avon Products Inc., shown in the table above. Consolidated 2021 2020 Tax 9,884,541 9,205,601 Civil 128,479 133,302 Labor 180,838 220,648 Total contingent liabilities 10,193,858 9,559,551 22.2.1 Tax Below are the most relevant tax contingencies related to the following matters: a) Infraction notices in which the Brazilian Federal Revenue Office requires IPI tax debts, due to the alleged non-observance of the minimum tax base, provided for in the legislation, when sales transactions destined to interdependent wholesalers. Currently, tax assessment notices are pending judgment at the administrative court level. As of December 31, 2021, the total amount under discussion classified as possible loss is R$ 2,009,562 (R$ 1,963,984 on December 31, 2020). b) Lawsuits in which the industrial establishment equivalence is discussed, as provided for in the Decree No. 8393 / 2015 , which now requires IPI taxation of products listed in the referred legal provision in outbound transactions carried out by interdependent wholesalers. On December 31, 2021, the amount under discussion is R$ (R$ on December 31, 2020). c) Administrative and judicial processes that discuss the illegality of changes in Federal State laws regarding the collection of ICMS and ICMS-ST. As of December 31, 2021, the total amount under discussion is R$ (R$ as of December 31, 2020). d) Infraction notices in which the Brazilian Federal Revenue Office requires IRPJ and CSLL tax debts to challenge the tax deductibility of the amortization of goodwill generated in the context of a corporate reorganization between related parties. Currently, the legality of the administrative decisions that rejected the motions for clarification presented to challenge the special appeals dismissed is being discussed in the courts. As of December 31, 2021, the total amount under discussion classified as possible loss is R$ (R$ as of December 31, 2020). e) Infraction notices in which the Finance Department of the Paulo Federal State requires the collection of ICMS-ST, which was fully collected by the recipient of the goods, the distributor. Currently, the process is pending judgment at the administrative court level. As of December 31, 2021, the total amount under discussion classified as possible loss is R$ 539,561 (R$ 529,660 as of December 31, 2020). f) Infraction notices in which the Brazilian Federal Revenue Office requires IPI tax debts for disagreeing with the tax classification adopted by the Company for some products. The tax assessment notices are awaiting judgment at the administrative court level. As of December 31, 2021, the total amount under discussion is R$ 662,991 (R$ 524,500 as of December 31, 2020). 22.2.2 Civil, commercial and other Below are the most relevant contingencies related to the following matters: a) Shareholder disputes On February 14, 2019, a purported shareholder’s class action complaint (Bevinal v. Avon Products, Inc., et al., No. 19-cv-1420) was filed in the United States District Court for the Southern District of New York against the Avon and certain former executive officers of Avon. The complaint was subsequently amended and recaptioned “In re Avon Products, Inc. Securities Litigation”. The amended complaint is brought on behalf of a purported class consisting of all purchasers or acquirers of Avon common stock between January 21, 2016 and November 1, 2017, inclusive. The complaint asserts violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) based on allegedly false or misleading statements and alleged market manipulation with respect to, among other things, changes made to Avon’s credit terms for Representatives in Brazil. The subsidiary Avon and the individual defendants filed a motion to dismiss which the court denied. During 2020, the parties reached an agreement on a settlement of this class action. The terms of settlement include releases by members of the class of claims against subsidiary Avon and the individual defendants and payment of R$ 75,352. Approximately R$ 10,393 of the settlement was paid by the Avon (which represented the remaining deductible under the Avon’s applicable insurance policies) and the remainder of the settlement was paid by subsidiary Avon’s insurers. On August 31, 2020, the court granted preliminary approval of the settlement, and on February 3, 2021, the court entered an order and judgment granting final approval of the settlement. 22.3 ICMS on PIS and COFINS base On May 13, 2021, the Brazilian Federal Supreme Court partially granted the motion to clarify filed by the Federal Government (Extraordinary Appeal No. 574.706/PR), aiming at restricting the effects of the decision, with general repercussion, that the ICMS does not integrate the tax base for purposes of assessment of the Profit Participation Program (PIS) and of the Contribution for the Financing of the Social Security (COFINS) and also determining that (i) the decision should produce effects as of March 15, 2017 (merit judgment), except for the court actions and administrative proceedings filed until such date; and (ii) the ICMS to be excluded from the PIS and COFINS base is the one indicated in the invoices. As a result of this decision, and after reviewing in detail the calculations related to such credits, the Company recognized, during the year ended December 31, 2021, the credits arising from such discussion in the amount of R$135,297.

OTHER LIABILITIES

OTHER LIABILITIES	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Other Liabilities	23. OTHER LIABILITIES Consolidated 2021 2020 Pension and post-employment health care plans (a) 673,458 783,184 Deferred revenue from performance obligations with customers (b) 393,046 422,353 Provisions for incentives to consultants 286,791 292,034 Provisions for operating expenses (marketing / technology, etc.) ( c ) 601,841 535,276 Provision for store renovation 105,165 99,702 Crer Para Ver (d ) 90,655 75,508 Provisions for rentals (e ) 55,500 70,598 Provision for restructuring (f ) 103,760 68,954 Long-term incentives (g ) 6,302 52,745 Insurance payables 127,413 159,094 Other Liabilities (h ) 214,635 245,526 Total 2,658,566 2,804,973 Current 1,716,110 1,691,834 Non-current 942,456 1,113,139 (*) some amounts originally presented as of December 31, 2020 were reclassified for a better disclosure, including the balance related to discontinued operations that is disclosed in note 23. a) As of December 31, 2021, there is R$445,804 (R$609,691 as of December 31, 2020) related to Avon's pension plans, and R$34,774 (R$39,029 as of December 31, 2020) related to post-employment plans of subsidiary Avon, and R$124,649 (R$134,194 as of December 31, 2020) related to post-employment healthcare plans of subsidiary Natura Cosmeticos and R$68,230 as of December 31, 2021 related to post-employment healthcare plans of subsidiary &Co International. b) Refers to the deferral of revenue of performance obligations related to loyalty programs based on points, sale of gift cards not yet converted into products and programs and events to honor direct selling consultants, of which R$235,308 (R$318,686 as of December 31, 2020) related to subsidiary Avon, R$121,341 (R$103,667 as of December 31, 2020) related to subsidiary consolidated and R$36,397 related to subsidiary & Co International. c) Refers to the Company’s operating provisions mainly due to spending on provision of technology services, marketing and advertising. d) Refers to Social program contribution for developing the quality of education. e) Refers to the (grace) period granted by lessors for the start of payment of rental of certain retail stores, for rental agreements that were not included in the initial measurement of lease liabilities / right of use of the subsidiary The Body Shop, in accordance with the exceptions permitted under IFRS 16 / (CPC 06 (R2)). f) Provision for costs directly related to the plan for integration and changes in the organizational structure, mainly of subsidiary Avon organizational structure. g) Refers substantially to the variable remuneration plans for subsidiary Avon executive officers. h) Refers to several provisions such as indemnities and long-term contractual obligations. Post-employment health care and Pension plan a) Defined benefit pension and postretirement plans (Avon) The subsidiary Avon has contributory and noncontributory defined benefit retirement plans for substantially all of its employees. The benefits of these plans are generally based on the employee’s length of service and the average compensation near retirement, and certain plans have vesting requirements. The plans are funded based on legal requirements and cash flow. The largest defined benefit pension plan of the subsidiary Avon outside the United States (“US”) is in the United Kingdom (“UK”). The UK defined benefit pension plan was frozen for future accruals as of April 1, 2013. The US defined benefit pension plan, the Avon Products, Inc. Personal Retirement Account Plan (the “PRA”), is closed to employees hired on or after January 1, 2015. Qualified retirement benefits for US-based employees hired on or after January 1, 2015 will be provided exclusively through Personal Savings Account Plan (the “PSA”), as described in note 29.3. The most recent actuarial valuation of plan assets and the present value of the defined benefit obligation was carried out on December 31, 2021. The present value of the defined benefit obligation and the respective cost of current services and cost of past services were measured at projected unit credit method. The change in actuarial liabilities for the years ended December 31, 2021 and 2020 are shown below: Pension plan 2021 2020 Balance at beginning of year 609,961 413,070 Cost of services – current 24,660 28,015 Interest cost – recognized in the income statement 10,934 13,760 Administrative costs 2,698 2,476 Company contributions (49,516 ) (17,212 ) Benefits paid (6,413 ) (4,611 ) Actuarial gain (loss) in OCI (99,991 ) 74,460 Reclassifications 18,045 (14,451 ) Others (72,252 ) (2,814 ) Foreign currency changes 7,678 117,268 Balance at end of year 445,804 609,961 The significant actuarial assumptions for the determination of the actuarial liability are discount rate and rate of compensation increase. The details of the assumptions are as follows: 2021 2020 Discount rate 0.65 9.20 0.30 to 8.50% Rate of compensation increase 1.80% to 6.60% 1.80% to 6.60% The fair values of each major class of plan assets are presented below: Consolidated 2021 2020 Cash and cash equivalent 191,958 173,563 Equity instruments of other entities 1,066,370 918,222 Government bonds 1,482,650 2,633,587 Corporate bonds 1,802,394 525,886 Real estate 12,834 8,314 Other 12,276 10,393 Total 4,568,482 4,269,965 b) Post-employment health care plan (Natura Cosméticos) Post-employment health care plan as detailed in note . The number of active employees eligible for the healthcare plan after termination is closed to new inclusions. As of December 31, 2021 and , the obligation weighted average duration is around and years, respectively, and its actuarial calculation base is as follows:  993 (2020: 1,064) active employees of the subsidiaries Natura Cosméticos and Natura Indústria;  473 (2020: 537) retired and dependent on the subsidiaries Natura Cosméticos and Natura Indústria. The actuarial liability was calculated, as of December 31, 2021 and 2020, considering the following main assumptions: 2021 2020 Discount rate 9.01% 7.02% Initial growth rate of medical cost 4.25% 3.75% Inflation rate 3.40% 3.10% Final growth rate of medical cost 7.79% 6.97% Growth rate of medical costs due to aging - costs Per age range 1.25% to 4.75% p.a. Per age range 1.25% to 4.75% p.a. Growth rate of medical costs by aging - contributions 0.00% 0.00% Percentage of adherence to the plan in retirement Bradesco Plan 60.00% / Unimed Plan 85.00% Bradesco Plan 69.00% / Unimed Plan 84.00% Schedule of disabled mortality Mercer Disability Mercer Disability Schedule of mortality AT- 2000 AT- 2000 Schedule of turnover Proportional calculation at the time of service Proportional calculation at the time of service Increasing the initial level of growth in medical costs at a real rate of 4.25% and increasing the annual discount rate from 7.02% to 9.01% generated a gain of R$28,254 in OCI. The table below sets forth the medical inflation rate and the discount rate sensitivity analysis, and their respective effect on the balance (present value of the obligation, or “PVO”) accounted as on the actuarial liabilities (maintaining the other assumptions): Rate Chance PVO Discount rate 9.01% 0.5% increase 105,731 Discount rate 9.01% 0.5% decrease 148,971 Rate of compensation 7.79% 1% increase 148,175 Rate of compensation 7.79% 1% decrease 105,933 The changes of actuarial liabilities for the years ended December 31, 2021 and 2020, is set forth in the table below: Consolidated 2021 2020 Balance at the beginning of the year 134,194 98,792 Cost of the current service of subsidiary Natura Cosméticos 939 620 Cost of interest 9,326 7,223 Expenses paid (2,679 ) ( 2,069 ) Actuarial gains (losses) in OCI (17,131 ) 29,628 Balance at end of year 124,649 134,194

SHAREHOLDER'S EQUITY

SHAREHOLDER'S EQUITY	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Shareholder's Equity	24 SHAREHOLDER’S EQUITY 24.1 Capital Stock As of December 31, 2021, the capital stock is R$12,481,683, consisting of 1,379,584,737 registered common shares, with no par value (R$12,377,999, composed of 1,375,158,636 shares as of December 31, 2020). 24.2 Dividends and interest on shareholder's equity payable The shareholders are entitled to receive every year a mandatory minimum dividend of 30% of net income, considering principally the following adjustments:  Increase in the amounts resulting from the reversal, in the period, of previously recognized reserves for contingencies.  Decrease in the amounts intended for the recognition, in the period, of the legal reserve and reserve for contingencies.  Whenever the amount of the minimum mandatory dividend exceeds the realized portion of net income for the year, management may propose, and the General Meeting approves, allocate the excess to the constitution of the unrealized profit reserve (article 197 of Law 6,404/76). In addition, dividends were proposed for the year ended December 31, 2021 in the amount of R$ 180,772, equivalent to the remuneration of R$0.1315 per share based on earnings in the period. According to the Company’s bylaws and in the article 197 of law nr. 6.604/76 the amount of R$133,616 referring to the portion of minimum mandatory dividends exceeding the realized net income for the year will be submitted to approval in the Annual General Meeting to be held in April 2022, for constitution of unrealized profit reserve. The Board of Directors may pay or credit interest on net equity in accordance with applicable law. 24.3 Treasury shares As of December 31, 2021 and 2020, item “Treasury shares” has the following composition: Number of shares Amount R$ (thousands) Average price per share - R$ Balance as of December 31, 2020 316,701 11,667 38.04 Used (754,719 ) (34,438 ) 45.63 Acquired 5,337,558 174,113 32.62 Balance as of December 31, 2021 4,899,540 151,342 30.89 The minimum and maximum cost of the balance of treasury shares as of December 31, 2021 and 2020 are R$25.74 and R$50.93, respectively. 24.4 Capital reserve In the year ended December 31, 2021, the capital reserve had decreased by R$650,196, due to the absorption of losses, for the year ended December 31, 2020, and an increase of R$76,865 (R$52,041 as of December 31, 2020) referring to the changes of the purchase option and restricted share plans. The acquisition of the subsidiary Avon resulted in the issue of Natura &Co shares for the total subscription amount of R$ 13,274,894. Of this amount, R$ 3,397,746 were allocated to the share capital account and the remainder amount of R$ 9,877,148 were allocated to the Company’s capital reserve. This incorporation of shares was approved at the Company’s Board of Directors meeting held on January 3, 2020. The approval of the capital increase of R$ 2,000,000, approved on June 30, 2020, allocated the amount R$ 1,118 to the capital reserve. The capital reserve decreased by R$147,592 in the year ended December 31, 2020, due to the allocation to the profit reserve and an increase of R$ 58,496, due to the effects of IAS 29 - Accounting in Hyperinflationary Economy (CPC 42), and an increase of R$52,041 referring to the changes of the purchase option and restricted share plans. The capital reserve as of December 31, 2021 amounted to R$10,478,804 (R$11,052,135 as of December 31, 2020). 24.5 Legal p rofit reserve On December 31, 2021, the profit reserve increase by R$751,057 (R$269,186 as of December 31, 2020), being (i) increase of R$870,749 related to profit retention reserve; (ii) decrease of R$6,390 related to the movement of stock option plans and restricted shares and (iii) decrease of R$113,302 referring to the reclassification of subvention reserve. The retained profit reserve balance as of December 31, 2021 was R$871,223 (R$120,166 as of December 31, 2020). 24.6 Cumulative translation adjustment – Other comprehensive income The Company recognizes in this equity item the exchange rate variation effect from investments in foreign subsidiaries, including exchange rate variations in a hyperinflationary economy, actuarial gains and losses arising from the employee benefit plan, and the effect from cash flow hedge operations. For exchange rate variation, the accumulated effect will be reversed to income statement as a gain or loss only in the event of disposal or write-off of the investment. For actuarial losses and gains, the amounts will be recognized when the actuarial liability is remeasured. The cash flow hedge transactions are transferred to the income statement in case an ineffective portion is identified or when the hedge relationship is terminated.

OPERATING SEGMENTS

OPERATING SEGMENTS	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Reporting Segment	25 OPERATING SEGMENT The determination of the Company’s operating segments is based on its Corporate Governance structure, which divides the business into the following segments for purposes of decision making and Management analysis. Since January 3, 2020, as a result of the acquisition of Avon, the Company’s Management has the following corporate governance structure:  Natura &Co Latam Operation – all operations of the subsidiaries Natura Cosméticos, Avon, Aesop and TBS located in Brazil and Latin America;  Avon International – all operations of the subsidiary Avon , except for Avon operations located in Brazil and Latin America;  The Body Shop International – all operations of the subsidiary The Body Shop , except for The Body Shop operations located in Brazil and Latin America; and  Aesop International - all operations of the subsidiary Aesop , except for Aesop operations located in Brazil and Latin America. Segment performance is evaluated primarily by earnings before interest, tax, depreciation and amortization as shown below. Net revenue by segment is as follows for the year ended December 31, 2021:  Natura &Co – 55.8%  Avon International – 23.2%  The Body Shop International – 14.5%  Aesop International – 6.5% The accounting policies for each segment are applied uniformly as described in note 3. The following tables provide the summarized financial information related to the segments and geographic distribution of the Company’s commercial operations for December 31, 2021 and 2020. 25.1 Operating segments 2021 Reconciliation to net income (loss) for the year Financial Revenue Performance assessed by the Company Depreciation and amortization Financial income Financial expense Income tax Net income (loss) Natura &Co Latam 22,413,401 2,595,653 (871,973 ) 3,181,237 (3,881,418 ) 165,137 1,188,636 Avon International 1 9,329,325 272,655 (830,931 ) 421,123 (894,318 ) 210,705 (919,316 ) The Body Shop International 1 5,821,776 1,023,095 (795,127 ) 63,939 (137,834 ) (158,973 ) (4,900 ) Aesop International 1 2,600,185 622,944 (293,492 ) 30,380 (75,372 ) (90,277 ) 194,183 Corporate expenses - (604,594 ) - 309,884 (44,598 ) 921,394 582,086 Consolidated 40,164,687 3,909,753 (2,791,523 ) 4,006,563 (5,033,540 ) 1,047,986 1,040,689 2020 Reconciliation to net income (loss) for the year Financial Revenue Performance assessed by the company Depreciation and amortization Financial income Financial expense Income tax Income (loss) Natura &Co Latam 20,542,345 2,369,517 (874,584 ) 3,402,578 (3,891,641 ) (428,191 ) 577,679 Avon International 1 9,097,375 185,914 (814,678 ) 979,267 (1,442,216 ) (121,603 ) (1,213,315 ) The Body Shop International 1 5,332,922 935,255 (761,224 ) 82,736 (157,705 ) (66,626 ) 32,436 Aesop International 1 1,949,338 606,544 (268,092 ) 23,152 (72,056 ) (55,219 ) 234,328 Corporate expenses - (731,889 ) (278 ) 250,658 (210,192 ) 396,895 (294,806 ) Consolidated 36,921,980 3,365,339 (2,718,856 ) 4,738,391 (5,773,810 ) (274,744 ) (663,678 ) 2019 Reconciliation to net income (loss) for the year Financial Revenue Performance assessed by the company Depreciation and amortization Financial income Financial expense Income tax Income (loss) Natura &Co Latam 9,113,856 1,372,172 (370,953 ) 1,893,333 (2,613,294 ) 41,623 322,880 The Body Shop International 1 4,028,660 806,357 (559,921 ) 44,953 (99,765 ) (37,736 ) 153,888 Aesop International 1 1,302,174 351,944 (186,542 ) 9,337 (34,204 ) (47,768 ) 92,768 Corporate expenses - (61,809 ) - 8,161 (48,611 ) (311,810 ) (414,069 ) Consolidated 14,444,690 2,468,664 (1,117,416 ) 1,955,784 (2,795,874 ) (355,691 ) 155,467 2021 2020 Non-current assets Total assets Current liabilities Non-current liabilities Non-current assets Total assets Current liabilities Non-current liabilities Natura &Co Latam 18,060,879 29,580,551 7,462,550 8,794,843 20,228,016 30,706,123 9,349,461 9,060,600 Avon International 1 14,286,498 17,512,750 2,783,907 5,100,109 12,486,733 16,036,743 3,467,099 5,625,774 The Body Shop International 1 8,166,363 10,813,064 1,690,622 2,485,200 7,821,884 10,474,191 2,291,459 1,812,991 Aesop International 1 1,520,514 2,542,125 610,451 648,695 1,395,628 2,148,869 488,662 618,531 Corporate expenses 964,359 - 1,146,347 1,159,041 250,516 1,551,671 562,905 253,007 Consolidated 42,998,613 60,448,490 13,693,877 18,187,888 42,182,777 60,917,597 16,159,586 17,370,903 2020 2019 Non-current assets Total assets Current liabilities Non-current liabilities Non-current assets Total assets Current liabilities Non-current liabilities Natura &Co Latam 20,228,016 30,706,123 9,349,461 9,060,600 4,574,087 9,328,858 3,116,454 8,235,678 Avon International 1 12,486,733 16,036,743 3,467,099 5,625,774 - - - - The Body Shop International 1 7,821,884 10,474,191 2,291,459 1,812,991 6,146,960 7,369,250 1,065,447 1,477,149 Aesop International 1 1,395,628 2,148,869 488,662 618,531 1,033,408 1,435,830 255,616 590,917 Corporate expenses 250,516 1,551,671 562,905 253,007 - 3,050,574 3,080,906 - Consolidated 42,182,777 60,917,597 16,159,586 17,370,903 11,754,455 21,184,512 7,518,423 10,303,744 1 The operations of these segments located in Latin American countries (Latam) are presented in the Natura &Co Latam segment. 25.2 Net revenue and non-current assets, by geographical area of operations Net revenue Non-current assets 2021 2020 2019 2021 2020 Asia 3,719,131 2,929,063 782,940 1,216,942 768,878 North America 6,227,104 5,120,953 1,750,957 6,459,026 5,939,728 Mexico 3,879,033 3,205,609 767,361 3,640,644 3,263,833 Other 2,348,070 1,915,344 983,596 2,818,382 2,675,896 South America 17,436,131 16,484,363 8,340,025 14,250,548 14,810,020 Brazil 10,481,869 11,113,810 6,324,227 11,953,325 12,159,245 Argentina 2,973,638 1,999,461 794,749 1,036,205 1,041,392 Other 3,980,624 3,371,092 1,221,049 1,261,018 1,609,383 Europe, Middle East and Africa (EMEA) 11,771,601 11,580,586 2,909,968 19,276,178 19,615,198 United Kingdom 4,187,200 4,117,699 2,115,385 12,162,597 17,059,017 Other 7,584,402 7,462,887 794,583 7,113,581 2,556,181 Oceania 1,010,721 807,015 660,800 1,795,919 1,048,953 Consolidated 40,164,687 36,921,980 14,444,690 42,998,613 42,182,777 There is no other individual foreign country that represents more than 10% of net revenue or non-current assets in the foreign market for the years ended December 31, 2021, 2020, and 2019.

NET REVENUE

NET REVENUE	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
NET REVENUE	26 NET REVENUE Consolidated Revenue: 2021 2020 2019 Domestic market 14,329,931 15,373,742 8,907,766 Foreign market 36,894,728 31,784,934 10,739,036 Other sales 418,217 538,942 61,302 Subtotal 51,642,876 47,697,618 19,708,104 Returns and cancellations (644,693 ) (617,140 ) (73,183 ) Commercial discounts and rebates (1,238,667 ) (1,062,204 ) (1,292,134 ) Taxes on sales (9,594,829 ) (9,096,294 ) (3,898,097 ) Subtotal (11,478,189 ) (10,775,638 ) (5,263,414 ) Total net revenue 40,164,687 36,921,980 14,444,690

OPERATING INCOME (EXPENSES) AND

OPERATING INCOME (EXPENSES) AND COST OF SALES	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
OPERATING INCOME (EXPENSES) AND COST OF SALES	27 . OPERATING INCOME (EXPENSES) AND COST OF SALES Classified by function Consolidated 2021 2020 2019 Cost of sales 14,011,525 13,229,715 4,033,454 Selling, marketing and logistics expenses 16,999,225 15,702,787 6,395,586 Administrative, R&D, IT, and project expenses 6,958,866 5,955,996 2,405,576 Total 37,969,616 34,888,498 12,834,616 Classified by nature Cost of sales 14,011,525 13,229,715 4,033,454 Raw material/packaging material/resale 12,115,805 11,222,801 3,457,481 Employee benefits expense (note 29) 568,936 638,525 293,374 Depreciation and amortization 254,476 215,355 57,443 Other 1,072,308 1,153,034 225,156 Selling, marketing and logistics expenses 16,999,225 15,702,787 6,395,586 Logistics costs 2,654,546 2,479,156 797,055 Personnel expenses (note 29) 4,547,391 4,198,147 1,667,202 Marketing, sales force and other selling expenses 8,388,848 7,568,365 3,164,875 Depreciation and amortization 1,405,423 1,301,657 766,454 Impairment 3,017 155,462 - Administrative, R&D, IT and project expenses 6,958,866 5,955,996 2,405,576 Innovation expenses 223,472 270,256 89,675 Personnel expenses (note 29) 2,886,281 2,498,024 1,223,586 Other administrative expenses 2,717,489 1,985,872 798,796 Depreciation and amortization 1,131,624 1,201,844 293,519 Total 37,969,616 34,888,498 12,834,616

EMPLOYEE BENEFITS

EMPLOYEE BENEFITS	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
EMPLOYEE BENEFITS	28 EMPLOYEE BENEFITS Consolidated 2021 2020 2019 Payroll, profit sharing and bonuses 5,911,837 5,407,990 2,315,517 Pension Plan 243,511 186,373 93,528 Share-based payments and social charges (note 32.3) (a) 228,131 231,962 118,608 Health care, food and other benefits 712,983 684,992 253,510 Charges, taxes and social contributions 701,521 635,248 231,384 INSS 204,625 188,131 171,615 Total 8,002,608 7,334,696 3,184,162 a) The variation in the subsidiary over 2021 is basically due to transfer of employees from Natura Cosmeticos S.A. to Natura &Co Holding, as well as the increase for the 2021 grant, net of social charges associated with the variation in the value of the Company's share. 28.1 Share-based payments The share-based payment plans that were in place before the corporate restructuring on December 18, 2019 were originally granted considering Natura Cosméticos shares that were traded at B3. As a result of the corporate restructuring, Natura Cosméticos shares originally granted were replaced by the Natura &Co's shares. Such modification did not impact the executives and the respective plans. Awards granted in 2021 The awards granted in 2021 are either related to the “Co-Investment Plan” or the “Long-Term Incentive Plan” program. Under the “Co-Investment Plan”, eligible employees may invest part of their payout from the Profit Share Program in the purchase of Natura &Co Holding’s shares. Natura &Co Holding will then grant awards ("Matching Awards”) to match such purchased shares on a 1:1 ratio. The Matching Awards vest in 3 equal instalments over three years. The “Long-Term Incentive Plan” consists of granting of Natura &Co Holding’s shares to eligible employees. Certain “Long-Term Incentive Plan” awards are only subject to a requirement to remain in employment over the vesting period. The awards referred to as “Performance Shares” are subject to both a requirement to remain employed over the vesting period and meeting certain performance conditions. The changes in the number of outstanding share-based awards are as follows: Stock Option Plan and Strategy Acceleration Plan Average exercise price per option – R$ Options (thousands) Balance as of December 31, 2020 16.43 15,523 Granted 30.87 6,650 Expired/Canceled 20.76 (183 ) Exercised 18.80 (1,853 ) Balance as of December 31, 2021 21.05 20,137 Restricted shares (thousands) Performance shares (thousands) Balance as of December 31, 2020 4,361 5,579 Granted 3,435 3,402 Expired/Canceled (590 ) (936 ) Exercised (1,712 ) - Balance as of December 31, 2021 5,494 8,045 The number of shares above and throughout this disclosure note: Do not include the Avon Products Inc. plans that were in place prior to the acquisition by Natura &Co, as covered in the separate section 29.2 below; Are shown already considering the stock split approved at the Extraordinary Shareholders Meeting held on September 17, 2019; Are presented using B3 equivalents for awards that are to be exercised / settled in ADRs, to ensure consistency; The number of performance shares is disclosed assuming achievement of performance conditions at target, whereas the expense recognized in the year reflects the latest reassessment of the number of awards expected to vest. The share-based payment expense recognized in the year ended December 31, 2021 amounted to net of social charges R$ 228,133 (R$ 231,939 as of December 31, 2020). The outstanding share-based awards as at the end of the period have the following maturity dates, fair values and exercise prices As of December 31, 2021 - StockOptions Grant date Conditions for acquiring the rights from grant date Exercise price - R$ Fair value at grant date (R$) Existing shares (thousands) Maximum remaining contractual life (years) Vested options (thousands) March 17, 2014 From 2 4 28.94 4.27 82 0.2 82 March 16, 2015 From 2 4 13.47 4.85 to 5.29 104 1.2 104 July 28, 2015 (Acceleration Strategy) From 4 5 12.77 6.20 to 6.23 495 1.6 495 March 15, 2016 From 2 4 12.71 7.16 to 7.43 93 2.2 93 July 11, 2016 (Acceleration Strategy) From 4 5 11.28 6.84 to 6.89 1,650 2.5 1,650 March 10, 2017 From 2 4 12.46 6.65 to 6.68 378 3.2 378 March 10, 2017 (Acceleration Strategy) From 4 5 12.46 6.87 to 6.89 2,000 3.2 895 March 12, 2018 From 2 4 16.83 7.96 to 8.21 1,554 4.2 890 March 12, 2018 Acceleration strategy) From 3 5 12.04 to 16.83 8.21 to 9.67 3,800 4.2 950 April 12, 2019 From 2 4 23.41 11.71 to 11.82 1,431 5.2 391 April 12, 2019 Acceleration strategy) From 4 5 23.41 11.51 to 11.71 1,900 5.2 - March 31, 2021 From 4 5 48.98 29.08 to 29.81 1,100 9.3 - December 17, 2021 From 3 4 27.28 17.58 to 18.16 5,550 10.0 - 20,137 5,928 As of December 31, 2021 – Restricted shares Grant date Conditions for acquiring the rights from grant date Existing shares (thousands) Fair value at grant date (R$) Remaining contractual life (years) March 12, 2018 - Plan I, August 13, 2018 - Extraordinary Plan VI From 2 4 248 12.25 to 15.90 0.2 April 12, 2019 – Plan I From 2 4 569 21.62 to 22.53 1.2 April 12, 2019 – Plan II From 1 3 156 22.14 to 22.85 0.2 March 27, 2020 – Co-Investment Plan From 1 3 1,312 29.00 1.3 March 31, 2021 From 1 3 3,209 48.13 2.3 5,494 As of December 31, 202 1 – Performance shares Grant date Conditions for acquiring the rights from grant date Existing shares (thousands) Fair value at grant date (R$) Maximum remaining contractual life (years) Undelivered shares (thousands) May 21, 2019 Achievement of performance conditions, 3 years of service plus an additional holding period of 1 year for certain awards. 539 28.10 to 45.70 0.5 to 1.5 539 September 30, 2020 Achievement of performance conditions, 2.5 years of service plus an additional holding period of 1 year for certain awards. 4,303 48.56 to 73.46 1.3 to 2.3 4,303 March 31, 2021 Achievement of performance conditions, 3 years of service plus an additional holding period of 1 year for certain awards. 3,203 46.57 to 50.98 2.3 to 3.3 3,203 8,045 8,045 As of December 31, 2021, the market price was R$25.43 per share, already considering the stock split (R$ 52.50 as of December 31, 2020). 28.2 Avon Products Inc. Plans Share-Based Compensation Plans Prior to being acquired by the Company, Avon Products Inc. (“Avon”) had two share-based incentive plans, the 2013 Stock Incentive Plan (the “2013 Plan”) and the Omnibus Incentive Plan 2016 (the “2016 Plan”), both plans approved by the shareholders, which provided for various types of share-based incentive compensation awards, including purchase options, restricted shares, restricted stock units, and performance restricted stock units. After the approval of the shareholders of the 2016 Plan in May 2016, there were no further awards made in the 2013 Plan. Stock options and restricted shares were issued in the 2016 Plan, and units of restricted shares and units of restricted performance were issued in the 2013 and 2016 Plans. There were also outstanding stock options under prior shareholder-approved plans. On January 3, 2020, after the conclusion of the transaction with Natura &Co, equity compensation was either cancelled in exchange for the right to receive an amount in cash or was converted into an award denominated in Natura &Co Shares. After the Transaction, the subsidiary Avon joined the Natura &Co Stock-Based Compensation Plan, so that the 2013 Plan and the 2016 Plan are no longer in effect. Under the Natura &Co Stock-Based Compensation Plan, the subsidiary Avon issued nominal cost options and performance stock units. Nominal cost options were granted in exchange for subsidiary Avon restricted stock units and performance restricted stock units and vested as a single tranche in line with the vesting date of the original subsidiary Avon awards. Nominal cost options will automatically exercise on vest date. Performance stock units generally vest after three years Stock Options Prior to being acquired by the Company, the subsidiary Avon granted premium-priced stock options, in which the strike price was equal to a 25% premium for both, respectively, from the closing market price of Avon stock price at the date of grant. The premium-priced purchase options vest on a three On January 3, 2020, upon the completion of Avon acquisition, each outstanding stock option, whether or not then vested or exercisable, was automatically canceled in exchange for the right to receive an amount in cash, without interest, equal to the number of the subsidiary Avon Common Shares underlying such stock option immediately prior to the effective time of the Transaction multiplied by the excess, if any, of the per share cash-out price over the strike price per share. The “per share cash-out price” was the closing price of a Common Share of the subsidiary Avon on the NYSE on the Transaction’s closing date. No amount was paid upon cancellation of stock option with a strike price per share that is greater than the per share cash-out price. Restricted Stock Units (RSU) and Performance Restricted Stock Units (PRSU) Prior to being acquired by the Company, during the years 2019, 2018, 2017 and 2016, Avon granted, performance restricted stock units that would vest and settle after three three On January 3, 2020, upon the completion of the Transaction with Natura &Co, each outstanding Restricted Stock Unit (“RSU”) was converted into an award denominated in Company’s shares equal to the number of Avon Common Shares subject to each RSU immediately prior to the Transaction multiplied by the Exchange Ratio of 0.30. In addition, each outstanding PRSU was converted into an award denominated in Company’s shares, that is subject only to time-based vesting, equal to the number of Avon Common Shares subject to each PRSU immediately prior to the Transaction, giving effect to market conditions that are deemed to be attained, multiplied by the Exchange Ratios of 0.30. The terms and conditions, including service conditions but excluding market conditions, applicable to each RSU and PRSU will continue in full force and effect with respect to the Company’s Nominal Cost Options. 28.3 Employee benefit plans The Company and some of its subsidiaries grant defined contribution retirement plans to eligible employees and, through some of their foreign subsidiaries, grant defined benefit plans to employees that are eligible. Defined contribution plans The Company, through its subsidiary Avon, offers a defined contribution plan for Avon employees in the United Kingdom (“UK”), which allows eligible participants to contribute eligible compensation through payroll deductions. The Company double employee contributions up to the first 5% of eligible compensation and therefore the maximum level provided by Avon is 10% of eligible compensation. In the year ended December 31, 2021, Avon made matching contributions to the contribution plan defined in the UK in the total amount of R$45,155 (R$39,200 in the period ended December 31, 2020), which follow the same investment allocation that the participant has selected for his or her own contributions. The Company, through its subsidiary Avon, offers a qualified defined contribution plan for U.S.-based employees, the Avon Personal Savings Account Plan (the “PSA”), which allows eligible participants to contribute up to 25% of eligible compensation through payroll deductions. The Company matches 100% of the employee contributions dollar for dollar up to the first 3% of eligible compensation and fifty cents For U.S.-based employees hired on or after January 1, 2015, the Company made additional contributions to a Retirement Savings Account (“RSA”) within the PSA. Such contributions will range from 3% to 6% of a participant’s eligible compensation depending on the sum of the participant’s age and length of service (as of December 31 of the prior year). Investment of such contributions will follow the same investment allocation that the participant has selected for his or her own contributions to the PSA. A participant will be vested in the RSA generally after three Defined and post-retirement benefit plans The Company, through its subsidiary Avon and certain subsidiaries, have contributory and noncontributory defined benefit retirement plans for substantially all employees of those subsidiaries. Benefits under these plans are generally based on an employee’s length of service and average compensation near retirement, and certain plans have vesting requirements. The actuarial liability for the health care plan of the Company refers to a post-employment benefit plan for employees and former employees who made fixed contributions to the cost of the health plan until April 30, 2010, date when the design of the health plan was changed, and the employees’ fixed contributions were eliminated. For those who have contributed to the medical plan for ten years or more, the right to maintenance is guaranteed as an indefinite (lifetime) beneficiary, and for those who have contributed for less than ten years, the right to maintenance is guaranteed as beneficiary, at the rate of one year for each year of fixed contribution. This group of current employees, in case of termination, may choose to remain on the plan in accordance with applicable legislation, assuming the payment of the monthly fee charged by the health plan operators. However, this monthly fee does not necessarily represent the user’s total cost, which is assumed by the Company, based on the excess cost grant, as an of additional benefit form. Avon’s largest defined benefit pension plan outside the United States (“US”) is in the UK, which has been frozen for future accruals as of April 1st 2013 . The U.S. defined benefit pension plan, the Personal Retirement Account Plan (the "PRA"), is closed to employees hired on or after January 1st, 2015 , so that qualified retirement benefits for US-based employees hired on or after January 1st, 2015 will be provided solely through the PSA.

FINANCE INCOME (EXPENSES)

FINANCE INCOME (EXPENSES)	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Financial Income (Expenses)	29 FINANCE INCOME (EXPENSES) Consolidated 2021 2020 2019 FINANCE INCOME: Interest on short-term investments 264,764 167,967 83,115 Gains on monetary and exchange rate variations (a) 1,785,259 1,752,503 854,025 Gains on swap and forward transactions (c) 1,814,450 2,532,487 961,185 Gains on swap and forward derivatives mark to market 20,929 12,314 1,709 Inflation adjustment reversal on provision for tax risks and tax liabilities - 42,378 25,469 Hyperinflationary economy adjustment (Argentina) 82,202 39,292 - Debt structuring revenue for acquisition of Avon - 95,145 - Other finance income 38,959 96,305 30,281 Subtotal 4,006,563 4,738,391 1,955,784 FINANCE EXPENSES: Interest on financing (*) (634,201 ) (709,323 ) (503,040 ) Interest on leases (210,669 ) (229,544 ) (134,579 ) Losses from monetary and exchange rate variations (b) (2,075,306 ) (2,671,372 ) (937,925 ) Losses on swap and forward transactions (d) (1,533,611 ) (1,579,695 ) (964,116 ) Losses on swap and forward derivatives mark to market (26,214 ) (13,691 ) (1,452 ) Adjustment of provision for tax, civil and labor risks and tax liabilities (25,731 ) (47,928 ) (13,822 ) Appropriation of funding costs (debentures and notes) (27,228 ) (11,082 ) (22,671 ) Interest on pension plan (11,339 ) (10,323 ) - Hyperinflationary economy adjustment (Argentina) (108,730 ) (20,625 ) (13,947 ) Debt structuring expenses for Avon acquisition - (110,741 ) (115,781 ) Other finance expenses (380,511 ) (369,486 ) (88,541 ) Subtotal (5,033,540 ) (5,773,810 ) (2,795,874 ) Net finance income (expenses), net (1,026,977 ) (1,035,419 ) (840,090 ) (*) Of the balances originally presented on December 31, 2020, R$395,540 of the finance expenses group and R$39,292 of the finance income were reclassified between lines for better presentation. Note that this reclassification does not impact the subtotal amount originally presented as finance income (expenses). The breakdown set forth below is intended to better explain the results of the foreign exchange hedging transactions entered into by the Company as well as its related items recorded in the financial income (expenses) and shown in the previous table: Consolidated 2021 2020 2019 (a) Gains on monetary and exchange rate variations 1,785,259 1,752,503 854,025 Gains on exchange rate variation on borrowings, financing and debentures 869,115 714,681 677,462 Exchange rate variation on imports 38,800 35,218 11,221 Exchange rate variation on export receivables 105,654 69,365 26,144 Exchange rate variation on accounts payable from foreign subsidiaries 364,101 450,468 132,397 Exchange variations of bank accounts in foreign currency 407,589 482,771 6,801 (b) Losses from monetary and exchange rate variations (2,075,306 ) (2,671,372 ) (937,925 ) Losses from exchange rate variation on borrowings (i) (1,121,305 ) (1,665,050 ) (768,939 ) Exchange rate variation on imports (52,082 ) (58,623 ) (33,718 ) Exchange rate variation on export receivables (123,607 ) (55,829 ) (23,393 ) Exchange rate variation on accounts payable from foreign subsidiaries (311,923 ) (365,214 ) (86,764 ) Exchange rate variation on financing (466,389 ) (525,173 ) (297 ) Exchange variations of bank accounts in foreign currency - (1,483 ) (24,814 ) (c) Gains on swap and forward transactions 1,814,450 2,532,487 961,185 Revenue from swap exchange coupons (ii) 713,401 409,788 182,897 Gains on exchange variations on swap instruments (ii) 1,101,049 2,122,699 778,288 (d) Losses on swap and forward transactions (1,533,611 ) (1,579,695 ) (964,116 ) Losses from exchange rate variation on swap instruments (ii) (843,085 ) (1,182,391 ) (690,409 ) Financial costs of swap instruments (ii) (690,526 ) (379,440 ) (273,707 ) Losses with exchange rate variations of forward instruments - (17,864 ) - (i) See comment on finance expense reclassification in the previous table. (ii) The original amounts presented in these lines as of December 31, 2021 were reclassified to give a better disclosure in the respective gains (R$ 202,005 ) and losses (R$ 490,450 ) on swap and forward transactions groups. This reclassification does not impact the subtotal amounts of the respective groups or any line presented in the finance income (expenses) tables originally presented and included in the previous table.

OTHER OPERATING INCOME (EXPENSE

OTHER OPERATING INCOME (EXPENSES), NET	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
OTHER OPERATING INCOME (EXPENSES), NET	30 . OTHER OPERATING INCOME (EXPENSES), NET Consolidated 2021 2020 2019 Other operating income, net Result on write-off of property, plant and equipment - 11,855 6,098 ICMS-ST ( a ) - 18,653 42,336 Tax Credits 11,391 105,234 21,402 PIS/COFINS credits ( b ) 203,694 - 95,614 Tax benefit for joining the amnesty progr am (c) 82,140 - - Incentive income 13,280 - - Proceeds from the sale of the customer portfolio 16,113 - 23,092 Tax contingencies 3,949 - - Other operating income 12,985 10,757 - Total other operating income 343,552 146,499 188,542 Other operating expenses, net Result on write-off of property, plant and equipment (3,610 ) - - Crer para Ver ( d ) (47,523 ) (54,500 ) (36,156 ) Expense on the sale of customer portfolio - (7,498 ) - Expenses related Avon acquisition - (303,916 ) (141,348 ) Transformation and integration plan ( e ) (511,048 ) (256,700 ) (51,520 ) Taxes contingencies - (10,100 ) - Other operating expenses (20,390 ) (29,975 ) (8,829 ) Total other operating expenses (582,571 ) (662,689 ) (237,853 ) Other operating income (expenses), net (239,019 ) (516,190 ) (49,311 ) (a) R efers to the requirement of ICMS tax substitution, for different Federal States of Brazil (details in note ). During , provision reversals were made due to the change in the loss estimate for some Federal States. (b) R efers to tax credits from PIS and COFINS related to non-inclusion of ICMS in the basis (R$ ) and credits arising out of investment grant (R$ ), and other tax credits (R$ ). (c) Refers to tax benefits in Brazil arising out of adhesion to state tax amnesty programs by the subsidiary Avon Cosméticos Ltda. (d) Allocation to Instituto Natura of operating profit from sales of the non-cosmetic product line “Crer Para Ver”, specifically allocated to social projects aimed at the development of education quality. (e) Expenses related to the implementation of the subsidiary Avon integration and transformation plan, which is based on five pillars, namely: (1) renewal of the brand; (2) optimization of retail operations; (3) improvement of omni-channel; (4) improvement of operating efficiency; and (5) organization redesign.

EARNINGS PER SHARE

EARNINGS PER SHARE	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
EARNINGS PER SHARE	31 EARNINGS PER SHARE The basic earnings per share are calculated by dividing the profit (loss) attributable to holders of Company by weighted average number of outstanding common shares, excluding common shares purchased by the Company and held as treasury shares. Consolidated 2021 2020 2019 Income (loss) attributable to the Company’s controlling shareholders 1,047,960 (650,196) 155,467 Weighted average of the number of outstanding common shares 1,377,932,809 1,246,180,219 865,660,042 Weighted average number of treasury shares (788,866) (572,130) - Weighted average number of outstanding common shares 1,377,143,943 1,245,608,090 865,660,042 Basic earnings (loss) per share - R$ 0.7610 (0.5220) 0.1796 Diluted earnings per share are calculated by adjusting the weighted average number of outstanding common shares, assuming the conversion of all potential common shares that would cause dilution. The Company has purchase options, restricted shares and strategy acceleration that would have a dilutive effect on any earnings per share. Considering that in the year ended December 31, 2020, the Company recorded a loss, any adjustment would have an anti-diluting effect and, therefore, the diluted earnings per share for the year ended December 31, 2020 are equivalent to the basic earnings per share. The diluted earnings per share for net income for the year ended December 31, 2021 and 2019 are presented below: Consolidated 2021 2019 Gain attributable to the Company’s controlling shareholders 1,047,960 155,467 Weighted average of the number of outstanding common shares 1,377,143,943 865,660,042 Adjustment for stock options and restricted shares(a) - 8,124,575 Weighted average number of treasury shares 19,531,951 - Weighted average number of outstanding common shares 1,396,675,894 873,784,617 Diluted earnings per share – R$ 0.7503 0.1779 (a) The number of shares and earnings per share already consider the stock split on September 17, 2019 and their retrospective effects. The basic and diluted loss per share for net loss of discontinued operations for the year ended December 31, 2021 and 2020 are presented below: Consolidated 2021 2020 Net loss attributable to the Company’s controlling shareholders (98,550 ) (143,112 ) Weighted average of the number of outstanding common shares 1,377,932,809 1,246,180,219 Adjustment for purchase options and restricted shares (788,866 ) (572,130 ) Weighted average number of ordinary shares for diluted earnings calculation 1,377,066,457 1,245,608,090 Basic loss per share - R$ (0.0716 ) (0.1149 )

TRANSACTIONS WITH RELATED PARTI

TRANSACTIONS WITH RELATED PARTIES	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
TRANSACTIONS WITH RELATED PARTIES	32 TRANSACTIONS WITH RELATED PARTIES During the Company’s operations, rights and obligations are generated between related parties, arising from administrative expenses and provision of services 32.1 Transactions with related parties In the year ended December 31, 2020, Natura &Co reimbursed the amount of R$ 148,274 of expenses regarding the transaction costs for the acquisition of Avon paid by its subsidiary Natura Cosméticos. This reimbursement was registered in the profit or loss line item “Other net operating expenses”. For the other transactions, they were not carried forward as income statement, as they refer to the transfer of expenses related to purchase option plans and restricted shares. 32.2 Transactions with uncontrolled and unconsolidated related parties Instituto Natura holds shares in the Essential Investment Fund. As of December 31, 2021, the balance is R$ 3,835 (R$ 3,414 as of December 31, 2020). On June 5, 2012, an agreement was entered between Indústria e Comércio de Cosméticos Natura Ltda., and Bres Itupeva Empreendimentos Imobiliários Ltda., (“Bres Itupeva”), for the construction and leasing of processing center to distribution and warehousing of products (HUB), in Itupeva, State of São Paulo. In 2019, Bres Itupeva granted its credits to BRC Securitizadora S.A., to which Natura makes monthly payments. Messrs. Antônio Luiz da Cunha Seabra, Guilherme Peirão Leal and Pedro Luiz Barreiros Passos, members of the Company’s controlling group, indirectly control Bres Itupeva. This agreement was amended on February 10, 2021, with Natura Cosméticos becoming the lessee. The amount involved in the transaction is recorded under item “Right of Use” of “Buildings” in the amount of R$60,998 (R$39,346 under “Buildings” of Property, Plant and Equipment as of December 31, 2020) and in the year ended December 31, 2020, the total amount paid as rent was R$14,094 (R$13,086 for the year ended December 31, 2020). On January 8, 2021, a transaction with related party was carried out between the subsidiary Natura Cosméticos S.A., as lessee and owner, Indústria e Comércio de Cosméticos Natura Ltda. and Natura &Co Holding S.A., as guarantors, and a special purpose company (Bresco IX) indirectly held by Messrs. Antônio Luiz da Cunha Seabra, Guilherme Peirão Leal and Pedro Luiz Barreiros Passos, (Co-Chairmen of the Board of Directors of the Company), as lessor and surface-right owner. This transaction was entered into with the purpose of expanding the Company’s distribution network and increasing its logistical efficiency through the installation of a new distribution hub in the State of Alagoas. This is a build-to-suit lease in which the property has not yet been delivered and, therefore, there was no disbursement during the year ended December 31, 2021. On May 12, 2021, a transaction was entered between the Natura Cosméticos S.A., as lessee, and Bresco Logística Fundo de Investimento Imobiliário, as lessor, indirectly held by Messrs. Antônio Luiz da Cunha Seabra, Guilherme Peirão Leal and Pedro Luiz Barreiros Passos. (Co-Chairmen of the Board of Directors of the Company). This transaction had the purpose of keeping the Company’s distribution hub activities in the city of Canoas, State of Rio Grande do Sul. The amount involved in the transaction is recorded under item “Right of Use” of “Buildings” in the amount of R$5,840 and in the year ended December 31, 2020, the total amount paid as rent was R$1,488. The subsidiary Natura Cosméticos S.A. and Raia Drogasil S.A. entered into a purchase and sale agreement and other covenants for selling products in Raia and Drogasil. Mr. Guilherme Peirão Leal and Mr. Pedro Luiz Barreiros Passos, (Co-Chairmen of the Board of Directors of the Company), indirectly hold shareholding interest in Raia Drogasil S.A. This contract was finalized during the year 2020. In the year ended December 31, 2021, there was no transfer of donation associated with the maintenance of the Company to Instituto Natura. As of December 31, 2020, the amount of R$692 was transferred, as donation associated to maintenance, referring to 0.5% of the net income assessed for the previous year and donation associated with the net income of sales of the Natura Crer Para Ver product line in the amount of R$35,000 as of December 31, 2021 (R$35,000 as of December 31, 2020). The Company has a structure of internal controls to support the identification, monitoring and approval of transactions between Related Parties. 32.3 Key management personnel compensation The total compensation of the key management personnel is as follows: 2021 2020 2019 Compensation Compensation Compensation Total Total Fixed Variable Total Fixed Variable Fixed Variable Board of Directors 15,043 72,187 87,230 16,123 65,011 81,134 22,056 30,919 52,975 Executive Board 51,576 71,162 122,738 49,187 80,218 129,405 32,963 42,142 75,105 66,619 143,349 209,968 65,310 145,229 210,539 55,019 73,061 128,080 The line item “Executive Board” includes the amount of R$ 1,201 related to the amortization of the Confidentiality and Non-Compete Agreement during the fiscal year ended December 31, 2020. The corresponding amount in 2021 was nil. Where changes in roles occurred during the year, the total for the year is reported in the row effective as of December 31, 2021. The totals in the table above include the employer social security charges. The amounts include increases and / or reversals of the cumulative expense recognized in the previous years due to reassessments of the number of awards expected to vest and re-estimation of the social security charges expected to be payable by the Company on vesting. 32.4 Share-based payments Breakdown of the Company executive officers’ share-based payments compensation: Options Option balance (number ) (a) Average fair value of options R$ Average exercise price 1 R$ 2021 2020 2019 2021 2020 2019 2021 2020 2019 Board of directors and executive board 11,750,270 12,847,760 13,059,677 12.47 8.64 8.40 21.21 16.49 16.51 Share balance (number) ² (a) Average fair value ² - R$ 2021 2020 2019 2021 2020 2019 Board of directors and executive board 4,472,638 5,293,874 1,012,641 45.34 51.20 19.23 (1) The number of options, their average fair value and average exercise price are shown after taking into account the stock split approved at the Extraordinary Shareholders’ Meeting held on September 17, 2019. (2) The number of restricted and performance shares and their average fair value are shown after taking into account the stock split approved at the Extraordinary Shareholders’ Meeting held on September 17, 2019. (a) The number of awards includes the awards non-vested and vested but not exercised. The stock option and award balances above do not include the awards related to the Avon Products Inc. plans that were in place prior to the acquisition by Natura &Co, as described in section 29.2. Certain awards are to be exercised in ADRs rather than B3 shares. The number of awards throughout this disclosure note have been presented using B3 equivalents to ensure consistency. The number of performance shares is disclosed assuming achievement of performance conditions at target, whereas the expense recognized in the year reflects the latest reassessment of the number of awards expected to vest.

COMMITMENTS

COMMITMENTS	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
COMMITMENTS	33. COMMITMENTS 33.1 Contracts related to supply In the ordinary course of its business, the Company enters into long-term agreements for provision of manufacturing, transportation, information technology services and electric power supply (with physical delivery, for its manufacturing activities). The agreements have termination clauses for noncompliance with essential obligations. In general, the minimum agreed upon is acquired and therefore there are no liabilities recorded in addition to the amount recognized on the accrual basis. The subsidiaries also have investment commitments in other companies that do not belong to the economic group, through the fulfillment of goals and other conditions established in the agreement in the amount of up to R$60,000, which arise from convertible debentures. Total minimum supply payments, measured at nominal value, according to the contract, are: 2021 2020 Less than one year 929,288 1,413,904 One to five years 460,081 885,990 Above 5 years 10,738 - Total 1,400,107 2,299,894

INSURANCE

INSURANCE	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
INSURANCE	34 INSURANCE The Company adopted an insurance policy that mainly considers risk concentration and its materiality, considering the nature of their activities and the guidance of their insurance advisors. As of December 31, 2021 and 2020, insurance coverage is as follows: Item Type of coverage Amount insured 2021 2020 Industrial complex and administrative sites Any damages to buildings, facilities, inventories, and machinery and equipment 6,008,031 5,658,558 Vehicles Fire, theft and collision for the vehicles insured by the Company 261,953 258,416 Loss of profits No loss of profits due to material damages to facilities buildings and production machinery and equipment 1,962,509 1,894,813 Transport Damages to products in transit 103,857 97,934 Civil liability Protection against error or complaints in the exercise of professional activity that affect third parties 2,445,664 2,326,621 Environmental liability Protection against environmental accidents that may result in environmental lawsuits 30,000 30,000

ADDITIONAL INFORMATION RELATING

ADDITIONAL INFORMATION RELATING TO THE STATEMENTS OF CASH FLOWS	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
ADDITIONAL INFORMATION RELATING TO THE STATEMENTS OF CASH FLOWS	35. ADDITIONAL INFORMATION RELATING TO THE STATEMENTS OF CASH FLOWS The following table presents additional information on transactions related to the cash flow statement: Consolidated 2021 2020 2019 Non-cash items Hedge accounting, net of tax effects (137,211 ) 116,348 70,569 Dividends declared and not yet paid 180,772 - 110,671 Stock and restricted shares option plans 138,122 102,508 - Net effect of acquisition of property, plant and equipment and intangible assets not yet paid 81,257 172,104 ( 18,645 ) Consideration for acquisition of subsidiary - 13,366,114 -

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Subsequent Events	36. SUBSEQUENT EVENTS Ukraine and Russia situation In February 2022, Russia launched a large-scale military invasion of Ukraine and is now engaged in a broad military conflict with Ukraine. In response, governments and authorities worldwide, including the United States and the European Union, have recently announced sanctions on certain industry sectors and parties in Russia. These and any additional sanctions, as well as any potential responses that may be provided by the governments of Russia or other jurisdictions, may adversely affect our business. As of the date of the financial statements there are no material impacts from the abovementioned matter in the Company’s consolidated financial statements, due to the Company’s limited operations in Russia and Ukraine (for relationship selling and production presence at Avon and a franchise operation for The Body Shop and Aesop). These two markets represent together less than 5% of the Group’s consolidated net revenues. The conflict resulted in the suspension of The Body Shop and Aesop operations in Russia and the exports from the Russia manufacturing facility to other countries in the region, which started to be supplied by our Poland facility. Avon, however, is currently continuing to supply to its network of representatives in Russia from its local plant to help them with their livelihoods. As of the date of the financial statements no major disruptions that could materially affect the recoverability of non-financial assets as well as any significant increase in credit risk that could lead to a material impairment of financial assets in Russia and/or in Ukraine have been noted. Ukraine operations include property, comprised of administrative offices and warehouse, that support the operations in the country and are temporarily idle as safety cannot be assured for the local workers. The Company cannot predict duration of the idling as it will depend on the remaining course of the conflict and the establishment of safe and stable operating and logistical conditions thereafter, as well as potential repairs of any damages sustained. As of the date of the financial statements the Company has confirmed that property as well as inventory held at those facilities have not been damaged and are in appropriate conditions to be operated and sold as safety conditions improve. Management is continuously monitoring the developments to assess any potential future impacts that may arise as a result of the ongoing crisis, including impairment of financial and non-financial assets in the following quarter in Ukraine for which management is currently assessing based on the best available information. Revolving Credit Facility On October 28, 2021, we, through our subsidiary Natura &Co Luxembourg, entered into a revolving credit facility in the principal amount up to U.S.$625.0 million. The revolving credit facility has a 36

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Current versus non-current classification	3.1 Current versus non-current classification The Company presents assets and liabilities in the balance sheet based on current/non-current classification. An asset is current when it is (i) expected to be realized or intended to be sold or consumed in the normal operating cycle; (ii) held primarily for the purpose of trading; (iii) expected to be realized within twelve twelve A liability is current when (i) it is expected to be realized in the normal operating cycle; (ii) it is held primarily for commercial purposes; (iii) it is due to be settled within twelve twelve Deferred tax assets and liabilities are classified as non-current assets and liabilities, as disclosed in note 3.17
Foreign currency translation	3.2 Foreign currency translation Functional currency The items included in the financial statements of the Company and each of the companies included in the consolidated financial statements are measured using the currency of the main economic environment in which each of the companies operates (“functional currency”). The financial statements are presented in the Company’s functional and presentation currency, the Brazilian Real. 3.2.1 Transactions and balances in a currency other than the functional currency Transactions in foreign currency, that is, any currency other than the functional currency, are translated into the functional currency of the entities included in these consolidated financial statements using the exchange rates prevailing on the dates of the transactions. Balance sheet account balances are translated using the exchange rates prevailing on the dates of the reporting period. Gains and losses from exchange rate variation arising from the settlement of such transactions and the translation of monetary assets and monetary liabilities denominated in foreign currency are recognized in the income statement as “finance income” and “finance expenses”. 3.2.2 Subsidiaries with different functional currency In preparing the consolidated financial statements, the income statement and cash flow statement and all other changes of assets and liabilities of foreign subsidiaries, whose functional currency is not the Brazilian Real, are translated into Brazilian Reais at the monthly average exchange rates, which approximates the exchange rate in effect on the date of the transactions. The balance sheet is translated into Brazilian Reais at the exchange rate prevailing at the reporting date. The effects of exchange rate variations resulting from these translations are presented under item Other Comprehensive Income (“OCI”) in the statement of comprehensive income, and in shareholders’ equity. The translation calculation is different for Natura Cosméticos S.A. – Argentina (“Natura Argentina”) and Cosmeticos Avon Sociedad Anonima Comercial E Industrial (“Avon Argentina"), which became a hyperinflationary economy as of July 1, 2018 (see below), in which other than the balance sheet, the revenue and expenses are translated into Reais at the exchange rates prevailing at the reporting date. 3.2.3 Hyperinflationary economy As of July 2018, Argentina has been considered a hyperinflationary economy. As per CPC 42 29 42 29 Non-monetary assets and liabilities recorded at historical cost and equity items of Natura Argentina and Avon Argentina were adjusted for inflation based on the aforementioned indexes, and effects of hyperinflation resulting from changes in the overall purchasing power were presented in the income statement. The income statement is adjusted at the end of each reporting period based on the variation in the general price index for the year. The net effect of inflation adjustment in 2021 30 For the translation of the accounting balances of the subsidiaries Natura Argentina and Avon Argentina to the reporting currency Reais used in the Company’s consolidated financial statements, the following procedures, as required by CPC 02 2 21 ➢ Assets, liabilities and net equity item balances were translated at the exchange rate prevailing at the reporting date (0.05437 and 0.06189 Argentine peso for each Brazilian Real on December 31, 2021 and 2020 ➢ Revenues and expenses of the year were translated at the exchange rate prevailing at the reporting date ( 0.05437 and 0.06189 Argentine peso for each Brazilian Real on December 31, 2021 and 2020 , respectively), instead of the average exchange rate of the year, which is used to translate currencies in non- economies. The accumulated inflation for the year ended December 31, 2021 was 50.6% (36.1% as of December 31, 2020), as per IPC index. During the year ended December 31, 2021, as a result of the application of the CPC 42 29 Consolidated 2021 2020 Net loss on hyperinflationary economy adjustment (165,826 ) (55,277 ) Impact on profit or loss (26,528 ) 18,667 Monthly average exchange rate impact 218,227 32,160 Capital reserve - 58,496 Profit reserve - 8,292
Consolidation	3.3 Consolidation The following procedures are applied in the preparation of the consolidated financial statements: a) Investments in subsidiaries The Company controls an entity when it is exposed to, or is entitled to, the variable returns arising from its involvement with the entity and can affect those returns by exercising its power over the entity. The financial statements of subsidiaries are included in the consolidated financial statements from the date when the Company obtains control until the date when the control ceases to exist. In the consolidated financial statements, the investments in subsidiaries are accounted for using the equity method. The financial statements of the subsidiaries are prepared at the same reporting date as the Company. Whenever necessary, adjustments are made to suit subsidiaries’ accounting policies to those of the Company. In accordance with the equity method, the portion attributable to the Company on the net income or loss for the year regarding these investments is recorded in the income statement of the Company under the item “share of profit (loss) of equity investees”. All intra-group balances, income and expenses and unrealized gains and losses arising from intra-group transactions are eliminated completely. The other comprehensive income (“OCI”) of subsidiaries is recorded directly in the Company’s shareholders’ equity under the item “OCI”. Below is a list of the Company’s direct subsidiaries as of December 31, 2021, 2020 and 2019: Interest - % 2021 2020 2019 Direct interest: Avon Products, Inc. 100.00 100.00 - Natura Cosméticos S.A. 100.00 100.00 100.00 Natura &Co International S.à r.l. 100.00 100.00 - The activities of the direct subsidiaries are described below: ➢ Avon Products, Inc.: a global manufacturer and marketer of beauty and related products, with operations started in 1886 and established under the laws of the State of New York in the United States of America on January 27, 1916. It conducts its business in the beauty sector and other consumer products through direct selling companies to create, manufacture and market beauty and non-beauty products. Its business is carried out mainly through one channel: direct selling. ➢ Natura S.A.: is a privately-held corporation, established in accordance with the laws of the Federative Republic of Brazil on June 6, 1993, for an indefinite term and the main focus of which is the commercialization of cosmetics and fragrances in general. It also operates through e-commerce and has an expanded network of its own physical stores. The subsidiaries The Body Shop International Limited (The Body Shop) and Holding Pty Ltd. (Aesop) are consolidated by this entity. ➢ Natura &Co International S.à r.l.: a company established in Luxembourg on February 14, 2020 with the main purpose of operating as the finance arm of the Company (a “ ”), centralizing the fundraising activities with external entities and providing funding for the other entities of the economic group on behalf of the company. Furthermore, the entity has also the purpose of managing and holding stakes in national and foreign companies. As of December 31, 2021, and 2020
Business combinations and goodwill	3.4 Business combination and goodwill Business combinations (except for those involving entities under common control) are accounted for by applying the acquisition method. The consideration transferred is measured at fair value as of the date of acquisition, as well as the identifiable assets acquired, and liabilities assumed. The consideration transferred does not include amounts related to the settlement of pre-existing relationships, which are generally recognized in the statement of profit or loss for the year. The Company determines that it has acquired a business when the acquired set of activities and assets include an input and a substantive process that together significantly contribute to the ability to create outputs. The acquired process is considered substantive if it is critical to the ability to continue producing outputs, and the inputs acquired include an organized workforce with the necessary skills, knowledge, or experience to perform that process or if it significantly contributes to the ability to continue producing outputs. The financial assets and liabilities assumed are assessed for appropriate classification and designation in accordance with the contractual terms, economic circumstances, and pertinent conditions as of the acquisition date. Acquisition-related costs are recorded as expenses as incurred and recognized as other operating expenses. Any goodwill arising from the transaction is tested annually for impairment, and when circumstances indicate that the carrying amount may be impaired. Goodwill is initially measured at cost, as the excess of the aggregate amount of: (i) the consideration transferred, measured at fair value; (ii) the amount of any non-controlling interest in the acquiree; and (iii) in a business combination achieved in stages, the fair value of the acquirer’s previously held equity interest in the acquiree at the acquisition date; over the net assets acquired (identifiable net assets acquired and the liabilities assumed). When this aggregate amount is lower than the net amount of the identifiable assets acquired and the liabilities assumed, a gain on a bargain purchase is immediately recognized in the income statement. Subsequently, goodwill is measured at cost less any accumulated impairment losses. For impairment testing, goodwill acquired in a business combination is, from the acquisition date, allocated to each of the Company’s cash-generating units (“CGU”) that are expected to benefit from the combination, irrespective of whether other assets or liabilities of the acquiree are assigned to those units. In a business combination involving entities under common control, in which all the combining entities or business are ultimately controlled by the same party or parties both before and after the business combination, and that control is not transitory, the Company applies the predecessor accounting method. When applying this method, the financial statements consider the historical accounting records of the acquired entity as equivalent to the Company’s records, reflecting (a) the operating results and equity position of the acquired company in previous years; (b) the operating results of the Company and its acquired entity resulting from the restructuring; (c) the Company’s assets and liabilities at historical cost (and at the preceding fair value, when applicable); and (d) the earnings per share of the Company in all years presented (adjusted when applicable). In these cases, therefore, there is no calculation of goodwill and any effect recorded in the shareholders’ equity.
Cash and cash equivalents	3.5 Cash and cash equivalents Cash and cash equivalents are maintained for the purpose of meeting short-term cash commitments, not for investment or other purposes. Cash and cash equivalents include cash, demand deposits and short-term investments realizable within 90
Financial Instruments	3.6 Financial instruments 3.6.1 Financial assets Initial recognition and measurement Upon initial recognition, a financial asset is measured at fair value plus or minus, in the case of a financial asset or financial liability not at fair value through profit or loss, transaction costs that are directly attributable to the acquisition or issue of the financial asset or financial liability. Subsequently, financial assets are measured at amortized cost, at fair value through other comprehensive income (“FVTOCI”), or at fair value through profit or loss (“FVTPL”). The classification of financial assets at initial recognition depends on the characteristics of the contractual cash flows of the financial asset and the business model of the Company for the management of these financial assets. The business model of the Company for managing financial assets refers to how the Company manages its financial assets to generate cash flows. The business model determines whether cash flows will result from collecting contractual cash flows, selling the financial assets, or both. Financial assets classified and measured at amortized cost are “non-derivative” financial assets held within a business model with the objective to hold financial assets to collect contractual cash flows, while financial assets classified and measured at fair value through OCI are held within a business model with the objective of holding financial assets to collect contractual cash flows and selling them. Subsequent measurement Financial assets at amortized cost Financial assets at amortized cost are subsequently measured using the effective interest method and are subject to impairment analysis. Gains or losses are recognized in the income statement when the asset is written off, modified, or impaired. The financial assets of the Company classified as amortized cost include balances of trade accounts receivable, other current assets and non-current assets balances (see note 6.6 Financial assets at fair value through profit or loss Financial assets at fair value through profit or loss are presented in the balance sheet at fair value with net changes in fair value recognized in the income statement. This category includes derivative instruments and short-term investments which the Company had not irrevocably elected to classify according to the fair value through OCI. Reassessment only occurs if there is either a change in the terms of the contract that significantly modifies the cash flows that would otherwise be required or a reclassification of a financial asset out of the fair value through profit or loss category. The financial assets measured at fair value through profit or loss are investment funds, government bonds, restricted cash, financial bills, mutual investment fund, Dynamo Beauty Ventures fund ("Fund DBV"), Certificate of Bank Deposits (CDB), carbon credit, financial and operational derivatives as presented in note 6.6. Derecognition (write-off) of financial instruments A financial asset (or, where applicable, part of a financial asset or part of a group of similar financial assets) is written off when the rights to receive cash flows from the asset have expired, when the Company transfers its rights or risk to receive cash flows from the asset or when the Company has assumed an obligation to pay the full amount of received cash flows, without significant delay, to a third party under an on-lending agreement and either (i) the Company has transferred substantially all risks and benefits of the asset, or (ii) the Company has neither transferred nor retained substantially all risks and benefits of the asset, but transferred the asset control. When the Company transfers its rights to receive cash flows of an asset or executes an on-lending agreement, it assesses whether, and at which extent, it has retained the risks and benefits of ownership. When the Company has neither transferred nor retained substantially all risks and benefits of the asset, nor transferred the control over the asset, the Company continues to recognize the asset transferred to the extent of its continued involvement. In this case, the Company also recognizes an associated liability. The transferred asset and the associated liability are measured on a basis that reflects the rights and obligations that the Company has retained. Impairment of financial assets The Company recognizes an allowance for expected credit losses (“ECL”) for all debt instruments not held at fair value through profit or loss. ECLs are based on the difference between the contractual cash flows due in accordance with the contract and all the cash flows that the Company expects to receive, discounted by an approximation of the original effective interest rate. ECLs are recognized in two 12 12 For trade accounts receivable, the Company applies a simplified approach in calculating ECLs. Therefore, the Company does not track changes in credit risk, but instead recognizes an allowance for losses based on the ECL at each reporting date. The Company has recorded a provision that is based on its historical credit loss experience, adjusted for forward-looking factors specific to the debtors and the economic environment. Further details are disclosed in note 5.6 The Company considers a financial asset in default when internal or external information indicates that the Company is unlikely to receive the outstanding contractual amounts in full. A financial asset is written off when there is no reasonable expectation of recovering the contractual cash flows. 3.6.2 Financial liabilities Initial recognition and measurement All financial liabilities are recognized initially at fair value and, in the case of borrowing, financing and debentures, net of directly attributable transaction costs. The Company’s main financial liabilities include borrowing in local and foreign currency, financing and debentures (note 20 6 21 21 19 24 25 Subsequent measurement For purposes of subsequent measurement, financial liabilities are classified in two Financial liabilities at fair value through profit or loss Financial liabilities at fair value through profit or loss include financial liabilities held for trading and financial liabilities classified upon initial recognition at fair value through profit or loss. Financial liabilities are classified as held for trading if they are incurred for the purpose of repurchasing in the short term. This category also includes derivative instruments entered into by the Company that are not classified as hedging instruments in the hedge relationships defined by CPC 38 39 Gains or losses on liabilities held for trading are recognized in the income statement. Financial liabilities designated upon initial recognition at fair value through profit or loss are designated at the initial date of recognition, and only if the criteria in CPC 48 9 Financial liabilities at amortized cost This is the most relevant category for the Company. After initial recognition, interest-bearing borrowing and financing are subsequently measured at amortized cost using the effective interest rate method. Gains and losses are recognized in profit or loss when the liabilities are written off as well as through the effective interest rate amortization process. Amortized cost is calculated by considering any premium or discount on acquisition and fees or costs that are an integral part of the effective interest rate method. The effective interest rate amortization is included as finance expenses in the income statement. This category generally applies to interest-bearing borrowing, financing and debentures (note 20 19 Derecognition A financial liability is written off when the obligation under the liability is discharged, canceled, or expires. When an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially modified, such an exchange or modification is treated as derecognition of the original liability and recognition of a new liability. The difference in the respective carrying amounts is recognized in the income statement. Offsetting of financial instruments Financial assets and financial liabilities are offset, and the net amount is reported in the balance sheet if there is a currently enforceable legal right to offset the recognized amounts and there is an intention to settle on a net basis, to realize the assets and settle the liabilities simultaneously. The offsetting of financial instruments is also applied to bank balances subject to the central treasury management system (“cash pooling”) instituted with the financial institution, in which the current account positions of the Company (including overdraft balances) are offset since the Company has a legally enforceable right to settle at the net amount and intends to settle the positions on a net basis. 3.6.3 Derivative financial instruments Derivative financial instruments transactions contracted by the Company consist of swaps and non-deliverable forwards (“NDF”) intended exclusively to hedge against foreign exchange risks related to statement of financial position, purchase of goods and property, plant and equipment, forecast exports and foreign-denominated cash flows for capital contributions in foreign subsidiaries. They are measured at fair value, and changes are recognized through profit or loss, except when they are designated as cash flow hedge accounting, which changes in fair value are recorded in OCI. The fair value of derivative instruments is measured by the treasury department of the Company based on information on each contracted transaction and related market inputs as of the reporting date of the financial statements, such as interest and exchange rates. For the purpose of hedge accounting, hedges are classified as: (i) fair value hedges when hedging the exposure to changes in the fair value of a recognized asset or liability or an unrecognized firm commitment; (ii) cash flow hedges when hedging the exposure to variability in cash flows that is either attributable to a particular risk associated with a recognized asset or liability or a highly probable forecast transaction or the foreign currency risk in an unrecognized firm commitment; and that may affect the result or (iii) hedge Even with the adoption of CPC 48 9 38 39 7.2.21 48 9 At the inception of a hedge relationship, the Company formally designates and documents the hedge relationship to which it wishes to apply hedge accounting, the risk management goal and strategy for hedging. The documentation includes identification of the hedging instrument, the hedged item, the nature of the risk being hedged and how the Company will assess the effectiveness of changes in the hedging instrument’s fair value in offsetting the exposure to changes in the hedged item’s fair value or cash flows attributable to the hedged risk. Such hedges are expected to be highly effective in achieving offsetting changes in fair value or cash flows and are assessed on an ongoing basis to determine that they actually have been highly effective throughout the financial reporting periods for which they were designated. During the years ended December 31, 2021, 2020 2019 Cash flow hedges It consists in providing hedge against variation in cash flows attributable to a specific risk related to a known asset or liability or a highly probable forecast transaction and that may affect income statement. The effective portion of changes in fair value of derivative instruments that is designated and qualified as cash flow hedge is recognized in OCI and accumulated in the “gains (losses) from cash flow hedge operations” and “tax effect on gain (loss) from cash flow hedge operations”. In a cash flow hedge, the effective portion of gain or loss from the hedge instrument is recognized directly in OCI, in shareholders’ equity, while the ineffective portion of hedge is immediately recognized as finance income (expense). For the years ended December 31, 2021, 2020 2019 6.2 Hedge accounting is discontinued when the Company terminates the hedge relationship, the hedge instrument matures or is sold, revoked or executed, or no longer qualifies to hedge accounting. Any gains or losses recognized in OCI and accumulated in shareholders’ equity up to that date remain in shareholders’ equity and are recognized when the forecast transaction is eventually recognized in the income statement. If a forecast transaction results in the subsequent recognition of a non-financial asset or liability, the cumulative gain or loss in OCI is recycled to profit or loss during the same year for which the non-financial asset acquired or non-financial liability assumed affects the profit or loss. For example, when the non-financial asset is depreciated or sold. On the other hand, if a forecast transaction results in the subsequent recognition of a financial asset or liability, the cumulative gain or loss in OCI is recycled to profit or loss during the same period for which the financial asset acquired or financial liability assumed affects the profit or loss. For example, when financial income or expense is recognized. When the forecast transaction is no longer expected, cumulative gains or losses deferred in equity are immediately recognized in the income statement. The Company assesses, throughout the hedge term, the effectiveness of its derivative instruments, as well as changes in their fair value. For the years ended December 31, 2021, 2020 2019 6.6
Trade receivable	3.7 Trade accounts receivable Trade accounts receivable correspond to amounts receivable for the sale of goods and services in the ordinary course of the activities of the Company and are recognized to the extent that the consideration, which is unconditional, is due by the customer (that is, only the passage of time is required before payment of the consideration is due) and are measured on initial recognition at cost for the consideration to which the Company expects to be entitled in exchange for the products promised to the client. Subsequently, trade accounts receivable are measured at amortized cost by using the interest rate method and they are subject to impairment test (see note 3.1
Inventories	3.8 Inventories Inventories are valued at their average cost and the net realizable value, whichever is lower. Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and the estimated costs necessary to make the sale. The Company considers the following items when determining its allowance for inventory losses: discontinued products, products with slow turnover, expired products or products nearing the expiration date and products that do not meet quality standards, recorded as “cost of sales”.
Carbon credits – carbon neutral program	3.9 Carbon credits – carbon neutral program In 2007 This commitment, which now refers to the operations of all Natura &Co brands, and, despite Brazil having presented, in November 2021, during the twenty 26 Thus, considering the practices historically applied by the Company and the specificity of the commitments assumed and disclosed to the market and society, this commitment is considered a constructive obligation, according to CPC 25 37 The liability is estimated through audited carbon emission inventories carried out annually and valued based on the best estimate of the cash disbursement that will be required to settle the current obligation at the reporting date. As of December 31, 2021, the balance recorded as “Other non-current liabilities” (see note 24 2007 2021 The Company elected to make purchases of carbon credits by investing in projects with environmental benefits arising from the voluntary market. Thus, the costs incurred will generate carbon credits after completion or maturation of these projects. Such expenses are recorded in the line item “other current assets” (see note 15 Upon effective delivery of the related carbon neutral certificates to the Company, the obligation of being carbon neutral is effectively fulfilled; therefore, the asset balances are offset against those of the liabilities. The difference between the balances of assets and liabilities as of December 31, 2021 and 2020
Property, plant and equipment	3.10 Property, plant and equipment Property, plant and equipment is measured at cost of acquisition or construction, plus interest capitalized during construction period, in the case of qualifying assets, and reduced by accumulated depreciation and impairment losses, if applicable. Depreciation methods, useful lives and residual values are reviewed at each reporting date and adjusted, if applicable. Land is not depreciated. Depreciation of the other assets is calculated to reduce the cost of items of property, plant and equipment less their estimated residual values using the straight-line method over their useful lives and is recognized in the income statement. The estimated useful lives of the assets are mentioned in note 17 Gains and losses on disposals are calculated by comparing the proceeds from the sale with the carrying residual amount and are recognized in the income statement as “other operating expenses, net”. Subsequent expenditure is capitalized only if it is probable that the future economic benefits associated with the expenditure will flow to the Company.
Intangible assets	3.11 Intangible assets Intangible assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination is their fair value at the date of acquisition. Following initial recognition, intangible assets are reported at cost less any accumulated amortization and accumulated impairment losses. Internally generated intangible assets, excluding capitalized development costs, are not capitalized and the related expenditure is reflected in profit or loss in the year in which the expenditure is incurred. The useful lives of intangible assets are assessed as either finite or indefinite. Intangible assets with finite lives are amortized over the useful economic life and assessed for impairment whenever there is an indication that the intangible asset may be impaired. The amortization period and the method for an intangible asset with a finite useful life are reviewed at least at each reporting date. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset are considered to modify the amortization period or method, as appropriate, and are treated as changes in accounting estimates. The amortization expense regarding intangible assets with finite lives is recognized in the income statement in the expense category that is consistent with the function of the intangible assets. Intangible assets with indefinite useful lives are not amortized, but are tested for impairment annually, and when circumstances indicate that the carrying amount may be impaired, either individually or at the CGU level. The assessment of indefinite life is reviewed annually to determine whether the indefinite life continues to be supportable. If not, the useful life is changed from indefinite to finite on a prospective basis. An intangible asset is written off upon disposal (i.e., at the date the receiver of the asset obtains control) or when no future economic benefits are expected from its use or disposal. Any gain or loss arising upon write-offs of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included in the income statement in item “other operating expenses, net”. The main classes of intangible assets are set forth below: 3.11.1 Software Licenses of software and enterprise management systems acquired are capitalized and amortized according to the useful lives described in note 18 Business management system acquisition and implementation costs are capitalized as intangible assets when the asset is identified, when there is evidence that future economic benefits will be generated and when the asset is controlled by the Company, taking into consideration its economic and technological viability. Contracts involving hosting and/or processing of information in the cloud (“cloud computing arrangements”) generate intangible assets to the extent that on the contract start date, the Company obtains control of the software. Contracts which only provide the right of access to the supplier's software during the term of the contract are treated as a service contract and, consequently, recognized as an expense in the income statement as the service is provided (since the right of receiving access to the supplier's software does not give the Company, at the commencement date of the contract, the power to obtain the future economic benefits arising from the software itself and to restrict third parties' access to those benefits). The amounts incurred on software development recognized as assets are amortized under the straight-line method over its estimated useful life, based on the rates shown in Note 18 3.11.2 Trademarks and patents Separately acquired trademarks and patents are stated at their historical cost. Trademarks and patents acquired in a business combination are recognized at fair value on the date of acquisition. For trademarks and patents with definite useful lives, amortization is calculated under the straight-line method, based on the annual rates described in note 18 3.11.3 Relationship with retail clients, franchisees, sub-franchisees and agents Relationships with retail clients, franchisees, sub-franchisees and agents acquired in business combinations are recognized at fair value on the date of acquisition and amortization is calculated using the straight-line method, based on rates shown in note 18 3.11.4 Key money with defined useful life Key money with defined useful life is recorded at the acquisition cost and amortized using the straight-line method during the rental period, as shown in note 18 3.11.5 Technologies developed Technologies developed include technology for product development (including formulas, labeling data, manufacturing processes, regulatory approvals, product packaging and designs) arising from business combination, and are recognized at fair value on the date of acquisition and its amortization is calculated using the straight-line method, based on the rates shown in note 18
Impairment of non-financial assets	3.12 Impairment of non-financial assets The Company reviews, at each reporting date, whether there is an indication that an asset may be impaired. If any indication exists, or when the annual impairment testing for an asset is required, the Company estimates the asset’s recoverable amount. An asset’s recoverable amount is the higher of an asset or the CGU fair value less costs of disposal and its value in use. The recoverable amount is determined for an individual asset, unless the asset does not generate cash inflows that are largely independent from other assets or groups of assets. When the carrying amount of an asset or CGU exceeds its recoverable amount, the asset is considered impaired and is written off to its recoverable amount. In assessing value in use, the estimated future cash flows are discounted to their current value using a pre-tax discount rate that reflects the subsidiary’s weighted average cost of capital in which the CGU operates, which reflects the risks specific to the CGU and is derived from its existing business and respective risks. The Company bases its impairment calculation on most recent budgets and forecast calculations, which are prepared separately for each of the Company’s CGU to which the individual assets are allocated. These budgets and forecast calculations generally cover a period of five years. A long-term growth rate is calculated and applied to project future cash flows after the fifth year. Impairment losses are recognized in the income statement in expense categories consistent with the function of the impaired asset. For non-financial assets, excluding goodwill, an assessment is made at each reporting date to determine whether there is an indication that previously recognized impairment losses no longer exist or have decreased. If such indication exists, the Company estimates the assets or CGU’s recoverable amount. A previously recognized impairment loss is reversed only if there has been a change in the assumptions used to determine the asset’s recoverable amount since the last impairment loss was recognized. The reversal is limited so that the carrying amount of the asset does not exceed its recoverable amount, nor exceed the carrying amount that would have been determined, net of depreciation, had no impairment loss been recognized for the asset in prior years. Such reversal is recognized in the income statement. Goodwill is tested for impairment annually as of December 31, and when circumstances indicate that the carrying amount may be impaired. Impairment is determined for goodwill by assessing the recoverable amount of each CGU (or group of CGU) to which the goodwill relates. When the recoverable amount of the CGU is lower than its carrying amount, an impairment loss is recognized. Impairment losses relating to goodwill cannot be reversed in future periods. Intangible assets with indefinite useful lives are tested for impairment annually as of December 31, at the CGU level, as appropriate, and when circumstances indicate that the carrying amount may be impaired.
Leases	3.13 Lease The Company reviews, at the beginning of the contract, whether a contract is, or contains, a lease. That is, if the contract conveys the right to control the use of an identified asset for a period in exchange for consideration. The Company (as a lessee) applies a single recognition and measurement approach for all leases, except for short-term leases and leases of low-value assets. The Company recognizes lease liabilities to make lease payments and right-of-use assets representing the right to use the underlying assets. At the commencement date of the lease, the Company recognizes lease liabilities measured at the present value of lease payments to be made over the lease term. The lease payments include fixed payments (including in-substance fixed payments) less any lease incentives receivable, variable lease payments that depend on an index or a rate, and amounts expected to be paid under residual value guarantees. The lease payments also include the exercise price of a purchase option reasonably certain to be exercised by the Company and payments of penalties for terminating the lease, if the lease term reflects the Company exercising the option to terminate Variable lease payments that do not depend on an index or a rate are recognized as expenses (unless they are incurred to produce inventories) in the period in which the event or condition that triggers the payment occurs. On May 28, 2020, the IASB issued “Covid- 19 16 06 2 16 19 19 19 06 2 16 The positive impact arising from the relief provided by the amended standard totaled to R$80,037 on the Company’s statement of profit or loss which was recorded as “operating expenses and cost of sales” (R$58,700 in 2020 3.13.1 Right-of-use assets Right-of-use assets are recognized at the commencement date of the lease (i.e., the date the underlying asset is available for use). Right-of-use assets are measured at cost, less any accumulated depreciation and impairment losses, and adjusted for any remeasurement of lease liabilities. The cost of right-of-use assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. Right-of-use assets are depreciated using the straight-line method over the shorter of the lease term and the estimated useful lives of the assets, disclosed in note 19 The right-of-use assets are also subject to impairment, as disclosed in note 3.12 3.13.2 Lease At the lease commencement date, the Company recognizes liabilities measured at the current value of lease payments to be made over the lease term. The lease payments include fixed payments less any lease incentives receivable, variable lease payments that depend on an index or a rate, and amounts expected to be paid under residual value guarantees. The lease payments also include the strike price of a purchase option reasonably certain to be exercised by the Company and payments of penalties for terminating the lease, if the lease term reflects the Company exercising the option. Variable lease payments that do not depend on an index or a rate are recognized as expenses (unless they are incurred to produce inventories) in the period in which the event or condition that triggers the payment occurs. In calculating the current value of lease payments, the Company uses its incremental borrowing rate at the lease commencement date because the interest rate that is implicit in the lease is not readily determinable. After the commencement date, the amount of lease liabilities is increased to reflect the accretion of interest and reduced for the lease payments made. In addition, the carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, a change in the lease payments (i.e., changes to future payments resulting from a change in an index or rate used to determine such lease payments) or a change in the assessment of an option to purchase the underlying asset. The Company’s lease liabilities are disclosed in note 19 3.13.3 Short-term leases and leases of low-value assets The Company applies the short-term lease recognition exemption to its short-term leases regardless of their nature (that is, those leases that have a lease term of 12
Assets held for sale and discontinued operations	3.14 A ssets held for sale and discontinued operations The Company classifies non-current assets and disposal groups as held for sale if their carrying amounts will be recovered mainly through a sale transaction rather than through continuous use. Non-current assets and disposal groups classified as held for sale are measured at the lower of their carrying amount and fair value less costs to sell. Costs to sell are the incremental costs directly attributable to the disposal of an asset (disposal group), excluding finance expenses and income tax expense. The criteria for held for sale classification is regarded as met only when the sale is highly probable, and the asset or (disposal group) is available for immediate sale in its present condition. Actions required to complete the sale should indicate that it is unlikely that significant changes to the sale will be made or that the decision to sell will be withdrawn. Management must be committed to the plan to sell the asset and the expectation to sell to be completed within one Property, plant and equipment and intangible assets are not depreciated or amortized once classified as held for sale. Assets and liabilities classified as held for sale are presented separately as current items in the balance sheet. A disposal group qualifies as discontinued operation if it is a component of an entity that either has been disposed of, or is classified as held for sale, and: (i) represents a separate major line of business or geographical area of operations; (ii) is part of a single coordinated plan to dispose of a separate major line of business or geographical area of operations; or (iii) is a subsidiary acquired exclusively for the purpose of resale. Discontinued operations are excluded from the results of continuing operations and are presented as a single amount in the income statement as profit or loss after taxes in the income statement. The amounts presented as held for sale and discontinued operations come from Avon’s business combination process. These amounts refer to the discontinuity of the acquired company’s operations in North America and reflect the costs incurred in resolving contingencies associated with that operation. The Company presents these effects as part of its discontinued operations since it considers the discontinued operations of the subsidiary Avon as an extension of the Company and for assessing that this presentation reliably represents the essence of the associated transaction.
Trade payable and reverse factoring operations	3.15 Trade payable and reverse factoring operations The Company is party of a reverse factoring operation with a financial institution to facilitate administrative procedures for suppliers to advance receivables related to the routine purchases of the Company. In this operation, the financial institution separately offers to pay the supplier in advance in exchange for a discount and, when agreed between the bank and the supplier (the decision to join this transaction is solely and exclusively on the supplier), the Company pays the financial institution on the original payment date at the full-face value of the originating obligation. This operation does not change the amounts, nature and timing of the liability (including previously agreed-upon terms, prices and conditions) and it does not affect the Company with financial charges practiced by the financial institution, on performing a thorough analysis of suppliers by category. There is no guarantee given by the Company. Additionally, the payments made by the Company represent purchases of goods and services, are directly related to invoices from trade payable and do not change the Company’s cash flows. Thus, the Company continues to recognize the liability as a “trade accounts payables” and these transactions are presented as operating activities in the cash flow statement.
Provisions for tax, civil and labor risks	3.16 Provisions for tax , civil and labor risks Provisions are recognized when the Company have a legal or constructive obligation as a result of past events, and it is probable that an outflow of resources will be required to settle the obligation, and its value can be reliably estimated. Provisions are quantified at the current value of the expected outflow of resources to settle the obligations using the appropriate discount rate according to risks related to the liability. The provisions for tax, civil and labor risks are monetarily adjusted through the end of the reporting period to cover probable losses, based on the nature of the risk and the opinion of the Company’s legal advisors. The monetary adjustments are recorded in finance income (expenses) in note 30 Contingent assets are not recognized by the Company and are only disclosed, in case of probable receipt of economic benefits. If it is practically certain that economic benefits will be received, the asset and the corresponding gain are recorded in the financial statements of the year corresponding to the change in the estimate. A contingent liability recognized in a business combination is initially measured at its fair value. Subsequently, it is measured at the higher of the amount that would be recognized in accordance with the requirements for provisions above or the amount initially recognized less (when appropriate) cumulative amortization recognized in accordance with the requirements for revenue recognition. The Company has contracts that provide for the payment of success fees arising from tax, civil and labor proceedings in which it is a defendant. The Company, based on its best estimate, calculated, and provisioned the amounts for which it understands that there is an expectation of future disbursement.
Current and deferred income tax and social contribution	3.17 Current and deferred income tax and social contribution Current income tax assets and liabilities are measured at the amount expected to be recovered from or paid to the tax authorities based on the tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted at the reporting date in the countries where the Company operates and generates taxable income. The Company periodically assesses the tax treatment assumed in the determination of taxes on profit with respect to situations in which the applicable tax regulation gives rise to interpretations that may be different and considers whether it is likely that the tax authority would accept the uncertain tax treatment. The Company assesses these taxes balances based on the most probable or expected value, depending on which method is assessed as the one The Company has material uncertain tax positions, and which - in case of any unfavorable outcome under litigation - could result in a material adverse impact to the financial statements. In Brazil, they include the corporate income tax (“IRPJ”) and the social contribution on net income (“CSLL”), which are calculated based on taxable income by applying the 15% rate plus additional of 10% on taxable income exceeding R$ 240 for IRPJ and 9% for CSLL and considers the offset of tax losses, limited to 30% of annual taxable income. Taxable income reflects profit before taxes adjusted by non-taxable and non-deductible items (both temporary and permanent items). Deferred taxes represent tax debits and credits on temporary differences between tax base and accounting base of assets and liabilities on accrued tax losses. Deferred tax assets and liabilities are classified as “non-current” as required by CPC 32 12 The carrying amount of deferred tax assets is reviewed at each reporting date and reduced to the extent that it is no longer probable that sufficient taxable profit will be available to allow all or part of the deferred tax asset to be utilized. Unrecognized deferred tax assets are re-assessed at each reporting date and are recognized to the extent that it has become probable that future taxable profits will allow the deferred tax asset to be recovered. The estimate future taxable income requires judgements, estimates and interpretation of tax laws. Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted at the reporting date and reflect the uncertainties relating to these taxes, when applicable. Deferred tax assets and liabilities are offset if there is a legal feasible right to offset tax liabilities against tax assets, and if they are related to taxes registered by the same tax authority under the same taxable entity. Thus, for presentation purposes, tax asset and liability balances are disclosed separately.
Borrowings and financing	3.18 Borrowing and financing Borrowings and financing are initially recognized at fair value, net of transaction costs incurred and are, subsequently, measured at amortized cost. Any difference between raised and settled amounts is recognized in the income statement, using the effective interest rate method during the year in which the borrowing and financing are outstanding. Borrowings costs attributable to the acquisition, construction or production of an asset that necessarily requires a significant effort to be ready for its intended use or sale are capitalized as part of the cost of the corresponding asset. All other borrowing costs are recorded as expense in the period they are incurred. Borrowing costs consist of interest and other costs incurred by an entity related to a borrowing.
Employee benefits	3.19 Employee benefits 3.19.1 Short-term benefits The obligations of short-term benefits for employees are recognized as personnel expenses as the corresponding service is rendered. The liability is recognized at the amount of the expected payment if the Company has a legal or constructive obligation to pay the amount due to services rendered by the employee in the past and the obligation can be reliably estimated. 3.19.2 Profit sharing program The Company recognizes a liability and an expense for its profit-sharing program based on criteria that considers the profit attributable to its shareholders and which is tied to the achievement of specific operational goals and objectives established and approved in the beginning of each year. 3.19.3 Defined contribution plans Obligations to contribute to defined contribution plans are recognized in the income statement as personnel expenses when the related services are rendered by employees. Contributions paid in advance are recognized as an asset to the extent that a cash refund or a reduction in future payments is possible. 3.19.4 Defined benefit plans The Company’s net obligation for defined benefit plans (retirement and post-employment health care) is calculated for each plan based on the estimated amount of the future benefit that beneficiaries will receive in return for services rendered in previous years. This amount is discounted to its current value and is presented net of any plan asset’s fair value. The calculation of the defined benefit plan obligation is carried out annually by an external and independent actuary using the Projected Unit Credit Method. When the calculation results in a potential asset for the Company, the asset to be recognized is limited to the current value of economic benefits available in the form of future reimbursements or reductions in future contributions. To calculate the current value of economic benefits, any applicable minimum cost requirements are considered. The current service cost and accrued interest on the present value of the liability are recognized in the statement of profit or loss and the actuarial gains and losses, generated by the remeasurement of the liability due to changes in actuarial assumptions, are recognized in “OCI”. In case of changes or reductions in the plan, the effects of the cost of past services are recognized in the income statement on its occurrence date.
Share-based payment	3.20 Share-based payments The Company’s executive officers are granted the following purchase option plans, settled exclusively with its own shares: i) ii) iii) iv) The plans are measured at fair value at the grant date. In determining the fair value, the Company uses an adequate valuation method, details of which are disclosed in note 29.1 The cost of transactions settled with equity instruments is recognized, together with a corresponding increase in shareholders’ equity under “additional paid-in capital”, throughout the period in which the service conditions are fulfilled, ending on the date on which the employee is fully vested in the right to the award (vesting date). The cumulative expense recognized for equity instruments transactions settled on each base date up to the vesting date reflects the extent to which the vesting period has transpired and the Company’s best estimate of the number of equity instruments to be vested. The expense or credit of the year is recorded in the income statement under “selling or administrative expenses”, depending on the internal department where the eligible employee is allocated. For the purchase options plan and the strategy-acceleration program, even after expiration of the term for exercise, the recognized expense is not reversed since the right has been vested in executive officers. When an award of equity instruments settlement is canceled (except when the cancellation occurs due to loss of right over the equity instrument for not fulfilling the grant conditions), it is treated as if it had been acquired on the date of cancellation, and any expense not recognized is registered immediately. This includes any award for which the Company or the counterparty have the option of not fulfilling the non-vesting obligation. The dilution effect of options granted is reflected as additional share dilution in the calculation of diluted earnings per share (note 32
Dividends and interest on equity	3.21 Dividends and interest on net equity The proposed payment of dividends and interest on net equity made by the Management that is within the portion equivalent to the minimum mandatory dividend is recorded in the line item “Dividends and interest on net equity” in current liabilities, as it is considered a legal obligation provided for by the Company’s bylaws; However, the portion of dividends exceeding minimum mandatory dividends, as declared by the Management after the reporting date, referred to in the financial statements, but before the authorization date for the issuing of the financial statements, is recognized in the line item “Additional proposed dividend”, in shareholders’ equity. For corporate and accounting purposes, interest on net equity is stated as allocation of income directly in shareholders’ equity.
Treasury shares	3.22 Treasury shares The Company’s own equity instruments which are reacquired (treasury shares) are recognized at acquisition cost and deducted from shareholders’ equity. No gain or loss is recognized in the income statement regarding the purchase, sale, issue or cancellation of the Company’s own equity instruments. Upon disposal or transfer of treasury shares to beneficiaries of share-based payment plans (settled in shares), the amount of the consideration received is recognized as an increase in shareholders’ equity, and any gain or loss resulting from the transaction is recorded as a capital reserve.
Subsidies and government grants	3.23 Subsidies and g overnment grants Subsidies and government grants are recognized where there is reasonable assurance that the subsidy will be received, and all attached conditions will be complied with. When the subsidy relates to an expense item, it is recognized as income on a systematic basis over the periods in which the related costs, for which it is intended to offset, are accounted for. When the subsidy relates to an asset, it is recognized as income in equal amounts over the expected useful life of the related asset. Subsidies received during the year ended December 31, 2020 amounted to R$192,686 and are related to measures introduced by governments where the Company operates as a measure to mitigate the impact of the Covid- 19 2019 2020 2021 2020
Operating segments	3.24 Operating segments The information per business segment is presented in note 26 The main decision-making body of the Company, which is responsible for defining the allocation of funds and for the performance assessment of the operating segments, is the Board of Directors. Additionally, the Company has a Group’s Operational Committee (“GOC”) that includes the CEOs of Natura &Co Holding, Natura &Co Latam, Avon International, The Body Shop and Aesop, in addition to representatives of key business areas (Finance, Human Resources, Business Strategy and Development, Legal, Innovation and Sustainability, Operations and Corporate Governance), which advises the Board of Directors and is responsible for, among others things, monitoring the implementation of short and long-term strategies and making recommendations to the Board of Directors regarding the management of the Company, from the perspective of its results, allocation of funds among business units, cash flow and talent management.
Revenue from contracts with customers	3.25 Revenue from contract s with customer s Revenue from contracts with customer is recognized when control of the goods or services is transferred to the customer at an amount that reflects the fair value of the consideration the Company expects to be entitled in exchange for those goods or services. The Company has concluded that it is the principal in its revenue arrangements. The Company considers whether there are other promises in the contract that are separate performance obligations to which a portion of the transaction price needs to be allocated. In determining the transaction price, the effects of variable consideration, existence of a significant financing component, non-cash consideration, and consideration payable to the customer (if any) are considered. The nature and other considerations on the transaction price and the moment in which the performance obligation is fulfilled for each of the main revenue streams are shown below. 3.25.1 Direct sales Revenue from direct sales is generated by sales to the Company’s consultants (our customers) based on the fair value of consideration received/receivable, excluding discounts, rebates and taxes or charges on sales. Revenue from sales is recognized when the performance obligation is fulfilled, i.e., when the promised product is physically delivered, and the Consultant obtains control over the product. 3.25.2 Direct sales – Additional charges and penalties for late payments The Company charges their customers (Consultants) additional charges and penalties for late payments in the settlement of sales receivables. Due to the level of uncertainty in collecting these amounts (variable consideration), the subsidiaries recognize revenue from additional charges and penalties based on the consideration that Company expects to be entitled given its history of collection from customers. 3.25.3 Retail sales The Company, which operates in the retail market, measures sales revenues based on the fair value of the consideration received/receivable, excluding discounts, rebates and taxes or charges on sales. These revenues are recognized when the performance obligation is fulfilled, i.e., when the promised product is physically delivered, and the consumer obtains control over the product. 3.25.4 Other performance obligation 3.25.4.1 Loyalty program (points campaign) The Company offers points campaign (loyalty program), in which customers accumulate points - while buying the Company’s products - to be exchanged (redeemed) for products in the future. Measurement of points is based on their expected cost, plus a margin. The amount allocated to the loyalty program is deferred and the revenue is recognized upon redemption of the points accumulated by consultants for retail and direct sales, or when they expire or are no longer considered redeemable. The loyalty program points are valid for up to approximately 5 months 3.25.4.2 Program for recognition of Natura and Avon consultants’ performance The Company has performance recognition programs, in which the consultants are awarded based on different indicators, for example, volume of purchases, length of service, among others. The Company believes that this performance recognition program has an added value and hence is considered a commitment to our network. Measurement of performance recognition programs is based on their expected cost, plus a margin. The amount allocated to performance recognition programs is deferred and revenue is recognized when awards are delivered to the Company’s Consultants. 3.25.4.3 Events The Company organizes events to encourage and recognize the best Consultants. The Company believes that these events have an added value for the Consultants, in addition to generating in them an expectation to participate in these events. Thus, the Company has determined that these events are a performance obligation. Measurement of events is based on their expected cost, plus a margin. The amount allocated to events is deferred and the revenue is recognized when the event is held. 3.25.4.4 Franchises (courses, training and consulting/outfit and opening) Upon execution of the agreement, the Company charges from franchisees a fixed amount, part of which is allocated to courses, training and consultancy to train and instruct the franchisee to sell “Natura” and “The Body Shop” brand products. In addition, other part of the charged amounts refers to outfit (specific products to be used at the franchisee store) and inauguration (franchisee’s store opening event). The Company believes that these items represent a material right and, for such, they are considered a performance obligation. Measurement is based on the market value of these items, being initially recognized as deferred revenue. When the franchisee’s store is opened, this deferred revenue is allocated to the income statement. 3.25.4.5 Franchisees (advertising fund) Upon the execution of the agreement, the Company charges from franchisees a fixed amount, a part of which is for the advertising fund (monthly delivery of showcases). The Company believes that this item represents a material right and, for such, it was considered a performance obligation. Measurement is based on the market value of this item, being initially recognized as deferred revenue. This deferred revenue is allocated to income statement upon the delivery of showcases to the franchisees. 3.25.4.6 Franchises (brand right of use) Upon the execution of the agreement, the Company charges from franchisees a fixed amount, part of which is for the use of the “Natura” brand. The Company assesses that this item represents a material right and, therefore, it was considered a performance obligation. Measurement is based on residual value, i.e., the remaining value after excluding the market value of courses, training and consultancy services, outfit and inauguration, and the advertising fund. This amount is initially recognized as deferred revenue which is allocated to income statement, on a straight-line basis, over the term of the franchise agreement. 3.25.4.7 Royalty revenues Sales by franchisees and sub-franchisees of the subsidiary The Body Shop are recognized when performance obligations are satisfied, goods are transferred to the customer and the customer is in control. The performance obligation is the license to operate in the market. Revenues are allocated to the license and are recognized over time, in accordance with the license agreement. Under CPC 47 15 3.25.4.8 Incentives related to “free-of-charge” products and promotional gifts The Company grants incentives related to “free-of-charge” products and promotional gifts for its customers (Natura and Avon Consultants and/or end consumers). Since it is considered a material right, the Company recognizes it as a performance obligation. Considering that the delivery of products and the fulfillment of the performance obligation to deliver “free-of-charge” products or promotional gifts occurs at the same time, the Company concluded that an allocation of prices and monitoring these two performance obligations separately are not applicable. Thus, revenue is recognized when the physical transfer of the product occurs, and the customer obtains control of the product.
Sales taxes	3.26 Sales taxes Expenses and assets are recognized net of sales taxes, except (i) when sales taxes incurred on the purchase of goods or services are not recoverable from the tax authorities, in which case the sales tax is recognized as part of the acquisition cost of the asset or expense item, as the case may be; (ii) when the amounts receivable and payable are presented together with the sales taxes amount; and (iii) when the net amount of sales taxes, recoverable or payable, is included as a component of the amounts receivable or payable in the balance sheet. Tax incentives related to taxes on sales for the current year are recognized in the income statement for the year and recorded in net sales. 3.26.1 Exclusion of ICMS from the tax bases for calculating contributions to PIS and COFINS On March 31, 2017, the Company - based on the conclusion of the judgment by the Full Bench of the Federal Supreme Court (STF) of Extraordinary Appeal No. 574,706 Until 2021 On May 13, 2021, the STF partially granted the motion to clarify filed by the Federal Government (Extraordinary Appeal No. 574,706 one 3.26.2 Concept of supplies for calculating credits of PIS and COFINS contributions The Company claims that PIS and COFINS credits are measured and calculated reliably and based on the best interpretation of current legislation and the country’s jurisprudential scenario, whose evolution is permanently assessed by the Company and its legal advisors.
Statement of added value	3.27 Statement of added value The purpose of this statement is to show the wealth created by the Company and its distribution during a certain period and it is presented by the Company, as required by Brazilian corporate law. The statement of added value was prepared using information obtained in the same accounting records used to prepare the financial statements and pursuant to the provisions of the Brazilian accounting standard CPC 09
Earnings per share	3.28 Earnings per share The basic earnings per share are calculated by dividing the profit (loss) attributable to holders of Company by weighted average number of outstanding common shares, excluding common shares purchased by the Company and held as treasury shares. Diluted earnings per share are calculated by adjusting the weighted average number of outstanding common shares, assuming the conversion of all potential common shares that would cause dilution. The Company has purchase options, restricted shares, strategy acceleration and performance shares that would have a dilutive effect on any earnings per share. CPC 41 33 32 41 33
New standards, amendments and interpretations issued but not yet effective	3.29 New standards, amendments and interpretations issued but not yet effective The new and amended standards and interpretations that are issued, but not yet effective, up to the date of issue of the Company’s financial statements are disclosed below, except for those which, in the Management’s assessment, cannot produce any effect on the financial statements. The Company intends to adopt these new and amended standards and interpretations, if applicable, when they become effective. 3.29.1 Amendments to IAS 1 26 1 In January 2020, the IASB issued amendments to paragraphs 69 76 1 26 1 The amendments are effective for years beginning after January 1, 2023 and must be applied retrospectively. Considering the nature of the proposed amendments and the Company’s history of compliance with covenants, the Company currently believes that the amended standard has a low impact on the process of preparing the financial statements. 3.29.2 Amendments to IFRS 3 15 1 00 2 In May 2020, the IASB issued amendments to IFRS 3 15 1 00 2 3 2 37 25 21 19 The amendments are effective for annual reporting periods beginning on or after January 1, 2022 and, although not having any current impact on the Company, they may be applicable to new business combinations in the future. 3.29.3 Clarification of the application of the fees in the “ 10 9 48 As part of its 2018 2020 9 48 The amendment is effective for years beginning on or after January 1, 2022. Although the changes do not have an immediate effect on the Company, they will apply to changes and/or derecognition of liabilities to be evaluated in the future. 3.29.4 Amendments to IAS 37 25 In May 2020, the IASB issued amendments to IAS 37 The amendment is effective for years beginning on or after January 1, 2022. The Company is currently assessing the potential impact the amendments might have. However, considering the nature of the Company's operations and the absence of significant contracts assessed as onerous, no significant effects are expected. 3.29.5 Inclusion of the definition of “accounting estimates” in IAS 8 23 In February 2021, the IASB issued amendments to IAS 8 23 The amendment is effective for years beginning on or after January 1, 2023. The Company does not expect these changes will have a material impact. 3.29.6 Amendments to IAS 1 2 In February 2021, the IASB issued amendments to IAS 1 Practice Statement 2 The amendments to the IAS are effective for years beginning on or after January 1, 2023. The Company is currently assessing the potential impact the amendments will have. 3.29.7 Amendments to IAS 12 32 In May 2021, the IASB issued amendments to IAS 12 The amendments to the IAS 12
New standards, amendments and interpretations of standards adopted for the first time for the year beginning on January 1st, 2020	3.30 New standards, amendments and interpretations of standards adopted for the first time for the year beginning on January 1, 2021 The Company applied for the first-time certain standards and amendments, which were effective for years beginning on or after January 1, 2021. The Company has not early adopted any other standard, interpretation or amendment that has been issued but is not yet effective. 3.30.1 Amendments to IFRS 9 39 7 4 16 48 38 40 1 11 06 2 2 In 2020 9 39 7 4 16 48 38 40 1 11 06 2 1 Considering the extinction of LIBOR LIBOR LIBOR For the borrowing and financing presented in note 20 Libor 4131 61 Libor 2023 For contracts that do not have a specific clause, a renegotiation will be carried out between the parties. These contracts, however, involve contractual arrangements with commercial partners in irrelevant amounts or intra-group financing operations which do not have an impact on the consolidated financial statements. Accordingly, no change to the risk management strategy was needed to be made by the Company due to the change in the indexes of financial contracts linked to LIBOR 3.30.2 Amendments to IFRS 16 06 2 19 On May 28, 2020, the IASB issued “Covid- 19 16 06 2 19 3.13

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Polices (Tables)	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Schedule of Company’s subsidiaries presented an impact on Hyperinflationary Economies	During the year ended December 31, 2021, as a result of the application of the CPC 42 29 Consolidated 2021 2020 Net loss on hyperinflationary economy adjustment (165,826 ) (55,277 ) Impact on profit or loss (26,528 ) 18,667 Monthly average exchange rate impact 218,227 32,160 Capital reserve - 58,496 Profit reserve - 8,292
Summary of Information About Company Principal Subsidiaries	Below is a list of the Company’s direct subsidiaries as of December 31, 2021, 2020 and 2019: Interest - % 2021 2020 2019 Direct interest: Avon Products, Inc. 100.00 100.00 - Natura Cosméticos S.A. 100.00 100.00 100.00 Natura &Co International S.à r.l. 100.00 100.00 -

BUSINESS COMBINATIONS (Tables)

BUSINESS COMBINATIONS (Tables)	12 Months Ended
	Dec. 31, 2021
Disclosure of detailed information about business combination [abstract]
Schedule of preliminary fair value calculation of consideration transferred	In thousands of R$, except for the Number of Avon outstanding common shares as of January 3, 2020 536,383,776 Multiplied by the exchange ratio of 0.600 Natura &Co Holding Shares per each Avon common share 321,830,266 Multiplied by the market price of Natura &Co shares on January 3, 2020 41.00 Compensation in the issue of shares 13,195,041 Adjustment to the transferred compensation (a) 171,073 Fair value of the Compensation to be transferred 13,366,114 a) Related to the effects of replacements and settlements of share-based payment plans, of which the amount of roughly R$80,000 refers to the share-based payment plans of Avon, in which it was substituted by Natura &Co, and approximately R$ 91,000 refers to the share purchase option plans liquidated as part of the conclusion of the transaction. These are pre-combination installments that were regarded as a transferred compensation.
Schedule of preliminary allocation prepared by Company and resulting goodwill	The fair values of the identifiable assets and liabilities of Avon as of the date of acquisition were: In thousands of R$ Purchase consideration transferred (1) 13,366,114 Fair value of acquired assets: Cash and cash equivalents 2,636,108 Trade receivables (2) 1,135,269 Inventories 1,919,683 Other current assets 1,031,136 Assets held for sale 199,050 Property, plant and equipment 2,912,482 Deferred income tax and social contribution 667,034 Right-of-use (3) 564,669 Other non-current assets 475,096 Judicial deposits 283,885 Recoverable taxes 531,930 Surplus pension plan (other assets) 553,297 Intangible assets (4) 5,846,812 Fair value of liabilities assumed: Borrowing, financing and debentures 7,256,583 Trade accounts payables 2,915,418 Payroll, profit sharing and social contributions 621,203 Dividends and interest on net equity payable 405,916 Derivative financial instruments 15,518 Other operating expenses 999,653 Provision for restructuring (other liabilities) 152,896 Lease liabilities 777,200 Tax liabilities 341,258 Income tax and social contribution 30,068 Provision for tax, civil and labor risks (5) 1,757,940 Deferred income tax and social contribution (6) 592,534 Other liabilities 1,007,623 Total identifiable net assets at fair value 1,882,641 Non-controlling interest 27,555 Goodwill arising on acquisition (7) 11,511,028 ( 1 Refers to the fair value of the acquired shares, which is the amount disbursed on the shares exchange. ( 2 The fair value of the trade accounts receivable amounts to R$ 1,135,269 and is equivalent to it carrying amount and, it is expected that the carrying amount can be collected. ( 3 The Company measured the lease liabilities acquired using the current value of the remaining lease payments on the date of acquisition. The right-of-use assets were measured at an amount equal to the lease liabilities and adjusted to reflect the favorable terms of the lease relative to market terms. ( 4 The fair value of intangibles includes the intangible assets acquired and recognized by Avon before the allocation of the fair value, in the amount of R$ 291,235, plus the effects of the allocation of the fair values described below. Fair value for the intangibles “Avon” tradename, power brands and developed technology has been calculated based on the income approach and the relief-from-royalty method. The relief-from-royalty method is often used to calculate the value of a trademark or trade name. This method is based on the concept that if an entity owns a trademark, it does not have to pay for the use of it and therefore is relieved from paying a royalty. The amount of that theoretical payment is used as a surrogate for income attributable to the intangibles. The valuation is obtained by calculating the current value of the savings in royalties Fair value for relationship with sales representatives has been calculated based on the Multi Period Excess Earnings Method (“MEEM”), method that isolates the income/cash flow that is related to the intangible asset being valued and estimates fair value through the sum of the discounted future excess earnings attributable to the intangible asset. (6) Consists of deferred tax liabilities of approximately R$ 81,423 related to Avon opening balance and net position of deferred tax asset and liabilities related to purchasing price allocation of tax liabilities of R$ 511,111. (7) Goodwill is attributable to strong market position and geographic regions and will result in a more diversified and balanced global portfolio, as well as expected future profitability and operational synergies, such as supply, manufacturing, distribution and efficiency of the administrative structure and revenue growth. This goodwill arising from the transaction is not expected to result in a tax benefit, that is, deductible for tax purposes. (5) Contingent liabilities assumed in the acquisition that are considered current obligations arising from past events and that can be measured reliably were recognized and are initially measured at fair value on the acquisition date and subsequently measured in accordance with the requirements of CPC 15 (R1) (IFRS 3), to a higher amount that would be recognized in accordance with CPC 25 (IAS 37). The fair value of the contingent liabilities includes the liabilities assumed and recognized by Avon before the allocation of the fair value, in the amount of R$ 872,993, plus the effects of the allocation of the fair values, which totaled R$ 820,103. The table below shows the total amount of contingent liabilities assumed on the date of the transaction, including the attributed fair value:
Schedule of fair value of intangible assets	Nature Fair value Useful life “Avon” tradename Represents the fair value of the “Avon” tradename. The relief-from-royalty method has been applied considering a benchmark of similar royalty transactions. 2,022,163 Indefinite Power brands Represents the fair value of Avon’s main brands. The relief-from-royalty method has been applied considering a benchmark of similar royalty transactions as well as the relative importance of the respective brands for Avon’s revenue generation. 517,592 20 years Technology developed Represents the fair value of all technology necessary to develop Avon products, including formulae, labeling data, manufacturing processes, regulatory approvals, product packaging, and designs. The relief-from-royalty method has been applied based on existing contractual relations involving Avon’s developed technology. 1,131,573 5 years Sales Representatives Represents the fair value of the relationship between Avon and its sales representatives. Fair value is calculated based on the active representatives by country as of the valuation date, multiplied by the respective average ticket price as well as projected information on the average ticket growth which includes future inflation. The churn rate and the projected information have been considered as significant assumptions. 1,884,249 7 to 12 years 5,555,577
Schedule of the total amount of contingent liabilities assumed on the date of the transaction, including the attributed fair value	In thousands of R$ Tax 1,381,418 Civil 157,832 Labor 218,690 Total 1,757,940

FINANCIAL RISK MANAGEMENT (Tabl

FINANCIAL RISK MANAGEMENT (Tables)	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Summary of Derivative Instruments	To hedge the current balance sheet positions of the Company against market risks, the following derivative instruments are used and consist of the balances in the following table, as of December 31, 2021 and 2020 Description Fair value (Level 2) Consolidated 2021 2020 Financial derivatives 516,386 1,857,869 Operating derivatives 251 (11,092 ) Total 516,637 1,846,777
Summary of financial derivative positions	As of December 31, 2021 and 2020 Financial derivatives Consolidated Fair value Gain (loss) of fair value adjustment Description 2021 2020 2021 2020 Swap agreement s: (a) Asset position: Long position - U.S. dollar 6,881,981 4,683,900 978,350 421,897 Liability position: Post-fixed CDI Rate: Short position in CDI (6,348,442 ) (2,803,797 ) (823,887 ) (172,885 ) Forward contracts (NDF): Liability position: Post-fixed CDI Rate: (137 ) - (137 ) - Short position at interbank rate (17,016 ) (22,234 ) 94 (16,778 ) Total net derivative instruments: 516,386 1,857,869 154,420 232,234 a) Swap transactions consist of swapping the exchange rate variation for a correction related to a percentage of the fluctuation of the Certificate of Bank Deposits (post-fixed CDI), in the case of Brazil.
Schedule of changes in net financial derivatives	Below are the changes in net derivatives balances for the years ended on December 31, 2021 and 2020 Consolidated Balance as of December 31, 2019 725,572 Losses from swap and forward derivative contracts 1,090,299 Payment of funds due to settlement of derivative transactions – operating activity (211,722 ) Proceeds received due to settlements - financing activity 38,835 Exchange rate variation (OCI) 203,793 Balance as of December 31, 2020 1,846,777 Losses from swap and forward derivative contracts 441,554 Payment of funds due to settlement of derivative transactions – operational activity (1,570,584 ) Proceeds received due to settlements - financing activity 9,040 Exchange rate variation (OCI) (210,150 ) Balance as of December 31, 2021 516,637
Schedule of operating forward derivative instruments	As of December 31, 2021 and 2020 Description Fair value 2021 2020 Net position in GBP and USD (404 ) (7,670 ) Forward contracts 655 (3,422 ) Total of derivative instruments, net 251 (11,092 )
Disclosure Of Net Asset Exposure	For the foreign exchange risk sensitivity analysis, the Company’s Management believes that it is important to consider, in addition to the assets and liabilities with exposure to fluctuations in exchange rates recorded in the balance sheet, the fair value of the financial instruments entered into by the Company to hedge certain exposures as of December 31, 2021 and 2020, as set forth in the table below: Consolidated 2021 2020 Borrowing and financing in foreign currency in Brazil (a) (5,897,015 ) (4,246,692 ) Trade accounts receivable in foreign currency in Brazil 307,433 236,782 Trade accounts payable in foreign currencies in Brazil (37,390 ) (14,459 ) Fair value of financial derivatives 6,882,499 4,680,478 Net asset exposure 1,255,527 656,109 (a)
Disclosure Of Net Foreign Exchange Exposure	The following table shows the projection of the incremental loss that would have been recognized in profit or loss for the subsequent year, if the current net foreign exchange exposure remains static, based on the following scenarios: Consolidated Parity - R$ vs US$ 5.5805 5.7021 4.2765 2.8510 Scenario Scenario Scenario I Scenario II Operation/Instrument Real Probable Depreciation 25% Depreciation 50% Assets denominated in US$ Fair value of “financial” derivatives 6,882,499 7,032,419 5,274,315 3,516,210 Trade accounts receivable in foreign currency in Brazil 307,433 314,130 235,597 157,065 Liabilities denominated in US$ Borrowing and financing in foreign currency in Brazil (5,897,015 ) (6,025,469 ) (4,519,102 ) (3,012,734 ) Trade accounts payable in foreign currencies in Brazil (37,390 ) (38,204 ) (28,653 ) (19,102 ) Impact on net income and shareholders’ equity 1,255,527 27,349 (293,370 ) (614,089 )
Disclosure of Detailed Information About Cash Flow Hedged Items	The positions of derivative instruments designated as outstanding cash flow hedge on December 31, 2021 are set out below: Cash flow hedge instrument – Consolidated Other comprehensive income Hedged item Notional currency Fair value Accumulated contract gain (loss) Gain (loss) in the period Currency Swap – US$/R$ Currency BRL 533,539 64,145 (215,944 ) Forward agreements (The Body Shop and Avon) Currency BRL - - 5,173 Forward contract (Natura Indústria) Currency BRL (129 ) (129 ) 621 Total 533,410 64,016 (210,150 )
Disclosure of changes in cash flow hedge reserve recorded in OCI	The changes in cash flow hedge reserve recorded in OCI are shown below: Consolidated Cash flow hedge balance as of December 31, 2019 42,729 Change in the fair value of hedge instrument recognized in OCI 178,006 Tax effects on fair value of hedge instrument (61,658 ) Cash flow hedge balance as of December 31, 2020 159,077 Change in the fair value of hedge instrument recognized in OCI (210,150 ) Tax effects on fair value of hedge instrument 72,939 Cash flow hedge balance as of December 31, 2021 21,866
Disclosure of Detailed Information About Interest Rate Risks of Transactions	Consolidated Total borrowing, financing, and debentures - in local currency (note 20 (6,914,117 ) Operations in foreign currency with derivatives related to CDI (a) (5,802,715 ) Short-term investments (notes 7 8 2,636,599 Net exposure (10,080,233 ) a) Refers to transactions involving derivatives related to CDI to hedge the borrowing, financing and debentures arrangements raised in foreign currency in Brazil.
Summary of Net Exposure to Interest Rate Risk by Scenario	The following tables show the projection of incremental loss that would have been recognized in profit or loss for the following year, assuming that the current net liability exposure is static and the following scenarios: Description Company Risk Probable scenario Scenario II Scenario III Consolidated Net liability Rate increase (110,883 ) (369,189 ) (627,495 )
Summary of net working capital	Management monitors the Company’s liquidity level considering the expected cash flows in exchange for unused credit facilities, as shown in the following table: Consolidated 2021 2020 Total current assets 17,449,877 18,734,820 Total current liabilities (13,693,877 ) (16,159,586 ) Total net working capital 3,756,000 2,575,234
Disclosure of Maturity Analysis for Non-Derivative Financial Liabilities	Consolidated Less than one One five Over five Total expected cash flow Interest to be accrued Carrying amount Borrowing, financing and debentures 1,339,240 7,288,382 7,495,223 16,122,845 (3,406,013 ) 12,716,832 Lease liability 1,154,697 2,086,269 829,511 4,070,477 (522,615 ) 3,547,862 Trade accounts payables, related parties and reverse factoring operations 6,770,579 - - 6,770,579 - 6,770,579 Dividends payable 180,772 - - 180,772 - 180,772 As of December 31, 2021, the carrying amount of financial liabilities, measured using the amortized cost method, considering interest payments at a floating rate and the value of debt securities reflecting the forward market interest rates, may be changed due to the variation in floating interest rates. Their corresponding maturities, considering that the Company is in compliance with contractual covenants, are evidenced below:
Disclosure of carrying amounts and fair values of the Company’s financial instruments	The carrying amounts and fair values of the Company’s financial instruments as of December 31, 2021 and 2020 Consolidated Carrying amount Fair value Note Classification by category Fair value hierarchy 2021 2020 2021 2020 Financial assets Cash and cash equivalent 7 Cash and banks Amortized cost Level 2 3,349,398 4,436,576 3,349,398 4,436,576 Certificate of bank deposits Amortized cost Level 2 7,639 808,988 7,639 808,988 Repurchase operations Fair value through profit or loss Level 2 650,220 576,108 650,220 576,108 4,007,257 5,821,672 4,007,257 5,821,572 Short-term investments 8 Government securities Fair value through profit or loss Level 2 435,898 864,940 435,898 864,940 Restricted cash Fair value through profit or loss Level 2 44 40,425 44 40,425 Financial treasury bills Fair value through profit or loss Level 2 646,586 505,152 646,586 505,152 Loan investment fund Fair value through profit or loss Level 2 896,212 817,253 896,212 817,253 DBV Fund Fair value through profit or loss Level 3 36,921 16,104 36,921 16,104 Certificate of bank deposits Fair value through profit or loss Level 2 - 292,878 - 292,878 2,015,661 2,536,752 2,015,661 2,536,752 Trade receivables 9 Amortized cost Level 2 3,476,359 3,597,535 3,476,359 3,597,535 Judicial deposits 13 Amortized cost Level 2 585,284 566,190 585,284 566,190 Carbon Credits 15 Fair value through profit or loss Level 2 11,479 4,097 11,479 4,097 Sublease receivables 15 Amortized cost Level 2 347,174 357,538 347,174 357,538 Receivables from service providers 15 Amortized cost Level 1 162,268 135,030 - 135,030 4,582,564 4,660,390 4,582,564 4,660,390 Financial and operating derivatives Fair value – Hedge accounting instruments Level 2 533,410 1,768,122 533,410 1,768,122 Financial and operating derivatives Fair value through profit or loss Level 2 441,719 139,856 441,719 139,856 975,129 1,907,978 975,129 1,907,978 Financial liabilities Borrowing, financing and debentures 20 Borrowing in local currency Amortized cost Level 2 (6,914,117 ) (9,591,809 ) (2,100,465 ) (9,466,921 ) Foreign currency borrowings Amortized cost Level 2 (5,802,715 ) (4,231,104 ) (5,755,272 ) (4,459,081 ) (12,716,832 ) (13,822,913 (7,855,737 ) (13,926,002 ) Carbon credits Fair value through profit or loss Level 2 (19,511 ) (5,560 ) (19,511 ) (5,560 ) Financial and operating derivatives Fair value through profit or loss Level 2 (458,492 ) (61,201 ) (458,492 ) (61,201 ) Lease 19 Amortized cost Level 2 (3,547,862 ) (3,858,455 ) (3,547,862 ) (3,858,455 ) Trade payable and reverse factoring operations 21 Amortized cost Level 2 (6,770,579 ) (6,774,205 ) (6,770,579 ) (6,774,205 ) Insurance payable 24 Amortized cost Level 2 (127,413 ) (159,094 ) (127,413 ) (159,094 ) Dividends payable 25 Amortized cost Level 2 (180,772 ) - (180,772 ) -

CASH AND CASH EQUIVALENTS (Tabl

CASH AND CASH EQUIVALENTS (Tables)	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Schedule of Detailed Information About Cash And Cash Equivalents	Consolidated 2021 2020 Cash and banks 3,349,398 4,436,576 Certificate of bank deposits (a) 7,639 808,988 Repurchase operations (b) 650,220 576,108 4,007,257 5,821,672 (a) As of December 31, 202 1 , investments in Certificate of Bank Deposits (“CDB”) bear interest at an average rate of 103.0 % of the CDI (103.2% in 2020) with daily maturities redeemable with the issuer itself, without significative loss of value. (b) Repurchase operations are securities issued by banks with a commitment by the bank to repurchase the securities, and by the client to resell the security, at a defined interest rate and within a predetermined term, which are backed by public or private securities (depending on the financial institution) and are registered within the Central Agency for Custody and Financial Settlement of Securities (“CETIP”). As of December 31, 2021, repurchase operations are remunerated at an average rate of 100.0% of CDI (100.0% of the CDI as of December 31, 2020).

SHORT-TERM INVESTMENTS (Tables)

SHORT-TERM INVESTMENTS (Tables)	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Schedule of Short-Term Investments	Consolidated 2021 2020 Mutual investment funds (a) 896,212 817,253 Certificate of bank deposits - 292,878 Treasury bills (b) 646,586 505,152 Government securities (LFT) (c) 435,898 864,940 DBV fund 36,921 16,104 Restricted cash 44 40,425 2,015,661 2,536,752 Current 1,978,740 2,520,648 Non-current 36,921 16,104 (a) Mutual investment funds refer to the investments of some subsidiaries of the Company, which are concentrated in the Natura entities of the Hispanic America mainly in Argentina, Chile, Colombia and Mexico. (b) As of December 31, 2021, investments in Treasury bills are remunerated at an average rate of 120.0% of the CDI (136.6% as of December 31, 2020). (c) As of December 31, 2021, investments in Government securities (LFT) are remunerated at an average rate of 102.0% of the CDI (105.9% of the CDI as of December 31, 2020).
Schedule of Detailed Information About Investment Portfolio	The breakdown of securities constituting the Essential Investment Fund portfolio, regarding which the Company holds 100% interest, on December 31, 2021 and 2020 is as follows: Consolidated 2021 2020 Certificate of bank deposits (CDB) - 292,878 Repurchase operations (cash and cash equivalents) 569,349 576,108 Financial letter 646,586 505,152 Government securities (LFT) 428,865 864,940 1,644,800 2,239,078

TRADE RECEIVABLES (Tables)

TRADE RECEIVABLES (Tables)	12 Months Ended
	Dec. 31, 2021
Statement [Line Items]
Schedule of Detailed Information About Trade Receivables	Consolidated 2021 2020 Trade receivables 3,930,340 4,029,643 (-) Allowance for expected credit losses (453,981 ) (432,108 ) 3,476,359 3,597,535
Schedule of Trade Receivables by Exposure to Doubtful Accounts	The following table shows trade receivables by exposure to allowance for expected credit losses as of December 31, 2021 and 2020: Consolidated 2021 2020 Trade receivables Allowance for expected credit losses Trade receivables Allowance for expected credit losses Current 2,488,412 (80,087 ) 1,988,583 (53,352 ) Past due: Up to 30 days 937,227 (68,782 ) 1,506,460 (76,848 ) 31 to 60 days 140,757 (56,784 ) 173,121 (56,124 ) 61 to 90 days 97,713 (49,731 ) 111,735 (54,172 ) 91 to 180 days 266,231 (198,597 ) 249,744 (191,612 ) 3,930,340 (453,981 ) 4,029,643 (432,108 )
Trade receivables [member]
Statement [Line Items]
Schedule of Allowance For Credit Losses	The changes in the allowance for expected credit losses for the year ended December 31, 2021 and 2020 are as follows: Consolidated Balance as of December 31, 2019 (107,995 ) Additions, net of reversals (640,676 ) Write-offs (a) 372,660 Exchange rate variation (56,097 ) Balance as of December 31, 2020 (432,108 ) Additions, net of reversals (837,822 ) Write-offs (a) 817,446 Exchange rate variation (1,497 ) Balance as of December 31, 2021 (453,981 ) (a) Refers to accounts overdue for more than 180 days, which are written off when the Company has no expectation of recovering the trade receivables and sales of customer portfolios.

INVENTORIES (Tables)

INVENTORIES (Tables)	12 Months Ended
	Dec. 31, 2021
Disclosure of Inventories [Abstract]
Schedule of Inventories	Consolidated 2021 2020 Finished products 4,619,237 3,925,215 Raw materials and packaging 1,166,681 1,015,156 Auxiliary materials 195,364 170,188 Products in progress 38,189 36,025 (-) Provision for inventory losses (615,945 ) (602,314 ) 5,403,526 4,544,270
Schedule of Changes In The Provision For Inventory Losses	The changes in the provision for inventory losses for the years ended December 31, 2021 and 2020 are as follows: Consolidated Balance as of December 31, 2019 (185,232 ) Additions, net of reversals (a) (673,201 ) Write-offs (b) 354,692 Exchange rate variation (98,573 ) Balance as of December 31, 2020 * (602,314 ) Additions, net of reversals (a) (407,207 ) Write-offs (b) 396,233 Exchange rate variation (2,657 ) Balance as of December 31, 2021 (615,945 ) (*) the original amounts presented as of December 31, 2020 were reclassified for a better disclosure. Note that this reclassification does not impact the total amount originally presented as provision for inventory losses. a) It refers to the recognition of net allowance for losses due to discontinuation, expiration and quality, to cover expected losses on the realization of inventories, pursuant to the policy of the Company. b) It consists of write-offs of products for which there already had an allowance for losses, where the Company has no expectation of sales/realization.

RECOVERABLE TAXES (Tables)

RECOVERABLE TAXES (Tables)	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Schedule of Current Tax Assets	Consolidated 2021 2020 ICMS on purchase of goods (a) 732,853 681,147 Taxes on purchase of goods – foreign subsidiaries 313,214 230,260 ICMS on purchases of PP&E 12,138 9,578 PIS and COFINS on purchase of property, plant and equipment and purchase of goods (b) 984,737 780,841 Withholding income tax 56,356 23,637 Withholding PIS, COFINS and CSLL 1,673 1,669 Tax on Manufactured Goods - IPI (c) 114,179 77,096 Other 164,099 199,333 2,379,249 2,003,561 Current 1,029,625 1,071,349 Non-current 1,349,624 932,212 a) Tax credits related to the tax on the circulation of goods, interstate and inter-municipal transport and communication services (ICMS) were generated mainly by purchases, whose tax rate is higher than the average of sales. The Company expects to realize these credits during the ordinary course of business through offsetting with sales operations in the domestic market. b) The accumulated tax credits of PIS and COFINS basically arise from credits on purchases of raw materials used in the production and from purchase of property, plant and equipment, as well as credits arising out of the exclusion of ICMS from the calculation basis of the PIS/COFINS. The realization of these credits normally occurs through offsetting with sales operations in the domestic market. c) The balance will be used to offset IPI ( Imposto sobre Produtos Industrializados ) payable in future operations of the Company.

INCOME TAX AND SOCIAL CONTRIB_2

INCOME TAX AND SOCIAL CONTRIBUTION (Tables)	12 Months Ended
	Dec. 31, 2021
Deferred tax assets and liabilities [abstract]
Summary of breakdown of deferred income tax and social contribution – Assets	i) Breakdown of deferred income tax and social contribution – Assets: Consolidated 2021 2020 Tax loss carryforwards (a) 2,099,768 492,384 Allowance for expected credit losses 224,231 205,033 Provision for inventory losses 244,854 169,181 PP&E and Intangible assets – Depreciation and amortization 308,406 351,784 Lease liabilities 441,860 155,470 Other accruals, reserves and provision for tax, civil and labor risks (b) 418,861 519,293 Employee benefits 317,835 479,536 Other temporary differences 433,041 448,991 Total Deferred Tax Assets 4,488,856 2,821,671 Effect of changes in fair value of derivative instruments, including hedge accounting transactions (c) (137,410 ) (638,965 ) PP&E and Intangible assets – useful life adjustment (312,914 ) (328,698 ) Employee benefits (215,235 ) (197,458 ) Right-of-use assets (423,095 ) (171,788 ) Fair value of identifiable net assets in business combination (d) (1,002,167 ) (1,108,693 ) Other temporary differences (438,001 ) (324,389 ) Total Deferred Tax Liabilities (2,528,823 ) (2,769,991 ) Net Deferred income tax and social contribution 1,960,033 (51,680 ) Deferred income taxes and social contribution assets (e) 2,954,074 1,339,725 Deferred income taxes and social contribution liabilities (e) (994,041 ) (1,288,045 ) a) The variation in the period is due to increase in tax loss carryforwards and negative basis resulted from the recording of approximately R$823 million related to the subsidiary Avon Luxembourg S.A.R.L in the period, resulting from corporate restructuring and expectation of realization of the recorded amount. b) Includes (i) allowance under the accrual basis, reflecting authentic expenses incurred in the year, but for which suppliers have not issued invoice, a (ii) deferred revenue and (iii) other accruals not currently deductible for tax. c) Variation in the period refers to settlement of hedge instruments associated to Bonds with exposition to foreign exchange variation. d) The balance includes deferred income tax liability on the fair value of net identifiable assets in the acquisition of the subsidiaries Avon, The Body Shop and Aesop. e) Balance already includes any offsetting of deferred tax assets and liabilities of the same nature and originating from the same jurisdiction.
Schedule of tax losses carryforwards for which no deferred tax asset recognised	As of December 31, 2021, the Company had balances of deferred income tax asset on tax losses in the amount of R$12.3 billion (R$13.3 billion as of December 31, 2020) which do not expire and had not been recognized in accounting books due to historical analyses of recoverability in the respective operations. Of these amounts, R$8.2 billion are from the subsidiary Natura &Co Luxembourg Holdings S.á.r.l (previously known as “Avon Luxembourg”). Item Amount Indefinite Expiration Definite Expiration Net o perating l oss (a) 10,486,753 9,890,238 596,515 Credits (b) 668,067 - 668,067 Other future deductible Items 1,170,092 83,584 1,086,508 Total 12,324,912 9,973,822 2,351,090 a) During 2022, exp R$168 million are expected, the remaining expirations would start to occur in 2023 and future periods with the majority of tax losses. b) During 2022, expiration of approximately R$10 million are expected; the remaining expirations would start to occur in 2023 and in future periods, with the majority of claims subject to statute of limitations in 2027 .
Summary of reconciliation of income tax and social contribution	12.2 Reconciliation of income tax and social contribution: Consolidated 2021 2020 2019 Income (loss) before income tax and social contribution (7,297 ) (388,935 ) 304,566 Taxes on Company formation - 206,592 Income (loss) before income tax and social contribution (1) (7,297 ) (388,935 ) 511,158 Income tax and social contribution at the rate of 34% 2,481 132,238 (173,794 ) Benefit of expenses with research and technological innovation 26,277 23,033 19,228 Tax incentives - 10,018 12,457 I nvestment subsidies (a) 469,863 128,173 24,864 Effect from differences of tax rates of entities abroad (139,924 ) (166,394 ) 26,907 Taxation of profits of foreign subsidiaries (77,072 ) (56,194 ) (60,305 ) Deferred income tax recognized (not recognized) from tax losses carryforward (b) 888,900 (104,160 ) (8,893 ) Tax benefits of interest on own equity (IOE) - 10,275 37,628 Exercise of purchase options and restricted share plans (57,526 ) (9,770 ) 9,697 Non-Deductible donation and contribution - (12,509 ) (4,136 ) U nited K ingdom Tax Law r ate c hange (c) (180,174 ) (63,428 ) - Withholding Taxes - (63,754 ) - Transfer pricing adjustments (36,807 ) (67,529 ) (1,156 ) Other permanent differences 151,968 (34,743 ) (31,596 ) Income tax and social contribution revenue (expenses) 1,047,986 (274,744 ) (149,099 ) Income tax and social contribution - current (923,476 ) (292,828 ) (94,780 ) Income tax and social contribution - deferred 1,971,462 18,084 (54,319 ) Effective Rate- % (14.362 ) (70.6 ) 29.2 a) The Company has tax incentives arising from its ordinary operations (Investment subsidies). b) As of December 31, 2021, the Company had balances of deferred income tax asset on tax losses in the amount of R$ 12.3 13.3 8.2 c) During 2021 and 2020 , the income tax rate in the UK was changed. In 2021 , the enacted tax rate increased from 19% to 25% ( 17% to 19% in 2020 ) which resulted in an increase in the Company’s deferred tax liabilities associated with UK. Such increase was accrued through deferred income tax expense during 2021 and 2020. ( 1 ) At consolidated level, income (loss) before income tax and social contribution included the losses with discontinued operations.
Summary of changes in deferred asset and liability income tax and social contribution	The changes in deferred asset and liability income tax and social contribution for the years ended December 31, 2021 and 2020 were as follows: Consolidated Asset Liability Balance at December 31, 2019 374,448 (450,561 ) E ffect on income statement (19,639 ) 37,723 Reserve for grant of options and restricted shares 96,181 - OCI impact (61,658 ) - Currency Translation Effect 283,359 (314,527 ) Business combination 667,034 (560,680) Balance at December 31, 2020 1,339,725 (1,288,045 ) Effect on income statement 1,728,281 243,180 Reserve for grant of options and restricted shares (106,979 ) - Transfer between income tax and deferred social contribution – assets and liabilities 16,437 (16,437 ) OCI impact 72,939 - Currency translation effect (96,329 ) 67,261 Balance as of December 31, 2021 2,954,074 (994,041 )

JUDICIAL DEPOSITS (Tables)

JUDICIAL DEPOSITS (Tables)	12 Months Ended
	Dec. 31, 2021
Judicial Deposits [Abstract]
Summary of detailed information about judicial deposits	The judicial deposits held by the Company as of December 31, 2021 and 2020 are as follows: Consolidated 2021 2020 Unaccrued tax proceedings (a) 273,295 262,654 Accrued tax proceedings (b) 266,828 252,961 Unaccrued civil proceedings 8,212 9,671 Accrued civil proceedings 2,821 2,189 Unaccrued labor proceedings 11,970 14,166 Accrued labor proceedings 22,158 24,549 Total judicial deposits 585,284 566,190 a) The tax proceedings related to these judicial deposits refer mainly to the ICMS-ST, disclosed in note 23.2.1, contingent liabilities - possible risk of loss. b) The tax proceedings related to these judicial deposits basically refer to the sum of amounts disclosed in note 23.1.1 and the amount accrued as explained in the note 22 .
Summary of detailed information about changes in judicial deposits	Changes in judicial deposits balances for the year ended December 31, 2021 and 2020 are presented below: Consolidated Balance as of December 31, 2019 337,255 Acquisition of subsidiary 283,885 New deposits 18,377 Redemptions (64,761 ) Inflation adjustment 11,242 Payments / write-offs for expenses (17,739 ) Exchange rate variation (2,069 ) Balance as of December 31, 2020 566,190 New deposits 39,071 Redemptions (21,533 ) Inflation adjustment 15,246 Payments / write-offs for expenses (13,645 ) Exchange rate variation (45 ) Balance as of December 31, 2021 585,284

ASSETS HELD FOR SALE (Tables)

ASSETS HELD FOR SALE (Tables)	12 Months Ended
	Dec. 31, 2021
ASSETS HELD FOR SALE
Schedule of the changes in assets classified as held for sale	Consolidated 2021 2020 Balance at the beginning of the year 181,279 199,050 Additions (a) 9,028 25,779 Transfer to property, plant and equipment, other assets and liabilities (b) (25,779 ) (29,610 ) Sale (c) (97,905 ) (61,760 ) Exchange rate variation (13,702 ) 47,820 Balance as of the end of the year 52,921 181,279 a) During the third quarter of 2021, the subsidiary Avon made its operations in India available for sale. b) In the first quarter of 2021, the subsidiary Avon identified new circumstances in the sale transaction of the Saudi Arabia operation, which in 2020 was classified as an available-for-sale asset, which resulted in the reclassification of this transaction from held for sale to property, plant and equipment. At the time of the reclassification, an actual depreciation was recorded, resulting in an immaterial impact on the consolidated financial statements. c) During the third and fourth quarters of 2021, the subsidiary Avon completed the sale of the operations located in Spain, India and Saudi Arabia, resulting in a gain of roughly R$14,600.

OTHER CURRENT AND NONCURRENT _2

OTHER CURRENT AND NONCURRENT ASSETS (Tables)	12 Months Ended
	Dec. 31, 2021
Other Assets [Abstract]
Summary of detailed information about other assets	Consolidated 2021 2020* Marketing and advertising advances 80,078 48,767 Supplier advances 350,830 257,703 Employee advances 17,402 65,180 Rent advances and guarantee deposit (a) 172,465 183,793 Advance insurance expenses 160,911 201,573 Overfunded pension plan (b) 1,043,799 683,425 Customs broker advances - Import taxes 60,739 34,016 Sublease receivables (c) 347,174 357,538 Carbon credits 11,479 4,097 Receivables from service providers ( d ) 162,268 135,030 Other 268,066 172,666 2,675,211 2,143,788 Current 912,160 616,120 Non-current 1,763,051 1,527,668 (*) some amounts originally presented as of December 31, 2020 were reclassified for a better disclosure. Note that this reclassification does not impact the total amount originally presented as current and non-current assets. a) Mainly related to: (i) advances of lease agreements that were not included in the initial measurement of lease liabilities / right-of-use of the subsidiary The Body Shop, in accordance with the exemptions on IFRS 16 06 b) Pension plan arising from the acquisition of Avon. The variation in the period is due to the valuation of funds linked to the pension plan mainly in the United Kingdom (see note 24). c) Refers to the sublease receivable from the New York office owned by the subsidiary Avon. d) Refers to receivables mainly arising from damage that occurred with carriers and insurance companies.

PROPERTY, PLANT AND EQUIPMENT (

PROPERTY, PLANT AND EQUIPMENT (Tables)	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Summary Of Detailed Information About Property, Plant And Equipment	Consolidated Useful life range (in years) 2020 Additions Write-offs Write-offs Impairment Transfers Exchange rate variation 2021 Cost: Vehicles 2 to 5 79,227 4,951 (59,053 ) - 6,702 7,074 38,901 Tooling 3 187,852 2,097 - - 2,042 (151 ) 191,840 Tools and accessories 3 to 20 85,678 19,526 (538 ) - 5,233 1,099 110,998 Facilities 3 to 60 293,471 700 (14,486 ) - 21,231 2,536 303,452 Machinery and accessories 3 to 15 1,819,693 37,229 (98,228 ) - 85,451 115,798 1,959,943 Leasehold improvements 2 to 20 963,957 104,795 (51,588 ) (2,074) 93,589 19,825 1,128,504 Buildings 14 to 60 1,899,176 6,233 (13,322 ) 394 (6,944 ) 96,750 1,982,287 Furniture and fixture 2 to 25 566,548 107,077 (40,259 ) 3,948 19,304 3,509 660,127 Land - 661,613 295 (1,203 ) - (2,372 ) (29,960 ) 628,373 IT equipment 3 to 15 543,772 58,192 (57,574 ) - 68,645 21,545 634,580 Other assets - 36,687 - (3,628 ) - - (1,423 ) 31,636 Projects in progress - 408,385 606,440 (26,425 ) - (429,760 ) 2,806 561,446 Total cost 7,546,059 947,535 (366,304 ) 2,268 (136,879 ) 239,408 8,232,087 Depreciation value: Vehicles (33,042 ) (19,229 ) 47,501 - (5,738 ) 1,051 (9,457 ) Tooling (166,536 ) (7,705 ) - - - 77 (174,164 ) Tools and accessories (39,159 ) (32,867 ) 750 - 3,145 2,391 (65,740 ) Facilities (176,726 ) (16,453 ) 13,072 - (2,705 ) (608 ) (183,420 ) Machinery and accessories (578,762 ) (198,805 ) 91,864 - 8,463 (51,168 ) (728,408 ) Leasehold improvements (480,554 ) (153,822 ) 48,057 - (5,561 ) (10,742 ) (602,622 ) Buildings (179,729 ) (89,292 ) 13,835 - 2,801 (45,941 ) (298,326 ) Furniture and fixture (318,611 ) (95,673 ) 31,464 (291) (353 ) 13,858 (369,606 ) IT equipment (311,856 ) (115,735 ) 52,971 - (7,982 ) (9,493 ) (392,095 ) Other assets (26,027 ) (16,013 ) 1,369 - - 9,830 (30,841 ) Total depreciation (2,311,002 ) (745,594 ) 300,883 (291 ) (7,930 ) (90,745 ) (2,854,679 ) Net total 5,235,057 201,941 (65,421 ) 1,977 (144,809 ) 148,663 5,377,408 Consolidated Useful life range (in years) 2019 Acquisition of subsidiary Additions Write-offs Write-offs Impairment Transfers Exchange rate variation 2020 Cost: Vehicles 2 to 5 45,578 25,789 14,594 (17,274 ) - 1,184 9,356 79,227 Tooling 3 192,556 - 1,243 (19,713 ) - 5,650 8,116 187,852 Tools and accessories 3 to 20 11,974 52,410 11,625 (1,743 ) - 5,888 5,524 85,678 Facilities 3 to 60 309,772 1,431 81 (3,599 ) - 8,791 (23,005 ) 293,471 Machinery and accessories 3 to 15 866,451 740,328 20,098 (5,134 ) - 58,649 139,301 1,819,693 Leasehold improvements 2 to 20 615,103 58,548 34,324 (8,761 ) - 51,588 213,155 963,957 Buildings 14 to 60 386,957 1,203,081 12,275 - (115 ) 48,551 248,427 1,899,176 Furniture and fixture 2 to 25 397,727 32,566 32,530 (6,300 ) (26 ) 11,239 98,812 566,548 Land - 35,157 570,572 57 - - 4,252 51,575 661,613 IT equipment 3 to 15 297,228 112,369 27,254 (10,652 ) - 36,554 81,019 543,772 Other assets - - 36,423 - - - - 264 36,687 Other assets and projects in progress - 156,011 78,965 440,170 (592 ) - (305,305 ) 39,136 408,385 Total cost 3,314,514 2,912,482 594,251 (73,768 ) (141 ) (72,959 ) 871,680 7,546,059 Depreciation value: Vehicles (16,924 ) - (24,150 ) 10,081 - (2,093 ) 44 (33,042 ) Tooling (175,938 ) - (10,092 ) 19,684 - - (190 ) (166,536 ) Tools and accessories (3,255 ) - (42,932 ) - - 10 7,018 (39,159 ) Facilities (167,362 ) - (19,933 ) 285 - 1,044 9,240 (176,726 ) Machinery and accessories (416,736 ) - (193,657 ) 2,759 - (1,202 ) 30,074 (578,762 ) Leasehold improvements (267,371 ) - (130,631 ) 7,124 (4,900 ) (4,107 ) (80,669 ) (480,554 ) Buildings (101,785 ) - (88,593 ) - - - 10,649 (179,729 ) Furniture and fixture (193,973 ) - (81,287 ) 4,744 (284 ) 4,093 (51,904 ) (318,611 ) IT equipment (197,281 ) - (96,768 ) 8,591 (36 ) - (26,362 ) (311,856 ) Other assets - - (25,078 ) - - - (949 ) (26,027 ) Total depreciation (1,540,625 ) - (713,121 ) 53,268 (5,220 ) (2,255 ) (103,049 ) (2,311,002 ) Net total 1,773,889 2,912,482 (118,870 ) (20,500 ) (5,361 ) (75,214 ) 768,631 5,235,057

INTANGIBLE ASSETS (Tables)

INTANGIBLE ASSETS (Tables)	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill	Consolidated Useful life range (in years) 2020 Additions Write-offs Reversal (provision) of impairment Transfers Exchange rate variation 2021 Cost: Software 2.5 to 10 2,059,150 88,101 (114,805 ) - 280,959 179,212 2,492,617 Trademarks and patents (defined useful life) 20 to 25 894,578 - - - - (4,744 ) 889,834 Trademarks and patents (indefinite useful life) - 5,747,057 - - - - 141,566 5,888,623 Goodwill Avon (note 4) - 13,299,849 - - - - 81,341 13,381,190 Goodwill (a) - 142,090 - - - - 1,090 143,180 Goodwill The Body Shop - 1,946,741 - - - - 116,931 2,063,672 Goodwill acquisition of The Body Shop stores - 1,456 - - - - - 1,456 Relationship with retail clients 10 2,785 - - - - 95 2,880 Key money (indefinite useful life) (c) - 26,769 - (3,619 ) 1,984 - (149 ) 24,985 Key money (defined useful life) (d) 3 to 18 10,860 2,500 - (2,288 ) (5,555 ) 8,846 14,363 Relationship with franchisees and sub franchisees and sales representative (e) 7 to 15 2,959,519 - (446 ) - - 31,485 2,990,558 Technology developed (by acquired subsidiary) 5 1,595,041 - - - - (14,233 ) 1,580,808 Intangible under development 2 to 10 108,275 359,834 (1,326 ) - (147,768 ) (41,239 ) 277,776 Total cost 28,794,170 450,435 (120,196 ) (304 ) 127,636 500,201 29,751,942 Accumulated amortization: Software (1,022,498 ) (373,753 ) 116,429 - 3,760 (93,705 ) (1,369,767 ) Trademarks and patents (100,043 ) (45,782 ) - - - 2,638 (143,187 ) Key money (8,871 ) (185 ) - - 1,667 (9,128 ) (16,517 ) Relationship with retail clients (2,839 ) (286 ) - - - (93 ) (3,218 ) Relationship with franchisees and sub franchisees (419,061 ) (306,451 ) 446 - - (3,983 ) (729,049 ) Technology developed (319,009 ) (320,183 ) - - - 6,866 (632,326 ) Other intangible assets (4,721 ) (1,280 ) 1,326 - - 4,380 (295 ) Total accrued amortization (1,877,042 ) (1,047,920 ) 118,201 - 5,427 (93,025 ) (2,894,359 ) Net total 26,917,128 (597,485 ) (1,995 ) (304 ) 133,063 407,176 26,857,583 Consolidated Useful life range (in years) 2019 Acquisition of subsidiary Additions Write-offs Reversal (provision) of impairment Transfers Exchange rate variation 2020 Cost: Software 2.5 to 10 1,313,090 291,555 82,718 (15,095 ) - 258,092 128,790 2,059,150 Trademarks and patents (defined useful life) 20 to 25 116,805 517,592 - - - - 260,181 894,578 Trademarks and patents (indefinite useful life) - 2,171,585 2,022,163 - - - - 1,553,309 5,747,057 Goodwill Avon (note 4) - - 11,511,028 - - - - 1,788,821 13,299,849 Goodwill (a) - 100,237 - - - - - 41,853 142,090 Goodwill (b) - 1,434,369 34,251 - - - - 478,121 1,946,741 Goodwill acquisition of The Body Shop stores - 1,456 - - - - - - 1,456 Relationship with retail clients 10 1,987 - - - - - 798 2,785 Key money (indefinite useful life) (c) - 17,801 - - - - 1,315 7,653 26,769 Key money (defined useful life) (d) 3 to 18 12,447 - 150 - (2,051 ) 1,647 (1,333 ) 10,860 Relationship with franchisees and sub franchisees and sales representative (e) 7 to 15 602,958 1,884,249 - - - - 472,312 2,959,519 Technology developed (by acquired subsidiary) 5 - 1,131,573 - - - - 463,468 1,595,041 Other intangible assets 2 to 10 110,288 159 176,015 (15,024 ) - (175,414 ) 12,251 108,275 Total cost 5,883,023 17,392,570 258,883 (30,119 ) (2,051 ) 85,640 5,206,224 28,794,170 Accumulated amortization: Software (649,347 ) - (365,184 ) 44 - (3,643 ) (4,368 ) (1,022,498 ) Trademarks and patents (44,108 ) - (36,548 ) - - - (19,387 ) (100,043 ) Key money (2,197 ) - (535 ) - - 10 (6,149 ) (8,871 ) Relationship with retail clients (1,939 ) - (252 ) - - - (648 ) (2,839 ) Relationship with franchisees and sub franchisees (95,772 ) - (278,048 ) - - - (45,241 ) (419,061 ) Technology developed - - (294,713 ) - - - (24,296 ) (319,009 ) Other intangible assets (13,159 ) - (6,496 ) 15,020 - - (86 ) (4,721 ) Total accrued amortization (806,522 ) - (981,776 ) 15,064 - (3,633 ) (100,175 ) (1,877,042 ) Net total 5,076,501 17,392,570 (722,893 ) (15,055 ) (2,051 ) 82,007 5,106,049 26,917,128 a) Goodwill related to the acquisition of subsidiary Emeis Holdings Pty Ltd. acquisition, classified as future economic benefits from synergies. It does not have defined useful life and it is subject to annual impairment tests. b) Goodwill related to the acquisition of subsidiary The Body Shop, classified as future economic benefits from synergies. It does not have defined useful life and it is subject to annual impairment tests. In addition, on June 30, 2020, the subsidiary The Body Shop International Limited acquired the entity Aeon Forest Co. Ltd, for R$ 133,275 (¥ 2,632,000). On October 1, 2020, the transaction was concluded and resulted in an assigned amount of goodwill of R$ 34,251. c) Key money with indefinite useful life refers to payments made to former tenants, to get the right to rent the property under lease and can be subsequently negotiated with future tenants in the case of termination of the lease agreement. This balance was considered the scope of the lease standard (CPC 06 2 16 3.13.1 d) Key money with defined useful life refers to payments made to ex-tenants or lessors, to obtain the right to rent the property under the terms of the lease and which cannot be negotiated or recovered later. This balance was considered as the scope of the lease standard (CPC 06 16 e) The balance refers to identifiable intangible assets from relationship with the subsidiary The Body Shop franchisees and sub-franchisees (relationship where the franchisee owns all rights to operate within a territory) and sub-franchisees (relationship where a franchisee operate a single store within a market), with estimated useful life of 15 years.
Disclosure Of Information For Cash-generating Units	CGU groups Trademarks and patents Goodwill Total 2021 2020 2021 2020 2021 2020 Natura &Co Latam 5,403 5,403 10,041,156 9,994,861 10,046,559 10,000,264 Avon International 2,991,963 2,850,397 3,340,035 3,304,988 6,331,998 6,155,385 TBS International 3,063,662 2,896,660 2,063,672 1,946,741 5,127,334 4,843,401 Aesop International - - 143,180 142,090 143,180 142,090 Total 6,061,028 5,752,460 15,588,043 15,388,680 21,649,071 21,141,140
Disclosure Of Detailed Information About Assumptions Used To Calculate The Fair Value Less Cost To Sell	The main assumptions used to calculate the value in use as of December 31, 2021 are presented below: Aesop The Body Shop Avon International Natura &Co Latam Measurement of recoverable value Discounted cash flow based on financial budgets approved by Board of Directors during a discretionary period of five years with a terminal value projected for the end of the period. Budgeted gross margin Gross margins are based on average amounts obtained in the 2 years prior to the beginning of the budgeted period and projections for the next 5 years. Estimated cost Costs based on historical data and market trends, optimization of retail and direct sales operations (renewal of the geographical presence of stores, revitalization of the franchise network) and physical expansion with growth in market share. Revenue Growth rates Growth rates are initially based on published industry research and adjusted by the expected performance for each segment given the initiatives in place for each segment as well as the respective macroeconomic environment that apply to each segment and are included in the budgets approved by Board of Directors. Perpetuity growth rate (*) Constant growth of 4.80%. Constant growth of 4.40%. Constant growth of 4.70%. Constant growth of 5.50%. Discount rate Discount rates represent the risk assessment in the current market, specific to each group of CGU, taking into account the value of money over time and the individual risks of related assets that were not incorporated in the assumptions included in the cash flow model. These cash flows were discounted using a discount rate of 13.93% p.a. for business segments of Natura &Co Latam; 11.18% p.a. for Avon International, 8.83% for TBS International and 11.19% for Aesop International, in real terms. The discount rate was based on the weighted average cost of capital that reflects the specific risk of each segment. (*) The rates are based on published market analyzes and projections regarding the reporting segment in which they operate and adjusted to reflect the assumptions considered by Management in the approved projections and to reflect the inflation differential of other currencies, when applicable.

RIGHT OF USE AND LEASE LIABIL_2

RIGHT OF USE AND LEASE LIABILITIES (Tables)	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Schedule of Quantitative Information About Right-Of-Use Assets	a) Right-of-use assets Consolidated Useful life in Years (a) 2020 Additions Write-offs Impairment (b) Transfers (c) Exchange rate variation 2021 Cost: Vehicles 3 157,867 32,288 (23,519 ) - - 1,426 168,062 Machinery and equipment 3 to 10 53,048 4,278 (24,140 ) - - 443 33,629 Buildings 3 to 10 1,616,833 300,181 (436,405 ) (4,690 ) 3,363 63,736 1,543,018 IT equipment 10 30,000 4,224 (3,904 ) - - 1,483 31,803 Retail stores 3 to 10 3,338,104 505,871 (489,808 ) - 3,888 59,540 3,417,595 Tools and accessories 3 3,187 256 (2,460 ) - - 70 1,053 Total cost 5,199,039 847,098 (980,236 ) (4,690 ) 7,251 126,698 5,195,160 Depreciation value: Vehicles (63,422 ) (50,181 ) 20,808 - - 1,286 (91,509 ) Machinery and equipment (21,045 ) (10,772 ) 15,067 - - (383 ) (17,133 ) Buildings (399,765 ) (268,902 ) 182,535 - (3,069 ) (17,844 ) (507,045 ) IT equipment (19,161 ) (8,364 ) 3,904 - - (789 ) (24,410 ) Retail stores (1,291,346 ) (659,109 ) 485,123 - - 6,820 (1,458,512 ) Tools and accessories (2,253 ) (681 ) 2,460 - - (108 ) (582 ) Total accrued depreciation (1,796,992 ) (998,009 ) 709,897 - (3,069 ) (11,018 ) (2,099,191 ) Net total 3,402,047 (150,912 ) (270,338 ) (4,690 ) 4,182 115,680 3,095,969 Consolidated Useful life in Years (a) 2019 Subsidiary Acquisition Additions Write-offs Impairment (b) Transfers (c) Exchange rate variation 2020 Cost: Vehicles 3 40,018 42,467 61,878 (441 ) - - 13,945 157,867 Machinery and equipment 3 to 10 15,578 14,034 11,265 - - - 12,171 53,048 Buildings 3 to 10 784,900 489,740 146,695 (16,094 ) - - 211,592 1,616,833 IT equipment 10 283 18,429 6,211 (323 ) - - 5,400 30,000 Retail stores 3 to 10 2,350,377 - 384,502 (25,189 ) (148,050 ) (2,962 ) 779,426 3,338,104 Tools and accessories 3 2,803 - - - - - 384 3,187 Total cost 3,193,959 564,670 610,551 (42,047 ) (148,050 ) (2,962 ) 1,022,918 5,199,039 Depreciation value: Vehicles (8,109 ) - (54,558 ) 192 - - (947 ) (63,422 ) Machinery and equipment (4,317 ) - (14,899 ) - - - (1,829 ) (21,045 ) Buildings (97,190 ) - (291,431 ) 12,448 - - (23,592 ) (399,765 ) IT equipment (214 ) - (18,694 ) - - - (253 ) (19,161 ) Retail stores (463,332 ) - (643,441 ) 3,527 - - (188,100 ) (1,291,346 ) Tools and accessories (936 ) - (936 ) - - - (381 ) (2,253 ) Total accrued depreciation (574,098 ) - (1,023,959 ) 16,167 - - (215,102 ) (1,796,992 ) Net total 2,619,861 564,670 (413,408 ) (25,880 ) (148,050 ) (2,962 ) 807,816 3,402,047 a) The useful lives applied refer to the term of the contracts in which the Company is sure that it will use the assets underlying the lease contracts according to the contractual terms. b) On December 31, 2021, an impairment of R$4,690 was recorded referring to the impairment loss of some stores of the and The Body Shop. On December 31, 2020, an impairment of R$148,050 was recorded; out of this amount R$140,050 was related to the legacy stores of subsidiary The Body Shop, which were previously included in the store closure plan, which were subsequently impacted by the effects of pandemic, predominantly in the United States. In the current estimate of the value in use, an annual pre-tax discount rate of 6.59% was used. c) Refers to key money related to store rentals. This amount is transferred from “right of use” to "intangible assets” when a new commercial agreement with the lessor is not yet signed
Schedule Of Detailed Information About Cash Outflow Related To Leases	Consolidated 2021 2020 Amounts recognized in the statement of profit or loss and losses for the years ended December 31, 2021 and 2020 Financial expense on lease 210,669 229,544 Amortization of right-of-use 998,009 1,023,959 Appropriation in the result of variable lease installments not included in the measurement of lease liabilities 70,075 45,952 Sublease revenue (30,026 ) (27,079 ) Short-term lease expenses and low-value assets 83,468 72,546 Benefits granted by lessor related to Covid-19 (80,037 ) (58,700 ) Other lease-related expenses 58,609 40,206 Impairment losses 4,690 144,500 Total 1,315,457 1,470,928 Amounts recognized in the financing activities in the cash flow statement Lease payments (principal) 1,077,611 843,338 Amounts recognized in the operating activities in the cash flow statement Lease payments (interest) 219,574 225,420 Variable lease payments, not included in the measurement of lease liabilities 70,787 33,835 Short-term and low-value assets lease payments 74,188 51,675 Other lease-related payments 95,824 82,150 Total 1,537,984 1,236,418
Schedule Of Lease Obligation	b) Lease liabilities Consolidated 2021 2020 Current 1,005,523 1,059,661 Non-current 2,542,339 2,798,794 Total 3,547,862 3,858,455
Schedule Of Changes In The Balance Of Lease Obligation	Below are the changes in lease liability balances for the year ended December 31, 2021 and 2020: Consolidated Balance as of December 31, 2019 2,517,565 New contracts and modifications 559,905 Acquisition of subsidiary 777,200 Lease payments – principal (843,338 ) Lease payments – interest (225,420 ) Appropriation of financial charges 229,544 Write-offs (a) (193,174 ) Exchange rate variation (OCI) 1,036,173 Balance as of December 31, 2020 3,858,455 New contracts and modifications 737,899 Lease payments (principal) (1,077,611 ) Lease payments (interest) (219,574 ) Appropriation of financial charges 210,669 Write-offs (a) (105,790 ) Exchange rate variation (OCI) 143,814 Balance as of December 31, 2021 3,547,862 a)
Schedule Of Maturities Of The Balance Of Non-current Lease Liabilities	The maturity analysis of the lease liability non-current balance of are as follows: Consolidated 2021 2020 2022 - 419,240 2023 749,030 408,977 2024 575,223 406,572 2025 onwards (2025 onwards to the year 2020) 716,879 1,564,005 2026 onwards 501,207 - Total 2,542,339 2,798,794
Schedule of lease rates applied, according to the lease terms based on maturity.	The table below set forth the rates applied, according to the lease terms: As described in note 3.13.2, the Company applied its incremental borrowing rate as the discount rate on lease liabilities. Considering that the Company’s lease contracts are substantially contracts with payment flows indexed by inflation indices and, also considering the disclosure suggestions published in CVM Circular Letter 02/19, the Company presents below additional information on the characteristics of the lease contracts so that users of the financial statements may, at its discretion, carry out projections of future payment flows indexed to inflation. Most of the lease liabilities refer to subsidiaries Avon, The Body Shop and Aesop operations, which contracts were signed substantially in developed economies countries. Therefore, for these countries, the potential effects of the discount would not be significant given its history of low inflation rates. Contractual Payments - Consolidated Maturity Average discount rate 2022 2023 2024 2025 2026 Onwards 2027 2022-2023 0.5% to 10.8% 21,498 10,100 8,829 7,835 5,451 6,048 2024-2026 1.1% to 12.2% 1,182,969 675,518 527,363 637,337 310,950 33,917 2027-2029 1.7% to 14% 30,421 32,638 35,490 38,684 37,527 40,940 2030-2032 2.2% to 15.5% 3,212 2,992 3,390 3,850 4,371 12,645 Total 1,238,100 721,248 575,072 687,706 358,299 93,550 Projected inflation 1 5% 3% 3% 3% 3% 3% ¹ Rates obtained through future prices of DI coupons versus National Consumer Price Index (IPCA) observed in B 3

BORROWING, FINANCING AND DEBE_2

BORROWING, FINANCING AND DEBENTURES (Tables)	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Schedule Of Detailed Information About Borrowing	Reference Consolidated 2021 2020 Local currency: Financing Agency for Studies and Projects FINEP 44,193 73,076 Debentures A 1,922,732 4,042,515 BNDES - 7,789 BNDES – FINAME - 15 Promissory Note (1) - 773,949 Working capital – Mexico Operation - 14,453 Working capital – The Body Shop Operation B 526,743 500,835 Working capital – Avon Operation 164,491 145,495 Notes – Avon (2) C 4,255,958 4,033,682 Total in local currency 6,914,117 9,591,809 Foreign currency: BNDES - 1,639 Representative debt securities (“Notes”) (2) D 5,523,287 3,969,226 Resolution nº 4131 62 E 279,428 260,239 Total in foreign currency 5,802,715 4,231,104 Grand total 12,716,832 13,822,913 Current 945,069 3,805,649 Non-current 11,771,763 10,017,264 Debentures Current 350,145 2,169,786 Non-current 1,572,587 1,872,729
Schedule Of Additional Information About Borrowings	Reference Currency Maturity Charges Effective interest rate Guarantees A Real By August 2024 Interest of 112% of the CDI 1.00% + CDI and 1.15% + CDI, with maturity dates in September 2022 and August 2024. 113.0% CDI + 1.15% - CDI +1.30% None B Pounds April 2024 Sonia + interest 2.9 Sonia + interest 2.9 “Corporate” guarantee from the subsidiary Natura Cosméticos until December 2021 and “Aval” guarantee from Natura &Co from January 2022. C Dollar March 2023 and March 2043 Interest of 6.45% p.a. and 8.45% p.a. Interest of 6.45% p.a. and 8.45% p.a. None D Dollar May 2028 Interest of 4.125% p.a. 5.79% “Aval” Guarantee from Natura &Co E Dollar May 2022 Sonia + interest 1.1% p.a. Sonia + interest 1.1 “Aval” Guarantee from subsidiary Indústria e Comércio de Cosméticos Natura Ltda.
Schedule Of Changes In Balances Of Borrowing	Consolidated Balance as of December 31, 2019 10,786,374 Acquisition of subsidiary 7,250,735 New borrowing and financing 1,354,765 Repayment (8,483,892 ) Appropriation of financial charges, net of new borrowing and financing costs 1,029,705 Financial charges payment (1,293,094 ) Exchange rate variation (unrealized) 973,442 Exchange rate variation (realized) 35,429 Translation effects (OCI) 2,169,449 Balance as of December 31, 2020 13,822,913 New borrowing and financing (a) 6,425,565 Repayment (b) (7,989,607 ) Appropriation of financial charges 661,429 Financial charges payment (783,935 ) Exchange rate variation (unrealized) 252,190 Translation effects (OCI) 328,277 Balance as of December 31, 2021 12,716,832
Schedule Of Maturity Analysis For Noncurrent Borrowings	Consolidated 2021 2020 2022 - 586,002 2023 2,812,260 6,306,782 2024 (2024 onwards for 2020) 2,249,609 3,124,480 2025 onwards 6,709,894 - Total 11,771,763 10,017,264
Schedule of detailed information about Notes - Avon	Notes - Avon Main US$ Main R$ Annual percentage interest rate Maturity Unguaranteed 461,883 2,577,538 6.50% March 15, 2023 Unguaranteed 216,085 1,205,862 8.45% March 15, 2043

TRADE PAYABLE AND REVERSE FAC_2

TRADE PAYABLE AND REVERSE FACTORING OPERATIONS (Tables)	12 Months Ended
	Dec. 31, 2021
TRADE PAYABLE AND REVERSE FACTORING OPERATIONS
TRADE PAYABLE AND REVERSE FACTORING OPERATIONS	Consolidated 2021 2020 Domestic trade payable 5,296,080 5,462,377 Foreign trade payable (a) 1,104,189 1,014,356 Subtotal 6,400,269 6,476,733 Reverse factoring operations (b) 370,310 297,472 Total 6,770,579 6,774,205

TAX LIABILITIES (Tables)

TAX LIABILITIES (Tables)	12 Months Ended
	Dec. 31, 2021
Dislosure Of Tax Liabilities [Abstract]
Schedule of detailed information about tax liabilities	a) The Company has discussions about the illegality of changes in state laws to charge ICMS-ST. Part of the amount recorded as tax payable but not yet paid is being discussed in court by Company, and in some cases, the amounts are deposited in court, as mentioned in note 13. Consolidated 2021 2020 ICMS (ordinary) 150,396 134,165 ICMS-ST provision (a) 58,188 61,521 Taxes on invoicing abroad 340,648 364,291 Withholding tax (IRRF) 148,081 131,368 Other taxes payable - foreign subsidiaries 138,461 136,232 Income tax 7,062 15,943 PIS and COFINS payable 144 11,857 INSS and service tax (ISS) payable 29,359 32,954 Other 8,888 6,490 Total 881,227 894,821 Current 766,430 785,367 Non-current 114,797 109,454

PROVISION FOR TAX, CIVIL AND _2

PROVISION FOR TAX, CIVIL AND LABOR RISKS (Tables)	12 Months Ended
	Dec. 31, 2021
Disclosure of other provisions [line items]
Schedule of tax, civil and labor provision and contingent liabilities	Consolidated Tax Civil Labor Contingent liabilities (business combination) Total 2021 2020 2021 2020 2021 2020 2021 2020 2021 2020 Balance at the beginning of the year 931,771 127,842 219,374 30,653 251,339 61,571 797,693 - 2,200,177 220,066 Acquisition of subsidiary (1) - 671,667 - 102,208 - 163,962 - 820,103 - 1,757,940 Additions 47,116 169,824 181,856 329,294 90,855 44,566 (22 ) 9,772 319,805 553,456 Reversals (2) (78,488 ) (71,797 ) (35,433 ) (62,013 ) (77,727 ) (4,601 ) (195,070 ) (67,482 ) (386,718 ) (205,893 ) Payments (4,965 ) (54,590 ) (88,266 ) (118,047 ) (39,553 ) (48,792 ) - - (132,784 ) (221,429 ) Inflation adjustment 4,698 5,623 2,723 4,164 7,860 6,508 10,450 21,671 25,731 37,966 Exchange rate variation (OCI) (25,609 ) 83,202 12,471 32,424 2,201 27,284 (15,466 ) 13,629 (26,403 ) 156,539 Transfers (3) (12,429 ) - 12,965 (99,309 ) (1,503 ) 841 - - (967 ) (98,468 ) Balance as of the end of the year 862,094 931,771 305,690 219,374 233,472 251,339 597,585 797,693 1,998,841 2,200,177 Current 230,097 199,733 Non-current 1,768,744 2,000,444 The changes in the provision for tax, civil and labor risks and contingent liabilities are presented below: (1) Amounts arising from tax, labor and civil lawsuits with probability of possible and remote loss in the amount of R$709,751, R$55,624 and R$119,572, respectively, measured and recorded at the estimated fair value resulting from the business combination with Avon, in accordance with paragraph 23 of CPC 15/IFRS 3, additionally, the fair value of contingent liabilities includes liabilities assumed and recognized by Avon prior to the allocation of fair value, in the amount of R$872,993. (2) Reversals mainly refer to adhesion to state tax amnesty programs and change of labor proceedings estimates. (3) Amounts related to the 2020 period resulted from other liabilities of subsidiary Avon related to proceedings previously recognized as contingent liabilities being reclassified as other trade accounts payable.
Schedule of contingencies assessed as possible risk of loss	Consolidated 2021 2020 Tax 9,884,541 9,205,601 Civil 128,479 133,302 Labor 180,838 220,648 Total contingent liabilities 10,193,858 9,559,551

OTHER LIABILITIES (Table)

OTHER LIABILITIES (Table)	12 Months Ended
	Dec. 31, 2021
Disclosure of defined benefit plans [line items]
Disclosure Of Detailed Information About Other Liabilities [Text Block]	Consolidated 2021 2020 Pension and post-employment health care plans (a) 673,458 783,184 Deferred revenue from performance obligations with customers (b) 393,046 422,353 Provisions for incentives to consultants 286,791 292,034 Provisions for operating expenses (marketing / technology, etc.) ( c ) 601,841 535,276 Provision for store renovation 105,165 99,702 Crer Para Ver (d ) 90,655 75,508 Provisions for rentals (e ) 55,500 70,598 Provision for restructuring (f ) 103,760 68,954 Long-term incentives (g ) 6,302 52,745 Insurance payables 127,413 159,094 Other Liabilities (h ) 214,635 245,526 Total 2,658,566 2,804,973 Current 1,716,110 1,691,834 Non-current 942,456 1,113,139 (*) some amounts originally presented as of December 31, 2020 were reclassified for a better disclosure, including the balance related to discontinued operations that is disclosed in note 23. a) As of December 31, 2021, there is R$445,804 (R$609,691 as of December 31, 2020) related to Avon's pension plans, and R$34,774 (R$39,029 as of December 31, 2020) related to post-employment plans of subsidiary Avon, and R$124,649 (R$134,194 as of December 31, 2020) related to post-employment healthcare plans of subsidiary Natura Cosmeticos and R$68,230 as of December 31, 2021 related to post-employment healthcare plans of subsidiary &Co International. b) Refers to the deferral of revenue of performance obligations related to loyalty programs based on points, sale of gift cards not yet converted into products and programs and events to honor direct selling consultants, of which R$235,308 (R$318,686 as of December 31, 2020) related to subsidiary Avon, R$121,341 (R$103,667 as of December 31, 2020) related to subsidiary consolidated and R$36,397 related to subsidiary & Co International. c) Refers to the Company’s operating provisions mainly due to spending on provision of technology services, marketing and advertising. d) Refers to Social program contribution for developing the quality of education. e) Refers to the (grace) period granted by lessors for the start of payment of rental of certain retail stores, for rental agreements that were not included in the initial measurement of lease liabilities / right of use of the subsidiary The Body Shop, in accordance with the exceptions permitted under IFRS 16 / (CPC 06 (R2)). f) Provision for costs directly related to the plan for integration and changes in the organizational structure, mainly of subsidiary Avon organizational structure. g) Refers substantially to the variable remuneration plans for subsidiary Avon executive officers. h) Refers to several provisions such as indemnities and long-term contractual obligations.
Avon [member]
Disclosure of defined benefit plans [line items]
Schedule of detailed information about movements of actuarial liabilities	Pension plan 2021 2020 Balance at beginning of year 609,961 413,070 Cost of services – current 24,660 28,015 Interest cost – recognized in the income statement 10,934 13,760 Administrative costs 2,698 2,476 Company contributions (49,516 ) (17,212 ) Benefits paid (6,413 ) (4,611 ) Actuarial gain (loss) in OCI (99,991 ) 74,460 Reclassifications 18,045 (14,451 ) Others (72,252 ) (2,814 ) Foreign currency changes 7,678 117,268 Balance at end of year 445,804 609,961 The change in actuarial liabilities for the years ended December 31, 2021 and 2020 are shown below:
Schedule of significant actuarial assumptions for the determination of the actuarial liability	The significant actuarial assumptions for the determination of the actuarial liability are discount rate and rate of compensation increase. The details of the assumptions are as follows: 2021 2020 Discount rate 0.65 9.20 0.30 to 8.50% Rate of compensation increase 1.80% to 6.60% 1.80% to 6.60%
Schedule of fair values of each major class of plan assets	The fair values of each major class of plan assets are presented below: Consolidated 2021 2020 Cash and cash equivalent 191,958 173,563 Equity instruments of other entities 1,066,370 918,222 Government bonds 1,482,650 2,633,587 Corporate bonds 1,802,394 525,886 Real estate 12,834 8,314 Other 12,276 10,393 Total 4,568,482 4,269,965
Natura Cosmticos SA [Member]
Disclosure of defined benefit plans [line items]
Schedule of detailed information about movements of actuarial liabilities	Consolidated 2021 2020 Balance at the beginning of the year 134,194 98,792 Cost of the current service of subsidiary Natura Cosméticos 939 620 Cost of interest 9,326 7,223 Expenses paid (2,679 ) ( 2,069 ) Actuarial gains (losses) in OCI (17,131 ) 29,628 Balance at end of year 124,649 134,194 The changes of actuarial liabilities for the years ended December 31, 2021 and 2020, is set forth in the table below:
Schedule of significant actuarial assumptions for the determination of the actuarial liability	2021 2020 Discount rate 9.01% 7.02% Initial growth rate of medical cost 4.25% 3.75% Inflation rate 3.40% 3.10% Final growth rate of medical cost 7.79% 6.97% Growth rate of medical costs due to aging - costs Per age range 1.25% to 4.75% p.a. Per age range 1.25% to 4.75% p.a. Growth rate of medical costs by aging - contributions 0.00% 0.00% Percentage of adherence to the plan in retirement Bradesco Plan 60.00% / Unimed Plan 85.00% Bradesco Plan 69.00% / Unimed Plan 84.00% Schedule of disabled mortality Mercer Disability Mercer Disability Schedule of mortality AT- 2000 AT- 2000 Schedule of turnover Proportional calculation at the time of service Proportional calculation at the time of service
Schedule of detailed information about sensitivity analysis for actuarial assumptions	The table below sets forth the medical inflation rate and the discount rate sensitivity analysis, and their respective effect on the balance (present value of the obligation, or “PVO”) accounted as on the actuarial liabilities (maintaining the other assumptions): Rate Chance PVO Discount rate 9.01% 0.5% increase 105,731 Discount rate 9.01% 0.5% decrease 148,971 Rate of compensation 7.79% 1% increase 148,175 Rate of compensation 7.79% 1% decrease 105,933

SHAREHOLDER'S EQUITY (Table)

SHAREHOLDER'S EQUITY (Table)	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Schedule of Composition of Share Capital	Number of shares Amount R$ (thousands) Average price per share - R$ Balance as of December 31, 2020 316,701 11,667 38.04 Used (754,719 ) (34,438 ) 45.63 Acquired 5,337,558 174,113 32.62 Balance as of December 31, 2021 4,899,540 151,342 30.89

OPERATING SEGMENTS (Tables)

OPERATING SEGMENTS (Tables)	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Summary of operating segment	2020 Reconciliation to net income (loss) for the year Financial Revenue Performance assessed by the company Depreciation and amortization Financial income Financial expense Income tax Income (loss) Natura &Co Latam 20,542,345 2,369,517 (874,584 ) 3,402,578 (3,891,641 ) (428,191 ) 577,679 Avon International 1 9,097,375 185,914 (814,678 ) 979,267 (1,442,216 ) (121,603 ) (1,213,315 ) The Body Shop International 1 5,332,922 935,255 (761,224 ) 82,736 (157,705 ) (66,626 ) 32,436 Aesop International 1 1,949,338 606,544 (268,092 ) 23,152 (72,056 ) (55,219 ) 234,328 Corporate expenses - (731,889 ) (278 ) 250,658 (210,192 ) 396,895 (294,806 ) Consolidated 36,921,980 3,365,339 (2,718,856 ) 4,738,391 (5,773,810 ) (274,744 ) (663,678 ) 2019 Reconciliation to net income (loss) for the year Financial Revenue Performance assessed by the company Depreciation and amortization Financial income Financial expense Income tax Income (loss) Natura &Co Latam 9,113,856 1,372,172 (370,953 ) 1,893,333 (2,613,294 ) 41,623 322,880 The Body Shop International 1 4,028,660 806,357 (559,921 ) 44,953 (99,765 ) (37,736 ) 153,888 Aesop International 1 1,302,174 351,944 (186,542 ) 9,337 (34,204 ) (47,768 ) 92,768 Corporate expenses - (61,809 ) - 8,161 (48,611 ) (311,810 ) (414,069 ) Consolidated 14,444,690 2,468,664 (1,117,416 ) 1,955,784 (2,795,874 ) (355,691 ) 155,467 2021 Reconciliation to net income (loss) for the year Financial Revenue Performance assessed by the Company Depreciation and amortization Financial income Financial expense Income tax Net income (loss) Natura &Co Latam 22,413,401 2,595,653 (871,973 ) 3,181,237 (3,881,418 ) 165,137 1,188,636 Avon International 1 9,329,325 272,655 (830,931 ) 421,123 (894,318 ) 210,705 (919,316 ) The Body Shop International 1 5,821,776 1,023,095 (795,127 ) 63,939 (137,834 ) (158,973 ) (4,900 ) Aesop International 1 2,600,185 622,944 (293,492 ) 30,380 (75,372 ) (90,277 ) 194,183 Corporate expenses - (604,594 ) - 309,884 (44,598 ) 921,394 582,086 Consolidated 40,164,687 3,909,753 (2,791,523 ) 4,006,563 (5,033,540 ) 1,047,986 1,040,689
Summary of operating segments of assets and liabilities	2021 2020 Non-current assets Total assets Current liabilities Non-current liabilities Non-current assets Total assets Current liabilities Non-current liabilities Natura &Co Latam 18,060,879 29,580,551 7,462,550 8,794,843 20,228,016 30,706,123 9,349,461 9,060,600 Avon International 1 14,286,498 17,512,750 2,783,907 5,100,109 12,486,733 16,036,743 3,467,099 5,625,774 The Body Shop International 1 8,166,363 10,813,064 1,690,622 2,485,200 7,821,884 10,474,191 2,291,459 1,812,991 Aesop International 1 1,520,514 2,542,125 610,451 648,695 1,395,628 2,148,869 488,662 618,531 Corporate expenses 964,359 - 1,146,347 1,159,041 250,516 1,551,671 562,905 253,007 Consolidated 42,998,613 60,448,490 13,693,877 18,187,888 42,182,777 60,917,597 16,159,586 17,370,903 2020 2019 Non-current assets Total assets Current liabilities Non-current liabilities Non-current assets Total assets Current liabilities Non-current liabilities Natura &Co Latam 20,228,016 30,706,123 9,349,461 9,060,600 4,574,087 9,328,858 3,116,454 8,235,678 Avon International 1 12,486,733 16,036,743 3,467,099 5,625,774 - - - - The Body Shop International 1 7,821,884 10,474,191 2,291,459 1,812,991 6,146,960 7,369,250 1,065,447 1,477,149 Aesop International 1 1,395,628 2,148,869 488,662 618,531 1,033,408 1,435,830 255,616 590,917 Corporate expenses 250,516 1,551,671 562,905 253,007 - 3,050,574 3,080,906 - Consolidated 42,182,777 60,917,597 16,159,586 17,370,903 11,754,455 21,184,512 7,518,423 10,303,744 1 The operations of these segments located in Latin American countries (Latam) are presented in the Natura &Co Latam segment.
Summary of revenue and assets by geographical area wise	Net revenue Non-current assets 2021 2020 2019 2021 2020 Asia 3,719,131 2,929,063 782,940 1,216,942 768,878 North America 6,227,104 5,120,953 1,750,957 6,459,026 5,939,728 Mexico 3,879,033 3,205,609 767,361 3,640,644 3,263,833 Other 2,348,070 1,915,344 983,596 2,818,382 2,675,896 South America 17,436,131 16,484,363 8,340,025 14,250,548 14,810,020 Brazil 10,481,869 11,113,810 6,324,227 11,953,325 12,159,245 Argentina 2,973,638 1,999,461 794,749 1,036,205 1,041,392 Other 3,980,624 3,371,092 1,221,049 1,261,018 1,609,383 Europe, Middle East and Africa (EMEA) 11,771,601 11,580,586 2,909,968 19,276,178 19,615,198 United Kingdom 4,187,200 4,117,699 2,115,385 12,162,597 17,059,017 Other 7,584,402 7,462,887 794,583 7,113,581 2,556,181 Oceania 1,010,721 807,015 660,800 1,795,919 1,048,953 Consolidated 40,164,687 36,921,980 14,444,690 42,998,613 42,182,777

NET REVENUE (Tables)

NET REVENUE (Tables)	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Summary of revenue by Geographical Area Wise	Consolidated Revenue: 2021 2020 2019 Domestic market 14,329,931 15,373,742 8,907,766 Foreign market 36,894,728 31,784,934 10,739,036 Other sales 418,217 538,942 61,302 Subtotal 51,642,876 47,697,618 19,708,104 Returns and cancellations (644,693 ) (617,140 ) (73,183 ) Commercial discounts and rebates (1,238,667 ) (1,062,204 ) (1,292,134 ) Taxes on sales (9,594,829 ) (9,096,294 ) (3,898,097 ) Subtotal (11,478,189 ) (10,775,638 ) (5,263,414 ) Total net revenue 40,164,687 36,921,980 14,444,690

OPERATING INCOME (EXPENSES) A_2

OPERATING INCOME (EXPENSES) AND COST OF SALES (Tables)	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Summary of operating income (expenses) and cost of sales classified by function and nature	Classified by function Consolidated 2021 2020 2019 Cost of sales 14,011,525 13,229,715 4,033,454 Selling, marketing and logistics expenses 16,999,225 15,702,787 6,395,586 Administrative, R&D, IT, and project expenses 6,958,866 5,955,996 2,405,576 Total 37,969,616 34,888,498 12,834,616 Classified by nature Cost of sales 14,011,525 13,229,715 4,033,454 Raw material/packaging material/resale 12,115,805 11,222,801 3,457,481 Employee benefits expense (note 29) 568,936 638,525 293,374 Depreciation and amortization 254,476 215,355 57,443 Other 1,072,308 1,153,034 225,156 Selling, marketing and logistics expenses 16,999,225 15,702,787 6,395,586 Logistics costs 2,654,546 2,479,156 797,055 Personnel expenses (note 29) 4,547,391 4,198,147 1,667,202 Marketing, sales force and other selling expenses 8,388,848 7,568,365 3,164,875 Depreciation and amortization 1,405,423 1,301,657 766,454 Impairment 3,017 155,462 - Administrative, R&D, IT and project expenses 6,958,866 5,955,996 2,405,576 Innovation expenses 223,472 270,256 89,675 Personnel expenses (note 29) 2,886,281 2,498,024 1,223,586 Other administrative expenses 2,717,489 1,985,872 798,796 Depreciation and amortization 1,131,624 1,201,844 293,519 Total 37,969,616 34,888,498 12,834,616

EMPLOYEE BENEFITS (Tables)

EMPLOYEE BENEFITS (Tables)	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Summary of Employee Benefit Expense	Consolidated 2021 2020 2019 Payroll, profit sharing and bonuses 5,911,837 5,407,990 2,315,517 Pension Plan 243,511 186,373 93,528 Share-based payments and social charges (note 32.3) (a) 228,131 231,962 118,608 Health care, food and other benefits 712,983 684,992 253,510 Charges, taxes and social contributions 701,521 635,248 231,384 INSS 204,625 188,131 171,615 Total 8,002,608 7,334,696 3,184,162 a) The variation in the subsidiary over 2021 is basically due to transfer of employees from Natura Cosmeticos S.A. to Natura &Co Holding, as well as the increase for the 2021 grant, net of social charges associated with the variation in the value of the Company's share.
Summary of Number and Weighted Average Number of Shares	The changes in the number of outstanding share-based awards are as follows: Stock Option Plan and Strategy Acceleration Plan Average exercise price per option – R$ Options (thousands) Balance as of December 31, 2020 16.43 15,523 Granted 30.87 6,650 Expired/Canceled 20.76 (183 ) Exercised 18.80 (1,853 ) Balance as of December 31, 2021 21.05 20,137 Restricted shares (thousands) Performance shares (thousands) Balance as of December 31, 2020 4,361 5,579 Granted 3,435 3,402 Expired/Canceled (590 ) (936 ) Exercised (1,712 ) - Balance as of December 31, 2021 5,494 8,045
Summary of Terms and Conditions of Share-based Payment Arrangement	The outstanding share-based awards as at the end of the period have the following maturity dates, fair values and exercise prices As of December 31, 2021 - StockOptions Grant date Conditions for acquiring the rights from grant date Exercise price - R$ Fair value at grant date (R$) Existing shares (thousands) Maximum remaining contractual life (years) Vested options (thousands) March 17, 2014 From 2 4 28.94 4.27 82 0.2 82 March 16, 2015 From 2 4 13.47 4.85 to 5.29 104 1.2 104 July 28, 2015 (Acceleration Strategy) From 4 5 12.77 6.20 to 6.23 495 1.6 495 March 15, 2016 From 2 4 12.71 7.16 to 7.43 93 2.2 93 July 11, 2016 (Acceleration Strategy) From 4 5 11.28 6.84 to 6.89 1,650 2.5 1,650 March 10, 2017 From 2 4 12.46 6.65 to 6.68 378 3.2 378 March 10, 2017 (Acceleration Strategy) From 4 5 12.46 6.87 to 6.89 2,000 3.2 895 March 12, 2018 From 2 4 16.83 7.96 to 8.21 1,554 4.2 890 March 12, 2018 Acceleration strategy) From 3 5 12.04 to 16.83 8.21 to 9.67 3,800 4.2 950 April 12, 2019 From 2 4 23.41 11.71 to 11.82 1,431 5.2 391 April 12, 2019 Acceleration strategy) From 4 5 23.41 11.51 to 11.71 1,900 5.2 - March 31, 2021 From 4 5 48.98 29.08 to 29.81 1,100 9.3 - December 17, 2021 From 3 4 27.28 17.58 to 18.16 5,550 10.0 - 20,137 5,928 As of December 31, 2021 – Restricted shares Grant date Conditions for acquiring the rights from grant date Existing shares (thousands) Fair value at grant date (R$) Remaining contractual life (years) March 12, 2018 - Plan I, August 13, 2018 - Extraordinary Plan VI From 2 4 248 12.25 to 15.90 0.2 April 12, 2019 – Plan I From 2 4 569 21.62 to 22.53 1.2 April 12, 2019 – Plan II From 1 3 156 22.14 to 22.85 0.2 March 27, 2020 – Co-Investment Plan From 1 3 1,312 29.00 1.3 March 31, 2021 From 1 3 3,209 48.13 2.3 5,494 As of December 31, 202 1 – Performance shares Grant date Conditions for acquiring the rights from grant date Existing shares (thousands) Fair value at grant date (R$) Maximum remaining contractual life (years) Undelivered shares (thousands) May 21, 2019 Achievement of performance conditions, 3 years of service plus an additional holding period of 1 year for certain awards. 539 28.10 to 45.70 0.5 to 1.5 539 September 30, 2020 Achievement of performance conditions, 2.5 years of service plus an additional holding period of 1 year for certain awards. 4,303 48.56 to 73.46 1.3 to 2.3 4,303 March 31, 2021 Achievement of performance conditions, 3 years of service plus an additional holding period of 1 year for certain awards. 3,203 46.57 to 50.98 2.3 to 3.3 3,203 8,045 8,045

FINANCE INCOME (EXPENSES)_ (Tab

FINANCE INCOME (EXPENSES) (Tables)	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Summary of Detailed Information About Financial Income Expense	Consolidated 2021 2020 2019 FINANCE INCOME: Interest on short-term investments 264,764 167,967 83,115 Gains on monetary and exchange rate variations (a) 1,785,259 1,752,503 854,025 Gains on swap and forward transactions (c) 1,814,450 2,532,487 961,185 Gains on swap and forward derivatives mark to market 20,929 12,314 1,709 Inflation adjustment reversal on provision for tax risks and tax liabilities - 42,378 25,469 Hyperinflationary economy adjustment (Argentina) 82,202 39,292 - Debt structuring revenue for acquisition of Avon - 95,145 - Other finance income 38,959 96,305 30,281 Subtotal 4,006,563 4,738,391 1,955,784 FINANCE EXPENSES: Interest on financing (*) (634,201 ) (709,323 ) (503,040 ) Interest on leases (210,669 ) (229,544 ) (134,579 ) Losses from monetary and exchange rate variations (b) (2,075,306 ) (2,671,372 ) (937,925 ) Losses on swap and forward transactions (d) (1,533,611 ) (1,579,695 ) (964,116 ) Losses on swap and forward derivatives mark to market (26,214 ) (13,691 ) (1,452 ) Adjustment of provision for tax, civil and labor risks and tax liabilities (25,731 ) (47,928 ) (13,822 ) Appropriation of funding costs (debentures and notes) (27,228 ) (11,082 ) (22,671 ) Interest on pension plan (11,339 ) (10,323 ) - Hyperinflationary economy adjustment (Argentina) (108,730 ) (20,625 ) (13,947 ) Debt structuring expenses for Avon acquisition - (110,741 ) (115,781 ) Other finance expenses (380,511 ) (369,486 ) (88,541 ) Subtotal (5,033,540 ) (5,773,810 ) (2,795,874 ) Net finance income (expenses), net (1,026,977 ) (1,035,419 ) (840,090 ) (*) Of the balances originally presented on December 31, 2020, R$395,540 of the finance expenses group and R$39,292 of the finance income were reclassified between lines for better presentation. Note that this reclassification does not impact the subtotal amount originally presented as finance income (expenses).
Summary of Foreign Exchange Hedging Transactions and the Related Balancing Items in the Income Statement	Consolidated 2021 2020 2019 (a) Gains on monetary and exchange rate variations 1,785,259 1,752,503 854,025 Gains on exchange rate variation on borrowings, financing and debentures 869,115 714,681 677,462 Exchange rate variation on imports 38,800 35,218 11,221 Exchange rate variation on export receivables 105,654 69,365 26,144 Exchange rate variation on accounts payable from foreign subsidiaries 364,101 450,468 132,397 Exchange variations of bank accounts in foreign currency 407,589 482,771 6,801 (b) Losses from monetary and exchange rate variations (2,075,306 ) (2,671,372 ) (937,925 ) Losses from exchange rate variation on borrowings (i) (1,121,305 ) (1,665,050 ) (768,939 ) Exchange rate variation on imports (52,082 ) (58,623 ) (33,718 ) Exchange rate variation on export receivables (123,607 ) (55,829 ) (23,393 ) Exchange rate variation on accounts payable from foreign subsidiaries (311,923 ) (365,214 ) (86,764 ) Exchange rate variation on financing (466,389 ) (525,173 ) (297 ) Exchange variations of bank accounts in foreign currency - (1,483 ) (24,814 ) (c) Gains on swap and forward transactions 1,814,450 2,532,487 961,185 Revenue from swap exchange coupons (ii) 713,401 409,788 182,897 Gains on exchange variations on swap instruments (ii) 1,101,049 2,122,699 778,288 (d) Losses on swap and forward transactions (1,533,611 ) (1,579,695 ) (964,116 ) Losses from exchange rate variation on swap instruments (ii) (843,085 ) (1,182,391 ) (690,409 ) Financial costs of swap instruments (ii) (690,526 ) (379,440 ) (273,707 ) Losses with exchange rate variations of forward instruments - (17,864 ) - (i) See comment on finance expense reclassification in the previous table. (ii) The original amounts presented in these lines as of December 31, 2021 were reclassified to give a better disclosure in the respective gains (R$ 202,005 ) and losses (R$ 490,450 ) on swap and forward transactions groups. This reclassification does not impact the subtotal amounts of the respective groups or any line presented in the finance income (expenses) tables originally presented and included in the previous table.

OTHER OPERATING INCOME (EXPEN_2

OTHER OPERATING INCOME (EXPENSES), NET (Tables)	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Summary of Detailed Information About Other Operating Income (Expense)	Consolidated 2021 2020 2019 Other operating income, net Result on write-off of property, plant and equipment - 11,855 6,098 ICMS-ST ( a ) - 18,653 42,336 Tax Credits 11,391 105,234 21,402 PIS/COFINS credits ( b ) 203,694 - 95,614 Tax benefit for joining the amnesty progr am (c) 82,140 - - Incentive income 13,280 - - Proceeds from the sale of the customer portfolio 16,113 - 23,092 Tax contingencies 3,949 - - Other operating income 12,985 10,757 - Total other operating income 343,552 146,499 188,542 Other operating expenses, net Result on write-off of property, plant and equipment (3,610 ) - - Crer para Ver ( d ) (47,523 ) (54,500 ) (36,156 ) Expense on the sale of customer portfolio - (7,498 ) - Expenses related Avon acquisition - (303,916 ) (141,348 ) Transformation and integration plan ( e ) (511,048 ) (256,700 ) (51,520 ) Taxes contingencies - (10,100 ) - Other operating expenses (20,390 ) (29,975 ) (8,829 ) Total other operating expenses (582,571 ) (662,689 ) (237,853 ) Other operating income (expenses), net (239,019 ) (516,190 ) (49,311 ) (a) R efers to the requirement of ICMS tax substitution, for different Federal States of Brazil (details in note ). During , provision reversals were made due to the change in the loss estimate for some Federal States. (b) R efers to tax credits from PIS and COFINS related to non-inclusion of ICMS in the basis (R$ ) and credits arising out of investment grant (R$ ), and other tax credits (R$ ). (c) Refers to tax benefits in Brazil arising out of adhesion to state tax amnesty programs by the subsidiary Avon Cosméticos Ltda. (d) Allocation to Instituto Natura of operating profit from sales of the non-cosmetic product line “Crer Para Ver”, specifically allocated to social projects aimed at the development of education quality. (e) Expenses related to the implementation of the subsidiary Avon integration and transformation plan, which is based on five pillars, namely: (1) renewal of the brand; (2) optimization of retail operations; (3) improvement of omni-channel; (4) improvement of operating efficiency; and (5) organization redesign.

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Summary of Basic Earnings Per Share	Consolidated 2021 2020 2019 Income (loss) attributable to the Company’s controlling shareholders 1,047,960 (650,196) 155,467 Weighted average of the number of outstanding common shares 1,377,932,809 1,246,180,219 865,660,042 Weighted average number of treasury shares (788,866) (572,130) - Weighted average number of outstanding common shares 1,377,143,943 1,245,608,090 865,660,042 Basic earnings (loss) per share - R$ 0.7610 (0.5220) 0.1796
Summary of Diluted Earnings Per Share	The diluted earnings per share for net income for the year ended December 31, 2021 and 2019 are presented below: Consolidated 2021 2019 Gain attributable to the Company’s controlling shareholders 1,047,960 155,467 Weighted average of the number of outstanding common shares 1,377,143,943 865,660,042 Adjustment for stock options and restricted shares(a) - 8,124,575 Weighted average number of treasury shares 19,531,951 - Weighted average number of outstanding common shares 1,396,675,894 873,784,617 Diluted earnings per share – R$ 0.7503 0.1779 (a) The number of shares and earnings per share already consider the stock split on September 17, 2019 and their retrospective effects.
Summary of basic earnings per share for net loss of discontinued operations	The basic and diluted loss per share for net loss of discontinued operations for the year ended December 31, 2021 and 2020 are presented below: Consolidated 2021 2020 Net loss attributable to the Company’s controlling shareholders (98,550 ) (143,112 ) Weighted average of the number of outstanding common shares 1,377,932,809 1,246,180,219 Adjustment for purchase options and restricted shares (788,866 ) (572,130 ) Weighted average number of ordinary shares for diluted earnings calculation 1,377,066,457 1,245,608,090 Basic loss per share - R$ (0.0716 ) (0.1149 )

TRANSACTIONS WITH RELATED PAR_2

TRANSACTIONS WITH RELATED PARTIES (Tables)	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Summary of Total Compensation of the Company's Management	2021 2020 2019 Compensation Compensation Compensation Total Total Fixed Variable Total Fixed Variable Fixed Variable Board of Directors 15,043 72,187 87,230 16,123 65,011 81,134 22,056 30,919 52,975 Executive Board 51,576 71,162 122,738 49,187 80,218 129,405 32,963 42,142 75,105 66,619 143,349 209,968 65,310 145,229 210,539 55,019 73,061 128,080
Summary of the Company Officers and Executives' Compensation	Breakdown of the Company executive officers’ share-based payments compensation: Options Option balance (number ) (a) Average fair value of options R$ Average exercise price 1 R$ 2021 2020 2019 2021 2020 2019 2021 2020 2019 Board of directors and executive board 11,750,270 12,847,760 13,059,677 12.47 8.64 8.40 21.21 16.49 16.51 Share balance (number) ² (a) Average fair value ² - R$ 2021 2020 2019 2021 2020 2019 Board of directors and executive board 4,472,638 5,293,874 1,012,641 45.34 51.20 19.23 (1) The number of options, their average fair value and average exercise price are shown after taking into account the stock split approved at the Extraordinary Shareholders’ Meeting held on September 17, 2019. (2) The number of restricted and performance shares and their average fair value are shown after taking into account the stock split approved at the Extraordinary Shareholders’ Meeting held on September 17, 2019. (a) The number of awards includes the awards non-vested and vested but not exercised.

COMMITMENTS (Tables)

COMMITMENTS (Tables)	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Summary of Contractual Commitments	Total minimum supply payments, measured at nominal value, according to the contract, are: 2021 2020 Less than one year 929,288 1,413,904 One to five years 460,081 885,990 Above 5 years 10,738 - Total 1,400,107 2,299,894

INSURANCE (Tables)

INSURANCE (Tables)	12 Months Ended
	Dec. 31, 2021
Text Block [Abstract]
Summary of Types of Insurance Coverage	The Company adopted an insurance policy that mainly considers risk concentration and its materiality, considering the nature of their activities and the guidance of their insurance advisors. As of December 31, 2021 and 2020, insurance coverage is as follows: Item Type of coverage Amount insured 2021 2020 Industrial complex and administrative sites Any damages to buildings, facilities, inventories, and machinery and equipment 6,008,031 5,658,558 Vehicles Fire, theft and collision for the vehicles insured by the Company 261,953 258,416 Loss of profits No loss of profits due to material damages to facilities buildings and production machinery and equipment 1,962,509 1,894,813 Transport Damages to products in transit 103,857 97,934 Civil liability Protection against error or complaints in the exercise of professional activity that affect third parties 2,445,664 2,326,621 Environmental liability Protection against environmental accidents that may result in environmental lawsuits 30,000 30,000

ADDITIONAL INFORMATION RELATI_2

ADDITIONAL INFORMATION RELATING TO THE STATEMENTS OF CASH FLOWS (Tables)	12 Months Ended
	Dec. 31, 2021
Additional Cash Flow Information [Abstract]
Summary of Additional Information On Transactions Related To Cash Flow Statement	The following table presents additional information on transactions related to the cash flow statement: Consolidated 2021 2020 2019 Non-cash items Hedge accounting, net of tax effects (137,211 ) 116,348 70,569 Dividends declared and not yet paid 180,772 - 110,671 Stock and restricted shares option plans 138,122 102,508 - Net effect of acquisition of property, plant and equipment and intangible assets not yet paid 81,257 172,104 ( 18,645 ) Consideration for acquisition of subsidiary - 13,366,114 -

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Company's subsidiaries presented an impact on Hyperinflationary Economies (Details) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Summary of Significant Accounting Polices [Abstract]
Net loss on hyperinflationary economy adjustment	R$ 165826	R$ 55277
Impact on profit or loss	(26,528)	18,667
Monthly average exchange rate impact	218,227	32,160
Capital reserve		58,496
Profit reserve		R$ 8292

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Summary of Information About Company Principal Subsidiaries (Detail)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Avon Products, Inc
Statement [Line Items]
Direct ownership	100.00%	100.00%
Natura Cosméticos S.A. [Member]
Statement [Line Items]
Direct ownership	100.00%	100.00%	100.00%
Natura &Co International S.à r.l.
Statement [Line Items]
Direct ownership	100.00%	100.00%

SUMMARY OF SIGNIFICANT ACCOUN_6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2021BRL (R$)	Dec. 31, 2020BRL (R$)	Dec. 31, 2019BRL (R$)
Statement1 [Line Items]
Number of subsidiaries directly or indirectly controlled that have significant interests held by non-controlling shareholders	0	0
Gains (losses) related to the ineffective portion recognized in the income statement	R$ 0	R$ 0	R$ 0
Impairment loss of non-financial assets, excluding goodwill			0
Period of lease term of short-term leases	12 months
Maximum period of assets held for sale to be disposed	1 year
Gain (loss) recognized in the income statement regarding the purchase, sale, issue or cancellation of the Company’s own equity instruments	R$ 0
Subsidies received during the year		R$ 192686000	R$ 0
Maximum period of loyalty program points	5 months
Number of periodic cycles of loyalty program points	6
Number of performance obligations of supply contracts	2
Tax incentives recognized from tax exclusions	R$ 135297000
Rates of inflation	50.60%	36.10%
Period covered by budgets and forecast calculations	5 years
Applicable tax rate	(14.362%)	(70.60%)	29.20%
Tax loss carryforward on taxable income | %	30.00%
Amount of provision reversed	R$ 297216000
IFRS 16 [Member]
Statement1 [Line Items]
Positive impact arising from the relief of “Covid-19-Related Rent Concessions”	R$ 80037000	R$ 58700000
Argentina, Pesos [Member]
Statement1 [Line Items]
Closing foreign exchange rate	0.05437	0.06189
Revenues and expenses of the year were translated at the exchange rate prevailing at the reporting date	0.05437	0.06189
Corporate Income Tax IRPJ [Member]
Statement1 [Line Items]
Applicable tax rate	15.00%
Additional applicable tax rate	10.00%
Income Taxable	R$ 240000
Social Contribution CSLL [Member]
Statement1 [Line Items]
Applicable tax rate	9.00%
Bottom of range [member]
Statement1 [Line Items]
Change in market value of hedged items | %	80.00%
Applicable tax rate	19.00%	17.00%
Top of range [member]
Statement1 [Line Items]
Change in market value of hedged items | %	125.00%
Applicable tax rate	25.00%	19.00%

BUSINESS COMBINATIONS - Summary

BUSINESS COMBINATIONS - Summary of the preliminary fair value calculation of the consideration transferred (Details)	Jan. 03, 2020BRL (R$)R$ / sharesshares
Summary of the preliminary fair value calculation of the consideration transferred
Exchange ratio per each common share of acquiree	0.6
Avon Products, Inc
Summary of the preliminary fair value calculation of the consideration transferred
Number of Avon common shares outstanding as of January 3, 2020 | shares	536,383,776
Multiplied by the exchange ratio of 0.600 Natura &Co Holding Shares per each Avon common share	321,830,266
Multiplied by the market price of Natura &Co shares on January 3, 2020 | R$ / shares	R$ 41
Compensation in the issue of shares	R$ 13195041000
Adjustment to the transferred compensation	171,073,000	[1]
Fair value of the Compensation to be transferred	13,366,114,000	[2]
Settlements of share-based payment plan, consideration recognised	80,000
Stock option plans liquidated for consideration recognised	R$ 91000
[1]	Related to the effects of replacements and settlements of share-based payment plans, of which the amount of roughly R$80,000 refers to the share-based payment plans of Avon, in which it was substituted by Natura &Co, and approximately R$ 91,000 refers to the share purchase option plans liquidated as part of the conclusion of the transaction. These are pre-combination installments that were regarded as a transferred compensation.
[2]	Refers to the fair value of the acquired shares, which is the amount disbursed on the shares exchange.

BUSINESS COMBINATIONS - Schedul

BUSINESS COMBINATIONS - Schedule of preliminary allocation prepared by Company and resulting goodwill (Details) - BRL (R$) R$ in Thousands		Dec. 31, 2021	Dec. 31, 2020	Jan. 03, 2020
Fair value of liabilities assumed:
Financial effects of the allocation of the fair values of contingent liabilities assumed and recognized		R$ 597585	R$ 797693
Avon Products, Inc
Schedule of fair values of the identifiable assets and liabilities acquired as at the date of acquisition
Purchase consideration transferred	[1]			R$ 13366114
Fair value of acquired assets:
Cash and cash equivalent				2,636,108
Trade receivables	[2]			1,135,269
Inventories				1,919,683
Other current assets				1,031,136
Assets held for sale				199,050
Property, plant and equipment				2,912,482
Deferred income tax and social contribution				667,034
Right of use	[3]			564,669
Other non-current assets				475,096
Judicial deposits				283,885
Recoverable taxes				531,930
Surplus pension plan (other assets)				553,297
Intangible assets	[4]			5,846,812
Fair value of liabilities assumed:
Borrowings, financing and debentures				7,256,583
Trade accounts payables				2,915,418
Payroll, profit sharing and social contributions				621,203
Dividends and interest on net equity payable				405,916
Derivative financial instruments				15,518
Other operating expenses				999,653
Provision for restructuring (other liabilities)				152,896
Lease liabilities				777,200
Tax liabilities				341,258
Income tax and social contribution				30,068
Provision for tax, civil and labor risks	[5]			1,757,940
Deferred income tax and social contribution (6)	[6]			592,534
Other liabilities				1,007,623
Total identifiable net assets at fair value				1,882,641
Non-controlling interest				27,555
Goodwill arising on acquisition	[7]			11,511,028
Trade receivables	[2]			1,135,269
Intangible assets acquired and recognized before the allocation of the fair value				291,235
Contingent liabilities assumed and recognized before the allocation of the fair value				872,993
Financial effects of the allocation of the fair values of contingent liabilities assumed and recognized				R$ 820103
[1]	Refers to the fair value of the acquired shares, which is the amount disbursed on the shares exchange.
[2]	The fair value of the trade accounts receivable amounts to R$ 1,135,269 and is equivalent to it carrying amount and, it is expected that the carrying amount can be collected.
[3]	The Company measured the lease liabilities acquired using the current value of the remaining lease payments on the date of acquisition. The right-of-use assets were measured at an amount equal to the lease liabilities and adjusted to reflect the favorable terms of the lease relative to market terms.
[4]	The fair value of intangibles includes the intangible assets acquired and recognized by Avon before the allocation of the fair value, in the amount of R$ 291,235, plus the effects of the allocation of the fair values described below.
[5]	Contingent liabilities assumed in the acquisition that are considered current obligations arising from past events and that can be measured reliably were recognized and are initially measured at fair value on the acquisition date and subsequently measured in accordance with the requirements of CPC 15 (R1) (IFRS 3), to a higher amount that would be recognized in accordance with CPC 25 (IAS 37). The fair value of the contingent liabilities includes the liabilities assumed and recognized by Avon before the allocation of the fair value, in the amount of R$ 872,993, plus the effects of the allocation of the fair values, which totaled R$ 820,103. The table below shows the total amount of contingent liabilities assumed on the date of the transaction, including the attributed fair value:
[6]	Consists of deferred tax liabilities of approximately R$ 81,423 related to Avon opening balance and net position of deferred tax asset and liabilities related to purchasing price allocation of tax liabilities of R$ 511,111.
[7]	Goodwill is attributable to strong market position and geographic regions and will result in a more diversified and balanced global portfolio, as well as expected future profitability and operational synergies, such as supply, manufacturing, distribution and efficiency of the administrative structure and revenue growth. This goodwill arising from the transaction is not expected to result in a tax benefit, that is, deductible for tax purposes.

BUSINESS COMBINATIONS - Sched_2

BUSINESS COMBINATIONS - Schedule of fair value of intangible assets (Details) R$ in Thousands	Jan. 03, 2020BRL (R$)
Schedule of fair values of the identifiable assets and liabilities acquired as at the date of acquisition
Estimated fair value	R$ 5555577
Avon Products, Inc | Power brands
Schedule of fair values of the identifiable assets and liabilities acquired as at the date of acquisition
Estimated fair value	R$ 517592
Estimated useful life	20 years
Avon Products, Inc | Technology developed
Schedule of fair values of the identifiable assets and liabilities acquired as at the date of acquisition
Estimated fair value	R$ 1131573
Estimated useful life	5 years
Avon Products, Inc | Sales representatives
Schedule of fair values of the identifiable assets and liabilities acquired as at the date of acquisition
Estimated fair value	R$ 1884249
Avon Products, Inc | Sales representatives | Minimum
Schedule of fair values of the identifiable assets and liabilities acquired as at the date of acquisition
Estimated useful life	7 years
Avon Products, Inc | Sales representatives | Maximum
Schedule of fair values of the identifiable assets and liabilities acquired as at the date of acquisition
Estimated useful life	12 years
Avon Products, Inc | “Avon” tradename
Schedule of fair values of the identifiable assets and liabilities acquired as at the date of acquisition
Estimated fair value with indefinite useful life	R$ 2022163

BUSINESS COMBINATIONS - Sched_3

BUSINESS COMBINATIONS - Schedule of total amount of contingent liabilities assumed on date of transaction, including attributed fair value (Details) - Avon Products, Inc R$ in Thousands	Jan. 03, 2020BRL (R$)
Schedule of fair values of the identifiable assets and liabilities acquired as at the date of acquisition
Tax	R$ 1381418
Civil	157,832
Labor	218,690
Total	R$ 1757940	[1]
[1]	Contingent liabilities assumed in the acquisition that are considered current obligations arising from past events and that can be measured reliably were recognized and are initially measured at fair value on the acquisition date and subsequently measured in accordance with the requirements of CPC 15 (R1) (IFRS 3), to a higher amount that would be recognized in accordance with CPC 25 (IAS 37). The fair value of the contingent liabilities includes the liabilities assumed and recognized by Avon before the allocation of the fair value, in the amount of R$ 872,993, plus the effects of the allocation of the fair values, which totaled R$ 820,103. The table below shows the total amount of contingent liabilities assumed on the date of the transaction, including the attributed fair value:

BUSINESS COMBINATIONS - Additio

BUSINESS COMBINATIONS - Additional information (Details) R$ in Thousands	Jan. 03, 2020BRL (R$)
Disclosure of detailed information about business combination [line items]
Percentage of voting shares acquired	100.00%
Avon Products, Inc
Disclosure of detailed information about business combination [line items]
Transaction costs incurred until the conclusion of the transaction	R$ 112000
Deferred tax liabilities	81,423
Net position of deferred tax asset and liabilities related to purchasing price allocation of tax liabilities	511,111
Net revenues contributed by acquiree since the acquisition date	18,612,091
Losses of acquiree since the acquisition date	(1,542,596)
Revenue of acquiree through the date the acquisition was completed	R$ 0

CRITICAL ACCOUNTING ESTIMATES_2

CRITICAL ACCOUNTING ESTIMATES AND ASSUMPTIONS - Additional Information (Details) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Statement1 [Line Items]
Tax losses carried forward	R$ 12324912	R$ 13369187
Bottom of range [member]
Statement1 [Line Items]
Term for budgeted cash flow	3 years
Top of range [member]
Statement1 [Line Items]
Term for budgeted cash flow	5 years

FINANCIAL RISK MANAGEMENT - Sum

FINANCIAL RISK MANAGEMENT - Summary of Derivative Instruments (Detail) - Fair value [member] - BRL (R$) R$ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Disclosure Of Derivative Financial Instruments [Line Items]
Financial derivatives	R$ 516386	R$ 1857869
Operational derivatives	251	(11,092)
Total	R$ 516637	R$ 1846777

FINANCIAL RISK MANAGEMENT - S_2

FINANCIAL RISK MANAGEMENT - Summary of Derivative Positions (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020
Disclosure of fair value measurement of liabilities [line items]
Total net derivative financial instruments		R$ 516386	R$ 1857869
Total net derivative financial instruments		154,420	232,234
Short Position CDI Floating Rate Swap Contract One [Member]
Disclosure of fair value measurement of liabilities [line items]
Derivative financial liabilities		(6,348,442)	(2,803,797)
Gain (Loss) on Derivative Financial Liabilities		(823,887)	(172,885)
Post-fixed CDI Rate
Disclosure of fair value measurement of liabilities [line items]
Derivative financial liabilities		(137)	0
Gain (Loss) on Derivative Financial Liabilities		(137)	0
Short position at interbank rate
Disclosure of fair value measurement of liabilities [line items]
Derivative financial liabilities		(17,016)	(22,234)
Gain (Loss) on Derivative Financial Liabilities		94	(16,778)
Long Position US Dollar Swap Contract One [Member]
Disclosure of fair value measurement of liabilities [line items]
Derivative financial assets	[1]	6,881,981	4,683,900
Gain (Loss) on Derivative Financial Assets	[1]	R$ 978350	R$ 421897
[1]	Swap transactions consist of swapping the exchange rate variation for a correction related to a percentage of the fluctuation of the Certificate of Bank Deposits (post-fixed CDI), in the case of Brazil.

FINANCIAL RISK MANAGEMENT - Sch

FINANCIAL RISK MANAGEMENT - Schedule of changes in net financial derivatives (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
FINANCIAL RISK MANAGEMENT
Balance at beginning of period	R$ 1846777	R$ 725572
Losses from swap and forward derivative contracts	441,554	1,090,299
Payment of funds due to settlement of derivative transactions – operational activity	(1,570,584)	(211,722)
Proceeds received due to settlements – financing activity	9,040	38,835
Exchange rate variation (OCI)	(210,150)	203,793
Balance at end of period	R$ 516637	R$ 1846777

FINANCIAL RISK MANAGEMENT - S_3

FINANCIAL RISK MANAGEMENT - Schedule of operating forward derivative instruments (Detail) - Fair value [member] - BRL (R$) R$ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Net position in GBP and USD [Member]
Disclosure Of Derivatives Are Measured At Fair Value With Gains And Losses Recognized In The Group Of Costs Of Products Sold [Line Items]
Derivative instruments	R$ 404	R$ 7670
Forward contracts [member]
Disclosure Of Derivatives Are Measured At Fair Value With Gains And Losses Recognized In The Group Of Costs Of Products Sold [Line Items]
Derivative instruments	655
Derivative instruments		(3,422)
Derivative [Member]
Disclosure Of Derivatives Are Measured At Fair Value With Gains And Losses Recognized In The Group Of Costs Of Products Sold [Line Items]
Derivative instruments	R$ 251
Derivative instruments		R$ 11092

FINANCIAL RISK MANAGEMENT - S_4

FINANCIAL RISK MANAGEMENT - Summary of Net Asset Exposure (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2021	Dec. 31, 2020
Disclosure Of Net Asset Exposure [Abstract]
Borrowings and financing in foreign currency in Brazil	[1]	R$ 5897015	R$ 4246692
Trade accounts receivable in foreign currency in Brazil		307,433	236,782
Trade accounts payable in foreign currencies in Brazil		(37,390)	(14,459)
Fair value of financial derivatives		6,882,499	4,680,478
Net asset exposure		R$ 1255527	R$ 656109
[1]	Excluding transaction costs.

FINANCIAL RISK MANAGEMENT - Dis

FINANCIAL RISK MANAGEMENT - Disclosure Of Net Foreign Exchange Exposure (Detail) - BRL (R$)		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020
Disclosure Of Net Foreign Exchange Exposure [Line Items]
Fair value of “financial” derivatives		R$ 6882499000	R$ 4680478000
Trade accounts receivable in foreign currency in Brazil		307,433,000	236,782,000
Borrowings and financing in foreign currency in Brazil	[1]	(5,897,015,000)	(4,246,692,000)
Trade accounts payable in foreign currencies in Brazil		(37,390,000)	R$ 14459000
Scenario - Real (5.5805 Parity - R$ vs US$) | USD
Disclosure Of Net Foreign Exchange Exposure [Line Items]
Fair value of “financial” derivatives		6,882,499,000
Trade accounts receivable in foreign currency in Brazil		307,433,000
Borrowings and financing in foreign currency in Brazil		(5,897,015,000)
Trade accounts payable in foreign currencies in Brazil		(37,390,000)
Impact on net income and shareholders’ equity		R$ 1255527000
Scenario - Real (5.5805 Parity - R$ vs US$) | Brazilian real per US dollar
Disclosure Of Net Foreign Exchange Exposure [Line Items]
Closing foreign exchange rate		5.5805
Scenario - Probable (5.7021 Parity - R$ vs US$) | USD
Disclosure Of Net Foreign Exchange Exposure [Line Items]
Fair value of “financial” derivatives		R$ 7032419000
Trade accounts receivable in foreign currency in Brazil		314,130,000
Borrowings and financing in foreign currency in Brazil		(6,025,469,000)
Trade accounts payable in foreign currencies in Brazil		(38,204,000)
Impact on net income and shareholders’ equity		R$ 27349000
Scenario - Probable (5.7021 Parity - R$ vs US$) | Brazilian real per US dollar
Disclosure Of Net Foreign Exchange Exposure [Line Items]
Closing foreign exchange rate		5.7021
Scenario I - Depreciation 25% (4.2765 Parity - R$ vs US$) | USD
Disclosure Of Net Foreign Exchange Exposure [Line Items]
Fair value of “financial” derivatives		R$ 5274315000
Trade accounts receivable in foreign currency in Brazil		235,597,000
Borrowings and financing in foreign currency in Brazil		(4,519,102,000)
Trade accounts payable in foreign currencies in Brazil		(28,653,000)
Impact on net income and shareholders’ equity		R$ 293370000
Scenario I - Depreciation 25% (4.2765 Parity - R$ vs US$) | Brazilian real per US dollar
Disclosure Of Net Foreign Exchange Exposure [Line Items]
Closing foreign exchange rate		4.2765
Foreign exchange rate, percentage of decrease		25.00%
Scenario II - Depreciation 50% (2.8510 Parity - R$ vs US$) | USD
Disclosure Of Net Foreign Exchange Exposure [Line Items]
Fair value of “financial” derivatives		R$ 3516210000
Trade accounts receivable in foreign currency in Brazil		157,065,000
Borrowings and financing in foreign currency in Brazil		(3,012,734,000)
Trade accounts payable in foreign currencies in Brazil		(19,102,000)
Impact on net income and shareholders’ equity		R$ 614089000
Scenario II - Depreciation 50% (2.8510 Parity - R$ vs US$) | Brazilian real per US dollar
Disclosure Of Net Foreign Exchange Exposure [Line Items]
Closing foreign exchange rate		2.851
Foreign exchange rate, percentage of decrease		50.00%
[1]	Excluding transaction costs.

FINANCIAL RISK MANAGEMENT - D_2

FINANCIAL RISK MANAGEMENT - Disclosure of Detailed Information About Cash Flow Hedged Items (Detail) R$ in Thousands	12 Months Ended
	Dec. 31, 2021BRL (R$)
Disclosure of financial assets [line items]
Fair value	R$ 533410
Accumulated contract gain (loss)	64,016
Gain (loss) in the period	R$ 210150
Currency Swap Contract One [Member]
Disclosure of financial assets [line items]
Hedged item	Currency
Notional currency	BRL
Fair value	R$ 533539
Accumulated contract gain (loss)	64,145
Gain (loss) in the period	R$ 215944
Forward agreements (The Body Shop and Avon)
Disclosure of financial assets [line items]
Hedged item	Currency
Notional currency	BRL
Fair value	R$ 0
Accumulated contract gain (loss)	0
Gain (loss) in the period	R$ 5173
Forward contract (Natura Indústria)
Disclosure of financial assets [line items]
Hedged item	Currency
Notional currency	BRL
Fair value	R$ 129
Accumulated contract gain (loss)	(129)
Gain (loss) in the period	R$ 621

FINANCIAL RISK MANAGEMENT - D_3

FINANCIAL RISK MANAGEMENT - Disclosure of Detailed Information About Cash Flow Hedged Reserve Booked Under Other Comprehensive Income (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of Detailed Information About Cash Flow Hedged Reserve Booked Under Other Comprehensive Income [Abstract]
Cash flow hedge beginning of balance	R$ 159077	R$ 42729
Change in the fair value of hedge instrument recognized in OCI	(210,150)	178,006	R$ 107337
Tax effects on fair value of hedge instrument	72,939	(61,658)	(36,768)
Cash flow hedge end of balance	R$ 21866	R$ 159077	R$ 42729

FINANCIAL RISK MANAGEMENT - D_4

FINANCIAL RISK MANAGEMENT - Disclosure of Detailed Information About Interest Rate Risks of Transactions (Detail) R$ in Thousands	12 Months Ended
	Dec. 31, 2021BRL (R$)
Disclosure Of Detailed Information About Interest Rate Risks Of Transactions [Line Items]
Total borrowing, financing, and debentures - in local currency	R$ 6914117
Operations in foreign currency with derivatives related to CDI	(5,802,715)	[1]
Short-term investments	2,636,599
Net exposure	R$ 10080233
[1]	Refers to transactions involving derivatives related to CDI to hedge the borrowing, financing and debentures arrangements raised in foreign currency in Brazil.

FINANCIAL RISK MANAGEMENT - S_5

FINANCIAL RISK MANAGEMENT - Summary of Net Exposure to Interest Rate Risk by Scenario (Detail) - Interest rate risk [member] R$ in Thousands	12 Months Ended
	Dec. 31, 2021BRL (R$)
Disclosure of risk management strategy related to hedge accounting [line items]
Risk	Rate increase
Probable scenario [Member]
Disclosure of risk management strategy related to hedge accounting [line items]
Net liability	R$ 110883
Scenario Two [Member]
Disclosure of risk management strategy related to hedge accounting [line items]
Net liability	(369,189)
Scenario Three [Member]
Disclosure of risk management strategy related to hedge accounting [line items]
Net liability	R$ 627495

FINANCIAL RISK MANAGEMENT - S_6

FINANCIAL RISK MANAGEMENT - Summary of Working Capital Calculation (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Net current assets (liabilities) [abstract]
Total current assets	R$ 17449877	R$ 18734820
Total current liabilities	(13,693,877)	(16,159,586)	R$ 7518423
Total net working capital	R$ 3756000	R$ 2575234

FINANCIAL RISK MANAGEMENT - D_5

FINANCIAL RISK MANAGEMENT - Disclosure of Maturity Analysis for Non-Derivative Financial Liabilities (Detail) R$ in Thousands	Dec. 31, 2021BRL (R$)
Disclosure of maturity analysis for non-derivative financial liabilities [line items]
Borrowings, financing and debentures	R$ 12716832
Lease liability	3,547,862
Trade accounts payables, related parties and reverse factoring operations	6,770,579
Dividends payable	180,772
Total expected cash flow [Member]
Disclosure of maturity analysis for non-derivative financial liabilities [line items]
Borrowings, financing and debentures	16,122,845
Lease liability	4,070,477
Trade accounts payables, related parties and reverse factoring operations	6,770,579
Dividends payable	180,772
Interest to be accrued [Member]
Disclosure of maturity analysis for non-derivative financial liabilities [line items]
Borrowings, financing and debentures, interest to be accrued	(3,406,013)
Lease, interest to be accrued	(522,615)
Trade accounts payables, related parties and reverse factoring operations	0
Dividends payable	0
Less than one year [member]
Disclosure of maturity analysis for non-derivative financial liabilities [line items]
Borrowings, financing and debentures	1,339,240
Lease liability	1,154,697
Trade accounts payables, related parties and reverse factoring operations	6,770,579
Dividends payable	180,772
One to five years [member]
Disclosure of maturity analysis for non-derivative financial liabilities [line items]
Borrowings, financing and debentures	7,288,382
Lease liability	2,086,269
Trade accounts payables, related parties and reverse factoring operations	0
Dividends payable	0
Over five years [member]
Disclosure of maturity analysis for non-derivative financial liabilities [line items]
Borrowings, financing and debentures	7,495,223
Lease liability	829,511
Trade accounts payables, related parties and reverse factoring operations	0
Dividends payable	R$ 0

FINANCIAL RISK MANAGEMENT - D_6

FINANCIAL RISK MANAGEMENT - Disclosure Of Carrying Amounts And Fair Values Of The Company's Financial Instruments (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2021	Dec. 31, 2020		Dec. 31, 2019	Dec. 31, 2018
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Cash and banks		R$ 3349398	R$ 4436576
Certificate of bank deposits	[1]	7,639	808,988
Repurchase operations	[2]	650,220	576,108
Total Cash and cash equivalent		4,007,257	5,821,672		R$ 4513582	R$ 1215048
Government securities	[3]	435,898	864,940
Restricted cash		44	40,425
Financial treasury bills	[4]	646,586	505,152
DBV fund		36,921	16,104
Certificate of bank deposits		0	292,878
Total short-term investments		2,015,661	2,536,752
Trade receivables		3,476,359	3,597,535
Receivables from service providers	[5]	162,268	135,030	[6]
Total receivables		4,582,564	4,660,390
Financial and operating derivatives		893,970	1,768,122
Total borrowing, financing and debentures		(12,716,832)	(13,822,913)
Financial and operating derivatives		(458,492)	(61,201)
Lease		(3,547,862)	(3,858,455)		R$ 2517565
Trade payable and reverse factoring operations		(6,770,579)	(6,774,205)
Dividends payable		(180,772)
Level 2 [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Financial and operating derivatives		975,129	1,907,978
Financial liabilities at amortised cost, category [member] | Level 2 [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Borrowing in local currency		(6,914,117)	(9,591,809)
Foreign currency borrowings		(5,802,715)	(4,231,104)
Lease		(3,547,862)	(3,858,455)
Trade payable and reverse factoring operations		(6,770,579)	(6,774,205)
Insurance payable		(127,413)	(159,094)
Dividends payable		(180,772)	0
Financial liabilities at fair value through profit or loss, category [member] | Level 2 [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Credits		(19,511)	(5,560)
Financial and operating derivatives		(458,492)	(61,201)
Fair Value Hedge Instrument [Member] | Level 2 [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Financial and operating derivatives		533,410	1,768,122
Financial assets at amortised cost, class [member] | Level 1 [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Receivables from service providers		162,268	135,030
Financial assets at amortised cost, class [member] | Level 2 [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Cash and banks		3,349,398	4,436,576
Certificate of bank deposits		7,639	808,988
Trade receivables		3,476,359	3,597,535
Judicial deposits		585,284	566,190
Sublease receivables		347,174	357,538
Financial assets at fair value through profit or loss, category [member] | Level 2 [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Repurchase operations		650,220	576,108
Government securities		435,898	864,940
Restricted cash		44	40,425
Financial treasury bills		646,586	505,152
Loan investment funds		896,212	817,253
Certificate of bank deposits		0	292,878
Carbon Credits		11,479	4,097
Financial and operating derivatives		441,719	139,856
Financial assets at fair value through profit or loss, category [member] | Level 3 [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
DBV fund		36,921	16,104
Fair value [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Total Cash and cash equivalent		4,007,257	5,821,572
Total short-term investments		2,015,661	2,536,752
Total receivables		4,582,564	4,660,390
Total borrowing, financing and debentures		(7,855,737)	(13,926,002)
Fair value [member] | Level 2 [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Financial and operating derivatives		975,129	1,907,978
Fair value [member] | Financial liabilities at amortised cost, category [member] | Level 2 [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Borrowing in local currency		(2,100,465)	(9,466,921)
Foreign currency borrowings		(5,755,272)	(4,459,081)
Lease		(3,547,862)	(3,858,455)
Trade payable and reverse factoring operations		(6,770,579)	(6,774,205)
Insurance payable		(127,413)	(159,094)
Dividends payable		(180,772)	0
Fair value [member] | Financial liabilities at fair value through profit or loss, category [member] | Level 2 [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Credits		(19,511)	(5,560)
Financial and operating derivatives		(458,492)	(61,201)
Fair value [member] | Fair Value Hedge Instrument [Member] | Level 2 [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Financial and operating derivatives		533,410	1,768,122
Fair value [member] | Financial assets at amortised cost, class [member] | Level 1 [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Receivables from service providers		0	135,030
Fair value [member] | Financial assets at amortised cost, class [member] | Level 2 [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Cash and banks		3,349,398	4,436,576
Certificate of bank deposits		7,639	808,988
Trade receivables		3,476,359	3,597,535
Judicial deposits		585,284	566,190
Sublease receivables		347,174	357,538
Fair value [member] | Financial assets at fair value through profit or loss, category [member] | Level 2 [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Repurchase operations		650,220	576,108
Government securities		435,898	864,940
Restricted cash		44	40,425
Financial treasury bills		646,586	505,152
Loan investment funds		896,212	817,253
Certificate of bank deposits		0	292,878
Carbon Credits		11,479	4,097
Financial and operating derivatives		441,719	139,856
Fair value [member] | Financial assets at fair value through profit or loss, category [member] | Level 3 [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
DBV fund		R$ 36921	R$ 16104
[1]	As of December 31, 202 1 , investments in Certificate of Bank Deposits (“CDB”) bear interest at an average rate of 103.0 % of the CDI (103.2% in 2020) with daily maturities redeemable with the issuer itself, without significative loss of value.
[2]	Repurchase operations are securities issued by banks with a commitment by the bank to repurchase the securities, and by the client to resell the security, at a defined interest rate and within a predetermined term, which are backed by public or private securities (depending on the financial institution) and are registered within the Central Agency for Custody and Financial Settlement of Securities (“CETIP”). As of December 31, 2021, repurchase operations are remunerated at an average rate of 100.0% of CDI (100.0% of the CDI as of December 31, 2020).
[3]	As of December 31, 2021, investments in Government securities (LFT) are remunerated at an average rate of 102.0% of the CDI (105.9% of the CDI as of December 31, 2020).
[4]	As of December 31, 2021, investments in Treasury bills are remunerated at an average rate of 120.0% of the CDI (136.6% as of December 31, 2020).
[5]	Refers to receivables mainly arising from damage that occurred with carriers and insurance companies.
[6]	some amounts originally presented as of December 31, 2020 were reclassified for a better disclosure. Note that this reclassification does not impact the total amount originally presented as current and non-current assets.

FINANCIAL RISK MANAGEMENT - Add

FINANCIAL RISK MANAGEMENT - Additional Information (Detail) - BRL (R$)	12 Months Ended
	Dec. 31, 2021	May 04, 2021
Disclosure of detailed information about financial instruments [line items]
Average period of commitments for foreign currency of receivables and payables	6 months
Net exposure to foreign exchange rate variation in other countries	R$ 0
Percentage of borrowings linked to CDI rate	99.40%
Scenario I - Depreciation 25% (4.2765 Parity - R$ vs US$) | Brazilian real per US dollar
Disclosure of detailed information about financial instruments [line items]
Closing foreign exchange rate	4.2765
Foreign exchange rate, percentage of decrease	25.00%
Scenario II - Depreciation 50% (2.8510 Parity - R$ vs US$) | Brazilian real per US dollar
Disclosure of detailed information about financial instruments [line items]
Closing foreign exchange rate	2.851
Foreign exchange rate, percentage of decrease	50.00%
Scenario Two [Member]
Disclosure of detailed information about financial instruments [line items]
Percentage of reasonably possible increase in unobservable input, liabilities	25.00%
Borrowings interest rate	12.81%
Scenario Three [Member]
Disclosure of detailed information about financial instruments [line items]
Percentage of reasonably possible increase in unobservable input, liabilities	50.00%
Borrowings interest rate	15.38%
Probable scenario [Member]
Disclosure of detailed information about financial instruments [line items]
Period of future interest rates are considered in sensitivity analysis	90 days
Borrowings interest rate	10.25%
Probable scenario [Member] | Brazilian real per US dollar
Disclosure of detailed information about financial instruments [line items]
Period of future currency rates are considered in sensitivity analysis	90 days
Closing foreign exchange rate	5.7021
Natura Cosmticos SA [Member] | ESG debt securities (“Notes ESG”)
Disclosure of detailed information about financial instruments [line items]
Borrowings interest rate		4.125%

Financial Risk Management - A_2

Financial Risk Management - Additional Information (Details - Textuals 1) £ in Thousands, R$ in Thousands, $ in Billions	May 04, 2021BRL (R$)	Dec. 31, 2021BRL (R$)	May 04, 2021USD ($)	Apr. 23, 2021GBP (£)	Apr. 23, 2021BRL (R$)	Mar. 31, 2021GBP (£)	Dec. 31, 2020GBP (£)	Dec. 31, 2020BRL (R$)
Disclosure of detailed information about financial instruments [line items]
Reduction in the recoverable amount								R$ 148050
Percentage of reasonably possible increase (decrease) in unobservable input, investment assets		1.00%
Percentage of Discount Applied in Unobservable Input Investment Assets		16.70%
Increase (decrease) in the fair value of the investment due to 1% increase (decrease) in the applied discount (16.7%)		R$ 438
Operations The Body Shop [Member] | Working capital loan [member]
Disclosure of detailed information about financial instruments [line items]
Line of Credit Facility, Maximum Borrowing Capacity				£ 100,000	R$ 742000	£ 70,000	£ 70,000	R$ 500835
Natura Cosmticos SA [Member] | ESG debt securities (“Notes ESG”)
Disclosure of detailed information about financial instruments [line items]
Borrowings interest rate	4.125%		4.125%
Borrowings, maturity	May 3, 2028
Notional Amount	R$ 5600000		$ 1
Minimum target percentage of reduction in greenhouse gas emissions	13.00%
Minimum target percentage of usage of recycled plastic in packaging	25.00%
Period before target date for lack of report issued by an external verifier attesting to fulfilment of environment goals	30 days
Description of estimated interest rate increase for non-compliance for fulfilment of environment goals	65-basis point

CASH AND CASH EQUIVALENTS - Sum

CASH AND CASH EQUIVALENTS - Summary of Detailed Information About Cash And Cash Equivalents (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Disclosure of cash and cash equivalents
Cash and banks		R$ 3349398	R$ 4436576
Certificate of bank deposits	[1]	7,639	808,988
Repurchase operations	[2]	650,220	576,108
Total Cash and cash equivalent		R$ 4007257	R$ 5821672	R$ 4513582	R$ 1215048
[1]	As of December 31, 202 1 , investments in Certificate of Bank Deposits (“CDB”) bear interest at an average rate of 103.0 % of the CDI (103.2% in 2020) with daily maturities redeemable with the issuer itself, without significative loss of value.
[2]	Repurchase operations are securities issued by banks with a commitment by the bank to repurchase the securities, and by the client to resell the security, at a defined interest rate and within a predetermined term, which are backed by public or private securities (depending on the financial institution) and are registered within the Central Agency for Custody and Financial Settlement of Securities (“CETIP”). As of December 31, 2021, repurchase operations are remunerated at an average rate of 100.0% of CDI (100.0% of the CDI as of December 31, 2020).

CASH AND CASH EQUIVALENTS - S_2

CASH AND CASH EQUIVALENTS - Summary of Detailed Information About Cash And Cash Equivalents (Parenthetical) (Detail)	Dec. 31, 2021	Dec. 31, 2020
Text Block [Abstract]
Average deposit remuneration rate	103.00%	103.20%
Average repurchase operations remuneration rate	100.00%	100.00%

SHORT-TERM INVESTMENTS - Summar

SHORT-TERM INVESTMENTS - Summary of Short-Term Investments (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2021	Dec. 31, 2020
Disclosure of short-term investments
Mutual Investment Funds	[1]	R$ 896212	R$ 817253
Certificate of bank deposits		0	292,878
Treasury bills	[2]	646,586	505,152
Government bonds (LFT)	[3]	435,898	864,940
DBV fund		36,921	16,104
Restricted cash		44	40,425
Total short-term investments		2,015,661	2,536,752
Current		1,978,740	2,520,648
Non-current		R$ 36921	R$ 16104
[1]	Mutual investment funds refer to the investments of some subsidiaries of the Company, which are concentrated in the Natura entities of the Hispanic America mainly in Argentina, Chile, Colombia and Mexico.
[2]	As of December 31, 2021, investments in Treasury bills are remunerated at an average rate of 120.0% of the CDI (136.6% as of December 31, 2020).
[3]	As of December 31, 2021, investments in Government securities (LFT) are remunerated at an average rate of 102.0% of the CDI (105.9% of the CDI as of December 31, 2020).

SHORT-TERM INVESTMENTS - Summ_2

SHORT-TERM INVESTMENTS - Summary of Short-Term Investments (Parenthetical) (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Short Term Investments [Line Items]
Short-term investments	R$ 1978740	R$ 2520648
Treasury Bills [Member]
Short Term Investments [Line Items]
Average rate of remuneration for shor-term investments	120.00%	136.60%
Government Bonds LFT [Member]
Short Term Investments [Line Items]
Average rate of remuneration for shor-term investments	102.00%	105.90%

SHORT-TERM INVESTMENTS - Summ_3

SHORT-TERM INVESTMENTS - Summary of Detailed Information About Investment Portfolio (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2021	Dec. 31, 2020
Short Term Investments [Abstract]
Certificate of Bank Deposits (CDB)		R$ 0	R$ 292878
Repurchase operations (cash and cash equivalents)		569,349	576,108
Financial letter	[1]	646,586	505,152
Government securities (LFT)		428,865	864,940
Exclusive Investment Fund Portfolio		R$ 1644800	R$ 2239078
[1]	As of December 31, 2021, investments in Treasury bills are remunerated at an average rate of 120.0% of the CDI (136.6% as of December 31, 2020).

TRADE RECEIVABLES - Summary of

TRADE RECEIVABLES - Summary of Detailed Information About Trade Receivables (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Disclosure of financial assets [line items]
Trade receivables	R$ 3930340	R$ 4029643
(-) Allowance for expected credit losses	(453,981)	(432,108)
Trade Receivables, Net	R$ 3476359	R$ 3597535

TRADE RECEIVABLES - Summary o_2

TRADE RECEIVABLES - Summary of Trade Receivables by Exposure to Doubtful Accounts (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of financial assets [line items]
Trade receivables	R$ 3930340	R$ 4029643
Allowance for expected credit losses	(453,981)	(432,108)
Trade Receivables [member]
Disclosure of financial assets [line items]
Trade receivables	3,930,340	4,029,643
Allowance for expected credit losses	(453,981)	(432,108)	R$ 107995
Current [member] | Trade Receivables [member]
Disclosure of financial assets [line items]
Trade receivables	2,488,412	1,988,583
Allowance for expected credit losses	(80,087)	(53,352)
Up to 30 days [member] | Trade Receivables [member]
Disclosure of financial assets [line items]
Trade receivables	937,227	1,506,460
Allowance for expected credit losses	(68,782)	(76,848)
31 to 60 days [member] | Trade Receivables [member]
Disclosure of financial assets [line items]
Trade receivables	140,757	173,121
Allowance for expected credit losses	(56,784)	(56,124)
61 to 90 days [member] | Trade Receivables [member]
Disclosure of financial assets [line items]
Trade receivables	97,713	111,735
Allowance for expected credit losses	(49,731)	(54,172)
91 to 180 days [member] | Trade Receivables [member]
Disclosure of financial assets [line items]
Trade receivables	266,231	249,744
Allowance for expected credit losses	R$ 198597	R$ 191612

TRADE RECEIVABLES - Summary o_3

TRADE RECEIVABLES - Summary of Allowance For Credit Losses (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020
Disclosure of financial assets [line items]
Beginning Balance		R$ 432108
Ending balance		(453,981)	R$ 432108
Trade Receivables [member]
Disclosure of financial assets [line items]
Beginning Balance		(432,108)	(107,995)
Additions, net of reversals		(837,822)	(640,676)
Write-offs	[1]	817,446	372,660
Exchange variation		(1,497)	(56,097)
Ending balance		R$ 453981	R$ 432108
[1]	Refers to accounts overdue for more than 180 days, which are written off when the Company has no expectation of recovering the trade receivables and sales of customer portfolios.

INVENTORIES - Summary of Invent

INVENTORIES - Summary of Inventories (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2021	Dec. 31, 2020		Dec. 31, 2019
Disclosure of Inventories [Abstract]
Finished products	R$ 4619237	R$ 3925215
Raw materials and packaging	1,166,681	1,015,156
Auxiliary materials	195,364	170,188
Products in progress	38,189	36,025
(-) Provision for inventory losses	(615,945)	(602,314)	[1]	R$ 185232
Current Inventories	R$ 5403526	R$ 4544270
[1]	the original amounts presented as of December 31, 2020 were reclassified for a better disclosure. Note that this reclassification does not impact the total amount originally presented as provision for inventory losses.

INVENTORIES - Summary of Change

INVENTORIES - Summary of Changes In The Provision For Inventory Losses (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2021		Dec. 31, 2020
Disclosure of Changes In The Provision For Inventory Losses [Abstract]
Beginning balance		R$ 602314	[1]	R$ 185232
Additions, net of reversals	[2]	(407,207)		(673,201)
Write-offs	[3]	396,233		354,692
Exchange rate variation		(2,657)		(98,573)
Ending balance		R$ 615945		R$ 602314	[1]
[1]	the original amounts presented as of December 31, 2020 were reclassified for a better disclosure. Note that this reclassification does not impact the total amount originally presented as provision for inventory losses.
[2]	It refers to the recognition of net allowance for losses due to discontinuation, expiration and quality, to cover expected losses on the realization of inventories, pursuant to the policy of the Company.
[3]	It consists of write-offs of products for which there already had an allowance for losses, where the Company has no expectation of sales/realization.

RECOVERABLE TAXES - Summary of

RECOVERABLE TAXES - Summary of Current Tax Assets (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2021	Dec. 31, 2020
Text Block [Abstract]
ICMS on purchase of goods (a)	[1]	R$ 732853	R$ 681147
Taxes on purchase of goods – foreign subsidiaries		313,214	230,260
ICMS on purchases of PP&E		12,138	9,578
PIS and COFINS on purchase of property, plant and equipment and purchase of goods (b)	[2]	984,737	780,841
Withholding income tax		56,356	23,637
Withholding PIS, COFINS and CSLL		1,673	1,669
Tax on Manufactured Goods - IPI (c)	[3]	114,179	77,096
Other		164,099	199,333
Total		2,379,249	2,003,561
Current		1,029,625	1,071,349
Non-current		R$ 1349624	R$ 932212
[1]	Tax credits related to the tax on the circulation of goods, interstate and inter-municipal transport and communication services (ICMS) were generated mainly by purchases, whose tax rate is higher than the average of sales. The Company expects to realize these credits during the ordinary course of business through offsetting with sales operations in the domestic market.
[2]	The accumulated tax credits of PIS and COFINS basically arise from credits on purchases of raw materials used in the production and from purchase of property, plant and equipment, as well as credits arising out of the exclusion of ICMS from the calculation basis of the PIS/COFINS. The realization of these credits normally occurs through offsetting with sales operations in the domestic market.
[3]	The balance will be used to offset IPI ( Imposto sobre Produtos Industrializados ) payable in future operations of the Company.

INCOME TAX AND SOCIAL CONTRIB_3

INCOME TAX AND SOCIAL CONTRIBUTION - Summary of Breakdown of Deferred Income Tax And Social Contribution Assets (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2020		Dec. 31, 2021		Dec. 31, 2019
Deferred tax assets and liabilities [abstract]
Tax loss carryforwards	[1]	R$ 492384		R$ 2099768
Allowance for expected credit losses		205,033		224,231
Provision for inventory losses		169,181		244,854
PP&E and Intangible assets – Depreciation and amortization		351,784		308,406
Lease liabilities		155,470		441,860
Other accruals, reserves and provision for tax, civil and labor risks	[2]	519,293		418,861
Employee benefits		479,536		317,835
Other temporary differences		448,991		433,041
Total Deferred Tax Assets		2,821,671		4,488,856
Effect of changes in fair value of derivative instruments, including hedge accounting transactions	[3]	(638,965)		(137,410)
PP&E and Intangible assets – useful life adjustment		(328,698)		(312,914)
Employee benefits		(197,458)		(215,235)
Right of use assets		(171,788)		(423,095)
Fair value of identifiable net assets in business combination	[4]	(1,108,693)		(1,002,167)
Other temporary differences		(324,389)		(438,001)
Total Deferred Tax Liabilities		(2,769,991)		(2,528,823)
Net Deferred income tax and social contribution		(51,680)		1,960,033
Deferred income taxes and social contribution assets		1,339,725	[5]	2,954,074	[5]	R$ 374448
Deferred income taxes and social contribution liabilities		(1,288,045)	[5]	R$ 994041	[5]	R$ 450561
Increase (decrease) in tax loss carryforwards and negative basis		R$ 823000
[1]	The variation in the period is due to increase in tax loss carryforwards and negative basis resulted from the recording of approximately R$823 million related to the subsidiary Avon Luxembourg S.A.R.L in the period, resulting from corporate restructuring and expectation of realization of the recorded amount.
[2]	Includes (i) allowance under the accrual basis, reflecting authentic expenses incurred in the year, but for which suppliers have not issued invoice, a (ii) deferred revenue and (iii) other accruals not currently deductible for tax.
[3]	Variation in the period refers to settlement of hedge instruments associated to Bonds with exposition to foreign exchange variation.
[4]	The balance includes deferred income tax liability on the fair value of net identifiable assets in the acquisition of the subsidiaries Avon, The Body Shop and Aesop.
[5]	Balance already includes any offsetting of deferred tax assets and liabilities of the same nature and originating from the same jurisdiction.

INCOME TAX AND SOCIAL CONTRIB_4

INCOME TAX AND SOCIAL CONTRIBUTION - Summary of tax losses carryforwards for which no deferred tax asset recognised (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2021	Dec. 31, 2020
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Net Operating Loss (a)	[1]	R$ 10486753
Credits (b)	[2]	668,067
Other future deductible Items		1,170,092
Total		12,324,912	R$ 13300000
Net Operating Loss, expected expirations during 2022		168,000
Credits, expected expirations during 2022		10,000
Indefinite Expiration Period [member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Net Operating Loss (a)	[1]	9,890,238
Credits (b)	[2]
Other future deductible Items		83,584
Total		9,973,822
Definite Expiration Period
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Net Operating Loss (a)	[1]	596,515
Credits (b)	[2]	668,067
Other future deductible Items		1,086,508
Total		R$ 2351090
[1]	During 2022, exp R$168 million are expected, the remaining expirations would start to occur in and future periods with the majority of tax losses.
[2]	During 2022, expiration of approximately R$10 million are expected; the remaining expirations would start to occur in 2023 and in future periods, with the majority of claims subject to statute of limitations in 2027 .

INCOME TAX AND SOCIAL CONTRIB_5

INCOME TAX AND SOCIAL CONTRIBUTION - Summary of Reconciliation of Income Tax And Social Contribution (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Reconciliation of accounting profit multiplied by applicable tax rates [abstract]
Income (loss) before income tax and social contribution		R$ 7297	R$ 388935	R$ 304566
Taxes on Company formation				206,592
Income (loss) before income tax and social contribution	[1]	(7,297)	(388,935)	511,158
Income tax and social contribution at the rate		2,481	132,238	(173,794)
Benefit of expenses with research and technological innovation		26,277	23,033	19,228
Tax incentives			10,018	12,457
Investment subsidies	[2]	469,863	128,173	24,864
Effect from differences of tax rates of entities abroad		(139,924)	(166,394)	26,907
Taxation of profits of foreign subsidiaries		(77,072)	(56,194)	(60,305)
Deferred income tax recognized (not recognized) from tax losses carryforward	[3]	888,900	(104,160)	(8,893)
Tax benefits of interest on own equity (IOE)			10,275	37,628
Exercise of purchase options and restricted share plans		(57,526)	(9,770)	9,697
Non-Deductible donation and contribution			(12,509)	(4,136)
United Kingdom Tax Law rate change (c)	[4]	(180,174)	(63,428)
Withholding Taxes			(63,754)
Transfer pricing adjustments		(36,807)	(67,529)	(1,156)
Other permanent differences		151,968	(34,743)	(31,596)
Income tax and social contribution revenue (expenses)		1,047,986	(274,744)	(149,099)
Income tax and social contribution - current		(923,476)	(292,828)	(94,780)
Income tax and social contribution - deferred		R$ 1971462	R$ 18084	R$ 54319
Effective Rate		(14.362%)	(70.60%)	29.20%
Income tax and social contribution, applicable tax rate		34.00%
[1]	At consolidated level, income (loss) before income tax and social contribution included the losses with discontinued operations.
[2]	The Company has tax incentives arising from its ordinary operations (Investment subsidies).
[3]	As of December 31, 2021, the Company had balances of deferred income tax asset on tax losses in the amount of R$ 12.3 13.3 8.2
[4]	During 2021 and 2020 , the income tax rate in the UK was changed. In 2021 , the enacted tax rate increased from 19% to 25% ( 17% to 19% in 2020 ) which resulted in an increase in the Company’s deferred tax liabilities associated with UK. Such increase was accrued through deferred income tax expense during 2021 and 2020.

INCOME TAX AND SOCIAL CONTRIB_6

INCOME TAX AND SOCIAL CONTRIBUTION - Summary of changes In Deferred Asset And Liability Income Tax And Social Contribution (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2021		Dec. 31, 2020
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Begining balance, asset		R$ 1339725	[1]	R$ 374448
Beginning balance, liability		(1,288,045)	[1]	(450,561)
Ending balance, asset	[1]	2,954,074		1,339,725
Ending balance, liability	[1]	(994,041)		(1,288,045)
Effect on income statement [Member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Increase decrease in deferred tax asset		1,728,281		(19,639)
Increase decrease in deferred tax liability		243,180		37,723
Reserve for grant of options and restricted shares [Member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Increase decrease in deferred tax asset		(106,979)		96,181
Increase decrease in deferred tax liability
Transfer between income tax and deferred social contribution – assets and liabilities [member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Increase decrease in deferred tax asset		16,437
Increase decrease in deferred tax liability		(16,437)
OCI impact
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Increase decrease in deferred tax asset		72,939		(61,658)
Increase decrease in deferred tax liability
Currency Translation Effect [member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Increase decrease in deferred tax asset		(96,329)		283,359
Increase decrease in deferred tax liability		R$ 67261		(314,527)
Business combination [member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Increase decrease in deferred tax asset				667,034
Increase decrease in deferred tax liability				R$ 560680
[1]	Balance already includes any offsetting of deferred tax assets and liabilities of the same nature and originating from the same jurisdiction.

INCOME TAX AND SOCIAL CONTRIB_7

INCOME TAX AND SOCIAL CONTRIBUTION - Additional Information (Details) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2021		Dec. 31, 2020		Dec. 31, 2019
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Deferred tax assets potentially need to be offset with the recording of a valuation allowance	R$ 67
Description of evidence supporting recognition of deferred tax asset when utilisation is dependent on future taxable profits in excess of profits from reversal of taxable temporary differences and entity has suffered loss in jurisdiction to which deferred tax asset relates	deferred tax assets could potentially need to be offset with the recording of a valuation allowance during the next 12 months. The deferred tax assets are associated with Avon subsidiary operations that suffered a loss in earnings before tax during 2021.
Applicable tax rate	(14.362%)		(70.60%)		29.20%
Tax loss carryforwards	R$ 2954074	[1]	R$ 1339725	[1]	R$ 374448
Deferred income tax asset on tax losses	R$ 12324912		13,300,000
Credit amounts			R$ 33600
Bottom of range [member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Applicable tax rate	19.00%		17.00%
Top of range [member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Applicable tax rate	25.00%		19.00%
Natura and Co Luxembourg Holdings Sarl [member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Tax loss carryforwards			R$ 823000
Deferred income tax asset on tax losses	R$ 8200000
[1]	Balance already includes any offsetting of deferred tax assets and liabilities of the same nature and originating from the same jurisdiction.

JUDICIAL DEPOSITS - Summary of

JUDICIAL DEPOSITS - Summary of Detailed Information About Judicial Deposits (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement [Line Items]
Judicial deposits		R$ 585284	R$ 566190	R$ 337255
Unaccrued tax proceedings [Member]
Statement [Line Items]
Judicial deposits	[1]	273,295	262,654
Accrued tax proceedings [Member]
Statement [Line Items]
Judicial deposits	[2]	266,828	252,961
Unaccrued civil proceedings [Member]
Statement [Line Items]
Judicial deposits		8,212	9,671
Accrued civil proceedings [Member]
Statement [Line Items]
Judicial deposits		2,821	2,189
Unaccrued labor proceedings [Member]
Statement [Line Items]
Judicial deposits		11,970	14,166
Accrued labor proceedings [Member]
Statement [Line Items]
Judicial deposits		R$ 22158	R$ 24549
[1]	The tax proceedings related to these judicial deposits refer mainly to the ICMS-ST, disclosed in note 23.2.1, contingent liabilities - possible risk of loss.
[2]	The tax proceedings related to these judicial deposits basically refer to the sum of amounts disclosed in note 23.1.1 and the amount accrued as explained in the note 22 .

JUDICIAL DEPOSITS - Summary o_2

JUDICIAL DEPOSITS - Summary of Detailed Information About Changes In Judicial Deposits (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Judicial Deposits [Abstract]
Deposits - Beggining balance	R$ 566190	R$ 337255
Acquisition of subsidiary		283,885
New deposits	39,071	18,377
Redemptions	(21,533)	(64,761)
Inflation adjustment	15,246	11,242
Payments / Write-offs for expenses	(13,645)	(17,739)
Exchange rate variation	(45)	(2,069)
Deposits - Ending balance	R$ 585284	R$ 566190

ASSETS HELD FOR SALE (Detail)

ASSETS HELD FOR SALE (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020
ASSETS HELD FOR SALE
Balance at the beginning of the year		R$ 181279	R$ 199050
Additions	[1]	9,028	25,779
Transfer to Property, Plant and Equipment, other assets and liabilities	[2]	(25,779)	(29,610)
Sale	[3]	(97,905)	(61,760)
Exchange rate variation		(13,702)	47,820
Balance as of the end of the year		R$ 52921	R$ 181279
[1]	During the third quarter of 2021, the subsidiary Avon made its operations in India available for sale.
[2]	In the first quarter of 2021, the subsidiary Avon identified new circumstances in the sale transaction of the Saudi Arabia operation, which in 2020 was classified as an available-for-sale asset, which resulted in the reclassification of this transaction from held for sale to property, plant and equipment. At the time of the reclassification, an actual depreciation was recorded, resulting in an immaterial impact on the consolidated financial statements.
[3]	During the third and fourth quarters of 2021, the subsidiary Avon completed the sale of the operations located in Spain, India and Saudi Arabia, resulting in a gain of roughly R$14,600.

ASSETS HELD FOR SALE - Addition

ASSETS HELD FOR SALE - Additional Information (Detail) R$ in Thousands	12 Months Ended
	Dec. 31, 2021BRL (R$)
Disclosure of analysis of single amount of discontinued operations [line items]
Sale of the operations	R$ 14600

OTHER CURRENT AND NONCURRENT _3

OTHER CURRENT AND NONCURRENT ASSETS (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2021	Dec. 31, 2020	[1]
Other Assets [Abstract]
Marketing and advertising advances		R$ 80078	R$ 48767
Supplier advances		350,830	257,703
Employee advances		17,402	65,180
Rent advances and guarantee deposit	[2]	172,465	183,793
Advance insurance expenses		160,911	201,573
Overfunded pension plan	[3]	1,043,799	683,425
Customs broker advances - Import taxes		60,739	34,016
Sublease receivables	[4]	347,174	357,538
Carbon credits		11,479	4,097
Receivables from service providers	[5]	162,268	135,030
Other		268,066	172,666
Total		2,675,211	2,143,788
Current		912,160	616,120
Non-current		R$ 1763051	R$ 1527668
[1]	some amounts originally presented as of December 31, 2020 were reclassified for a better disclosure. Note that this reclassification does not impact the total amount originally presented as current and non-current assets.
[2]	Mainly related to: (i) advances of lease agreements that were not included in the initial measurement of lease liabilities / right-of-use of the subsidiary The Body Shop, in accordance with the exemptions on IFRS 16 06
[3]	Pension plan arising from the acquisition of Avon. The variation in the period is due to the valuation of funds linked to the pension plan mainly in the United Kingdom (see note 24).
[4]	Refers to the sublease receivable from the New York office owned by the subsidiary Avon.
[5]	Refers to receivables mainly arising from damage that occurred with carriers and insurance companies.

PROPERTY, PLANT AND EQUIPMENT -

PROPERTY, PLANT AND EQUIPMENT - Summary Of Detailed Information About Property, Plant And Equipment (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	R$ 5235057	R$ 1773889
Acquisition of subsidiary		2,912,482
Additions	201,941	(118,870)
Write-offs	(65,421)	(20,500)
Write-offs Impairment	1,977	5,361
Transfers	(144,809)	(75,214)
Exchange rate variation	148,663	768,631
Property, Plant And Equipment, Ending	5,377,408	5,235,057
Gross carrying amount [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	7,546,059	3,314,514
Acquisition of subsidiary		2,912,482
Additions	947,535	594,251
Write-offs	(366,304)	(73,768)
Write-offs Impairment	2,268	141
Transfers	(136,879)	(72,959)
Exchange rate variation	239,408	871,680
Property, Plant And Equipment, Ending	8,232,087	7,546,059
Gross carrying amount [member] | Vehicles [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	79,227	45,578
Acquisition of subsidiary		25,789
Additions	4,951	14,594
Write-offs	(59,053)	(17,274)
Write-offs Impairment
Transfers	6,702	1,184
Exchange rate variation	7,074	9,356
Property, Plant And Equipment, Ending	R$ 38901	R$ 79227
Gross carrying amount [member] | Vehicles [member] | Bottom of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	2 years	2 years
Gross carrying amount [member] | Vehicles [member] | Top of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	5 years	5 years
Gross carrying amount [member] | Tooling [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	3 years	3 years
Property, Plant And Equipment, Beginning	R$ 187852	R$ 192556
Acquisition of subsidiary
Additions	2,097	1,243
Write-offs		(19,713)
Write-offs Impairment
Transfers	2,042	5,650
Exchange rate variation	(151)	8,116
Property, Plant And Equipment, Ending	191,840	187,852
Gross carrying amount [member] | Tools and accessories [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	85,678	11,974
Acquisition of subsidiary		52,410
Additions	19,526	11,625
Write-offs	(538)	(1,743)
Write-offs Impairment
Transfers	5,233	5,888
Exchange rate variation	1,099	5,524
Property, Plant And Equipment, Ending	R$ 110998	R$ 85678
Gross carrying amount [member] | Tools and accessories [member] | Bottom of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	3 years	3 years
Gross carrying amount [member] | Tools and accessories [member] | Top of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	20 years	20 years
Gross carrying amount [member] | Facilities [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	R$ 293471	R$ 309772
Acquisition of subsidiary		1,431
Additions	700	81
Write-offs	(14,486)	(3,599)
Write-offs Impairment
Transfers	21,231	8,791
Exchange rate variation	2,536	(23,005)
Property, Plant And Equipment, Ending	R$ 303452	R$ 293471
Gross carrying amount [member] | Facilities [member] | Bottom of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	3 years	3 years
Gross carrying amount [member] | Facilities [member] | Top of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	60 years	60 years
Gross carrying amount [member] | Machinery and accessories [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	R$ 1819693	R$ 866451
Acquisition of subsidiary		740,328
Additions	37,229	20,098
Write-offs	(98,228)	(5,134)
Write-offs Impairment
Transfers	85,451	58,649
Exchange rate variation	115,798	139,301
Property, Plant And Equipment, Ending	R$ 1959943	R$ 1819693
Gross carrying amount [member] | Machinery and accessories [member] | Bottom of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	3 years	3 years
Gross carrying amount [member] | Machinery and accessories [member] | Top of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	15 years	15 years
Gross carrying amount [member] | Leasehold improvements [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	R$ 963957	R$ 615103
Acquisition of subsidiary		58,548
Additions	104,795	34,324
Write-offs	(51,588)	(8,761)
Write-offs Impairment	(2,074)
Transfers	93,589	51,588
Exchange rate variation	19,825	213,155
Property, Plant And Equipment, Ending	R$ 1128504	R$ 963957
Gross carrying amount [member] | Leasehold improvements [member] | Bottom of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	2 years	2 years
Gross carrying amount [member] | Leasehold improvements [member] | Top of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	20 years	20 years
Gross carrying amount [member] | Buildings [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	R$ 1899176	R$ 386957
Acquisition of subsidiary		1,203,081
Additions	6,233	12,275
Write-offs	(13,322)
Write-offs Impairment	394	115
Transfers	(6,944)	48,551
Exchange rate variation	96,750	248,427
Property, Plant And Equipment, Ending	R$ 1982287	R$ 1899176
Gross carrying amount [member] | Buildings [member] | Bottom of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	14 years	14 years
Gross carrying amount [member] | Buildings [member] | Top of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	60 years	60 years
Gross carrying amount [member] | Furniture and fixtures [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	R$ 566548	R$ 397727
Acquisition of subsidiary		32,566
Additions	107,077	32,530
Write-offs	(40,259)	(6,300)
Write-offs Impairment	3,948	26
Transfers	19,304	11,239
Exchange rate variation	3,509	98,812
Property, Plant And Equipment, Ending	R$ 660127	R$ 566548
Gross carrying amount [member] | Furniture and fixtures [Member] | Bottom of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	2 years	2 years
Gross carrying amount [member] | Furniture and fixtures [Member] | Top of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	25 years	25 years
Gross carrying amount [member] | Land [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life
Property, Plant And Equipment, Beginning	R$ 661613	R$ 35157
Acquisition of subsidiary		570,572
Additions	295	57
Write-offs	(1,203)
Write-offs Impairment
Transfers	(2,372)	4,252
Exchange rate variation	(29,960)	51,575
Property, Plant And Equipment, Ending	628,373	661,613
Gross carrying amount [member] | IT equipment [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	543,772	297,228
Acquisition of subsidiary		112,369
Additions	58,192	27,254
Write-offs	(57,574)	(10,652)
Write-offs Impairment
Transfers	68,645	36,554
Exchange rate variation	21,545	81,019
Property, Plant And Equipment, Ending	R$ 634580	R$ 543772
Gross carrying amount [member] | IT equipment [member] | Bottom of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	3 years	3 years
Gross carrying amount [member] | IT equipment [member] | Top of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	15 years	15 years
Gross carrying amount [member] | Other assets [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life
Property, Plant And Equipment, Beginning	R$ 36687
Acquisition of subsidiary		36,423
Additions
Write-offs	(3,628)
Write-offs Impairment
Transfers
Exchange rate variation	(1,423)	264
Property, Plant And Equipment, Ending	R$ 31636	R$ 36687
Gross carrying amount [member] | Other assets and projects in progress [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life
Property, Plant And Equipment, Beginning	R$ 408385	R$ 156011
Acquisition of subsidiary		78,965
Additions	606,440	440,170
Write-offs	(26,425)	(592)
Write-offs Impairment
Transfers	(429,760)	(305,305)
Exchange rate variation	2,806	39,136
Property, Plant And Equipment, Ending	561,446	408,385
Accumulated depreciation, amortisation and impairment [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(2,311,002)	(1,540,625)
Acquisition of subsidiary
Additions	(745,594)	(713,121)
Write-offs	300,883	53,268
Write-offs Impairment	(291)	5,220
Transfers	(7,930)	(2,255)
Exchange rate variation	(90,745)	(103,049)
Property, Plant And Equipment, Ending	(2,854,679)	(2,311,002)
Accumulated depreciation, amortisation and impairment [member] | Vehicles [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(33,042)	(16,924)
Acquisition of subsidiary
Additions	(19,229)	(24,150)
Write-offs	47,501	10,081
Write-offs Impairment
Transfers	(5,738)	(2,093)
Exchange rate variation	1,051	44
Property, Plant And Equipment, Ending	(9,457)	(33,042)
Accumulated depreciation, amortisation and impairment [member] | Tooling [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(166,536)	(175,938)
Acquisition of subsidiary
Additions	(7,705)	(10,092)
Write-offs		19,684
Write-offs Impairment
Transfers
Exchange rate variation	77	(190)
Property, Plant And Equipment, Ending	(174,164)	(166,536)
Accumulated depreciation, amortisation and impairment [member] | Tools and accessories [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(39,159)	(3,255)
Acquisition of subsidiary
Additions	(32,867)	(42,932)
Write-offs	750
Write-offs Impairment
Transfers	3,145	10
Exchange rate variation	2,391	7,018
Property, Plant And Equipment, Ending	(65,740)	(39,159)
Accumulated depreciation, amortisation and impairment [member] | Facilities [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(176,726)	(167,362)
Acquisition of subsidiary
Additions	(16,453)	(19,933)
Write-offs	13,072	285
Write-offs Impairment
Transfers	(2,705)	1,044
Exchange rate variation	(608)	9,240
Property, Plant And Equipment, Ending	(183,420)	(176,726)
Accumulated depreciation, amortisation and impairment [member] | Machinery and accessories [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(578,762)	(416,736)
Acquisition of subsidiary
Additions	(198,805)	(193,657)
Write-offs	91,864	2,759
Write-offs Impairment
Transfers	8,463	(1,202)
Exchange rate variation	(51,168)	30,074
Property, Plant And Equipment, Ending	(728,408)	(578,762)
Accumulated depreciation, amortisation and impairment [member] | Leasehold improvements [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(480,554)	(267,371)
Acquisition of subsidiary
Additions	(153,822)	(130,631)
Write-offs	48,057	7,124
Write-offs Impairment		4,900
Transfers	(5,561)	(4,107)
Exchange rate variation	(10,742)	(80,669)
Property, Plant And Equipment, Ending	(602,622)	(480,554)
Accumulated depreciation, amortisation and impairment [member] | Buildings [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(179,729)	(101,785)
Acquisition of subsidiary
Additions	(89,292)	(88,593)
Write-offs	13,835
Write-offs Impairment
Transfers	2,801
Exchange rate variation	(45,941)	10,649
Property, Plant And Equipment, Ending	(298,326)	(179,729)
Accumulated depreciation, amortisation and impairment [member] | Furniture and fixtures [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(318,611)	(193,973)
Acquisition of subsidiary
Additions	(95,673)	(81,287)
Write-offs	31,464	4,744
Write-offs Impairment	(291)	284
Transfers	(353)	4,093
Exchange rate variation	13,858	(51,904)
Property, Plant And Equipment, Ending	(369,606)	(318,611)
Accumulated depreciation, amortisation and impairment [member] | IT equipment [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(311,856)	(197,281)
Acquisition of subsidiary
Additions	(115,735)	(96,768)
Write-offs	52,971	8,591
Write-offs Impairment		36
Transfers	(7,982)
Exchange rate variation	(9,493)	(26,362)
Property, Plant And Equipment, Ending	(392,095)	(311,856)
Accumulated depreciation, amortisation and impairment [member] | Other assets [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(26,027)
Acquisition of subsidiary
Additions	(16,013)	(25,078)
Write-offs	1,369
Write-offs Impairment
Transfers
Exchange rate variation	9,830	(949)
Property, Plant And Equipment, Ending	R$ 30841	R$ 26027

INTANGIBLE ASSETS - Disclosure

INTANGIBLE ASSETS - Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2021		Dec. 31, 2020
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		R$ 26917128		R$ 5076501
Acquisition of subsidiary				17,392,570
Additions		(597,485)		(722,893)
Write-offs		(1,995)		(15,055)
Reversal (provision) of impairment		(304)		(2,051)
Transfers		133,063		82,007
Exchange rate variation		407,176		5,106,049
Intangible assets and goodwill, Ending		26,857,583		26,917,128
Gross carrying amount [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		28,794,170		5,883,023
Acquisition of subsidiary				17,392,570
Additions		450,435		258,883
Write-offs		(120,196)		(30,119)
Reversal (provision) of impairment		(304)		(2,051)
Transfers		127,636		85,640
Exchange rate variation		500,201		5,206,224
Intangible assets and goodwill, Ending		29,751,942		28,794,170
Gross carrying amount [member] | Software [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		2,059,150		1,313,090
Acquisition of subsidiary				291,555
Additions		88,101		82,718
Write-offs		(114,805)		(15,095)
Reversal (provision) of impairment
Transfers		280,959		258,092
Exchange rate variation		179,212		128,790
Intangible assets and goodwill, Ending		R$ 2492617		R$ 2059150
Gross carrying amount [member] | Software [member] | Bottom of range [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life		2 years 6 months		2 years 6 months
Gross carrying amount [member] | Software [member] | Top of range [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life		10 years		10 years
Gross carrying amount [member] | Trademarks and patents Finite [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		R$ 894578		R$ 116805
Acquisition of subsidiary				517,592
Additions
Write-offs
Reversal (provision) of impairment
Transfers
Exchange rate variation		(4,744)		260,181
Intangible assets and goodwill, Ending		R$ 889834		R$ 894578
Gross carrying amount [member] | Trademarks and patents Finite [member] | Bottom of range [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life		20 years		20 years
Gross carrying amount [member] | Trademarks and patents Finite [member] | Top of range [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life		25 years		25 years
Gross carrying amount [member] | Trademarks and patents Indefinite [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life
Intangible assets and goodwill, Beginning		R$ 5747057		R$ 2171585
Acquisition of subsidiary				2,022,163
Additions
Write-offs
Reversal (provision) of impairment
Transfers
Exchange rate variation		141,566		1,553,309
Intangible assets and goodwill, Ending		R$ 5888623		R$ 5747057
Gross carrying amount [member] | Goodwill Avon [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life
Intangible assets and goodwill, Beginning		R$ 13299849
Acquisition of subsidiary				11,511,028
Additions
Write-offs
Reversal (provision) of impairment
Transfers
Exchange rate variation		81,341		1,788,821
Intangible assets and goodwill, Ending		R$ 13381190		R$ 13299849
Gross carrying amount [member] | Goodwill Emeis Brazil Pty Ltd [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life	[1]
Intangible assets and goodwill, Beginning	[1]	R$ 142090		R$ 100237
Acquisition of subsidiary	[1]
Additions	[1]
Write-offs	[1]
Reversal (provision) of impairment	[1]
Transfers	[1]
Exchange rate variation		1,090		41,853
Intangible assets and goodwill, Ending	[1]	R$ 143180		R$ 142090
Gross carrying amount [member] | Goodwill The Body Shop International Limited [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life					[2]
Intangible assets and goodwill, Beginning	[2]	R$ 1946741		R$ 1434369
Acquisition of subsidiary	[2]			34,251
Additions					[2]
Write-offs					[2]
Reversal (provision) of impairment					[2]
Transfers					[2]
Exchange rate variation		116,931		478,121
Intangible assets and goodwill, Ending		R$ 2063672		R$ 1946741	[2]
Gross carrying amount [member] | Goodwill acquisition of The Body Shop stores [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life
Intangible assets and goodwill, Beginning		R$ 1456		R$ 1456
Acquisition of subsidiary
Additions
Write-offs
Reversal (provision) of impairment
Transfers
Exchange rate variation
Intangible assets and goodwill, Ending		R$ 1456		R$ 1456
Gross carrying amount [member] | Relationship with retail clients [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life		10 years		10 years
Intangible assets and goodwill, Beginning		R$ 2785		R$ 1987
Acquisition of subsidiary
Additions
Write-offs
Reversal (provision) of impairment
Transfers
Exchange rate variation		95		798
Intangible assets and goodwill, Ending		R$ 2880		R$ 2785
Gross carrying amount [member] | Key Money Indefinite [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life	[3]
Intangible assets and goodwill, Beginning	[3]	R$ 26769		R$ 17801
Acquisition of subsidiary	[3]
Additions	[3]
Write-offs	[3]	(3,619)
Reversal (provision) of impairment	[3]	1,984
Transfers	[3]			1,315
Exchange rate variation		(149)	[3]	7,653
Intangible assets and goodwill, Ending	[3]	24,985		26,769
Gross carrying amount [member] | Key Money Finite [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning	[4]	10,860		12,447
Acquisition of subsidiary	[4]
Additions	[4]	2,500		150
Write-offs	[4]
Reversal (provision) of impairment	[4]	(2,288)		(2,051)
Transfers	[4]	(5,555)		1,647
Exchange rate variation		8,846		(1,333)
Intangible assets and goodwill, Ending	[4]	R$ 14363		R$ 10860
Gross carrying amount [member] | Key Money Finite [member] | Bottom of range [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life	[4]	3 years		3 years
Gross carrying amount [member] | Key Money Finite [member] | Top of range [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life	[4]	18 years		18 years
Gross carrying amount [member] | Relationship with franchisees and sub franchisees [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning	[5]	R$ 2959519		R$ 602958
Acquisition of subsidiary	[5]			1,884,249
Additions	[5]
Write-offs	[5]	(446)
Reversal (provision) of impairment	[5]
Transfers	[5]
Exchange rate variation		31,485		472,312
Intangible assets and goodwill, Ending	[5]	R$ 2990558		R$ 2959519
Gross carrying amount [member] | Relationship with franchisees and sub franchisees [member] | Bottom of range [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life	[5]	7 years		7 years
Gross carrying amount [member] | Relationship with franchisees and sub franchisees [member] | Top of range [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life	[5]	15 years		15 years
Gross carrying amount [member] | Technology developed (by acquired subsidiary) [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life		5 years		5 years
Intangible assets and goodwill, Beginning		R$ 1595041
Acquisition of subsidiary				1,131,573
Additions
Write-offs
Reversal (provision) of impairment
Transfers
Exchange rate variation		(14,233)		463,468
Intangible assets and goodwill, Ending		1,580,808		1,595,041
Gross carrying amount [member] | Other intangible assets [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		108,275		110,288
Acquisition of subsidiary				159
Additions		359,834		176,015
Write-offs		(1,326)		(15,024)
Reversal (provision) of impairment
Transfers		(147,768)		(175,414)
Exchange rate variation		(41,239)		12,251
Intangible assets and goodwill, Ending		R$ 277776		R$ 108275
Gross carrying amount [member] | Other intangible assets [member] | Bottom of range [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life		2 years		2 years
Gross carrying amount [member] | Other intangible assets [member] | Top of range [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life		10 years		10 years
Accumulated depreciation, amortisation and impairment [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		R$ 1877042		R$ 806522
Acquisition of subsidiary
Additions		(1,047,920)		(981,776)
Write-offs		118,201		15,064
Reversal (provision) of impairment
Transfers		5,427		(3,633)
Exchange rate variation		(93,025)		(100,175)
Intangible assets and goodwill, Ending		(2,894,359)		(1,877,042)
Accumulated depreciation, amortisation and impairment [member] | Software [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		(1,022,498)		(649,347)
Acquisition of subsidiary
Additions		(373,753)		(365,184)
Write-offs		116,429		44
Reversal (provision) of impairment
Transfers		3,760		(3,643)
Exchange rate variation		(93,705)		(4,368)
Intangible assets and goodwill, Ending		(1,369,767)		(1,022,498)
Accumulated depreciation, amortisation and impairment [member] | Trademarks and patents Finite [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		(100,043)		(44,108)
Acquisition of subsidiary
Additions		(45,782)		(36,548)
Write-offs
Reversal (provision) of impairment
Transfers
Exchange rate variation		2,638		(19,387)
Intangible assets and goodwill, Ending		(143,187)		(100,043)
Accumulated depreciation, amortisation and impairment [member] | Relationship with retail clients [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		(2,839)		(1,939)
Acquisition of subsidiary
Additions		(286)		(252)
Write-offs
Reversal (provision) of impairment
Transfers
Exchange rate variation		(93)		(648)
Intangible assets and goodwill, Ending		(3,218)		(2,839)
Accumulated depreciation, amortisation and impairment [member] | Key Money Finite [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		(8,871)		(2,197)
Acquisition of subsidiary
Additions		(185)		(535)
Write-offs
Reversal (provision) of impairment
Transfers		1,667		10
Exchange rate variation		(9,128)		(6,149)
Intangible assets and goodwill, Ending		(16,517)		(8,871)
Accumulated depreciation, amortisation and impairment [member] | Relationship with franchisees and sub franchisees [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		(419,061)		(95,772)
Acquisition of subsidiary
Additions		(306,451)		(278,048)
Write-offs		446
Reversal (provision) of impairment
Transfers
Exchange rate variation		(3,983)		(45,241)
Intangible assets and goodwill, Ending		(729,049)		(419,061)
Accumulated depreciation, amortisation and impairment [member] | Technology developed (by acquired subsidiary) [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		(319,009)
Acquisition of subsidiary
Additions		(320,183)		(294,713)
Write-offs
Reversal (provision) of impairment
Transfers
Exchange rate variation		6,866		(24,296)
Intangible assets and goodwill, Ending		(632,326)		(319,009)
Accumulated depreciation, amortisation and impairment [member] | Other intangible assets [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		(4,721)		(13,159)
Acquisition of subsidiary
Additions		(1,280)		(6,496)
Write-offs		1,326		15,020
Reversal (provision) of impairment
Transfers
Exchange rate variation		4,380		(86)
Intangible assets and goodwill, Ending		R$ 295		R$ 4721
[1]	Goodwill related to the acquisition of subsidiary Emeis Holdings Pty Ltd. acquisition, classified as future economic benefits from synergies. It does not have defined useful life and it is subject to annual impairment tests.
[2]	Goodwill related to the acquisition of subsidiary The Body Shop, classified as future economic benefits from synergies. It does not have defined useful life and it is subject to annual impairment tests. In addition, on June 30, 2020, the subsidiary The Body Shop International Limited acquired the entity Aeon Forest Co. Ltd, for R$ 133,275 (¥ 2,632,000). On October 1, 2020, the transaction was concluded and resulted in an assigned amount of goodwill of R$ 34,251.
[3]	Key money with indefinite useful life refers to payments made to former tenants, to get the right to rent the property under lease and can be subsequently negotiated with future tenants in the case of termination of the lease agreement. This balance was considered the scope of the lease standard (CPC 06 2 16 3.13.1
[4]	Key money with defined useful life refers to payments made to ex-tenants or lessors, to obtain the right to rent the property under the terms of the lease and which cannot be negotiated or recovered later. This balance was considered as the scope of the lease standard (CPC 06 16
[5]	The balance refers to identifiable intangible assets from relationship with the subsidiary The Body Shop franchisees and sub-franchisees (relationship where the franchisee owns all rights to operate within a territory) and sub-franchisees (relationship where a franchisee operate a single store within a market), with estimated useful life of 15 years.

INTANGIBLE ASSETS - Disclosur_2

INTANGIBLE ASSETS - Disclosure Of Information For Cash-generating Units (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of information for cash-generating units [line items]
Total	R$ 26857583	R$ 26917128	R$ 5076501
Trademarks And Patents [member]
Disclosure of information for cash-generating units [line items]
Trademarks and patents	6,061,028	5,752,460
Goodwill [member]
Disclosure of information for cash-generating units [line items]
Goodwill	15,588,043	15,388,680
Intangible Assets And Goodwill With Indefinite Useful Life [member]
Disclosure of information for cash-generating units [line items]
Total	21,649,071	21,141,140
Natura and Co Latam [member] | Trademarks And Patents [member]
Disclosure of information for cash-generating units [line items]
Trademarks and patents	5,403	5,403
Natura and Co Latam [member] | Goodwill [member]
Disclosure of information for cash-generating units [line items]
Goodwill	10,041,156	9,994,861
Natura and Co Latam [member] | Intangible Assets And Goodwill With Indefinite Useful Life [member]
Disclosure of information for cash-generating units [line items]
Total	10,046,559	10,000,264
Avon International [member] | Trademarks And Patents [member]
Disclosure of information for cash-generating units [line items]
Trademarks and patents	2,991,963	2,850,397
Avon International [member] | Goodwill [member]
Disclosure of information for cash-generating units [line items]
Goodwill	3,340,035	3,304,988
Avon International [member] | Intangible Assets And Goodwill With Indefinite Useful Life [member]
Disclosure of information for cash-generating units [line items]
Total	6,331,998	6,155,385
TBS International [member] | Trademarks And Patents [member]
Disclosure of information for cash-generating units [line items]
Trademarks and patents	3,063,662	2,896,660
TBS International [member] | Goodwill [member]
Disclosure of information for cash-generating units [line items]
Goodwill	2,063,672	1,946,741
TBS International [member] | Intangible Assets And Goodwill With Indefinite Useful Life [member]
Disclosure of information for cash-generating units [line items]
Total	5,127,334	4,843,401
Aesop International [member] | Trademarks And Patents [member]
Disclosure of information for cash-generating units [line items]
Trademarks and patents
Aesop International [member] | Goodwill [member]
Disclosure of information for cash-generating units [line items]
Goodwill	143,180	142,090
Aesop International [member] | Intangible Assets And Goodwill With Indefinite Useful Life [member]
Disclosure of information for cash-generating units [line items]
Total	R$ 143180	R$ 142090

INTANGIBLE ASSETS - Disclosur_3

INTANGIBLE ASSETS - Disclosure Of Detailed Information About Assumptions Used To Calculate The Fair Value Less Cost To Sell (Detail)	12 Months Ended
	Dec. 31, 2021
Aesop [member]
Disclosure of information for cash-generating units [line items]
Measurement of impairment value (fair value less cost of disposal)	Discounted cash flow based on financial budgets approved by Board of Directors during a discretionary period of five years with a terminal value projected for the end of the period.
Budgeted gross margin	Gross margins are based on average amounts obtained in the 2 years prior to the beginning of the budgeted period and projections for the next 5 years.
Estimated costs	Costs based on historical data and market trends, optimization of retail and direct sales operations (renewal of the geographical presence of stores, revitalization of the franchise network) and physical expansion with growth in market share.
Revenue Growth rates	Growth rates are initially based on published industry research and adjusted by the expected performance for each segment given the initiatives in place for each segment as well as the respective macroeconomic environment that apply to each segment and are included in the budgets approved by Board of Directors.
Perpetuity growth rate	4.80%	[1]
Discount rate	11.19%
The Body Shop [member]
Disclosure of information for cash-generating units [line items]
Measurement of impairment value (fair value less cost of disposal)	Discounted cash flow based on financial budgets approved by Senior Management during a discretionary period of five years with a terminal value projected for the end of the period.
Budgeted gross margin	Gross margins are based on average amounts obtained in the 2 years prior to the beginning of the budgeted period and projections for the next 5 years.
Estimated costs	Costs based on historical data and market trends, optimization of retail and direct sales operations (renewal of the geographical presence of stores, revitalization of the franchise network) and physical expansion with growth in market share.
Revenue Growth rates	Growth rates are initially based on published industry research and adjusted by the expected performance for each segment given the initiatives in place for each segment as well as the respective macroeconomic environment that apply to each segment and are included in the budgets approved by Board of Directors.
Perpetuity growth rate	4.40%	[1]
Discount rate	8.83%
Avon International [member]
Disclosure of information for cash-generating units [line items]
Measurement of impairment value (fair value less cost of disposal)	Discounted cash flow based on financial budgets approved by Senior Management during a discretionary period of five years with a terminal value projected for the end of the period.
Budgeted gross margin	Gross margins are based on average amounts obtained in the 2 years prior to the beginning of the budgeted period and projections for the next 5 years.
Estimated costs	Costs based on historical data and market trends, optimization of retail and direct sales operations (renewal of the geographical presence of stores, revitalization of the franchise network) and physical expansion with growth in market share.
Revenue Growth rates	Growth rates are initially based on published industry research and adjusted by the expected performance for each segment given the initiatives in place for each segment as well as the respective macroeconomic environment that apply to each segment and are included in the budgets approved by Board of Directors.
Perpetuity growth rate	4.70%	[1]
Discount rate	11.18%
Natura and Co Latam [member]
Disclosure of information for cash-generating units [line items]
Measurement of impairment value (fair value less cost of disposal)	Discounted cash flow based on financial budgets approved by Senior Management during a discretionary period of five years with a terminal value projected for the end of the period.
Budgeted gross margin	Gross margins are based on average amounts obtained in the 2 years prior to the beginning of the budgeted period and projections for the next 5 years.
Estimated costs	Costs based on historical data and market trends, optimization of retail and direct sales operations (renewal of the geographical presence of stores, revitalization of the franchise network) and physical expansion with growth in market share.
Revenue Growth rates	Growth rates are initially based on published industry research and adjusted by the expected performance for each segment given the initiatives in place for each segment as well as the respective macroeconomic environment that apply to each segment and are included in the budgets approved by Board of Directors.
Perpetuity growth rate	5.50%	[1]
Discount rate	13.93%
[1]	The rates are based on published market analyzes and projections regarding the reporting segment in which they operate and adjusted to reflect the assumptions considered by Management in the approved projections and to reflect the inflation differential of other currencies, when applicable.

INTANGIBLE ASSETS - Additional

INTANGIBLE ASSETS - Additional information (Detail) - The Body Shop [member] - Aeon Forest Co., Ltd [member] ¥ in Thousands, R$ in Thousands	Oct. 01, 2020BRL (R$)	Jun. 30, 2020JPY (¥)	Jun. 30, 2020BRL (R$)
Disclosure of detailed information about intangible assets [line items]
Purchase price of entity		¥ 2,632,000	R$ 133275
Goodwill	R$ 34251

RIGHT OF USE AND LEASE LIABIL_3

RIGHT OF USE AND LEASE LIABILITIES - Schedule of Quantitative Information About Right-of-Use Assets (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2021		Dec. 31, 2020
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning		R$ 3402047		R$ 2619861
Subsidiary Acquisition				564,670
Additions		(150,912)		(413,408)
Write-offs		(270,338)		(25,880)
Impairment losses	[1]	(4,690)		(148,050)
Transfers	[2]	4,182		(2,962)
Exchange rate variation		115,680		807,816
Right of use, Ending		R$ 3095969		3,402,047
Annual pre-tax discount rate		6.59%
Cost Value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning		R$ 5199039		3,193,959
Subsidiary Acquisition				564,670
Additions		847,098		610,551
Write-offs		(980,236)		(42,047)
Impairment losses	[1]	(4,690)		(148,050)
Transfers	[2]	7,251		(2,962)
Exchange rate variation		126,698		1,022,918
Right of use, Ending		5,195,160		5,199,039
Depreciation value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning		(1,796,992)		(574,098)
Subsidiary Acquisition
Additions		(998,009)		(1,023,959)
Write-offs		709,897		16,167
Impairment losses	[1]
Transfers	[2]	(3,069)
Exchange rate variation		(11,018)		(215,102)
Right of use, Ending		R$ 2099191		R$ 1796992
Vehicles [member] | Cost Value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Useful life	[3]	3 years		3 years
Right of use, Beginning		R$ 157867		R$ 40018
Subsidiary Acquisition				42,467
Additions		32,288		61,878
Write-offs		(23,519)		(441)
Impairment losses	[1]
Transfers	[2]
Exchange rate variation		1,426		13,945
Right of use, Ending		168,062		157,867
Vehicles [member] | Depreciation value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning		(63,422)		(8,109)
Subsidiary Acquisition
Additions		(50,181)		(54,558)
Write-offs		20,808		192
Impairment losses	[1]
Transfers	[2]
Exchange rate variation		1,286		(947)
Right of use, Ending		(91,509)		(63,422)
Machinery and equipment [member] | Cost Value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning		53,048		15,578
Subsidiary Acquisition				14,034
Additions		4,278		11,265
Write-offs		(24,140)
Impairment losses	[1]
Transfers	[2]
Exchange rate variation		443		12,171
Right of use, Ending		R$ 33629		R$ 53048
Machinery and equipment [member] | Cost Value [member] | Bottom of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Useful life	[3]	3 years		3 years
Machinery and equipment [member] | Cost Value [member] | Top of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Useful life	[3]	10 years		10 years
Machinery and equipment [member] | Depreciation value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning		R$ 21045		R$ 4317
Subsidiary Acquisition
Additions		(10,772)		(14,899)
Write-offs		15,067
Impairment losses	[1]
Transfers	[2]
Exchange rate variation		(383)		(1,829)
Right of use, Ending		(17,133)		(21,045)
Buildings [member] | Cost Value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning		1,616,833		784,900
Subsidiary Acquisition				489,740
Additions		300,181		146,695
Write-offs		(436,405)		(16,094)
Impairment losses	[1]	(4,690)
Transfers	[2]	3,363
Exchange rate variation		63,736		211,592
Right of use, Ending		R$ 1543018		R$ 1616833
Buildings [member] | Cost Value [member] | Bottom of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Useful life	[3]	3 years		3 years
Buildings [member] | Cost Value [member] | Top of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Useful life	[3]	10 years		10 years
Buildings [member] | Depreciation value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning		R$ 399765		R$ 97190
Subsidiary Acquisition
Additions		(268,902)		(291,431)
Write-offs		182,535		12,448
Impairment losses			[1]
Transfers	[2]	(3,069)
Exchange rate variation		(17,844)		(23,592)
Right of use, Ending		R$ 507045		R$ 399765
IT equipment [member] | Cost Value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Useful life	[3]	10 years		10 years
Right of use, Beginning		R$ 30000		R$ 283
Subsidiary Acquisition				18,429
Additions		4,224		6,211
Write-offs		(3,904)		(323)
Impairment losses	[1]
Transfers	[2]
Exchange rate variation		1,483		5,400
Right of use, Ending		31,803		30,000
IT equipment [member] | Depreciation value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning		(19,161)		(214)
Subsidiary Acquisition
Additions		(8,364)		(18,694)
Write-offs		3,904
Impairment losses	[1]
Transfers	[2]
Exchange rate variation		(789)		(253)
Right of use, Ending		(24,410)		(19,161)
Retail stores [member] | Cost Value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning		3,338,104		2,350,377
Subsidiary Acquisition
Additions		505,871		384,502
Write-offs		(489,808)		(25,189)
Impairment losses	[1]			(148,050)
Transfers	[2]	3,888		(2,962)
Exchange rate variation		59,540		779,426
Right of use, Ending		R$ 3417595		R$ 3338104
Retail stores [member] | Cost Value [member] | Bottom of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Useful life	[3]	3 years		3 years
Retail stores [member] | Cost Value [member] | Top of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Useful life	[3]	10 years		10 years
Retail stores [member] | Depreciation value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning		R$ 1291346		R$ 463332
Subsidiary Acquisition
Additions		(659,109)		(643,441)
Write-offs		485,123		3,527
Impairment losses	[1]
Transfers	[2]
Exchange rate variation		6,820		(188,100)
Right of use, Ending		R$ 1458512		R$ 1291346
Tools and accessories [member] | Cost Value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Useful life	[3]	3 years		3 years
Right of use, Beginning		R$ 3187		R$ 2803
Subsidiary Acquisition
Additions		256
Write-offs		(2,460)
Impairment losses	[1]
Transfers	[2]
Exchange rate variation		70		384
Right of use, Ending		1,053		3,187
Tools and accessories [member] | Depreciation value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning		(2,253)		(936)
Subsidiary Acquisition
Additions		(681)		(936)
Write-offs		2,460
Impairment losses	[1]
Transfers	[2]
Exchange rate variation		(108)		(381)
Right of use, Ending		R$ 582		R$ 2253
[1]	On December 31, 2021, an impairment of R$4,690 was recorded referring to the impairment loss of some stores of the and The Body Shop. On December 31, 2020, an impairment of R$148,050 was recorded; out of this amount R$140,050 was related to the legacy stores of subsidiary The Body Shop, which were previously included in the store closure plan, which were subsequently impacted by the effects of pandemic, predominantly in the United States. In the current estimate of the value in use, an annual pre-tax discount rate of 6.59% was used.
[2]	Refers to key money related to store rentals. This amount is transferred from “right of use” to "intangible assets” when a new commercial agreement with the lessor is not yet signed
[3]	The useful lives applied refer to the term of the contracts in which the Company is sure that it will use the assets underlying the lease contracts according to the contractual terms.

RIGHT OF USE AND LEASE LIABIL_4

RIGHT OF USE AND LEASE LIABILITIES - Schedule of Quantitative Information About Right-of-Use Assets (Detail) (Parenthetical) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020
Disclosure of quantitative information about right-of-use assets [line items]
Impairment	[1]	R$ 4690	R$ 148050
Annual pre-tax discount rate		6.59%
Operations The Body Shop [Member]
Disclosure of quantitative information about right-of-use assets [line items]
Impairment			R$ 140050
[1]	On December 31, 2021, an impairment of R$4,690 was recorded referring to the impairment loss of some stores of the and The Body Shop. On December 31, 2020, an impairment of R$148,050 was recorded; out of this amount R$140,050 was related to the legacy stores of subsidiary The Body Shop, which were previously included in the store closure plan, which were subsequently impacted by the effects of pandemic, predominantly in the United States. In the current estimate of the value in use, an annual pre-tax discount rate of 6.59% was used.

RIGHT OF USE AND LEASE LIABIL_5

RIGHT OF USE AND LEASE LIABILITIES - Schedule of Detailed information about cash outflow related to leases (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Amounts recognized in the statement of profit or loss for the years ended December 31, 2021 and 2020
Financial expense on lease	R$ 210669	R$ 229544	R$ 134579
Amortization of right of use	998,009	1,023,959
Appropriation in the result of variable lease installments not included in the measurement of rental liabilities	70,075	45,952
Sublease revenue	(30,026)	(27,079)
Short-term lease expenses and low-value assets	83,468	72,546
Benefits granted by lessor related to Covid-19	(80,037)	(58,700)
Other lease-related expenses	58,609	40,206
Impairment losses	(4,690)	(144,500)
Total	1,315,457	1,470,928
Amounts recognized in the financing activities in the cash flow statement
Lease payments (principal)	1,077,611	843,338	R$ 497905
Values recognized in the operating cash flow statement
Lease payments (interest)	219,574	225,420
Variable lease payments, not included in the measurement of lease liabilities	70,787	33,835
Short-term and low-value assets leases payments	74,188	51,675
Other lease-related payments	95,824	82,150
Total	R$ 1537984	R$ 1236418

RIGHT OF USE AND LEASE LIABIL_6

RIGHT OF USE AND LEASE LIABILITIES - Schedule of Lease Obligation (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of quantitative information about right-of-use assets [abstract]
Current	R$ 1005523	R$ 1059661
Non-current	2,542,339	2,798,794
Total	R$ 3547862	R$ 3858455	R$ 2517565

RIGHT OF USE AND LEASE LIABIL_7

RIGHT OF USE AND LEASE LIABILITIES - Schedule of Changes In The Balance of Lease Obligations (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of quantitative information about right-of-use assets [abstract]
Beginning balance		R$ 3858455	R$ 2517565
New contracts and modifications		737,899	559,905
Acquisition of subsidiary			777,200
Lease payments – principal		(1,077,611)	(843,338)	R$ 497905
Lease payments – interest		(219,574)	(225,420)
Appropriation of financial charges		210,669	229,544	134,579
Write-offs	[1]	(105,790)	(193,174)
Exchange rate variation (OCI)		143,814	1,036,173
Ending balance		R$ 3547862	R$ 3858455	R$ 2517565
[1]	Refers mainly to the termination of contracts related to store leases.

RIGHT OF USE AND LEASE LIABIL_8

RIGHT OF USE AND LEASE LIABILITIES - Schedule of maturities of the balance of non-current lease liabilities (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Disclosure of quantitative information about right-of-use assets [line items]
Non-current lease liabilities	R$ 2542339	R$ 2798794
2022 [member]
Disclosure of quantitative information about right-of-use assets [line items]
Non-current lease liabilities		419,240
2023 [member]
Disclosure of quantitative information about right-of-use assets [line items]
Non-current lease liabilities	749,030	408,977
2024 [member]
Disclosure of quantitative information about right-of-use assets [line items]
Non-current lease liabilities	575,223	406,572
2025 onwards (2025 onwards to the year 2020) [member]
Disclosure of quantitative information about right-of-use assets [line items]
Non-current lease liabilities	716,879	1,564,005
2026 onwards [member]
Disclosure of quantitative information about right-of-use assets [line items]
Non-current lease liabilities	R$ 501207

RIGHT OF USE AND LEASE LIABIL_9

RIGHT OF USE AND LEASE LIABILITIES - Schedule of rates applied, according to the lease terms (Detail) R$ in Thousands	Dec. 31, 2021BRL (R$)
1 year [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	R$ 1238100
Lease terms, Estimated inflation rate	5.00%
2 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	R$ 721248
Lease terms, Estimated inflation rate	3.00%	[1]
3 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	R$ 575072
Lease terms, Estimated inflation rate	3.00%	[1]
4 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	R$ 687706
Lease terms, Estimated inflation rate	3.00%	[1]
5 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	R$ 358299
Lease terms, Estimated inflation rate	3.00%	[1]
Over five years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	R$ 93550
Lease terms, Estimated inflation rate	3.00%	[1]
Average discount rate 0.5 percent to 10.8 percent [member] | Bottom of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Lease terms, average discount rate	0.50%
Average discount rate 0.5 percent to 10.8 percent [member] | Top of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Lease terms, average discount rate	10.80%
Average discount rate 0.5 percent to 10.8 percent [member] | 1 year [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	R$ 21498
Average discount rate 0.5 percent to 10.8 percent [member] | 2 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	10,100
Average discount rate 0.5 percent to 10.8 percent [member] | 3 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	8,829
Average discount rate 0.5 percent to 10.8 percent [member] | 4 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	7,835
Average discount rate 0.5 percent to 10.8 percent [member] | 5 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	5,451
Average discount rate 0.5 percent to 10.8 percent [member] | Over five years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	R$ 6048
Average discount rate 1.1 percent to 12.2 percent [member] | Bottom of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Lease terms, average discount rate	1.10%
Average discount rate 1.1 percent to 12.2 percent [member] | Top of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Lease terms, average discount rate	12.20%
Average discount rate 1.1 percent to 12.2 percent [member] | 1 year [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	R$ 1182969
Average discount rate 1.1 percent to 12.2 percent [member] | 2 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	675,518
Average discount rate 1.1 percent to 12.2 percent [member] | 3 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	527,363
Average discount rate 1.1 percent to 12.2 percent [member] | 4 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	637,337
Average discount rate 1.1 percent to 12.2 percent [member] | 5 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	310,950
Average discount rate 1.1 percent to 12.2 percent [member] | Over five years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	R$ 33917
Average discount rate 1.7 percent to 14 percent [member] | Bottom of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Lease terms, average discount rate	1.70%
Average discount rate 1.7 percent to 14 percent [member] | Top of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Lease terms, average discount rate	14.00%
Average discount rate 1.7 percent to 14 percent [member] | 1 year [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	R$ 30421
Average discount rate 1.7 percent to 14 percent [member] | 2 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	32,638
Average discount rate 1.7 percent to 14 percent [member] | 3 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	35,490
Average discount rate 1.7 percent to 14 percent [member] | 4 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	38,684
Average discount rate 1.7 percent to 14 percent [member] | 5 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	37,527
Average discount rate 1.7 percent to 14 percent [member] | Over five years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	R$ 40940
Average discount rate 2.2 percent to 15.5 percent [member] | Bottom of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Lease terms, average discount rate	2.20%
Average discount rate 2.2 percent to 15.5 percent [member] | Top of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Lease terms, average discount rate	15.50%
Average discount rate 2.2 percent to 15.5 percent [member] | 1 year [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	R$ 3212
Average discount rate 2.2 percent to 15.5 percent [member] | 2 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	2,992
Average discount rate 2.2 percent to 15.5 percent [member] | 3 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	3,390
Average discount rate 2.2 percent to 15.5 percent [member] | 4 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	3,850
Average discount rate 2.2 percent to 15.5 percent [member] | 5 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	4,371
Average discount rate 2.2 percent to 15.5 percent [member] | Over five years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	R$ 12645
[1]	Rates obtained through future prices of DI coupons versus National Consumer Price Index (IPCA) observed in B 3

BORROWING, FINANCING AND DEBE_3

BORROWING, FINANCING AND DEBENTURES - Schedule Of Detailed Information About Borrowings (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of detailed information about borrowings [line items]
Borrowings	R$ 12716832	R$ 13822913	R$ 10786374
Current	945,069	3,805,649
Non-current	11,771,763	10,017,264
Debentures Current	350,145	2,169,786
Debentures Non-current	1,572,587	1,872,729
BRL | FINEP [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings	44,193	73,076
BRL | Debentures [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings	1,922,732	4,042,515
BRL | BNDES [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings	0	7,789
BRL | BNDES FINAME [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings	0	15
BRL | Promissory Notes [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings	0	773,949
BRL | Operations The Body Shop [Member] | Working Capital Loan [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings	526,743	500,835
BRL | Operations Avon [Member] | Working Capital Loan [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings	164,491	145,495
BRL | Notes - Avon [Member] | Working Capital Loan [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings	4,255,958	4,033,682
MXN | Operations Mexico [Member] | Working Capital Loan [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings	0	14,453
Local Currency
Disclosure of detailed information about borrowings [line items]
Borrowings	6,914,117	9,591,809
USD | BNDES [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings	0	1,639
USD | Representative debt securities (“Notes”) [member]
Disclosure of detailed information about borrowings [line items]
Borrowings	5,523,287	3,969,226
USD | Resolution [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings	279,428	260,239
Foreign Currency
Disclosure of detailed information about borrowings [line items]
Borrowings	R$ 5802715	R$ 4231104

BORROWING, FINANCING AND DEBE_4

BORROWING, FINANCING AND DEBENTURES - Schedule Of Detailed Information About Borrowings Charges (Detail)	12 Months Ended
	Dec. 31, 2021
Debentures [member] | BRL
Disclosure of detailed information about borrowings [line items]
Borrowings, original currency	Real
Borrowings, maturity	August 2024
Description of borrowing charges	Interest of 112
Description of effective interest rate for borrowings	113.0
Description of guarantees provided for borrowings	None
Working capital loan [member] | British Pounds | Operations The Body Shop [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings, original currency	Pounds
Borrowings, maturity	April 2024
Description of guarantees provided for borrowings	“Corporate” guarantee from the subsidiary Natura Cosméticos until December 2021 and “Aval” guarantee from Natura &Co from January 2022.
Working capital loan [member] | USD | Operations Avon [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings, original currency	Dollar
Borrowings, maturity	March 2023 and March 2043
Description of borrowing charges	Interest of 6.45
Description of effective interest rate for borrowings	Interest of 6.45
Description of guarantees provided for borrowings	None
Representative debt securities (“Notes”) [member] | USD
Disclosure of detailed information about borrowings [line items]
Borrowings, original currency	Dollar
Borrowings, maturity	May 2028
Description of borrowing charges	Interest of 4.125
Description of effective interest rate for borrowings	5.79
Description of guarantees provided for borrowings	“Aval” Guarantee from Natura &Co
Resolution [member] | USD
Disclosure of detailed information about borrowings [line items]
Borrowings, original currency	Dollar
Borrowings, maturity	May 2022
Description of borrowing charges	Sonia + interest 1.1
Description of effective interest rate for borrowings	Sonia + interest <span>1.1</span>
Description of guarantees provided for borrowings	“Aval” Guarantee from subsidiary Indústria e Comércio de Cosméticos Natura Ltda.

BORROWING, FINANCING AND DEBE_5

BORROWING, FINANCING AND DEBENTURES - Schedule of detailed information about borrowings (Parenthetical) (Detail)	12 Months Ended
	Dec. 31, 2021
Disclosure of detailed information about borrowings [line items]
Borrowings effective interest rate	113.00%
Bottom of range [member]
Disclosure of detailed information about borrowings [line items]
Borrowings, effective interest rate basis	CDI + 1.15%
Top of range [member]
Disclosure of detailed information about borrowings [line items]
Borrowings, effective interest rate basis	CDI + 1.30%
Notes maturing March 2023 [member] | USD | Operations Avon [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings, Interest rate basis	Interest of 6.45%
Borrowings, adjustment to interest rate basis	6.45%
Borrowings, effective interest rate basis	Interest of 6.45%
Borrowings, adjustment to effective interest rate basis	6.45%
Notes maturing March 2043 [member] | USD | Operations Avon [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings, Interest rate basis	Interest of 8.45%
Borrowings, adjustment to interest rate basis	8.45%
Borrowings, effective interest rate basis	Interest of 8.45%
Borrowings, adjustment to effective interest rate basis	8.45%
Debentures maturing march 2020 [member] | BRL
Disclosure of detailed information about borrowings [line items]
Annual percentage interest rate	112.00%
Debentures maturing september 2022 [member] | BRL
Disclosure of detailed information about borrowings [line items]
Annual percentage interest rate	1.00%
Borrowings, Interest rate basis	112% of the CDI
Debentures maturing august 2024 [member] | BRL
Disclosure of detailed information about borrowings [line items]
Annual percentage interest rate	1.15%
Working capital loan [member] | British Pounds | Operations The Body Shop [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings, Interest rate basis	2.9</span>% p.a." id="sjs-B35">Sonia + interest &lt;span style="border-left: none; border-right: none;">2.9&lt;/span>% p.a.
Borrowings, effective interest rate basis	<span style="border-left: none; border-right: none;"><span style="border-left: none; border-right: none;">2.9</span></span></span>% p.a." id="sjs-B36">Sonia + interest &lt;span style="border-left: none; border-right: none;">&lt;span style="border-left: none; border-right: none;">&lt;span style="border-left: none; border-right: none;">2.9&lt;/span>&lt;/span>&lt;/span>% p.a.
Borrowings, adjustment to effective interest rate basis	2.90%
Representative debt securities (“Notes”) [member] | USD
Disclosure of detailed information about borrowings [line items]
Annual percentage interest rate	4.125%
Borrowings, Interest rate basis	Interest of 4.125% p.a.
Borrowings, effective interest rate basis	5.79
Resolution no 413162 [member] | USD
Disclosure of detailed information about borrowings [line items]
Annual percentage interest rate	1.10%
Borrowings, Interest rate basis	Sonia + interest 1.1% p.a.

BORROWING, FINANCING AND DEBE_6

BORROWING, FINANCING AND DEBENTURES - Schedule Of Changes In Balances Of Borrowings (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2021		Dec. 31, 2020	Dec. 31, 2019
Disclosure of detailed information about borrowings [line items]
Balance at beginning	R$ 13822913		R$ 10786374
Acquisition of subsidiary			7,250,735
New borrowings and financing	6,425,565	[1]	1,354,765	R$ 5346145
Repayment	(7,989,607)	[2]	(8,483,892)	(2,643,575)
Appropriation of financial charges	661,429		1,029,705
Financial charges payment	(783,935)		(1,293,094)
Exchange variation (unrealized)	252,190		973,442
Exchange variation (realized)			35,429
Translation effects (other comprehensive income)	328,277		2,169,449
Balance at ending	R$ 12716832		R$ 13822913	R$ 10786374
[1]	New borrowing and financing raised within the year ended December 31, 2021 basically refer to the offer carried out by the Company of the notes linked to the sustainability goals in the amount of USD 1 billion, approximately R$ 5.6 billion (see note 20.1 .iv) and the new credit facility in the amount of one hundred million pounds (£ 100 million), approximately R$ 742 million, obtained by subsidiary The Body Shop (see note .iii).
[2]	The repayment made in the year ended December 31, 2021 mainly refer to the early redemption of the Company’s Notes in the amount of USD 750 million (corresponding to roughly R$ 4.0 billion, carried out in May 2021 (see note 20.1 .iii)) and to the settlements of the 2 nd series of the 7 th issue of debentures in the amount of R$ 1,827 million and of the 2 nd series of the 9 th issue of debentures in the amount of R$ 308 million, both carried out in September 2021. In addition, on April 15, 2021, the Company and its subsidiary redeemed the total principal amount due under their respective promissory notes, equivalent to R$ 500,000 of the Company and R$ 250,000 of the subsidiary

BORROWING, FINANCING AND DEBE_7

BORROWING, FINANCING AND DEBENTURES - Schedule of maturity analysis for non-current borrowings (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Disclosure of detailed information about borrowings [line items]
Borrowings, financing and debentures	R$ 11771763	R$ 10017264
2022 [member]
Disclosure of detailed information about borrowings [line items]
Borrowings, financing and debentures	0	586,002
2023 [member]
Disclosure of detailed information about borrowings [line items]
Borrowings, financing and debentures	2,812,260	6,306,782
2024 [member]
Disclosure of detailed information about borrowings [line items]
Borrowings, financing and debentures	2,249,609	3,124,480
2025 onwards [member]
Disclosure of detailed information about borrowings [line items]
Borrowings, financing and debentures	R$ 6709894	R$ 0

BORROWING, FINANCING AND DEBE_8

BORROWING, FINANCING AND DEBENTURES - Schedule Of detailed information about Notes - Avon (Details) R$ in Thousands, $ in Thousands	Dec. 31, 2021BRL (R$)	Dec. 31, 2021USD ($)
Unsecured Debt [Member]
Disclosure of detailed information about borrowings [line items]
Main	R$ 1205862	$ 216,085
Annual percentage interest rate	8.45%	8.45%
Notes 6 Point 5 Percent Due March 15 2023 [Member]
Disclosure of detailed information about borrowings [line items]
Main	R$ 2577538	$ 461,883
Annual percentage interest rate	6.50%	6.50%

BORROWING, FINANCING AND DEBE_9

BORROWING, FINANCING AND DEBENTURES - Additional Information (Detail) £ in Thousands, R$ in Thousands, $ in Thousands, € in Millions

May 21, 2021BRL (R$)

May 21, 2021USD ($)

May 04, 2021BRL (R$)

Apr. 23, 2021GBP (£)

Jul. 22, 2019BRL (R$)sharesDebentures

Sep. 21, 2018BRL (R$)shares

Sep. 28, 2017USD ($)shares

Sep. 30, 2021BRL (R$)

Dec. 31, 2021EUR (€)

Dec. 31, 2021BRL (R$)

Dec. 31, 2021USD ($)

Dec. 31, 2020BRL (R$)

Dec. 31, 2019BRL (R$)

Dec. 31, 2021USD ($)

May 21, 2021USD ($)

May 04, 2021USD ($)

Apr. 23, 2021BRL (R$)

Apr. 15, 2021BRL (R$)

Mar. 31, 2021GBP (£)

Dec. 31, 2020GBP (£)

Dec. 31, 2020BRL (R$)

Disclosure of detailed information about borrowings [line items]

Number Of Debentures Issued | shares

260,000

New borrowings and financing

R$ 6425565

[1]

R$ 1354765

R$ 5346145

Measurement period of earnings before interest, taxes, depreciation, and amortization in financial covenants

12 months

12 months

12 months

Unsecured Debt [Member]

Disclosure of detailed information about borrowings [line items]

Notional Amount

R$ 1205862

$ 216,085

Annual percentage interest rate

8.45%

8.45%

Unsecured Debentures [Member]

Disclosure of detailed information about borrowings [line items]

Notional Amount

R$ 1576450

R$ 1000000

$ 2,600,000

Number Of Debentures Issued

157,645

100,000

Nominal Unit Value

R$ 10

Interest Costs

R$ 3096

R$ 3888

Debt Issuance Cost

6,371

R$ 9466

Unsecured Debentures Due on March 16, 2020 [Member] | Tranche Three [Member]

Disclosure of detailed information about borrowings [line items]

Repayments Of Debentures

92,820

Settlement of debentures

92,820

Unsecured Debentures Due on September 25, 2020 [Member] | Tranche One [Member]

Disclosure of detailed information about borrowings [line items]

Number Of Debentures Issued | shares

77,273

Borrowings Maturity

September 25, 2020

Borrowings Interest Rate Basis

CDI rate + 1.4% p.a.

Repayments Of Debentures

664,090

Settlement of debentures

664,090

Unsecured Debentures Due on September 25, 2021 [Member] | Tranche One [Member]

Disclosure of detailed information about borrowings [line items]

Repayments Of Debentures

382,960

Settlement of debentures

382,960

Unsecured Debentures Due on September 25, 2021 [Member] | Tranche Two [Member]

Disclosure of detailed information about borrowings [line items]

Number Of Debentures Issued | shares

182,727

Borrowings Maturity

September 25, 2021

Borrowings Interest Rate Basis

CDI rate + 1.75% p.a.

Unsecured Debentures Due August 14, 2019 [Member]

Disclosure of detailed information about borrowings [line items]

Repayments Of Debentures

400,000

Amortization Of Borrowings

R$ 1000000000

Settlement of debentures

400,000

Unsecured Debentures Due September 21, 2020 [Member] | Tranche One [Member]

Disclosure of detailed information about borrowings [line items]

Number Of Debentures Issued | shares

38,904

Borrowings Adjustment To Interest Rate Basis

109.50%

Borrowings Maturity

September 21, 2020

Unsecured Debentures Due September 21, 2021 [Member]

Disclosure of detailed information about borrowings [line items]

Repayments Of Debentures

R$ 308000

Settlement of debentures

308,000

Unsecured Debentures Due September 21, 2021 [Member] | Tranche Two [Member]

Disclosure of detailed information about borrowings [line items]

Number Of Debentures Issued | shares

30,831

Borrowings Adjustment To Interest Rate Basis

110.50%

Borrowings Maturity

September 21, 2021

Unsecured Debentures Due September 21, 2022 [Member] | Tranche Three [Member]

Disclosure of detailed information about borrowings [line items]

Number Of Debentures Issued | shares

30,265

Borrowings Adjustment To Interest Rate Basis

112.00%

Borrowings Maturity

September 21, 2022

Unsecured Debentures Due September 28, 2021 [Member]

Disclosure of detailed information about borrowings [line items]

Repayments Of Debentures

1,827

1,827,000

Settlement of debentures

R$ 1827

1,827,000

Unsecured Debentures Due August 26, 2024 [Member] | Tranche One [Member]

Disclosure of detailed information about borrowings [line items]

Number Of Debentures Issued | shares

40,000

Borrowings Adjustment To Interest Rate Basis

1.00%

Borrowings Maturity

August 26, 2024

Borrowings Interest Rate Basis

100% of the cumulative variation of the Brazilian Interbank Deposits (“DI”) average daily rates plus 1%

Unsecured Debentures Due August 26, 2024 [Member] | Tranche Two [Member]

Disclosure of detailed information about borrowings [line items]

Number Of Debentures Issued | shares

9,570

Borrowings Adjustment To Interest Rate Basis

1.15%

Borrowings Maturity

August 26, 2024

Borrowings Interest Rate Basis

100% of the cumulative variation of the Brazilian Interbank Deposits (“DI”) average daily rates plus 1.15%

Unsecured Debentures Due August 26, 2024 [Member] | Tranche Three [Member]

Disclosure of detailed information about borrowings [line items]

Number Of Debentures Issued | shares

68,623

Borrowings Adjustment To Interest Rate Basis

1.15%

Borrowings Maturity

August 26, 2024

Borrowings Interest Rate Basis

100% of the cumulative variation of the Brazilian Interbank Deposits (“DI”) average daily rates plus 1.15%

Unsecured Debentures Due August 26, 2024 [Member] | Tranche Four [Member]

Disclosure of detailed information about borrowings [line items]

Number Of Debentures Issued | shares

39,452

Borrowings Adjustment To Interest Rate Basis

1.15%

Borrowings Maturity

August 26, 2024

Borrowings Interest Rate Basis

100% of the cumulative variation of the Brazilian Interbank Deposits (“DI”) average daily rates plus 1.15%

Promissory notes [member]

Disclosure of detailed information about borrowings [line items]

Notional Amount

R$ 500000

Promissory notes [member] | Tranche One [Member] | Series One [Member]

Disclosure of detailed information about borrowings [line items]

Repayments Of Debentures

R$ 4000000

$ 750,000

Settlement of debentures

4,000,000

$ 750,000

Promissory notes [member] | Natura Cosmticos SA [Member]

Disclosure of detailed information about borrowings [line items]

Notional Amount

R$ 4000000

$ 750,000

R$ 250000

Working capital loan [member] | Operations The Body Shop [Member]

Disclosure of detailed information about borrowings [line items]

Line of Credit Facility, Maximum Borrowing Capacity

£ 100,000

R$ 742000

£ 70,000

£ 70,000

R$ 500835

Borrowings Interest Rate Basis

Sonia rate + 2.9% per annum

Sonia + 2%

New borrowings and financing

€ 100

742,000

ESG debt securities (“Notes ESG”)

Disclosure of detailed information about borrowings [line items]

New borrowings and financing

5,600,000

$ 1,000,000

ESG debt securities (“Notes ESG”) | Natura Cosmticos SA [Member]

Disclosure of detailed information about borrowings [line items]

Notional Amount

R$ 5600000

$ 1,000,000

Borrowings Maturity

May 3, 2028

Notes Issuance Costs

9,777

Deferred Notes Issuance Costs

R$ 94300

Annual percentage interest rate

4.125%

4.125%

Target Percentage Of Reduction In Greenhouse Gas Emission

13.00%

13.00%

13.00%

Target Percentage Of Recycledplastic Use In Packaging

25.00%

25.00%

25.00%

[1]

New borrowing and financing raised within the year ended December 31, 2021 basically refer to the offer carried out by the Company of the notes linked to the sustainability goals in the amount of USD 1 billion, approximately R$ 5.6 billion (see note 20.1 .iv) and the new credit facility in the amount of one hundred million pounds (£ 100 million), approximately R$ 742 million, obtained by subsidiary The Body Shop (see note .iii).

TRADE PAYABLE AND REVERSE FAC_3

TRADE PAYABLE AND REVERSE FACTORING OPERATIONS (Details) - BRL (R$) R$ in Thousands		Dec. 31, 2021	Dec. 31, 2020
Trade Payables And Reverse Factoring Operations [Line Items]
Trade and other payables		R$ 6400269	R$ 6476733
Reverse factoring operations	[1]	370,310	297,472
Trade payables		6,770,579	6,774,205
Domestic trade payable [Member]
Trade Payables And Reverse Factoring Operations [Line Items]
Trade and other payables		5,296,080	5,462,377
Foreign trade payable [Member]
Trade Payables And Reverse Factoring Operations [Line Items]
Trade and other payables	[2]	R$ 1104189	R$ 1014356
[1]	The Company has contracts signed with Banco S.A. to directly structure a reverse factoring operation with the Company’s main suppliers. Further details on these operations are included in note 3.6.2.
[2]	Refers to imports mainly denominated in US dollars, Euros and British pounds.

TAX LIABILITIES - Schedule of d

TAX LIABILITIES - Schedule of detailed information about tax liabilities (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2021	Dec. 31, 2020
Dislosure Of Tax Liabilities [Line Items]
ICMS (ordinary)		R$ 150396	R$ 134165
ICMS-ST provision	[1]	58,188	61,521
Taxes on invoicing abroad		340,648	364,291
Withholding tax (IRRF)		148,081	131,368
Other taxes payable - foreign subsidiaries		138,461	136,232
Income tax		7,062	15,943
PIS and COFINS payable		144	11,857
INSS and service tax (ISS) payable		29,359	32,954
Others		8,888	6,490
Total		881,227	894,821
Current		766,430	785,367
Noncurrent		R$ 114797	R$ 109454
[1]	The Company has discussions about the illegality of changes in state laws to charge ICMS-ST. Part of the amount recorded as tax payable but not yet paid is being discussed in court by Company, and in some cases, the amounts are deposited in court, as mentioned in note 13.

PROVISION FOR TAX, CIVIL AND _3

PROVISION FOR TAX, CIVIL AND LABOR RISKS - Schedule of detailed information about other provisions (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020
Tax, civil and labor provision and contingent liabilities
Balance at the beginning of the year		R$ 2200177	R$ 220066
Acquisition of subsidiary	[1]		1,757,940
Additions		319,805	553,456
Reversals	[2]	(386,718)	(205,893)
Payments		(132,784)	(221,429)
Inflation adjustment		25,731	37,966
Exchange rate variation		(26,403)	156,539
Transfers	[3]	(967)	(98,468)
Balance as of the end of the year		1,998,841	2,200,177
Current		230,097	199,733
Non-current		1,768,744	2,000,444
Business Combination
Tax, civil and labor provision and contingent liabilities
Balance at the beginning of the year		797,693
Acquisition of subsidiary	[1]		820,103
Additions		22	9,772
Reversals	[2]	(195,070)	(67,482)
Payments
Inflation adjustment		10,450	21,671
Exchange rate variation		(15,466)	13,629
Transfers	[3]
Balance as of the end of the year		597,585	797,693
Amounts arising from lawsuits with probability of possible and remote loss		872,993
Tax
Tax, civil and labor provision and contingent liabilities
Balance at the beginning of the year		931,771	127,842
Acquisition of subsidiary	[1]		671,667
Additions		47,116	169,824
Reversals	[2]	(78,488)	(71,797)
Payments		(4,965)	(54,590)
Inflation adjustment		4,698	5,623
Exchange rate variation		(25,609)	83,202
Transfers	[3]	(12,429)
Balance as of the end of the year		862,094	931,771
Amounts arising from lawsuits with probability of possible and remote loss		709,751
Civil
Tax, civil and labor provision and contingent liabilities
Balance at the beginning of the year		219,374	30,653
Acquisition of subsidiary	[1]		102,208
Additions		181,856	329,294
Reversals	[2]	(35,433)	(62,013)
Payments		(88,266)	(118,047)
Inflation adjustment		2,723	4,164
Exchange rate variation		12,471	32,424
Transfers	[3]	(12,965)	(99,309)
Balance as of the end of the year		305,690	219,374
Amounts arising from lawsuits with probability of possible and remote loss		119,572
Labour
Tax, civil and labor provision and contingent liabilities
Balance at the beginning of the year		251,339	61,571
Acquisition of subsidiary	[1]		163,962
Additions		90,855	44,566
Reversals	[2]	(77,727)	(4,601)
Payments		(39,553)	(48,792)
Inflation adjustment		7,860	6,508
Exchange rate variation		2,201	27,284
Transfers	[3]	(1,503)	841
Balance as of the end of the year		233,472	R$ 251339
Amounts arising from lawsuits with probability of possible and remote loss		R$ 55624
[1]	Amounts arising from tax, labor and civil lawsuits with probability of possible and remote loss in the amount of R$709,751, R$55,624 and R$119,572, respectively, measured and recorded at the estimated fair value resulting from the business combination with Avon, in accordance with paragraph 23 of CPC 15/IFRS 3, additionally, the fair value of contingent liabilities includes liabilities assumed and recognized by Avon prior to the allocation of fair value, in the amount of R$872,993.
[2]	Reversals mainly refer to adhesion to state tax amnesty programs and change of labor proceedings estimates.
[3]	Amounts related to the 2020 period resulted from other liabilities of subsidiary Avon related to proceedings previously recognized as contingent liabilities being reclassified as other trade accounts payable.

PROVISION FOR TAX, CIVIL AND _4

PROVISION FOR TAX, CIVIL AND LABOR RISKS - Schedule of contingencies assessed as possible risk of loss (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Tax, civil and labor provision and contingent liabilities
Contingencies assessed as possible risk of loss	R$ 10193858	R$ 9559551
Tax
Tax, civil and labor provision and contingent liabilities
Contingencies assessed as possible risk of loss	9,884,541	9,205,601
Civil
Tax, civil and labor provision and contingent liabilities
Contingencies assessed as possible risk of loss	128,479	133,302
Labour
Tax, civil and labor provision and contingent liabilities
Contingencies assessed as possible risk of loss	R$ 180838	R$ 220648

PROVISION FOR TAX, CIVIL AND _5

PROVISION FOR TAX, CIVIL AND LABOR RISKS - Contingent liabilities additional information (Detail 2) R$ in Thousands	12 Months Ended
	Dec. 31, 2021BRL (R$)Number	Dec. 31, 2020BRL (R$)
Disclosure of contingent liabilities [line items]
Contingencies assessed as possible risk of loss	R$ 10193858	R$ 9559551
Contingencies resulting from the business combinations	597,585	797,693
Tax incentives recognized from tax exclusions	R$ 135297
Avon [member]
Disclosure of contingent liabilities [line items]
Settlement amount to be paid by entity		75,352
Civil, commercial and other lawsuits [member] | Avon [member]
Disclosure of contingent liabilities [line items]
Number of pending individual cases | Number	151
Number of new proceedings filed | Number	107
Number of cases dismissed, settled or otherwise resolved | Number	120
Settlement amount		10,393
IPI tax debts, due to the alleged non-observance of the minimum tax base [member] | Tax Contingency [member]
Disclosure of contingent liabilities [line items]
Contingencies assessed as possible risk of loss	R$ 2009562	1,963,984
Related to Decree nº 8.393/2015 [member] | Tax Contingency [member]
Disclosure of contingent liabilities [line items]
Contingencies assessed as possible risk of loss	1,907,246	1,660,532
Related to Collection of ICMS and ICMS-ST [member] | Tax Contingency [member]
Disclosure of contingent liabilities [line items]
Contingencies assessed as possible risk of loss	1,560,023	1,503,657
Related to IRPJ and CSLL tax debts [member] | Tax Contingency [member]
Disclosure of contingent liabilities [line items]
Contingencies assessed as possible risk of loss	1,419,237	1,396,782
Related to collection of ICMS-ST by Finance Department of the São Paulo Federal State [member] | Tax Contingency [member]
Disclosure of contingent liabilities [line items]
Contingencies assessed as possible risk of loss	539,561	529,660
IPI tax debts for disagreeing with the tax classification [member] | Tax Contingency [member]
Disclosure of contingent liabilities [line items]
Contingencies assessed as possible risk of loss	R$ 662991	R$ 524500

OTHER LIABILITIES - Schedule of

OTHER LIABILITIES - Schedule of detailed information about other liabilities (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2021	Dec. 31, 2020
Disclosure Of Other Liabilities [Abstract]
Pension and post-employment health care plans	[1]	R$ 673458	R$ 783184
Deferred revenue from performance obligations with customers	[2]	393,046	422,353
Provisions for incentives to consultants		286,791	292,034
Provisions for operating expenses (marketing / technology, etc.)	[3]	601,841	535,276
Provision for store renovation		105,165	99,702
Crer para Ver	[4]	90,655	75,508
Provisions for rentals	[5]	55,500	70,598
Provision for restructuring	[6]	103,760	68,954
Long-term incentives	[7]	6,302	52,745
Insurance payables		127,413	159,094
Other Liabilities	[8]	214,635	245,526
Total		2,658,566	2,804,973
Current		1,716,110	1,691,834
Non-current		R$ 942456	R$ 1113139
[1]	As of December 31, 2021, there is R$445,804 (R$609,691 as of December 31, 2020) related to Avon's pension plans, and R$34,774 (R$39,029 as of December 31, 2020) related to post-employment plans of subsidiary Avon, and R$124,649 (R$134,194 as of December 31, 2020) related to post-employment healthcare plans of subsidiary Natura Cosmeticos and R$68,230 as of December 31, 2021 related to post-employment healthcare plans of subsidiary &Co International.
[2]	Refers to the deferral of revenue of performance obligations related to loyalty programs based on points, sale of gift cards not yet converted into products and programs and events to honor direct selling consultants, of which R$235,308 (R$318,686 as of December 31, 2020) related to subsidiary Avon, R$121,341 (R$103,667 as of December 31, 2020) related to subsidiary consolidated and R$36,397 related to subsidiary & Co International.
[3]	Refers to the Company’s operating provisions mainly due to spending on provision of technology services, marketing and advertising.
[4]	Refers to Social program contribution for developing the quality of education.
[5]	Refers to the (grace) period granted by lessors for the start of payment of rental of certain retail stores, for rental agreements that were not included in the initial measurement of lease liabilities / right of use of the subsidiary The Body Shop, in accordance with the exceptions permitted under IFRS 16 / (CPC 06 (R2)).
[6]	Provision for costs directly related to the plan for integration and changes in the organizational structure, mainly of subsidiary Avon organizational structure.
[7]	Refers substantially to the variable remuneration plans for subsidiary Avon executive officers.
[8]	Refers to several provisions such as indemnities and long-term contractual obligations.

OTHER LIABILITIES - Schedule _2

OTHER LIABILITIES - Schedule of change in actuarial liabilities (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Disclosure of defined benefit plans [line items]
Balance at the beginning of the year	R$ 134194	R$ 98792
Interest cost - recognized in the income statement	(9,326)	(7,223)
Company contributions	(2,679)	(2,069)
Actuarial gain (loss) in OCI	17,131	(29,628)
Balance at end of year	124,649	134,194
Avon [member] | Pension Plan [member]
Disclosure of defined benefit plans [line items]
Balance at the beginning of the year	609,961	413,070
Cost of services - current	24,660	28,015
Interest cost - recognized in the income statement	10,934	13,760
Administrative costs	2,698	2,476
Company contributions	(49,516)	(17,212)
Benefits paid	(6,413)	(4,611)
Actuarial gain (loss) in OCI	(99,991)	74,460
Reclassifications	18,045	(14,451)
Others	(72,252)	(2,814)
Foreign currency changes	7,678	117,268
Balance at end of year	R$ 445804	R$ 609961

OTHER LIABILITIES - Schedule _3

OTHER LIABILITIES - Schedule of significant actuarial assumptions for the determination of the actuarial liability (Details) - Avon [member] - Pension Plan [member]	Dec. 31, 2021	Dec. 31, 2020
Bottom of range [member]
Disclosure of defined benefit plans [line items]
Discount rate	0.65%	0.30%
Rate of compensation increase	1.80%	1.80%
Top of range [member]
Disclosure of defined benefit plans [line items]
Discount rate	9.20%	8.50%
Rate of compensation increase	6.60%	6.60%

OTHER LIABILITIES - Schedule _4

OTHER LIABILITIES - Schedule of fair values of each major class of plan assets (Details) - Avon [member] - Pension Plan [member] - BRL (R$) R$ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Disclosure of defined benefit plans [line items]
Cash and cash equivalent	R$ 191958	R$ 173563
Equity instruments of other entities	1,066,370	918,222
Government bonds	1,482,650	2,633,587
Corporate bonds	1,802,394	525,886
Real estate	12,834	8,314
Other	12,276	10,393
Total	R$ 4568482	R$ 4269965

OTHER LIABILITIES - Schedule _5

OTHER LIABILITIES - Schedule of detailed information about actuarial liabilities computation (Detail) - Natura Cosmticos SA [Member]	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Disclosure of defined benefit plans [line items]
Discount rate	9.01%	7.02%
Initial growth rate of medical cost	4.25%	3.75%
Inflation rate	3.40%	3.10%
Final growth rate of medical cost	7.79%	6.97%
Growth rate of medical costs by aging - contributions	0.00%	0.00%
Schedule of disabled mortality	Mercer Disability	Mercer Disability
Schedule of mortality	2000</span>" id="sjs-B10">AT-&lt;span style="border-left: none; border-right: none;">2000&lt;/span>	2000</span>" id="sjs-C10">AT-&lt;span style="border-left: none; border-right: none;">2000&lt;/span>
Schedule of turnover	Proportional calculation at the time of service	Proportional calculation at the time of service
Bottom of range [member]
Disclosure of defined benefit plans [line items]
Growth rate of medical costs due to aging - costs	1.25%	1.25%
Top of range [member]
Disclosure of defined benefit plans [line items]
Growth rate of medical costs due to aging - costs	4.75%	4.75%
Bradesco Plan [Member] | Bottom of range [member]
Disclosure of defined benefit plans [line items]
Percentage of adherence to the plan in retirement	60.00%	69.00%
Unimed Plan [Member] | Top of range [member]
Disclosure of defined benefit plans [line items]
Percentage of adherence to the plan in retirement	85.00%	84.00%

OTHER LIABILITIES - Schedule _6

OTHER LIABILITIES - Schedule of detailed information about sensitivity analysis for actuarial assumptions (Detail) - Natura Cosmticos SA [Member] R$ in Thousands	Dec. 31, 2021BRL (R$)
Discount rate [member]
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Increased Actuarial Assumption Percentage	9.01%
Percentage of reasonably possible increase in actuarial assumption	0.50%
Increase (decrease) in defined benefit obligation due to reasonably possible increase in actuarial assumption	R$ 105731
Decreased Actuarial Assumption Percentage	9.01%
Percentage of reasonably possible decrease in actuarial assumption	0.50%
Increase (decrease) in defined benefit obligation due to reasonably possible decrease in actuarial assumption	R$ 148971
Rate of compensation
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Increased Actuarial Assumption Percentage	7.79%
Percentage of reasonably possible increase in actuarial assumption	1.00%
Increase (decrease) in defined benefit obligation due to reasonably possible increase in actuarial assumption	R$ 148175
Decreased Actuarial Assumption Percentage	7.79%
Percentage of reasonably possible decrease in actuarial assumption	1.00%
Increase (decrease) in defined benefit obligation due to reasonably possible decrease in actuarial assumption	R$ 105933

OTHER LIABILITIES - Schedule _7

OTHER LIABILITIES - Schedule of detailed information about movements of actuarial liabilities (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Disclosure of defined benefit plans [line items]
Balance at the beginning of the year	R$ 134194	R$ 98792
Cost of interest	9,326	7,223
Expenses paid	(2,679)	(2,069)
Actuarial gains (losses) in OCI	(17,131)	29,628
Balance at end of year	124,649	134,194
Natura Cosmticos SA [Member]
Disclosure of defined benefit plans [line items]
Cost of the current service of subsidiary Natura Cosméticos	R$ 939	R$ 620

OTHER LIABILITIES - Additional

OTHER LIABILITIES - Additional Information (Detail) R$ in Thousands		12 Months Ended
		Dec. 31, 2021BRL (R$)Employees	Dec. 31, 2020BRL (R$)Employees
Disclosure Of Other Liabilities [Line Items]
Pension and post-employment health care plans	[1]	R$ 673458	R$ 783184
Deferred revenue from performance obligations with customers	[2]	393,046	422,353
Post-retirement benefits [member]
Disclosure Of Other Liabilities [Line Items]
Pension and post-employment health care plans		34,774	39,029
Avon [member]
Disclosure Of Other Liabilities [Line Items]
Deferred revenue from performance obligations with customers		235,308	318,686
Avon [member] | Pension Plan [member]
Disclosure Of Other Liabilities [Line Items]
Pension and post-employment health care plans		445,804	609,691
Natura Cosmticos SA [Member]
Disclosure Of Other Liabilities [Line Items]
Deferred revenue from performance obligations with customers		R$ 121341	R$ 103667
Weighted average of life expectancy after retirement		20 years	19 years 9 months 18 days
Number of active employees | Employees		993	1,064
Number of retired and dependent employees. | Employees		473	537
Actuarial assumption of initial level of growth in medical cost.		4.25%
Actuarial gains (loss)		R$ 28254
Natura Cosmticos SA [Member] | Bottom of range [member]
Disclosure Of Other Liabilities [Line Items]
Actuarial assumption of discount rates		7.02%
Natura Cosmticos SA [Member] | Top of range [member]
Disclosure Of Other Liabilities [Line Items]
Actuarial assumption of discount rates		9.01%
Natura Cosmetics [Member] | Post-retirement benefits [member]
Disclosure Of Other Liabilities [Line Items]
Pension and post-employment health care plans		R$ 124649	R$ 134194
Natura &Co International S.à r.l.
Disclosure Of Other Liabilities [Line Items]
Deferred revenue from performance obligations with customers		36,397
Natura &Co International S.à r.l. | Post-retirement benefits [member]
Disclosure Of Other Liabilities [Line Items]
Pension and post-employment health care plans		R$ 68230
[1]	As of December 31, 2021, there is R$445,804 (R$609,691 as of December 31, 2020) related to Avon's pension plans, and R$34,774 (R$39,029 as of December 31, 2020) related to post-employment plans of subsidiary Avon, and R$124,649 (R$134,194 as of December 31, 2020) related to post-employment healthcare plans of subsidiary Natura Cosmeticos and R$68,230 as of December 31, 2021 related to post-employment healthcare plans of subsidiary &Co International.
[2]	Refers to the deferral of revenue of performance obligations related to loyalty programs based on points, sale of gift cards not yet converted into products and programs and events to honor direct selling consultants, of which R$235,308 (R$318,686 as of December 31, 2020) related to subsidiary Avon, R$121,341 (R$103,667 as of December 31, 2020) related to subsidiary consolidated and R$36,397 related to subsidiary & Co International.

SHAREHOLDER'S EQUITY - Schedule

SHAREHOLDER'S EQUITY - Schedule of changes in treasury shares (Detail) R$ / shares in Units, R$ in Thousands	12 Months Ended
	Dec. 31, 2021BRL (R$)R$ / sharesshares
Disclosure of classes of share capital [line items]
Balance at beginning of period | R$	R$ 11667
Balance at end of period | R$	R$ 151342
Bottom of range [member]
Disclosure of classes of share capital [line items]
Average price per share, outstanding at end of period | R$ / shares	R$ 25.74
Top of range [member]
Disclosure of classes of share capital [line items]
Average price per share, outstanding at beginning of period | R$ / shares	R$ 50.93
Treasury shares [member]
Disclosure of classes of share capital [line items]
Balance at beginning of period | R$	R$ 11667
Initial share capital (in shares) | shares	316,701
Average price per share, outstanding at beginning of period | R$ / shares	R$ 38.04
Used | R$	R$ 34438
Used (in shares) | shares	(754,719)
Average price per share, issued | R$ / shares	R$ 45.63
Share repurchase | R$	R$ 174113
Acquisition (in shares) | shares	5,337,558
Average price per share, purchased | R$ / shares	R$ 32.62
Balance at end of period | R$	R$ 151342
Total shares capital subscribed and paid-up (in shares) | shares	4,899,540
Average price per share, outstanding at end of period | R$ / shares	R$ 30.89

SHAREHOLDER'S EQUITY - Addition

SHAREHOLDER'S EQUITY - Additional Information (Detail) - BRL (R$) R$ / shares in Units, R$ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statements [Line Items]
Issued capital		R$ 12481683	R$ 12377999
Capital reserve		R$ 10478804	R$ 11052135
Dividend Rate		30.00%
Nominal common shares		1,379,584,737	1,375,158,636
Dividends declared and not yet distributed		R$ 180772
Dividends declared and not yet distributed, per share		R$ 0.1315
Portion of minimum mandatory dividends		R$ 133616
Hyperinflationary economy adjustment effect			R$ 66788	R$ 59818
Profit reserve related to retained earnings		871,223	120,166
Capital reserve [member]
Statements [Line Items]
Constitution of profit retention reserve	R$ 2000000	650,196	52,041
Increase (decrease) in equity	R$ 1118	52,041	(147,592)
Increase (decrease) through other changes, equity		76,865	58,496
Profit Reserve [Member]
Statements [Line Items]
Constitution of profit retention reserve		870,749
Increase (decrease) in equity		751,057	R$ 269186
Movement of stock option plans and restricted shares		(6,390)
Reclassification of subvention reserve		(113,302)
Natura Cosmetics [Member]
Statements [Line Items]
Total subscription price		13,274,894
Issued capital		3,397,746
Capital reserve		R$ 9877148

OPERATING SEGMENTS (Detail)

OPERATING SEGMENTS (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of operating segments [line items]
Financial revenue		R$ 40164687	R$ 36921980	R$ 14444690
Performance Assessed By Company		3,909,753	3,365,339	2,468,664
Depreciation and amortization		(2,791,523)	(2,718,856)	(1,117,416)
Financial income		4,006,563	4,738,391	1,955,784
Financial expenses		(5,033,540)	(5,773,810)	(2,795,874)
Income tax		1,047,986	(274,744)	(355,691)
Net income (loss)		1,040,689	(663,678)	155,467
Natura &Co LATAM
Disclosure of operating segments [line items]
Financial revenue		22,413,401	20,542,345	9,113,856
Performance Assessed By Company		2,595,653	2,369,517	1,372,172
Depreciation and amortization		(871,973)	(874,584)	(370,953)
Financial income		3,181,237	3,402,578	1,893,333
Financial expenses		(3,881,418)	(3,891,641)	(2,613,294)
Income tax		165,137	(428,191)	41,623
Net income (loss)		1,188,636	577,679	322,880
Avon International [member]
Disclosure of operating segments [line items]
Financial revenue	[1]	9,329,325	9,097,375
Performance Assessed By Company	[1]	272,655	185,914
Depreciation and amortization	[1]	(830,931)	(814,678)
Financial income	[1]	421,123	979,267
Financial expenses	[1]	(894,318)	(1,442,216)
Income tax	[1]	210,705	(121,603)
Net income (loss)	[1]	(919,316)	(1,213,315)
The Body Shop
Disclosure of operating segments [line items]
Financial revenue	[1]	5,821,776	5,332,922	4,028,660
Performance Assessed By Company	[1]	1,023,095	935,255	806,357
Depreciation and amortization	[1]	(795,127)	(761,224)	(559,921)
Financial income	[1]	63,939	82,736	44,953
Financial expenses	[1]	(137,834)	(157,705)	(99,765)
Income tax	[1]	(158,973)	(66,626)	(37,736)
Net income (loss)	[1]	(4,900)	32,436	153,888
Aesop [Member]
Disclosure of operating segments [line items]
Financial revenue	[1]	2,600,185	1,949,338	1,302,174
Performance Assessed By Company	[1]	622,944	606,544	351,944
Depreciation and amortization	[1]	(293,492)	(268,092)	(186,542)
Financial income	[1]	30,380	23,152	9,337
Financial expenses	[1]	(75,372)	(72,056)	(34,204)
Income tax	[1]	(90,277)	(55,219)	(47,768)
Net income (loss)	[1]	194,183	234,328	92,768
Corporate expenses [Member]
Disclosure of operating segments [line items]
Financial revenue
Performance Assessed By Company		(604,594)	(731,889)	(61,809)
Depreciation and amortization			(278)
Financial income		309,884	250,658	8,161
Financial expenses		(44,598)	(210,192)	(48,611)
Income tax		921,394	396,895	(311,810)
Net income (loss)		R$ 582086	R$ 294806	R$ 414069
[1]	The operations of these segments located in Latin American countries (Latam) are presented in the Natura &Co Latam segment.

OPERATING SEGMENTS - Summary of

OPERATING SEGMENTS - Summary of operating segments of assets and liabilities (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure Of Operating Segments Of Assets And Liabilities [Line Items]
Non-current assets		R$ 42998613	R$ 42182777	R$ 11754455
Total assets		60,448,490	60,917,597	21,184,512
Current liabilities		13,693,877	16,159,586	7,518,423
Non-current liabilities		18,187,888	17,370,903	10,303,744
Natura &Co Latam [Member]
Disclosure Of Operating Segments Of Assets And Liabilities [Line Items]
Non-current assets		18,060,879	20,228,016	4,574,087
Total assets		29,580,551	30,706,123	9,328,858
Current liabilities		7,462,550	9,349,461	3,116,454
Non-current liabilities		8,794,843	9,060,600	8,235,678
Avon International [member]
Disclosure Of Operating Segments Of Assets And Liabilities [Line Items]
Non-current assets	[1]	14,286,498	12,486,733
Total assets	[1]	17,512,750	16,036,743
Current liabilities	[1]	2,783,907	3,467,099
Non-current liabilities	[1]	5,100,109	5,625,774
The Body Shop [Member]
Disclosure Of Operating Segments Of Assets And Liabilities [Line Items]
Non-current assets	[1]	8,166,363	7,821,884	6,146,960
Total assets	[1]	10,813,064	10,474,191	7,369,250
Current liabilities	[1]	1,690,622	2,291,459	1,065,447
Non-current liabilities	[1]	2,485,200	1,812,991	1,477,149
Aesop International [member]
Disclosure Of Operating Segments Of Assets And Liabilities [Line Items]
Non-current assets	[1]	1,520,514	1,395,628	1,033,408
Total assets	[1]	2,542,125	2,148,869	1,435,830
Current liabilities	[1]	610,451	488,662	255,616
Non-current liabilities	[1]	648,695	618,531	590,917
Corporate expenses [Member]
Disclosure Of Operating Segments Of Assets And Liabilities [Line Items]
Non-current assets		964,359	250,516
Total assets			1,551,671	3,050,574
Current liabilities		1,146,347	562,905	3,080,906
Non-current liabilities		R$ 1159041	R$ 253007
[1]	The operations of these segments located in Latin American countries (Latam) are presented in the Natura &Co Latam segment.

OPERATING SEGMENTS - Summary _2

OPERATING SEGMENTS - Summary of revenue and assets by geographical area wise (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure Of Revenue And Assets By Geographical Area Wise [Line Items]
NET REVENUE	R$ 40164687	R$ 36921980	R$ 14444690
Non-current assets	42,998,613	42,182,777	11,754,455
Asia [Member]
Disclosure Of Revenue And Assets By Geographical Area Wise [Line Items]
NET REVENUE	3,719,131	2,929,063	782,940
Non-current assets	1,216,942	768,878
North America [Member]
Disclosure Of Revenue And Assets By Geographical Area Wise [Line Items]
NET REVENUE	6,227,104	5,120,953	1,750,957
Non-current assets	6,459,026	5,939,728
Mexico [Member]
Disclosure Of Revenue And Assets By Geographical Area Wise [Line Items]
NET REVENUE	3,879,033	3,205,609	767,361
Non-current assets	3,640,644	3,263,833
Other [Member]
Disclosure Of Revenue And Assets By Geographical Area Wise [Line Items]
NET REVENUE	2,348,070	1,915,344	983,596
Non-current assets	2,818,382	2,675,896
South America [Member]
Disclosure Of Revenue And Assets By Geographical Area Wise [Line Items]
NET REVENUE	17,436,131	16,484,363	8,340,025
Non-current assets	14,250,548	14,810,020
Brazil [Member]
Disclosure Of Revenue And Assets By Geographical Area Wise [Line Items]
NET REVENUE	10,481,869	11,113,810	6,324,227
Non-current assets	11,953,325	12,159,245
Argentina [Member]
Disclosure Of Revenue And Assets By Geographical Area Wise [Line Items]
NET REVENUE	2,973,638	1,999,461	794,749
Non-current assets	1,036,205	1,041,392
Other [Member]
Disclosure Of Revenue And Assets By Geographical Area Wise [Line Items]
NET REVENUE	3,980,624	3,371,092	1,221,049
Non-current assets	1,261,018	1,609,383
Europe [Member]
Disclosure Of Revenue And Assets By Geographical Area Wise [Line Items]
NET REVENUE	11,771,601	11,580,586	2,909,968
Non-current assets	19,276,178	19,615,198
United Kingdom [Member]
Disclosure Of Revenue And Assets By Geographical Area Wise [Line Items]
NET REVENUE	4,187,200	4,117,699	2,115,385
Non-current assets	12,162,597	17,059,017
Other [Member]
Disclosure Of Revenue And Assets By Geographical Area Wise [Line Items]
NET REVENUE	7,584,402	7,462,887	794,583
Non-current assets	7,113,581	2,556,181
Oceania [Member]
Disclosure Of Revenue And Assets By Geographical Area Wise [Line Items]
NET REVENUE	1,010,721	807,015	R$ 660800
Non-current assets	R$ 1795919	R$ 1048953

OPERATING SEGMENTS - Additional

OPERATING SEGMENTS - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2021Customer
Major Customer [Member] | Foreign countries [member]
Statement [Line Items]
Number of major customers	0
Benchmark for major customer	10.00%
Natura &Co LATAM
Statement [Line Items]
Percentage of entity's revenue	55.80%
Avon International [member]
Statement [Line Items]
Percentage of entity's revenue	23.20%
The Body Shop
Statement [Line Items]
Percentage of entity's revenue	14.50%
Aesop International [member]
Statement [Line Items]
Percentage of entity's revenue	6.50%

NET REVENUE - Summary of Revenu

NET REVENUE - Summary of Revenue by Geographical Area Wise (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Revenue:
Gross revenue	R$ 51642876	R$ 47697618	R$ 19708104
Returns and cancellations	(644,693)	(617,140)	(73,183)
Commercial discounts and rebates	(1,238,667)	(1,062,204)	(1,292,134)
Taxes on sales	(9,594,829)	(9,096,294)	(3,898,097)
Subtotal	(11,478,189)	(10,775,638)	(5,263,414)
Total net revenue	40,164,687	36,921,980	14,444,690
Domestic market [member]
Revenue:
Gross revenue	14,329,931	15,373,742	8,907,766
Foreign market [member]
Revenue:
Gross revenue	36,894,728	31,784,934	10,739,036
Other sales [member]
Revenue:
Gross revenue	R$ 418217	R$ 538942	R$ 61302

OPERATING INCOME (EXPENSES) A_3

OPERATING INCOME (EXPENSES) AND COST OF SALES - Summary of operating income (expenses) and cost of sales classified by function and nature (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Classified by function
Cost of sales	R$ 14011525	R$ 13229715	R$ 4033454
Selling, marketing and logistics expenses	16,999,225	15,702,787	6,395,586
Administrative, R&D, IT, and project expenses	6,958,866	5,955,996	2,405,576
Total	37,969,616	34,888,498	12,834,616
Classified by nature
Employee benefits expense (note 29)	8,002,608	7,334,696	3,184,162
Depreciation and amortization	2,791,523	2,718,856	1,117,416
Impairment	(304)	(2,051)
Total	37,969,616	34,888,498	12,834,616
Cost of sales [member]
Classified by nature
Raw material/packaging material/resale	12,115,805	11,222,801	3,457,481
Employee benefits expense (note 29)	568,936	638,525	293,374
Depreciation and amortization	254,476	215,355	57,443
Other	1,072,308	1,153,034	225,156
Selling, marketing and logistics expenses [member]
Classified by nature
Logistics costs	2,654,546	2,479,156	797,055
Employee benefits expense (note 29)	4,547,391	4,198,147	1,667,202
Marketing, sales force and other selling expenses	8,388,848	7,568,365	3,164,875
Depreciation and amortization	1,405,423	1,301,657	766,454
Impairment	3,017	155,462
Administrative, R&D, IT and project expenses [member]
Classified by nature
Innovation expenses	223,472	270,256	89,675
Employee benefits expense (note 29)	2,886,281	2,498,024	1,223,586
Other administrative expenses	2,717,489	1,985,872	798,796
Depreciation and amortization	R$ 1131624	R$ 1201844	R$ 293519

EMPLOYEE BENEFITS - Summary of

EMPLOYEE BENEFITS - Summary of Employee Benefit Expense (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disclosure of defined benefit plans [line items]
Payroll, profit sharing and bonuses		R$ 5911837	R$ 5407990	R$ 2315517
Pension Plan		243,511	186,373	93,528
Share-based payments and social charges	[1]	228,131	231,962	118,608
Health care, food and other benefits		712,983	684,992	253,510
Charges, taxes and social contributions		701,521	635,248	231,384
INSS		204,625	188,131	171,615
Total		R$ 8002608	R$ 7334696	R$ 3184162
[1]	The variation in the subsidiary over 2021 is basically due to transfer of employees from Natura Cosmeticos S.A. to Natura &Co Holding, as well as the increase for the 2021 grant, net of social charges associated with the variation in the value of the Company's share.

EMPLOYEE BENEFITS - Summary o_2

EMPLOYEE BENEFITS - Summary of Number and Weighted Average Number of Shares (Detail) shares in Thousands	12 Months Ended
	Dec. 31, 2021sharesR$ / shares
Stock Option [Member]
Disclosure Of Number And Weighted Average Exercise Prices Of Share Optionsline item [Line Items]
Average exercise price per option, Balance | R$ / shares	R$ 16.43
Average exercise price per option, Granted | R$ / shares	30.87
Average exercise price per option, Expired / Cancelled | R$ / shares	20.76
Average exercise price per option, Exercised | R$ / shares	18.8
Average exercise price per option, Balance | R$ / shares	R$ 21.05
Options, Balance	15,523
Options, Granted	6,650
Options, Expired / Cancelled	(183)
Options, Exercised	(5,928)
Options, Balance	20,137
Shares, Exercised	(1,853)
Restricted Stock [Member]
Disclosure Of Number And Weighted Average Exercise Prices Of Share Optionsline item [Line Items]
Shares, Balance	4,361
Shares, Granted	3,435
Shares, Expired/Canceled	(590)
Shares, Exercised	(1,712)
Shares, Balance	5,494
Performance Shares [Member]
Disclosure Of Number And Weighted Average Exercise Prices Of Share Optionsline item [Line Items]
Shares, Balance	5,579
Shares, Granted	3,402
Shares, Expired/Canceled	(936)
Shares, Exercised
Shares, Balance	8,045

EMPLOYEE BENEFITS - Summary o_3

EMPLOYEE BENEFITS - Summary of Terms and Conditions of Share-based Payment Arrangement (Detail) shares in Thousands	12 Months Ended
	Dec. 31, 2021sharesR$ / shares	Dec. 31, 2020shares
Stock Option [Member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Existing options | shares	20,137	15,523
Vested options | shares	5,928
Stock Option [Member] | March 17, 2014
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	March 17, 2014
Right acquisition conditions	2</span> to <span style="border-left: none; border-right: none;">4</span> years of service" id="sjs-B10">From &lt;span style="border-left: none; border-right: none;">2&lt;/span> to &lt;span style="border-left: none; border-right: none;">4&lt;/span> years of service
Exercise price	R$ 28.94
Fair value	R$ 4.27
Existing options | shares	82
Remaining contractual life	2 months 12 days
Vested options | shares	82
Stock Option [Member] | March 16, 2015
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	March 16, 2015
Right acquisition conditions	2</span> to <span style="border-left: none; border-right: none;">4</span> years of service" id="sjs-B19">From &lt;span style="border-left: none; border-right: none;">2&lt;/span> to &lt;span style="border-left: none; border-right: none;">4&lt;/span> years of service
Exercise price	R$ 13.47
Existing options | shares	104
Remaining contractual life	1 year 2 months 12 days
Vested options | shares	104
Stock Option [Member] | July 28, 2015 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	July 28, 2015 (Acceleration Strategy)
Right acquisition conditions	4</span> to <span style="border-left: none; border-right: none;">5</span> years of service" id="sjs-B27">From &lt;span style="border-left: none; border-right: none;">4&lt;/span> to &lt;span style="border-left: none; border-right: none;">5&lt;/span> years of service
Exercise price	R$ 12.77
Existing options | shares	495
Remaining contractual life	1 year 7 months 6 days
Vested options | shares	495
Stock Option [Member] | March 15, 2016
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	March 15, 2016
Right acquisition conditions	2</span> to <span style="border-left: none; border-right: none;">4</span> years of service" id="sjs-B35">From &lt;span style="border-left: none; border-right: none;">2&lt;/span> to &lt;span style="border-left: none; border-right: none;">4&lt;/span> years of service
Exercise price	R$ 12.71
Existing options | shares	93
Remaining contractual life	2 years 2 months 12 days
Vested options | shares	93
Stock Option [Member] | July 11, 2016 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	July 11, 2016 (Acceleration Strategy)
Right acquisition conditions	4</span> to <span style="border-left: none; border-right: none;">5</span> years of service" id="sjs-B43">From &lt;span style="border-left: none; border-right: none;">4&lt;/span> to &lt;span style="border-left: none; border-right: none;">5&lt;/span> years of service
Exercise price	R$ 11.28
Existing options | shares	1,650
Remaining contractual life	2 years 6 months
Vested options | shares	1,650
Stock Option [Member] | March 10, 2017
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	March 10, 2017
Right acquisition conditions	2</span> to <span style="border-left: none; border-right: none;">4</span> years of service" id="sjs-B51">From &lt;span style="border-left: none; border-right: none;">2&lt;/span> to &lt;span style="border-left: none; border-right: none;">4&lt;/span> years of service
Exercise price	R$ 12.46
Existing options | shares	378
Remaining contractual life	3 years 2 months 12 days
Vested options | shares	378
Stock Option [Member] | March 10, 2017 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	March 10, 2017 (Acceleration Strategy)
Right acquisition conditions	4</span> to <span style="border-left: none; border-right: none;">5</span> years of service" id="sjs-B59">From &lt;span style="border-left: none; border-right: none;">4&lt;/span> to &lt;span style="border-left: none; border-right: none;">5&lt;/span> years of service
Exercise price	R$ 12.46
Existing options | shares	2,000
Remaining contractual life	3 years 2 months 12 days
Vested options | shares	895
Stock Option [Member] | March 12, 2018
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	March 12, 2018
Right acquisition conditions	2</span> to <span style="border-left: none; border-right: none;">4</span> years of service" id="sjs-B67">From &lt;span style="border-left: none; border-right: none;">2&lt;/span> to &lt;span style="border-left: none; border-right: none;">4&lt;/span> years of service
Exercise price	R$ 16.83
Existing options | shares	1,554
Remaining contractual life	4 years 2 months 12 days
Vested options | shares	890
Stock Option [Member] | March 12, 2018 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	March 12, 2018 Acceleration strategy)
Right acquisition conditions	3</span> to <span style="border-left: none; border-right: none;">5</span> years of service" id="sjs-B75">From &lt;span style="border-left: none; border-right: none;">3&lt;/span> to &lt;span style="border-left: none; border-right: none;">5&lt;/span> years of service
Existing options | shares	3,800
Remaining contractual life	4 years 2 months 12 days
Vested options | shares	950
Stock Option [Member] | April 12, 2019
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	April 12, 2019
Right acquisition conditions	2</span> to <span style="border-left: none; border-right: none;">4</span> years of service" id="sjs-B82">From &lt;span style="border-left: none; border-right: none;">2&lt;/span> to &lt;span style="border-left: none; border-right: none;">4&lt;/span> years of service
Exercise price	R$ 23.41
Existing options | shares	1,431
Remaining contractual life	5 years 2 months 12 days
Vested options | shares	391
Stock Option [Member] | April 12, 2019 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	April 12, 2019 Acceleration strategy)
Right acquisition conditions	4</span> to <span style="border-left: none; border-right: none;">5</span> years of service" id="sjs-B90">From &lt;span style="border-left: none; border-right: none;">4&lt;/span> to &lt;span style="border-left: none; border-right: none;">5&lt;/span> years of service
Exercise price	R$ 23.41
Existing options | shares	1,900
Remaining contractual life	5 years 2 months 12 days
Vested options | shares
Stock Option [Member] | March 31, 2021
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	March 31, 2021
Right acquisition conditions	4</span> to <span style="border-left: none; border-right: none;">5</span> years of service" id="sjs-B98">From &lt;span style="border-left: none; border-right: none;">4&lt;/span> to &lt;span style="border-left: none; border-right: none;">5&lt;/span> years of service
Exercise price	R$ 48.98
Existing options | shares	1,100
Remaining contractual life	9 years 3 months 18 days
Vested options | shares
Stock Option [Member] | December 17, 2021
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	December 17, 2021
Right acquisition conditions	3</span> to <span style="border-left: none; border-right: none;">4</span> years of service" id="sjs-B106">From &lt;span style="border-left: none; border-right: none;">3&lt;/span> to &lt;span style="border-left: none; border-right: none;">4&lt;/span> years of service
Exercise price	R$ 27.28
Existing options | shares	5,550
Remaining contractual life	10 years
Vested options | shares
Stock Option [Member] | Bottom of range [member] | March 16, 2015
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	R$ 4.85
Stock Option [Member] | Bottom of range [member] | July 28, 2015 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	6.2
Stock Option [Member] | Bottom of range [member] | March 15, 2016
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	7.16
Stock Option [Member] | Bottom of range [member] | July 11, 2016 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	6.84
Stock Option [Member] | Bottom of range [member] | March 10, 2017
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	6.65
Stock Option [Member] | Bottom of range [member] | March 10, 2017 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	6.87
Stock Option [Member] | Bottom of range [member] | March 12, 2018
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	7.96
Stock Option [Member] | Bottom of range [member] | March 12, 2018 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Exercise price	12.04
Fair value	8.21
Stock Option [Member] | Bottom of range [member] | April 12, 2019
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	11.71
Stock Option [Member] | Bottom of range [member] | April 12, 2019 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	11.51
Stock Option [Member] | Bottom of range [member] | March 31, 2021
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	29.08
Stock Option [Member] | Bottom of range [member] | December 17, 2021
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	17.58
Stock Option [Member] | Top of range [member] | March 16, 2015
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	5.29
Stock Option [Member] | Top of range [member] | July 28, 2015 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	6.23
Stock Option [Member] | Top of range [member] | March 15, 2016
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	7.43
Stock Option [Member] | Top of range [member] | July 11, 2016 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	6.89
Stock Option [Member] | Top of range [member] | March 10, 2017
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	6.68
Stock Option [Member] | Top of range [member] | March 10, 2017 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	6.89
Stock Option [Member] | Top of range [member] | March 12, 2018
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	8.21
Stock Option [Member] | Top of range [member] | March 12, 2018 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Exercise price	16.83
Fair value	9.67
Stock Option [Member] | Top of range [member] | April 12, 2019
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	11.82
Stock Option [Member] | Top of range [member] | April 12, 2019 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	11.71
Stock Option [Member] | Top of range [member] | March 31, 2021
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	29.81
Stock Option [Member] | Top of range [member] | December 17, 2021
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	R$ 18.16
Restricted Stock [Member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Existing stock | shares	5,494
Vested stock | shares	5,494	4,361
Restricted Stock [Member] | March 31, 2021
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	March 31, 2021
Right acquisition conditions	1</span> to <span style="border-left: none; border-right: none;">3</span> years of service" id="sjs-B192">From &lt;span style="border-left: none; border-right: none;">1&lt;/span> to &lt;span style="border-left: none; border-right: none;">3&lt;/span> years of service
Fair value	R$ 48.13
Remaining contractual life	2 years 3 months 18 days
Existing stock | shares	3,209
Restricted Stock [Member] | August 13, 2018 – Extraordinary Plan VI
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	March 12, 2018 - Plan I, August 13, 2018 - Extraordinary Plan VI
Right acquisition conditions	2</span> to <span style="border-left: none; border-right: none;">4</span> years of service" id="sjs-B199">From &lt;span style="border-left: none; border-right: none;">2&lt;/span> to &lt;span style="border-left: none; border-right: none;">4&lt;/span> years of service
Remaining contractual life	2 months 12 days
Existing stock | shares	248
Restricted Stock [Member] | April 12, 2019 – Plan I
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	April 12, 2019 – Plan I
Right acquisition conditions	2</span> to <span style="border-left: none; border-right: none;">4</span> years of service" id="sjs-B205">From &lt;span style="border-left: none; border-right: none;">2&lt;/span> to &lt;span style="border-left: none; border-right: none;">4&lt;/span> years of service
Remaining contractual life	1 year 2 months 12 days
Existing stock | shares	569
Restricted Stock [Member] | April 12, 2019 – Plan II
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	April 12, 2019 – Plan II
Right acquisition conditions	1</span> to <span style="border-left: none; border-right: none;">3</span> years of service" id="sjs-B211">From &lt;span style="border-left: none; border-right: none;">1&lt;/span> to &lt;span style="border-left: none; border-right: none;">3&lt;/span> years of service
Remaining contractual life	2 months 12 days
Existing stock | shares	156
Restricted Stock [Member] | March 27, 2020 - Co-Investment Plan
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	March 27, 2020 – Co-Investment Plan
Right acquisition conditions	1</span> to <span style="border-left: none; border-right: none;">3</span> years of service" id="sjs-B217">From &lt;span style="border-left: none; border-right: none;">1&lt;/span> to &lt;span style="border-left: none; border-right: none;">3&lt;/span> years of service
Fair value	R$ 29
Remaining contractual life	1 year 3 months 18 days
Existing stock | shares	1,312
Restricted Stock [Member] | Bottom of range [member] | August 13, 2018 – Extraordinary Plan VI
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	R$ 12.25
Restricted Stock [Member] | Bottom of range [member] | April 12, 2019 – Plan I
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	21.62
Restricted Stock [Member] | Bottom of range [member] | April 12, 2019 – Plan II
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	22.14
Restricted Stock [Member] | Top of range [member] | August 13, 2018 – Extraordinary Plan VI
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	15.9
Restricted Stock [Member] | Top of range [member] | April 12, 2019 – Plan I
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	22.53
Restricted Stock [Member] | Top of range [member] | April 12, 2019 – Plan II
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	R$ 22.85
Performance Shares [Member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Existing stock | shares	8,045
Vested stock | shares	8,045	5,579
Performance Shares [Member] | March 31, 2021
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	March 31, 2021
Right acquisition conditions	Achievement of performance conditions, 3 years of service plus an additional holding period of 1 year for certain awards.
Existing stock | shares	3,203
Vested stock | shares	3,203
Performance Shares [Member] | May 21, 2019
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	May 21, 2019
Right acquisition conditions	Achievement of performance conditions, 3 years of service plus an additional holding period of 1 year for certain awards.
Existing stock | shares	539
Vested stock | shares	539
Performance Shares [Member] | September 30, 2020
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	September 30, 2020
Right acquisition conditions	Achievement of performance conditions, 2.5 years of service plus an additional holding period of 1 year for certain awards.
Existing stock | shares	4,303
Vested stock | shares	4,303
Performance Shares [Member] | Bottom of range [member] | March 31, 2021
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	R$ 46.57
Remaining contractual life	2 years 3 months 18 days
Performance Shares [Member] | Bottom of range [member] | May 21, 2019
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	R$ 28.1
Remaining contractual life	6 months
Performance Shares [Member] | Bottom of range [member] | September 30, 2020
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	R$ 48.56
Remaining contractual life	1 year 3 months 18 days
Performance Shares [Member] | Top of range [member] | March 31, 2021
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	R$ 50.98
Remaining contractual life	3 years 3 months 18 days
Performance Shares [Member] | Top of range [member] | May 21, 2019
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	R$ 45.7
Remaining contractual life	1 year 6 months
Performance Shares [Member] | Top of range [member] | September 30, 2020
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	R$ 73.46
Remaining contractual life	2 years 3 months 18 days

EMPLOYEE BENEFITS - Additional

EMPLOYEE BENEFITS - Additional Information (Detail) R$ / shares in Units, R$ in Thousands	12 Months Ended
	Dec. 31, 2021BRL (R$)InstallmentR$ / shares	Dec. 31, 2020BRL (R$)R$ / shares
Disclosure of terms and conditions of share-based payment arrangement [line items]
Share based compensation expense | R$	R$ 228133	R$ 231939
Share Price | R$ / shares	R$ 25.43	R$ 52.5
Matching Awards [member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Stock split, conversion ratio	1
Number of instalments | Installment	3
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Period	3 years

EMPLOYEE BENEFITS - Avon Produc

EMPLOYEE BENEFITS - Avon Products Inc. plans - Additional Information (Detail) R$ in Thousands	Jan. 03, 2020	Dec. 31, 2021BRL (R$)Plans	Dec. 31, 2020BRL (R$)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Number of share-based incentive plans | Plans		2
Exchange ratio per each common share of acquiree	0.6
UNITED KINGDOM
Disclosure of terms and conditions of share-based payment arrangement [line items]
Matching contributions made by entity		R$ 45155	R$ 39200
Personal Savings Account Plan (PSA)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Matching contributions made by entity		R$ 5188	R$ 5200
Maximum Percentage of Eligible Compensation by Eligible Participants		25.00%
Retirement Savings Account ("RSA")
Disclosure of terms and conditions of share-based payment arrangement [line items]
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Period		3 years
Stock Option [Member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Period		3 years
Restricted Stock Unit RSU [Member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Percentage of premium price which was equal to exercise price		25.00%
Exchange ratio per each common share of acquiree		0.3
Performance Restricted Stock Units (PRSU)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Period		3 years
Share-based Compensation Arrangement by Share-based Payment Award, Performance Period		3 years
Avon Products, Inc
Disclosure of terms and conditions of share-based payment arrangement [line items]
Threshold period of contribution to meet indefinite beneficiary criteria in medical plan		10 years
Period of benefit for each year of fixed contribution in medical plan		1 year
Avon Products, Inc | Top of range [member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Period of contribution to meet definite beneficiary criteria in medical plan		10 years
Avon Products, Inc | Personal Savings Account Plan (PSA) | UNITED STATES
Disclosure of terms and conditions of share-based payment arrangement [line items]
Employer Matching Contribution, Percentage of Match		100.00%
Avon Products, Inc | Personal Savings Account Plan (PSA) | UNITED STATES | Bottom of range [member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Percentage of eligible compensation for each dollar contributed for fifty cents		4.00%
Avon Products, Inc | Personal Savings Account Plan (PSA) | UNITED STATES | Top of range [member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Percentage of eligible compensation for each dollar contributed for dollar		3.00%
Percentage of eligible compensation for each dollar contributed for fifty cents		6.00%
Avon Products, Inc | Retirement Savings Account ("RSA") | UNITED STATES | Bottom of range [member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Percentage of eligible compensation for each dollar contributed for fifty cents		3.00%
Avon Products, Inc | Retirement Savings Account ("RSA") | UNITED STATES | Top of range [member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Percentage of eligible compensation for each dollar contributed for fifty cents		6.00%
Avon Products, Inc | Performance Restricted Stock Units (PRSU)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Exchange ratio per each common share of acquiree		0.3
Avon Products, Inc | Performance Restricted Stock Units (PRSU) | Bottom of range [member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Percentage of eligible compensation for employer contributions		5.00%
Avon Products, Inc | Performance Restricted Stock Units (PRSU) | Top of range [member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Percentage of eligible compensation for employer contributions		10.00%

FINANCE INCOME (EXPENSES)_ - Su

FINANCE INCOME (EXPENSES) - Summary of Detailed Information About Financial Income Expense (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
FINANCIAL INCOME:
Interest on short-term investments		R$ 264764	R$ 167967	R$ 83115
Gains on monetary and exchange rate variations		1,785,259	1,752,503	854,025
Gains on swap and forward transactions		1,814,450	2,532,487	961,185
Gains on swap and forward derivatives mark to market		20,929	12,314	1,709
Inflation adjustment reversal on provision for tax risks and tax liabilities			42,378	25,469
Hyperinflationary economy adjustment (Argentina)		82,202	39,292
Debt structuring revenue for acquisition of Avon			95,145
Other financial income		38,959	96,305	30,281
Total finance income		4,006,563	4,738,391	1,955,784
FINANCIAL EXPENSES:
Interest on financing	[1]	(634,201)	(709,323)	(503,040)
Interest on leases		(210,669)	(229,544)	(134,579)
Losses from monetary and exchange rate variations		(2,075,306)	(2,671,372)	(937,925)
Losses on swap and forward transactions		(1,533,611)	(1,579,695)	(964,116)
Losses on swap and forward derivatives mark to market		(26,214)	(13,691)	(1,452)
Adjustment of provision for tax, civil and labor risks and tax liabilities		(25,731)	(47,928)	(13,822)
Appropriation of funding costs (debentures and notes)		(27,228)	(11,082)	(22,671)
Interest on pension plan		(11,339)	(10,323)
Hyperinflationary economy adjustment (Argentina)		(108,730)	(20,625)	(13,947)
Debt structuring expenses for Avon acquisition			(110,741)	(115,781)
Other finance cost		(380,511)	(369,486)	(88,541)
Total finance expenses		(5,033,540)	(5,773,810)	(2,795,874)
Net financial income (expenses), net		(1,026,977)	(1,035,419)	R$ 840090
Reclassification Of Finance Income Group		202,005	39,292
Reclassification Of Finance Expenses Group		R$ 490450	R$ 395540
[1]	Of the balances originally presented on December 31, 2020, R$395,540 of the finance expenses group and R$39,292 of the finance income were reclassified between lines for better presentation. Note that this reclassification does not impact the subtotal amount originally presented as finance income (expenses).

FINANCE INCOME (EXPENSES)_ - _2

FINANCE INCOME (EXPENSES) - Summary of Foreign Exchange Hedging Transactions and the Related Balancing Items in the Income Statement (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Finance Income Cost [line items]
Gains on monetary and exchange rate variations		R$ 1785259	R$ 1752503	R$ 854025
Losses from monetary and exchange rate variations		(2,075,306)	(2,671,372)	(937,925)
Gains on swap and forward transactions		1,814,450	2,532,487	961,185
Revenue from swap exchange coupons	[1]	713,401	409,788	182,897
Gains from exchange variations on swap instruments	[1]	1,101,049	2,122,699	778,288
Losses on swap and forward transactions		(1,533,611)	(1,579,695)	(964,116)
Losses from exchange rate variation on swap instruments	[1]	(843,085)	(1,182,391)	(690,409)
Financial costs of swap instruments	[1]	(690,526)	(379,440)	(273,707)
Losses with exchange rate variations of forward instruments			(17,864)
Reclassification Of Finance Expenses Group		490,450	395,540
Reclassification Of Finance Income Group		202,005	39,292
Variation on borrowings, financing and debentures [member]
Finance Income Cost [line items]
Gains on monetary and exchange rate variations		869,115	714,681	677,462
Losses from monetary and exchange rate variations	[2]	(1,121,305)	(1,665,050)	(768,939)
Variation on imports [member]
Finance Income Cost [line items]
Gains on monetary and exchange rate variations		38,800	35,218	11,221
Losses from monetary and exchange rate variations		(52,082)	(58,623)	(33,718)
Variation on export receivables [member]
Finance Income Cost [line items]
Gains on monetary and exchange rate variations		105,654	69,365	26,144
Losses from monetary and exchange rate variations		(123,607)	(55,829)	(23,393)
Variation on trade payable from foreign subsidiaries [member]
Finance Income Cost [line items]
Gains on monetary and exchange rate variations		364,101	450,468	132,397
Losses from monetary and exchange rate variations		(311,923)	(365,214)	(86,764)
Variation on financing [member]
Finance Income Cost [line items]
Losses from monetary and exchange rate variations		(466,389)	(525,173)	(297)
Variations of bank accounts in foreign currency [member]
Finance Income Cost [line items]
Gains on monetary and exchange rate variations		407,589	482,771	6,801
Losses from monetary and exchange rate variations			R$ 1483	R$ 24814
[1]	The original amounts presented in these lines as of December 31, 2021 were reclassified to give a better disclosure in the respective gains (R$ 202,005 ) and losses (R$ 490,450 ) on swap and forward transactions groups. This reclassification does not impact the subtotal amounts of the respective groups or any line presented in the finance income (expenses) tables originally presented and included in the previous table.
[2]	See comment on finance expense reclassification in the previous table.

OTHER OPERATING INCOME (EXPEN_3

OTHER OPERATING INCOME (EXPENSES), NET (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Others operating income, net
Result on write-off of property, plant and equipment			R$ 11855	R$ 6098
ICMS-ST	[1]		18,653	42,336
Tax Credits		11,391	105,234	21,402
PIS/COFINS credits	[2]	203,694		95,614
Tax benefit for joining the amnesty program	[3]	82,140
Incentive income		13,280
Proceeds from the sale of the customer portfolio		16,113
Tax contingencies		3,949
Other operating income		12,985	10,757
Total Other operating income		343,552	146,499	188,542
Other operating expenses, net
Result on write-off of property, plant and equipment		(3,610)
Crer para Ver	[4]	(47,523)	(54,500)	(36,156)
Expense on the sale of customer portfolio			(7,498)
Expenses related Avon acquisition			(303,916)	(141,348)
Transformation and integration plan	[5]	(511,048)	(256,700)	(51,520)
Tax contingencies			(10,100)
Other operating expenses		(20,390)	(29,975)	(8,829)
Total other operating expenses		(582,571)	(662,689)	(237,853)
Other operating income (expenses), net		R$ 239019	R$ 516190	R$ 49311
[1]	R efers to the requirement of ICMS tax substitution, for different Federal States of Brazil (details in note ). During , provision reversals were made due to the change in the loss estimate for some Federal States.
[2]	R efers to tax credits from PIS and COFINS related to non-inclusion of ICMS in the basis (R$ ) and credits arising out of investment grant (R$ ), and other tax credits (R$ ).
[3]	Refers to tax benefits in Brazil arising out of adhesion to state tax amnesty programs by the subsidiary Avon Cosméticos Ltda.
[4]	Allocation to Instituto Natura of operating profit from sales of the non-cosmetic product line “Crer Para Ver”, specifically allocated to social projects aimed at the development of education quality.
[5]	Expenses related to the implementation of the subsidiary Avon integration and transformation plan, which is based on five pillars, namely: (1) renewal of the brand; (2) optimization of retail operations; (3) improvement of omni-channel; (4) improvement of operating efficiency; and (5) organization redesign.

OTHER OPERATING INCOME (EXPEN_4

OTHER OPERATING INCOME (EXPENSES), NET - Additional Information (Detail) R$ in Thousands	12 Months Ended
	Dec. 31, 2021BRL (R$)
Text Block [Abstract]
Exclusion of ICMS from PIS/COFINS base	R$ 104650
Tax credits from investment grant	96,767
Other tax credits	R$ 2277

EARNINGS PER SHARE - Summary of

EARNINGS PER SHARE - Summary of Basic Earnings Per Share (Detail) - BRL (R$) R$ / shares in Units, R$ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Earnings per share [abstract]
Income (loss) attributable to the Company’s controlling shareholders	R$ 1047960	R$ 650196	R$ 155467
Weighted average of the number of outstanding common shares	1,377,932,809	1,246,180,219	865,660,042
Weighted average number of treasury shares	(788,866)	(572,130)
Weighted average number of outstanding common shares	1,377,143,943	1,245,608,090	865,660,042
Basic earnings (loss) per share - R$	R$ 0.761	R$ 0.522	R$ 0.1796

EARNINGS PER SHARE - Summary _2

EARNINGS PER SHARE - Summary of Diluted Earnings Per Share (Detail) - BRL (R$) R$ / shares in Units, R$ in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Earnings per share [abstract]
Gain attributable to the Company’s controlling shareholders		R$ 1047960	R$ 650196	R$ 155467
Weighted average of the number of outstanding common shares		1,377,143,943	1,245,608,090	865,660,042
Adjustment for stock options and restricted shares	[1]		8,124,575
Weighted average number of treasury shares		19,531,951
Weighted average number of outstanding common shares		1,396,675,894		873,784,617
Diluted earnings per share - R$		R$ 0.7503		R$ 0.1779
[1]	The number of shares and earnings per share already consider the stock split on September 17, 2019 and their retrospective effects.

EARNINGS PER SHARE - Summary _3

EARNINGS PER SHARE - Summary of basic earnings per share for net loss of discontinued operations (Detail) - BRL (R$) R$ / shares in Units, R$ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Earnings per share [abstract]
Net loss attributable to the Company’s controlling shareholders	R$ 98550	R$ 143112
Weighted average of the number of outstanding common shares	1,377,932,809	1,246,180,219	865,660,042
Adjustment for stock options and restricted shares	R$ 788866	R$ 572130
Weighted average number of ordinary shares for diluted earnings calculation	1,377,066,457	1,245,608,090
Basic loss per share - R$	R$ 0.0716	R$ 0.1149

TRANSACTIONS WITH RELATED PAR_3

TRANSACTIONS WITH RELATED PARTIES - Additional Information (Detail) - BRL (R$) R$ in Thousands	May 12, 2021	Dec. 31, 2021	Dec. 31, 2020
Disclosure of subsidiaries [line items]
Rent Paid		R$ 14094	R$ 13086
Amortisation of intangible assets		1,995	15,055
Confidentiality and NonCompete Agreement [Member]
Disclosure of subsidiaries [line items]
Amortisation of intangible assets			1,201
Buildings [member]
Disclosure of subsidiaries [line items]
Purchases of property and other assets related party transaction		60,998	39,346
Fundo de Investimento Essencial [Member]
Disclosure of subsidiaries [line items]
Investments		3,835	3,414
Natura Cosmticos SA [Member]
Disclosure of subsidiaries [line items]
Reimbursement of transaction cost of acquisition			148,274
Purchases of property and other assets related party transaction	R$ 5840
Rent Paid			1,488
Donations associated with maintenance			R$ 692
Percentage of corresponding net income			0.50%
Donations associated with sale		R$ 35000	R$ 35000

TRANSACTIONS WITH RELATED PAR_4

TRANSACTIONS WITH RELATED PARTIES - Summary of Total Compensation of the Company's Management (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Key Management Personnel Compensation [Line Items]
Fixed	R$ 66619	R$ 65310	R$ 55019
Variable	143,349	145,229	73,061
Total	209,968	210,539	128,080
Board of Directors [Member]
Key Management Personnel Compensation [Line Items]
Fixed	15,043	16,123	22,056
Variable	72,187	65,011	30,919
Total	87,230	81,134	52,975
Executive Board [Member]
Key Management Personnel Compensation [Line Items]
Fixed	51,576	49,187	32,963
Variable	71,162	80,218	42,142
Total	R$ 122738	R$ 129405	R$ 75105

TRANSACTIONS WITH RELATED PAR_5

TRANSACTIONS WITH RELATED PARTIES - Summary of the Company Officers and Executives' compensation (Detail) - Officers [member]		12 Months Ended
		Dec. 31, 2021sharesR$ / shares	Dec. 31, 2020sharesR$ / shares	Dec. 31, 2019sharesR$ / shares
Officers and executives compensation [Line Items]
Option balance (number) | shares	[1]	11,750,270	12,847,760	13,059,677
Average fair value of options		R$ 12.47	R$ 8.64	R$ 8.4
Average exercise price	[2]	R$ 21.21	R$ 16.49	R$ 16.51
Restricted Shares [Member]
Officers and executives compensation [Line Items]
Share balance (number) | shares	[1],[3]	4,472,638	5,293,874	1,012,641
Average fair value	[3]	R$ 45.34	R$ 51.2	R$ 19.23
[1]	The number of awards includes the awards non-vested and vested but not exercised.
[2]	The number of options, their average fair value and average exercise price are shown after taking into account the stock split approved at the Extraordinary Shareholders’ Meeting held on September 17, 2019.
[3]	The number of restricted and performance shares and their average fair value are shown after taking into account the stock split approved at the Extraordinary Shareholders’ Meeting held on September 17, 2019.

COMMITMENTS - Additional Inform

COMMITMENTS - Additional Information (Detail) R$ in Thousands	Dec. 31, 2021BRL (R$)
Contractual Commitments Disclosure [Abstract]
Investment commitments	R$ 60000

COMMITMENTS - Summary of Contra

COMMITMENTS - Summary of Contractual Commitments (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Contractual commitments disclosure [line items]
Total	R$ 1400107	R$ 2299894
Less than one year [member]
Contractual commitments disclosure [line items]
Total	929,288	1,413,904
One to five years [member]
Contractual commitments disclosure [line items]
Total	460,081	885,990
Over five years [member]
Contractual commitments disclosure [line items]
Total	R$ 10738

INSURANCE - Summary of Types of

INSURANCE - Summary of Types of Insurance Coverage (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Industrial complex and administrative sites [member]
Disclosure of types of insurance contracts [line items]
Type of coverage	Any damages to buildings, facilities, inventories, and machinery and equipment
Amount insured	R$ 6008031	R$ 5658558
Vehicles [member]
Disclosure of types of insurance contracts [line items]
Type of coverage	Fire, theft and collision for the vehicles insured by the Company
Amount insured	R$ 261953	258,416
Loss of profits [member]
Disclosure of types of insurance contracts [line items]
Type of coverage	No loss of profits due to material damages to facilities buildings and production machinery and equipment
Amount insured	R$ 1962509	1,894,813
Transport [member]
Disclosure of types of insurance contracts [line items]
Type of coverage	Damages to products in transit
Amount insured	R$ 103857	97,934
Civil liability [member]
Disclosure of types of insurance contracts [line items]
Type of coverage	Protection against error or complaints in the exercise of professional activity that affect third parties
Amount insured	R$ 2445664	2,326,621
Environmental liability [member]
Disclosure of types of insurance contracts [line items]
Type of coverage	Protection against environmental accidents that may result in environmental lawsuits
Amount insured	R$ 30000	R$ 30000

ADDITIONAL INFORMATION RELATI_3

ADDITIONAL INFORMATION RELATING TO THE STATEMENTS OF CASH FLOWS - Summary of additional information on transactions related to the cash flow statement (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Non-cash items
Hedge accounting, net of tax effects	R$ 137211	R$ 116348	R$ 70569
Dividends declared and not yet paid	180,772		110,671
Stock and restricted shares option plans	138,122	102,508
Net effect of acquisition of property, plant and equipment and intangible assets not yet paid	81,257	172,104	(18,645)
Consideration for acquisition of subsidiary		R$ 13366114

Subsequent Events - Additional

Subsequent Events - Additional Information (Detail) $ in Millions	Oct. 28, 2021USD ($)	Feb. 28, 2022	Mar. 11, 2022BRL (R$)	Mar. 11, 2022USD ($)	Dec. 31, 2021BRL (R$)
Abnormally large changes in operations [member] | Russia and Ukraine
Subsequent Event
Number of markets which contributes revenue		2
Abnormally large changes in operations [member] | Russia and Ukraine | Top of range [member]
Subsequent Event
Group’s consolidated net revenues		5.00%
Major Borrowings [Member] | Revolving credit facility | Natura and Co Luxembourg Holdings Sarl [member]
Subsequent Event
Line of Credit Facility, Maximum Borrowing Capacity | $	$ 625
Period of borrowing term	36 months
Principal amount of borrowings obtained			R$ 1116200000	$ 200
Major Borrowings [Member] | Revolving credit facility | Natura and Co Luxembourg Holdings Sarl [member] | Brazilian real per US dollar
Subsequent Event
Exchange rate | R$					5.581